TUCSON, ARIZONA

Transcription

TUCSON, ARIZONA

STSA
SOU T HERN T HOR AC IC SURGIC A L A SSO C I AT ION
61 S T A N N UA L M E E T I N G
TUCSON, ARIZONA
JW MARRIOT T STARR PASS RESORT & SPA
NOV EMBER 5 – 8, 2014
SPECIAL THANKS
SPECIAL THANKS TO STSA
61ST ANNUAL MEETING CORPORATE SUPPORTERS
GOLD
Ethicon Endo-Surgery, Inc.
Medtronic, Inc.
St. Jude Medical, Inc.
SILVER
Edwards Lifesciences
Terumo Cardiovascular Systems
Thoratec Corporation
STSA 61st Annual Meeting 1
FUTURE MEETINGS
November 4-7, 2015
Disney’s Yacht & Beach Club Resort
Orlando, FL
November 9-12, 2016
Waldorf Astoria Naples
Naples, FL
November 8-11, 2017
JW Marriott San Antonio Hill Country Resort & Spa
San Antonio, TX
2 STSA 61st Annual Meeting
TABLE OF CONTENTS
Officers and Council . . . . . . . . . . . . . . . . . . . . . . . . . . 4
Committee Members . . . . . . . . . . . . . . . . . . . . . . . . . 5
Program at-a-Glance . . . . . . . . . . . . . . . . . . . . . . . . 6-7
Schedule of Activities . . . . . . . . . . . . . . . . . . . . . . . . 8-9
Continuing Medical Education Overview . . . . . . . . . . . .10-13
Education Disclosure Policy . . . . . . . . . . . . . . . . . . . 12-13
Schedule of Events . . . . . . . . . . . . . . . . . . . . . . . . 14-40
Surgical Motion Pictures . . . . . . . . . . . . . . . . . . . . . . 15
Postgraduate Program . . . . . . . . . . . . . . . . . . . . . . 16-19
Ethics Debate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Scientific Sessions . . . . . . . . . . . . . . . . . . . . . . . . 20-40
Basic Science Forum . . . . . . . . . . . . . . . . . . . . . . . .
23
Coding Update . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
History Presentation . . . . . . . . . . . . . . . . . . . . . . . . . 38
Scientific Papers . . . . . . . . . . . . . . . . . . . . . . . .
42-217
Past Meetings of the STSA . . . . . . . . . . . . . . . . . . . . .219
Clifford Van Meter President’s Award . . . . . . . . . . . . . . 220
Carolyn Reed President’s Award . . . . . . . . . . . . . . . . . 221
Congenital Heart Surgery President’s Award . . . . . . . . . . 221
Tiki Award . . . . . . . . . . . . . . . . . . . . . . . . . . .
221-222
Osler Abbott Award . . . . . . . . . . . . . . . . . . . . . . 222-223
Kent Trinkle Education Lectureship . . . . . . . . . . . . . . . . 224
Harold Urschel History Lectureship . . . . . . . . . . . . . . . .224
Hawley H. Seiler Residents Award . . . . . . . . . . . . . . 224-225
Mavroudis-Urschel Award . . . . . . . . . . . . . . . . . . . . .225
STSA Inspiration Award . . . . . . . . . . . . . . . . . . . . . . 226
Brooks Medical Student Scholarship . . . . . . . . . . . . 226-227
Exhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . 229-233
Necrology Report . . . . . . . . . . . . . . . . . . . . . . . . . 235
Honorary Members . . . . . . . . . . . . . . . . . . . . . . . . 236
Membership Roster . . . . . . . . . . . . . . . . . . . . . . 235-329
Geographic Listing of Members . . . . . . . . . . . . . . . 330-347
Constitution and Bylaws . . . . . . . . . . . . . . . . . . . 349-359
Relationship Disclosure Index . . . . . . . . . . . . . . . . 361-369
Program Participants . . . . . . . . . . . . . . . . . . . . . 371-376
SOUTHERN THORACIC SURGICAL ASSOCIATION
2014 OFFICERS AND COUNCIL
PRESIDENT
Richard L. Prager
Ann Arbor, MI
PRESIDENT-ELECT
John H. Calhoon
San Antonio, TX
VICE PRESIDENT
Jeffrey P. Jacobs
St. Petersburg, FL
SECRETARY/TREASURER
David R. Jones
New York, NY
SECRETARY/TREASURER-ELECT
Daniel L. Miller
Marietta, GA
COUNCIL CHAIR
Robert J. Cerfolio
Birmingham, AL
PAST PRESIDENT
Walter H. Merrill
Nashville, TN
COUNCILORS
Andrew C. Fiore
St. Louis, MO
John S. Ikonomidis
Charleston, SC
Christine L. Lau
Charlottesville, VA
CONTINUING MEDICAL EDUCATION DIRECTOR
Richard K. Freeman
Indianapolis, IN
HISTORIAN
John W. Hammon
Winston-Salem, NC
EDITOR
L. Henry Edmunds
Philadelphia, PA
COMMITTEE MEMBERS
PROGRAM COMMITTEE
Melanie A. Edwards (Co-Chair), St. Louis, MO
Jorge D. Salazar (Co-Chair), Jackson, MS
Robert J. Cerfolio, Birmingham, AL
Richard K. Freeman, Indianapolis, IN
Charles B. Huddleston, St. Louis, MO
Jeffrey P. Jacobs, St. Petersburg, FL
David R. Jones, New York, NY
Daniel L. Miller, Marietta, GA
Himanshu J. Patel, Ann Arbor, MI
Richard L. Prager, Ann Arbor, MI
Stephen C. Yang, Baltimore, MD
MEMBERSHIP COMMITTEE
Marc R. Moon (Chair), St. Louis, MO
Curtis G. Tribble, Charlottesville, VA
James R. Headrick, Chattanooga, TN
Edward Po-Chung Chen, Atlanta, GA
POSTGRADUATE COMMITTEE
Robert B. Lee (Co-Chair), Paducah, KY
Marcus G. Williams (Co-Chair), Bristol, TN
Paul J. Chai, New York, NY
Richard K. Freeman, Indianapolis, IN
John A. Howington, Evanston, IL
David R. Jones, New York, NY
Scott A. LeMaire, Houston, TX
Daniel L. Miller, Marietta, GA
Richard L. Prager, Ann Arbor, MI
Thomas C. Wozniak, Indianapolis, IN
CONTINUING MEDICAL EDUCATION COMMITTEE
Richard K. Freeman (Director), Indianapolis, IN
Melanie A. Edwards, St. Louis, MO
Robert B. Lee, Paducah, KY
Jorge D. Salazar, Jackson, MS
Marcus G. Williams, Bristol, TN
REPRESENTATIVE TO THE BOARD OF GOVERNORS
OF THE AMERICAN COLLEGE OF SURGEONS
Joseph B. Zwischenberger, Lexington, KY
REPRESENTATIVE TO THE ADVISORY COUNCIL
FOR CARDIOTHORACIC SURGERY FOR THE AMERICAN
COLLEGE OF SURGEONS
Shanda H. Blackmon, Rochester, MN
NOMINATING COMMITTEE Keith S. Naunheim (Chair), St. Louis, MO
Joseph S. Coselli, Houston, TX
Walter H. Merrill, Nashville, TN
BROOKS SCHOLARSHIP COMMITTEE M. Blair Marshall (Chair), Washington, DC
Kevin D. Accola, Orlando, FL
Joseph A. Dearani, Rochester, MN
David Tyler Greenfield, Kingsport, TN
THE ANNALS OF THORACIC SURGERY
L. Henry Edmunds, Philadelphia, PA
PROGRAM AT-A-GLANCE
WEDNESDAY, NOVEMBER 5, 2014
3:00 pm – 8:00 pm
Registration – Arizona Ballroom Foyer
7:45 pm – 10:00 pm
Surgical Motion Pictures – Arizona Ballroom 6–7
THURSDAY, NOVEMBER 6, 2014
6:30 am – 5:00 pm
6:30 am Continental Breakfast – Arizona Ballroom Foyer
7:00 am – 9:00 am
Postgraduate General Session –
Arizona Ballroom 6–7
9:00 am – 9:15 am
Break
9:15 am – 10:35 am
Postgraduate Subspecialty Breakout Sessions
Adult Cardiac Breakout– Arizona Ballroom 6–7 General Thoracic Breakout – Arizona Ballroom 2–3
Congenital Breakout – Arizona Ballroom 4–5
10:35 am – 10:50 am
Break
10:50 am – 11:20 am
Postgraduate Expert Panel Discussion
Education Our Future: I6 and Traditional Approaches
11:20 am – 12:00 pm
Postgraduate Special Session
William A. Baumgartner
ABTS Update
12:00 pm – 1:00 pm
Break
12:00 pm – 4:00 pm
Exhibits Open – Tucson Ballroom A-E
1:00 pm – 2:00 pm
Ethics Debate
Should a Thoracic Surgeon Transfer a Complicated Case to a Competing Medical Center Against the Hospital’s Order?
2:00 pm – 2:30 pm
Break & Visit Exhibits – Tucson Ballroom A-E
2:30 pm – 5:00 pm
First Scientific Session – Arizona Ballroom 6–7
FRIDAY, NOVEMBER 7, 2014
6:30 am – 5:30 pm
6:45 am – 11:00 am
6:45 am
Continental Breakfast – Tucson Ballroom A-E
7:00 am – 7:50 am
Basic Science Forum – Arizona Ballroom 6–7
8:00 am – 10:00 am
Second Scientific Session – Arizona Ballroom 6–7
10:00 am – 10:30 am
10:30 am – 10:50 amKent Trinkle Education Lectureship
Mark S. Slaughter, MD
University of Louisville, Louisville, KY The University
of Louisville and the Mason Dixon Line:
Re-establishing Ties With the STSA
10:50 am – 11:20 am
President’s Invited Lecturer
David M. Shahian, MD
Codman’s Legacy: Data, Reporting,
and Professional Responsibility
11:20 am – 12:00 pm
Presidential Address
Richard L. Prager, MD
Art and the Human Condition
12:00 pm
All Attendee Lunch – Ania Terrace
12:00 pm – 4:00 pm
1:00 pm – 2:00 pm
Dessert Served in the Exhibit Hall –
Tucson Ballroom A-E
2:00 pm – 3:30 pm
Third Scientific Session A–
Simultaneous Subspecialty Breakout Sessions
Adult Cardiac Breakout– Arizona Ballroom 6–7
General Thoracic Breakout – Arizona Ballroom 2–3
3:30 pm – 4:00 pm
4:00 pm – 5:00 pm
Third Scientific Session B –
5:00 pm – 6:00 pm
STSA Annual Business Meeting
STSA Members Only – Arizona Ballroom 6–7
6:00 pm – 7:00 pm
Residents Reception – San Luis 1-2
7:00 pm – 9:00 pm
President’s Mixer – Ania Terrace
SATURDAY, NOVEMBER 8, 2014
6:45 am – 11:00 am
6:45 am
Continental Breakfast – Arizona Ballroom Foyer
7:00 am – 8:00 am
Coding Update
Update on CPT and Physician Payment Issues for 2015
8:00 am – 9:00 am
Fourth Scientific Session A –
Transplant Breakout– Arizona 1
9:00 am – 9:30 am
Break
9:30 am – 9:50 am
Harold Urschel History Lectureship
Daniel L. Miller, MD
Osler Almon Abbott: The Man, The Award,
and His Legacy
9:50 am – 11:50 am
Fourth Scientific Session B – Arizona Ballroom 6–7
11:50 am
Program Adjourns
12:00 pm – 6:00 pm
Various Social & Sporting Events
See page 8 for details
7:00 pm – 11:00 pm Annual Awards Dinner & Dance –
SCHEDULE OF ACTIVITIES
THURSDAY, NOVEMBER 6
Spouse/Guest Hospitality Suite – San Xavier
Time: 8:00 am – 11:30 am
STSA is providing a complimentary hospitality room for spouses and guests
to mingle and make plans for exploring Tucson.
FRIDAY, NOVEMBER 7
Time: 8:30 am – 11:30 am
All Attendee Lunch – Ania Terrace
Time: 12:00 pm (Followed by dessert in the Exhibit Hall)
Cost: Complimentary
Residents Reception – San Luis 1-2
Time: 6:00 pm – 7:00 pm
Residents and fellows attending the meeting are invited to join STSA leaders
for this hour-long networking event. Spouses/guests are welcome.
President’s Mixer – Ania Terrace
Time: 7:00 pm – 9:00 pm
Cost: Complimentary
Attendees receive two tickets with registration. Additional tickets may be
purchased for $25. Visit the registration desk for details.
Gather with fellow meeting attendees for an evening of networking and fun.
SATURDAY, NOVEMBER 8
Time: 8:30 am – 11:30 am
Sonoita Winery Tour
Time: 12:00 pm – approximately 5:00 pm
Cost: $200.00 (Includes boxed lunch, transportation, professional guide,
winery admission, bottled water, souvenir wine glass, and gratuities.)
Advanced registration is required. Subject to cancellation if registration is
insufficient. Registrants will be notified in advance and refunds will be issued
if this event is cancelled.
Travel deep into the heart of Arizona’s wine country to visit two of the area’s
most beautiful wineries. Wine tasting begins immediately upon departure
from the resort, while the professional guide shares the history of Sonoita
and its wineries. Explore both Dos Cabezas WineWorks and Arizona Hops
and Vines vineyards, and learn about the craft of wine making while enjoying
a memorable wine tasting experience. The tour begins and ends at Starr
Circle, located in the resort’s main lobby. A rain or shine event!
Arizona Guided Hike
Time: 2:00 pm – approximately 4:00 pm
Cost: $70.00 (Includes professional guide, bottled water, small snack,
sunscreen and gratuities.)
Level of Difficulty: Easy to Moderate
Advanced registration is required. Subject to cancellation if registration is
insufficient. Registrants will be notified in advance and refunds will be issued
if this event is cancelled.
The beauty of the terrain and the ruggedness of the environment make a hike
in the Tucson Mountains a unique and wonderful experience. This adventure
will give you a real appreciation for the mesmerizing Arizona desert. The
diversity of plants and wildlife that coexist in the Sonoran Desert, affirm the
balance of nature. Your guide will share the flora and fauna and the incredible
vistas. All plans are taken care of and we supply the necessary materials.
Your only duty is to enjoy your visit with nature! The hike begins and ends at
Starr Circle, located in the resort’s main lobby.
Golf Tournament
Location: Starr Pass Golf Club
Time: 12:30 pm – 1:10 pm tee times available
Cost: $155.00 (Includes greens fees, baggage handling, shared golf cart, and
boxed lunch.)
A limited number of tee times are available – be sure to register in advance!
The Starr Pass Golf Club legend began more than 120 years ago when
Richard Starr crafted a trail through the rugged wilderness of the Tucson
Mountains. Today, Coyote’s sixth fairway marks this trail and has earned the
honor of being the signature hole at Starr Pass.
A true desert course, natural elements are used as hazards while showcasing
majestic vistas of the Catalina Mountains. Legends such as Arnold Palmer,
Phil Mickelson, Payne Stewart and Nancy Lopez have carved their way
through this historic golf course.
Please note the following dress code: Men must wear collared shirts and long
pants or Bermuda length shorts. Ladies must have a collar or sleeves on their
top. Shorts or skirts of appropriate length are allowed. Only soft-spiked shoes
or tennis shoes are allowed on the course.
If you wish to rent clubs, please call the golf club at 520.670.0406 (club rentals
fees are $49 plus tax and are not included in the above cost).
Annual Awards Dinner & Dance – Texas Tux in Arizona Theme
Reception: 7:00 pm – 8:00 pm – Arizona Ballroom Foyer
Dinner: 8:00 pm – 11:00 pm – Arizona Ballroom 6–7
100.00 per person
Cost: $
$35.00 for children 12 years of age or younger (chicken finger dinner)
Conclude your 61st Annual Meeting experience with the always-memorable
Annual Awards Dinner & Dance. Join fellow meeting attendees and their
families for an evening of dining and dancing. Advanced registration is
recommended. A limited number of tickets will be sold on site. Reduced ticket
prices are available for children 12 and under.
In honor of the JW Marriott Starr Pass desert landscape, the Awards Dinner &
Dance will have a Texas Tux in Arizona theme this year. Gentlemen are invited
to wear jeans with either a tuxedo shirt and jacket or a dark suit coat. Cowboy
boots and a ten-gallon hat are not required, but are encouraged! Ladies, as
always, can choose from the full spectrum of fancy attire, including cocktail
dresses, pants suits, floor length skirts—or maybe even a denim skirt, silk
blouse and cowboy boots. So feel free to wear black tie, Texas tux or any
combination of the two. The important thing is to be comfortable and have
fun. It will be the perfect finale to a great meeting.
Rising Starr Kids Club
Available daily
The Rising Starr Kids Club is a full-service children’s recreation program
offered for our guests ages 4 to 12, with three session options: morning,
afternoon, and full-day. Days are fun-filled with interactive games and
activities that take advantage of the Tucson Experience, including arts and
crafts, hikes, swimming, and more.
The Rising Starr Kids Club requires that all participants be fully toilet-trained,
and a parent or guardian be on property and reachable during child’s
participation. Pre-registration is necessary and can be done by contacting the
resort at 520.792.3500. Please ask to speak to the concierge to set up your
child’s reservation.
Baby-sitting Services
Baby-sitting services are available through Choice Options at 520.638.6538 or
Trusting Connections at 520.544.6611. Advanced reservations are required.
Other Resort Activities & Attractions
Explore a variety of desert adventures during your visit to the JW Marriott
Tucson Starr Pass Resort & Spa. Highlights include on-property Hashani Spa
& Fitness Center, Blur Teen Lounge, Starr Pass Golf Club, numerous dining
options, tennis courts, swimming pool with waterslide and lazy river, and
trails for hiking, biking, and jogging. Visit www.jwmarriottstarrpass.com or
call the Resort Concierge at 520.792.3500 for more information.
CONTINUING MEDICAL EDUCATION (CME) OVERVIEW
DISCUSSION OF PAPERS
Discussions of papers at the Annual Meeting are considered for publication in
The Annals of Thoracic Surgery. Please review the program outline carefully
to determine if you have a particular interest in some of the topics, then be
prepared to discuss them at the meeting. If you wish, you may request a copy
of the manuscript in advance of the meeting by contacting the author directly.
Each session has a limited amount of time reserved for discussion. Assigned
discussants are limited to two minutes and two questions.
PRESENTATION AND PUBLICATION
Authors of oral presentations are required to submit a manuscript for
consideration for publication in The Annals of Thoracic Surgery before noon
on Saturday, November 8, 2014. Manuscripts must be submitted via The
Annals online manuscript submission system at www.atseditorialoffice.
org. A paper copy of the manuscript will not be accepted for consideration.
Primary authors and co-authors that are delinquent in submitting their
manuscript to The Annals on time will not have their presentations
considered for publication in The Annals. In addition, these authors will not
have abstracts considered by the Program Committee of the STSA for two (2)
subsequent meetings.
ACCREDITATION
The Southern Thoracic Surgical Association is accredited by the
Accreditation Council for Continuing Medical Education (ACCME) to provide
continuing medical education for physicians. The STSA designates this
educational activity for a maximum of 21.25 AMA PRA Category 1 Credits™.
Physicians should only claim credit commensurate with the extent of their
participation in the activity.
STSA CME MISSION
The continuing medical education mission of the Southern Thoracic Surgical
Association is to design and deliver high-quality, practical, innovative, and
scientifically rigorous educational programming at its Annual Meeting in the
areas of cardiovascular, general thoracic, and congenital heart surgery, as
well as ethics and professionalism, leadership, and practice management.
Such educational programming is meant to advance the overall competence
of cardiovascular, general thoracic, and congenital heart surgeons, and
ultimately to help them improve their patient outcomes and promote patient
safety.
Continuing medical education activities are presented in a variety of
formats at an STSA Annual Meeting; these include [but are not limited to]
presentations of peer-reviewed scientific abstracts, updates on relevant
scientific research, didactic presentations, debates, video presentations, and
sub-specialty-specific break-out sessions. All educational sessions include
the opportunity for questions, answers, and discussion to further support
the educational needs of the meeting attendees and the program learning
objectives.
STSA educational activities are developed and provided with the intent
of confirming an existing knowledge base, imparting new knowledge,
enhancing competence in the content areas covered, and addressing
identified professional practice gaps. The expected results include
participants’ reporting greater confidence in their clinical care skills and a
willingness to change their behavior or adapt new strategies as appropriate.
ELECTRONIC CME EVALUATION
The STSA 61st Annual Meeting evaluation and CME credit claim process
is electronic. Registrants who wish to receive CME credit for sessions they
attend will be required to complete the electronic evaluation for the session.
This is the only way physicians can earn CME credit for their attendance.
Using the electronic evaluation system, registrants can complete the meeting
evaluation, claim CME credit, and print CME certificates. Certificates of
Attendance are also available for non-physician attendees.
The electronic evaluation provides attendees the opportunity to offer
feedback to the STSA Council and Program Committee regarding content
offered, including information about applicability of the content to current
practice, quality of the material presented, and recommendations for future
programming. This information is invaluable in the planning of future STSA
educational programs.
In addition to being useful for program planning, program evaluation and
future needs assessment are important components of the requirements
that the STSA must meet to maintain accreditation through the Accreditation
Council for Continuing Medical Education (ACCME). It is by meeting the
requirements set forth by the ACCME that the STSA is able to award CME
credit for educational programming.
The electronic evaluation can be completed by meeting registrants onsite at
computer kiosks located in the Arizona Ballroom Foyer.
Attendees can also access evaluations by visiting the online evaluation
website through personal computers or handheld devices at https://www.
xcdsystem.com/stsa. In order to make this process more convenient for
attendees, the meeting evaluations will be available online through Saturday,
November 22, 2014.
Attendees can log in to the evaluation website with the following information:
Username: E-mail Address (note, your username is the e-mail address that
you used to register for the Annual Meeting)
Password: STSA User ID (your user ID is printed on the bottom or your
meeting badge)
This process will allow STSA to maintain an electronic record of CME earned
by physicians. Files will be maintained for a minimum of six years. Any
questions regarding this procedure should be directed to STSA Headquarters
at (800) 685-7872 or via e-mail at [email protected].
STSA POLICY REGARDING DISCLOSURE
The Southern Thoracic Surgical Association will seek thorough financial
and commercial disclosure information, according to ACCME requirements
and recommendations, from all presenters, discussants, and moderators
participating in an STSA Annual Meeting. Failure or refusal to provide
disclosure information automatically disqualifies participation. All disclosure
information will be communicated to the learners through appropriate
means, including but not limited to the Annual Meeting Program Book.
STSA leadership, planning committee members, and staff will also provide
disclosure information to be kept on file and communicated to meeting
attendees through the STSA Annual Meeting Program Book.
All abstracts and disclosure statements will be reviewed approximately three
(3) months prior to the Annual Meeting by staff for unidentified conflicts
of interest. Any such potential conflicts will be brought to the attention
of the STSA President, Chairman, and CME Committee Chair for review
and resolution. Any potential conflicts of interest must be resolved before
presentation. If a conflict is deemed unresolvable, the paper cannot be
presented at the Annual Meeting.
The STSA Disclosure Policy (as outlined on page 12) will be communicated to
the learner via the Annual Meeting Program Book.
CONTINUING MEDICAL EDUCATION (CME) OVERVIEW
STSA EDUCATION DISCLOSURE POLICY
As a sponsor of continuing medical education accredited by the Accreditation
Council for Continuing Medical Education (ACCME), the Southern Thoracic
Surgical Association requires that any individual who is in a position to
control the content of an educational activity must disclose all relevant
financial relationships (including known relationships of his or her immediate
family, department, and partners) with any healthcare-related business or
other entity whose products or services may be discussed in, or directly
affected in the marketplace by, the educational content. The ACCME defines
a “relevant financial relationship” as a relationship of any amount occurring
within the previous twelve (12) months. The question of whether a disclosed
conflict situation could represent undue influence on the educational activity
by a commercial interest, or whether the disclosed information is sufficient
to consider an abstract, presentation, or other educational enduring material
to represent potentially biased information must be resolved prior to an
individual’s involvement in STSA educational programming.
Required disclosures include (1) financial interest of any amount (e.g.,
through ownership of stock, stock options, or bonds) (2) the receipt of any
amount of cash, goods or services within the current 12-month period (e.g.,
through research grants, employment, consulting fees, royalties, travel, or
gifts) or (3) a non-remunerative position of influence (e.g., as officer, director,
trustee or public spokesperson). NOTE: To avoid confusion with regard to
the question of “relevance,” STSA requires that anyone in a position to
control content (planners, speakers, authors, volunteer leaders, staff) must
review the content they are addressing and disclose relationships with
companies that have a material interest in the content being covered
regardless of the division of the company for which that relationship exists.
For instance, if a speaker will be referencing a product made by the X
division of ABC company, but his relationship is with the Y division, he must
still disclose the relationship. EXCLUDED from this disclosure requirement
are blind trusts or other passive investments such as mutual funds. In the
case of a financial or other relationship disclosure, the company, product/
service, and specific nature of the relationship must be noted. Disclosure is
mandatory for any person involved in the planning, management,
presentation, and/or evaluation of STSA educational activities.
Failure to disclose relevant financial relationships disqualifies the individual
from being a planning committee member, a teacher, or an author of
CME materials, and this individual cannot have any responsibility for the
development, management, presentation, or evaluation of STSA CME
activities. This requirement is intended neither to imply any impropriety of
such relationships nor to prejudice any individual presenter or author. It is
merely to identify such relationships through full disclosure, and to allow the
STSA to assess and resolve potential influences on the educational activity
prior to the planning and implementation of an educational activity. All
abstracts and presentations are reviewed for potential conflicts of interest.
All conflicts of interest must be resolved prior to presentation. Any abstract
/ paper with a conflict that is deemed unresolvable will not be presented at
the Annual Meeting. If no relevant financial relationships exist, the individual
must indicate this on the disclosure form.
Additionally, the fact that the presentation, paper, or other educational
product describes (a) the use of a device, product, or drug that is not FDA
approved or (b) an off-label use of an approved device, product, or drug must
also be disclosed. This requirement has been adopted in response to FDA
policy and recent case law involving medical societies, and is not intended to
prohibit or inhibit independent presentation or discussion regarding the uses
of devices, products, and drugs as described in (a) or (b) above.
For live presentations, all disclosures must be stated orally or on a slide at the
beginning of the presentation and will be noted in published material related
to the activity. Slides, handouts, and other materials utilized as part of an
educational activity cannot contain any advertising, trade names or a product
group message. Speakers are required to disclose that they have nothing to
disclose if this is the case.
Authors listed with a D next to their names have indicated, in accordance
with the ACCME Standards and the STSA Disclosure Policy, that they have
a financial or other relationship with a healthcare-related business or other
entity to disclose; or their paper’s content describes the use of a device,
product or drug, that is not FDA approved, or the off-label use of an approved
device, product or drug. Please refer to the Relationship Disclosure Index on
page 360 for a listing of all disclosure information.
OVERALL MEETING OBJECTIVES
To present recent advances in research, surgical techniques, patient
management, and the diagnosis and treatment of cardiothoracic disease
to cardiothoracic specialists and related health care professionals; and
to provide a forum for cardiothoracic surgeons and related healthcare
professionals to exchange ideas through open discussion periods and
question-and-answer sessions related to the practice of cardiothoracic
surgery.
After attending the STSA Annual Meeting, participants should have a
broader understanding of new and standard techniques and current research
specifically related to adult cardiac surgery, general thoracic surgery,
congenital heart surgery, and related transplant procedures. Attendees
can utilize knowledge gained from the STSA Annual Meeting to help select
appropriate surgical procedures and interventions and integrate state of the
art knowledge into their own practices.
TARGET AUDIENCE
The STSA Annual Meeting is intended for all professionals involved in
delivery of cardiothoracic care with particular emphasis on cardiothoracic
surgeons. Cardiothoracic residents, fellows, nurse practitioners, research
scientists, and other health care professionals may also benefit from various
sessions and interactions with cardiothoracic colleagues.
SPEAKER READY ROOM
The Speaker Ready Room is located in Arizona Ballroom 12. Speakers are
requested to go to this room upon arrival, or at least four hours prior to the
opening of their session to upload slides. Speakers will not be allowed to
bring their laptop to the podium.
SCHEDULE
OF EVENTS**
*SCHEDULE
*
SCHEDULEOF
OFEVENTS
EVENTSIS
ASSUBJECT
OF SEPTEMBER
TO CHANGE.
17, 2012. SCHEDULE
SUBJECT TO CHANGE.
SURGICAL MOTION PICTURES
7:45 pm – 10:00 pm
(Presentations are limited to ten minutes, followed by five minutes of
discussion.)
CME Credits Available: 2.25
Moderators: *Jeffrey P. Jacobs and *Stephen C. Yang
7:45 pm – 8:00 pm (page 42)
1V. R
epair of Simple Bicuspid Valve Defects Using Geometric Ring
Annuloplasty
DDomenico Mazzitelli1 , Steffen Pfeiffer2 , D*J. Scott Rankin 3 , Christian
Nöbauer1 , Christian Schreiber1 , Theodor Fischlein 2 , Rüdiger Lange1
1
Deutsches Herzzentrum Muenchen, Munich, Germany; 2Klinikum Nürnberg, Nürnberg, Germany; 3Vanderbilt University, Nashville, TN
8:00 pm – 8:15 pm (page 44)
2V. Endoluminal Suturing
*Shanda H. Blackmon
Mayo Clinic, Rochester, MN
8:15 pm – 8:30 pm (page 46)
3V. Minimally Invasive Transhiatal Esophagogastrectomy With Mediastinal Anatomosis: Technique and Avoidance of Pitfalls
Young Hong, Allison Linden, Lorenzo De Marchi, Nadime Haddad, *M. Blair Marshall
MedStar Georgetown University Hospital, Washington, DC
8:30 pm – 8:45 pm (page 48)
4V. Neonatal Surgical Repair of Aortico-Left Ventricular Tunnel
Vijay Sadasivam, Vijayakumar Raju, John N. Kheir, Gerald R. Marx, Sitaram M. Emani
Boston Children Hospital, Boston, MA
8:45 pm – 9:00 pm (page 50)
5V. SVC Resection for Germ Cell Tumor
*Shanda H. Blackmon1 , *Michael J. Reardon2
1
Mayo Clinic, Rochester, MN; 2Houston Methodist Hospital, Houston, TX
9:00 pm – 9:15 pm (page 52)
6V. A
ugmentation of Aorta in Repair of Hemitruncus
*Inder D. Mehta1 , Julie Park1 , Victor S. Lucas1 , *Ross M. Ungerleider 2
1
Ochsner Clinic Foundation/Medical Center, New Orleans, LA; 2Wake
Forest Baptist Medical Center, Winston-Salem, NC
9:15 pm – 9:30 pm (page 54)
7V. VATS Lobectomy in a Patient on Clopidogrel
D*Daniel L. Miller
9:30 pm – 9:45 pm (page 56)
8V. V
entricular Embolization of the Valve Prosthesis During Transapical Transcatheter Aortic Valve Implantation
Muhammad Aftab, Magdy M. El-Sayed Ahmed, Neil E. Strickman, *Ross M. Reul
Texas Heart Institute at Baylor St. Luke's Medical Center, Houston, TX
9:45 pm – 10:00 pm (page 58)
9V. Percutaneous Transfemoral Closure of a Pseudoaneurysm at the
Left Ventricular Apical Access Site for Transcatheter Aortic Valve
Implantation
Ashkan Karimi1 , James C. Fudge1 , Anthony A. Bavry1 , David Anderson1 , D*Charles T. Klodell1 , John W. Petersen1 , Marc Litt 2 , Floyd W. Burke1 , D*Thomas M. Beaver1
1
University of Florida, Gainesville, FL; 2Jacksonville Heart Center, Jacksonville, FL
*STSA Member D Relationship Disclosure
SCHEDULE OF EVENTS
POSTGRADUATE PROGRAM
7:00 am – 12:00 pm
The first portion of the Postgraduate Program is the General Session,
which will feature case presentations and expert panels with audience
response participation. Concurrent breakout sessions in adult cardiac,
general thoracic, and congenital heart surgery will take place between
9:15 am and 10:35 am. The General Session will continue at 10:50 am
with one Expert Panel Discussion. The Special Session will begin
at 11:20 am and program will adjourn at 12:00 pm. Summaries of
Postgraduate papers being presented will be posted to www.stsa.org
following the meeting.
GENERAL SESSION Arizona Ballroom 6–7
Case Presentations & Expert Panels with Audience Participation
Moderators: *Robert B. Lee and *Marcus G. Williams
Educational Objectives: Upon completion of this program participants
will be able to:
•
Identify current strategies for minimizing blood utilization during
and after cardiac operations.
• Develop treatment plans for patients at high risk for bleeding due to
coagulopathy.
• Explain the role of the team in cardiac surgery blood conservation.
• Define the indications for intervention on patients with anomalous
aortic origin of the coronary arteries.
• Apply the most appropriate surgical procedure for the anatomic
subtypes of anomalous aortic origin of the coronary arteries.
• Comprehend the scientific foundation of CT screening for lung cancer.
• Identify the currently accepted patient selection criteria for CT lung
cancer screening.
• Have a working knowledge of evidence-based follow up for patients undergoing CT screening found to have an abnormality.
• Assess the need for Veno-Venous vs. Veno-Arterial ECMO.
• Discuss preferred and alternative cannulation sites and techniques.
• Discuss the components of an ECMO circuit.
• Discuss anticoagulant management of an ECMO patient.
• Discuss weaning techniques and criteria for separation from ECMO.
7:00 am – 7:30 am
Adult Cardiac Case Presentation & Expert Panel: Current Management
and Blood Utilization in Adult Cardiac Surgery
Case Presenter: *Robert B. Lee
Vanderbilt University Medical Center, Franklin, TN
Expert Panelists: D*Victor A. Ferraris1 , D*Alan M. Speir2
1
University of Kentucky, Lexington, KY; 2Fairfax Hospital, Falls Church, VA
7:30 am – 8:00 am
Congenital Heart Surgery Case Presentation & Expert Panel:
Anomalous Origin of a Coronary Artery
Case Presenter: *Paul Chai
Columbia University Medical Center, New York, NY
Expert Panelists: *James Jaggers1, *Kirk R. Kanter2
1
Childrens Hospital Colorado, Aurora, CO; 2Emory University School of
Medicine, Atlanta, GA
8:00 am – 8:30 am
General Thoracic Case Presentation & Expert Panel: Lung Cancer
Screening at Academic and Non-academic Institutions
Case Presenter: *Robert B. Lee
Vanderbilt University Medical Center, Franklin, TN
Expert Panelists: D*Richard K. Freeman1 and *John A. Howintgon2
1
St. Vincent's Health and Hospital System/Indiana Heart Institute,
Indianapolis, IN; 2NorthShore University HealthSystem, Evanston, IL
8:30 am – 9:00 am
Critical Care Case Presentation & Expert Panel: ECMO & Your Hospital
Case Presenter: *Marcus G. Williams
Wellmont CVA Heart Institute, Bristol, TN
Expert Panelists: *Thomas C. Wozniak1, D*Joseph B. Zwischenberger2
1
Cardiovascular Surgical Services, P.C. – Methodist Professional Center,
Indianapolis, IN; 2University of Kentucky, Lexington, KY
9:00 am – 9:15 am
Break
ADULT CARDIAC BREAKOUT Arizona Ballroom
6–7
Moderators: D*Scott A. LeMaire and *J. Michael DiMaio
will be able to:
• Identify appropriate candidates for TAVR based on the current accepted U.S. commercial indications.
• Integrate the potential for TAVR into their decision process for patients with symptomatic severe aortic stenosis.
• Recognize cannulation options for minimally invasive cardiac surgery.
• Discuss alternative mitral valve repair techniques.
• Describe right thoracotomy for aortic valve replacement.
• Summarize the current role of Thoracic Endovascular Repair in Acute Type B dissection.
• Discuss the current outcomes of total arch replacement in Acute Type A dissection.
• Describe the use of moderate hypothermic circulatory arrest in Acute Type A dissection.
9:15 am – 9:42 am
TAVR 2014 Update
D*Michael J. Reardon
Houston Methodist Hospital, Houston, TX
9:42 am – 10:09 am
Minimally Invasive Valve Surgery
*Donald D. Glower
Duke University Medical Center, Durham, NC
10:09 am – 10:35 am
Current Management of Type A and B Acute Dissection
D*Edward P. Chen
Emory University School of Medicine, Atlanta, GA
GENERAL THORACIC BREAKOUT Arizona Ballroom 2–3
Moderators: D*Richard K. Freeman and *Stephen C. Yang
will be able to:
• Distinguish the factors that go in to determining the risk/benefit balance for surgical therapy vs. SBRT in the treatment of small tumors.
• Assess patient-related factors and technical factors that may contribute to the choice of operative vs. non-operative (SBRT) therapy for small tumors.
SCHEDULE OF EVENTS
• Review current treatment paradigms and their results for stage IIIa NSCLC.
• Appreciate associated morbidities and outcomes associated with multi-modality therapies for stage IIIa NSCLC.
• Identify the important biomarkers for the common histologic forms of
lung cancer.
•Interpret how biomarkers may influence the prognosis of lung cancer.
• Assess the influence of biomarkers and mutations on the selection of
adjuvant therapy for lung cancer patients.
9:15 am – 9:42 am
SBT vs. Sublobar Resection for One-centimeter Lesions
D*Traves D. Crabtree
Washington University School of Medicine, St. Louis, MO
9:42 am – 10:09 am
Current Management of Stage III-A (P123N2M0) Lung Cancer
*David R. Jones
Memorial Sloan-Kettering Cancer Center, New York, NY
10:09 am – 10:35 am
Lung Cancer Biomarkers, Mutations and Genetic Signatures for the
Thoracic Surgeon
*David H. Harpole, Jr.
CONGENITAL BREAKOUT Arizona Ballroom 4–5
Moderators: *Paul J. Chai and *Jorge D. Salazar
will be able to:
• Determine the best surgical option for all patients with Ebstein’s Anomaly.
• Formulate a treatment plan for neonates with Ebstein’s Anomaly.
• Identify anatomic features of borderline left ventricle and correlate with imaging findings.
• Describe various strategies to achieve biventricular circulation and identify populations best suited for this approach.
• Describe how the STS Congenital Heart Surgery Database can be used
for research, outcomes analysis, and quality improvement.
• List several recent examples of published research generated from the
STS Congenital Heart Surgery Database.
• Summarize strategies to use the STS Congenital Heart Surgery
Database to analyze outcomes and assess and improve quality.
9:15 am – 9:42 am
Surgical Treatment of Ebstein's Anomaly: From Neonate to Adult
*Christopher Knott-Craig
University of Tennessee Health Science Center/ Le Bonheur Children's
Medical Center, Memphis, TN
9:42 am – 10:09 am
Biventricular Repair in Borderline Hearts
DSitaram Emani
Children’s Hospital Boston, Boston, MA
10:09 am – 10:35 am
Use of STS Congenital National Database in Research Outcomes
Quality Assurance
*Jeffery P. Jacobs
Johns Hopkins All Children's Hospital, St. Petersburg, FL
10:35 am – 10:50 am
Break
GENERAL SESSION Arizona Ballroom 6–7
Expert Panel Discussion with Audience Response System
Moderators: D*Richard H. Feins
will be able to:
• Detect three positive characteristics and three negative characteristics
of the Integrated-6 approach.
• Detect three positive characteristics and three negative characteristics
of the traditional approach.
10:50 am – 11:20 am
Educating Our Future
I-6 Approach: Michael Argenziano
Columbia University, New York, NY
Traditional Approach: *Ara A. Vaporciyan
University of Texas, MD Anderson Cancer Center, Houston, TX
SPECIAL SESSION Arizona Ballroom 6–7
Introduction: *Richard L. Prager
will be able to:
• Describe the current ABTS Certification process.
• Better interpret Maintenance of Certification.
• Summarize the types and numbers of Thoracic Surgery Residency programs.
11:20 am – 12:00 pm
ABTS Update
*William A. Baumgartner
Executive Director, American Board of Thoracic Surgery,
Johns Hopkins University School of Medicine, Baltimore, MD
12:00 pm -1:00 pm
Break – Visit Exhibits
Tucson Ballroom A-E
12:00 pm – 4:00 pm
EXHIBITS OPEN
Tucson Ballroom A-E
ETHICS DEBATE Arizona Ballroom 6–7
1:00 pm – 2:00 pm
should be able to:
• Determine whether to transfer a complicated case to a competing medical center against the hospital’s order.
• Discuss relative responsibilities to the patient versus the hospital.
Should a Thoracic Surgeon Transfer a Complicated Case to a
Competing Medical Center Against the Hospital's Order?
Moderator: *Robert M. Sade,
Medical University of South Carolina, Charleston, SC
Pro: *Kathleen N. Fenton
International Children's Heart Foundation, Silver Spring, MD
Con: Jennifer L. Ellis
MedStar Heart Institute/Cleveland Clinic Heart and Vascular Institute,
Washington, D.C.
SCHEDULE OF EVENTS
FIRST SCIENTIFIC SESSION
2:00 pm – 2:30 pm
Tucson Ballroom A-E
2:30 pm – 5:00 pm
(Presentations are limited to seven minutes, followed by two minutes of
discussion from a selected discussant and an additional six minutes of
discussion open to the audience.)
Moderators: *David R. Jones and *Richard L. Prager
2:30 pm – 2:45 pm (page 60)
1. F
ifteen-year Experience With Aortic Valve Sparing – Aortic Root
Replacement With the Reimplantation Technique
Stefano Mastrobuoni1, Laurent De Kerchove1, Munir Boodhwani2,
Parla Astarci1, Jean Rubay1, Robert Verhelst1, Philippe Noirhomme1,
Gebrine El Khoury1
1
St. Luc's Hospital, Brussels, Belgium; 2University of Ottawa Heart
Institute, Ottawa ON, Canada
Discussant: *Duke E. Cameron, Johns Hopkins University School of
Medicine, Baltimore, MD
2:45 pm – 3:00 pm (page 62)
2. Effects of Delayed Surgical Resection on Short- and Long-term
Outcomes in Clinical Stage I Non-small Cell Lung Cancer
Pamela Samson, Aalok Patel, *Matthew Bott, *Traves Crabtree,
*Daniel Kreisel, *Alexander S. Krupnick, *George A. Patterson,
*Stephen Broderick, *Bryan Meyers, *Varun Puri
Discussant: *Melanie A. Edwards, Saint Louis University School of
Medicine, Saint Louis, MO
3:00 pm – 3:15 pm (page 64)
3. Long-term Outcomes After the Ross Procedure in Children Vary by
Age at Operation
Jennifer S. Nelson1, Clayton N. Pratt2, Sara K. Pasquali2, Janet E.
Donohue2, Sunkyung Yu2, Richard G. Ohye2, Edward L. Bove2, Jennifer
C. Hirsch-Romano2
1
University of North Carolina, Chapel Hill, NC; 2University of Michigan,
Ann Arbor, MI
Discussant: *Ross M. Ungerleider, Wake Forest School of Medicine,
Winston-Salem, NC
3:15 pm – 3:30 pm (page 66)
4. W
hen the Ross Is Not an Option: Systemic Semilunar Valve
Replacement in the Pediatric/Young Adult Population Using a
Porcine Full-root Bioprosthesis
*Jorge D. Salazar2, Bhawna Gupta2, *Charles D. Fraser, Jr.1, *John H.
Calhoon3, *Makram R. Ebeid2, *Mary B. Taylor2, *Ali Dodge-Khatami2
1
Baylor College of Medicine, Houston, TX; 2The University of
Mississippi Medical Center, Jackson, MS; 3University of Texas Health
Science Center San Antonio, San Antonio, TX
Discussant: D*John W. Brown, Indiana University School of Medicine,
Indianapolis, IN
3:30 pm – 3:45 pm (page 68)
5. The Impact of Video-assisted Thoracoscopic Surgery on Payment,
Healthcare Utilization, and Workplace Absenteeism for Patients
Undergoing Lung Resection
DThomas J. Watson1, DJiejing Qiu2
1
University of Rochester, Rochester, NY; 2Covidien, Inc., Mansfield, MA
Discussant: D*Betty C. Tong, Duke University Medical Center,
Durham, NC
3:45 pm – 4:00 pm (page 70)
6. The Impact of Transcatheter Aortic Valve Replacement on Surgical
AVR in Michigan
*Himanshu Patel1, Morley A. Herbert 3, Patricia F. Theurer2, Gail F. Bell2,
Jaelene Williams2, *Richard Prager1
1
University of Michigan, Ann Arbor, MI; 2MSTCVS Quality
Collaborative, Ann Arbor, MI; 3Southwest Data Consultants, Dallas, TX
Discussant: D*Michael J. Reardon, Methodist DeBaket Heart &
Vascular Center, Houston, TX
4:00 pm – 4:15 pm (page 72)
7. T
horacoscopy vs. Thoracotomy for Diaphragm Plication: A Value
Based Comparison
Onkar V. Khullar, Srini Tridandapani, *Felix G. Fernandez, *Seth D.
Force, *Allan Pickens
Discussant: *Theolyn N. Price, Cardiac & Thoracic Surgery Associates,
Colorado Springs, CO
4:15 pm – 4:30 pm (page 74)
8. L
earning Habits of the Current Cardiothoracic Resident: Analysis of
the In-training Examination Survey
David D. Odell1, Damien La Par12, Ryan A. Macke 4, Gabe Loor 3, Walter
F. DeNino11, Bill Stein7, Jennifer S. Nelson5, Kathleen Berfield9, John
Lazar 8, Vakhtang Tchantchaleishvili10, Samuel Youssef 6, Tom C.
Nguyen2
1
University of Pittsburgh School of Medicine, Pittsburgh, PA;
2
University of Texas Houston, Houston, TX; 3University of Minnesota,
Minneapolis, MN; 4University of Wisconsin, Madison, WI; 5University
of North Carolina, Chapel Hill, NC; 6Swedish Medical Center, Seattle,
WA; 7Emory University School of Medicine, Atlanta, GA; 8Lenox Hill
Hospital, New York, NY; 9University of Washington, Seattle, WA;
10
University of Rochester, Rochester, NY; 11Medical University of South
Carolina, Charleston, SC; 12University of Virginia, Charlottesville, VA
Discussant: *Stephen C. Yang, Johns Hopkins University School of
4:30 pm – 4:45 pm (page 76)
9. B
ilateral IMA Use for Coronary Artery Bypass Grafting Remains
Underutilized: A Propensity Matched Multi-Institution Analysis
*Damien J. LaPar1, *Ivan K. Crosby1, *Jeffrey B. Rich2, *Mohammed
A. Quader 3, *Alan M. Speir4, *John A. Kern1, *Irving L. Kron1, *Gorav
Ailawadi1
1
University of Virginia, Charlottesville, VA; 2Sentara Heart Hospital,
Norfolk, VA; 3Virginia Commonwealth University, Richmond, VA;
4
INOVA Heart and Vascular Center, Falls Church, VA
Discussant: *Michael R. Petracek, Vanderbilt University, Nashville, TN
SCHEDULE OF EVENTS
4:45 pm – 5:00 pm (page 78)
10. C
ontemporary Results of Open Surgical Repair in Patients
With Marfan Syndrome and Distal Aortic Dissection in the
Endovascular Era
D*Joseph Coselli, Ourania Preventza, Kim I. de la Cruz, Susan Y.
Green, Matt D. Price, *Scott A. LeMaire
Baylor College of Medicine/Texas Heart Institute, Houston, TX
Discussant: D*G. Chad Hughes, Duke University Medical Center,
Durham, NC
BASIC SCIENCE FORUM
6:45 am – 11:00 am
EXHIBITS OPEN
Tucson Ballroom A-E
7:00 am – 7:50 am
(Presentations are limited to five minutes, followed by two minutes of
discussion from a selected discussant and an additional one minute of
Moderator: *John S. Ikonomidis and *Christine L. Lau
7:00 am – 7:08 am (page 80)
1B. Pulsatile Flow Does Not Improve Function During Prolonged Ex Vivo Lung Perfusion
Erin Schumer, Keith Zoeller, Paul Linsky, Gretel Monreal, Michael Sobieski, Steven Koenig, *Mark Slaughter, Victor van Berkel
University of Louisville, Louisville, KY
Discussant: DMichael J. Weyant, University of Colorado,
Aurora, CO
7:08 am – 7:16 am (page 82)
2B. Circulating Tumor Cells From 4D Model Has Increased Activator Protein-1 Expression Compared to Primary Tumor
D*Min P. Kim3, Dhruva K. Mishra1, Chad Creighton2, Fengju Chen2, Michael J. Thrall3, Jonathan M. Kurie 4
1
Houston Methodist Research Institute, Houston, TX; 2Baylor College of Medicine, Houston, TX; 3Houston Methodist Hospital, Houston, TX; 4University of Texas MD Anderson Cancer Center, Houston, TX
Discussant: *Chadrick E. Denlinger, Medical University of South Carolina, Charleston, SC
7:16 am – 7:24 am (page 84)
3B. Are Histologic Abnormalities More Severe in Bicuspid Aortopathy?
Elbert Heng, James Stone, Thomas MacGillivray, Jennifer Walker, Joshua Baker, Gus Vlahakes, Hang Lee, *Thoralf Sundt
Massachusetts General Hospital, Boston, MA
Discussant: *Jorge D. Salazar, University of Mississippi School of Medicine, Jackson, MS
7:24 am – 7:32 am (page 86)
4B. Pediatric End-stage Failing Hearts Demonstrate Increased Cardiac
Stem Cells
Brody Wehman, Sudhish Sharma, Rachana Mishra, David L. Simpson, Savitha Deshmukh, *Sunjay Kaushal
University of Maryland Medical Center, Baltimore, MD
Discussant: D*John E. Mayer, Boston Children’s Hospital, Boston, MA
7:32 am – 7:40 am (page 88)
5B. Timing of Adding Blood to Prime Affects Inflammatory Response to Neonatal Cardiopulmonary Bypass
DBenjamin S. Schmidt, DMagan R. Lane, DVanessa M. DiPasquale, DLori P. Graf, D*Yoshio Ootaki, DJames E. Jordan, D*Ross M.
Ungerleider
Wake Forest Baptist Health, Winston Salem, NC
Discussant: E. Dean McKenzie, Texas Children’s Hospital, Houston, TX
7:40 am - 7:48 am (page 90)
6B. S
pinal Cord Ischemia Reperfusion Injury Induces Erythropoietin
Receptor Expression
Lisa S. Foley, Daine T. Bennett, Kirsten A. Freeman, Marshall Bell,
Joshua Mares, Xiangzhong Meng, *David A. Fullerton, *Thomas B.
Reece
University of Colorado, Aurora, CO
Discussant: *John W. Hammon, Wake Forest University Medical
Center, Winston-Salem, NC
SCHEDULE OF EVENTS
SECOND SCIENTIFIC SESSION
8:00 am – 10:00 am
Moderators: *Melanie A. Edwards and *Jorge D. Salazar
8:00 am – 8:15 am (page 92)
11. Surgical Therapy Is an Important Multimodality Component in
Patients With Distal Esophageal Adenocarcinoma Independent of
Regional Lymph Node Location
Boris Sepesi1, Henner M. Schmidt2, Michal Lada3, *Garrett L.
Walsh1, *Reza J. Mehran1, *David C. Rice1, *Jack A. Roth1, *Ara A.
Vaporciyan1, Jaffer A. Ajani1, Thomas J. Watson3, *Stephen G.
Swisher1, Donald E. Low 2, *Wayne L. Hofstetter1
1
University of Texas MD Anderson Cancer Center, Houston, TX; 2
Virginia Mason Medical Center, Seattle, WA; 3University of Rochester Medical Center, Rochester, NY
Discussant: *Mark J. Krasna, Jersey Shore University Medical Center, Neptune, NJ
8:15 am – 8:30 am (page 94)
12. T
he STS Adult Cardiac Surgery Database Version 2.73: More is
better!
Terry Shih1, Gaetano Paone2, Patricia F. Theurer 3, Donna McDonald5,
Gail F. Bell3, Jaelene K. Williams3, *David M. Shahian4, *Richard
Prager1
1
University of Michigan, Ann Arbor, MI; 2Henry Ford Hospital, Detroit, MI; 3MSTCVS Quality Collaborative, Ann Arbor, MI; 4Massachusetts General Hospital, Boston, MA; 5The Society of
Thoracic Surgery, Chicago, IL
Discussant: David M. Shahian, Massachusetts General Hospital, Boston, MA
8:30 am – 8:45 am (page 96)
13. A
Community-based Multi-disciplinary CT Screening Program
Improves Lung Cancer Survival
William D. Mayfield, D*Daniel L. Miller, Theresa D. Luu, Gerald A. Helms, Allan R. Muster, Vickie J. Beckler, Aaron Caan
WellStar Healthcare, Marietta, GA
Discussant: *John A. Howington, NorthShore University
HealthSystem, Evanston, IL
8:45 am – 9:00 am (page 98)
14. Moderate vs. Deep Hypothermia With Antegrade Cerebral Perfusion for Acute Type A Aortic Dissection
Bradley G. Leshnower, *Vinoud Thourani, *Michael Halkos, Eric Sarin, William B. Keeling, *Robert A. Guyton, *Edward P. Chen
Discussant: *Anthony L. Estrera, University of Texas Houston Medical School, Houston, TX
9:00 am – 9:15 am (page 100)
15. Establishing Contemporary Benchmarks for Surgical Pulmonary Valve Replacement: Analysis of The Society of Thoracic Surgeons
Congenital Heart Surgery Database
Amber D. Khanna1, Kevin Hill2, Sara K. Pasquali6, Amelia S. Wallace2, Joseph D. Kay1, Frederick A. Masoudi1, Marshall L. Jacobs3, *Jeffrey P. Jacobs 4, Tara Karamlou5
1
University of Colorado Anschutz Medical Campus, Aurora, CO; 2Duke University School of Medicine, Durham, NC; 3Johns Hopkins University School of Medicine, Baltimore, MD; 4 Johns Hopkins All Children's Hospital, St. Petersburg, FL; 5University of California, San Francisco, San Francisco, CA; 6University of Michigan, Ann Arbor, MI
Discussant: *Brian E. Kogon, Emory University, Children's Hospital at Egleston, Atlanta, GA
9:15 am – 9:30 am (page 102)
16. Longitudinal Trends in Morbidity and Mortality With Introduction of Robotic Assisted Thoracic Surgical Procedures at a Major Academic Cancer Center
Inderpal Sarkaria, Amanda A. Ghanie, Joe Dycoco, Rachel Grosser, David J. Finley, Nabil P. Rizk, James Huang, Prasad Adusumilli, Robert J. Downey, Manjit S. Bains, Valerie W. Rusch, *David R. Jones
Memorial Sloan-Kettering Cancer Center, New York, NY
Discussant: D*Mark W. Onaitis, Duke University Medical Center, Durham, NC
9:30 am – 9:45 am (page 104)
17. V
ariation in Outcomes for Risk-adjusted Pediatric and Congenital
Cardiac Operations: An Analysis of the Society of Thoracic Surgeons
(STS) Congenital Heart Surgery Database
*Jeffrey P. Jacobs1, Sean M. O'Brien2, Sara K. Pasquali3, *J. William
Gaynor4, Tara Karamlou7, Karl F. Welke5, Giovanni Filardo6, Jane M.
Han8, Sunghee Kim2, David M. Shahian9, Marshall L. Jacobs10
1
Johns Hopkins All Children's Heart Institute, St. Petersburg, FL; 2Duke
University School of Medicine, Durham, NC; 3University of Michigan,
Ann Arbor, MI; 4Children's Hospital of Philadelphia, Philadelphia, PA;
5
Children's Hospital of Illinois, Peoria, IL; 6Institute for Health Care
Research and Improvement, Dallas, TX; 7University of California San
Francisco, San Francisco, CA; 8The Society of Thoracic Surgeons,
Chicago, IL; 9Massachusetts General Hospital, Harvard Medical
School, Boston, MA; 10Johns Hopkins University, Baltimore, MD
Discussant: D*Frederick L. Grover, University of Colorado Denver,
Aurora, CO
9:45
am – 10:00 am (page 106)
18. R
esidents' Perceptions of Two- vs. Three-year Training Programs (2013 and 2014 TSRA/TSDA In-training Exam Survey
Tom C. Nguyen1, David Odell2, Elizabeth H. Stephens3, Gabriel Loor4,
Damien J. LaPar5, Walter F. DeNino6, Benjamin Wei7,Muhammad
Aftab8, Ryan A. Macke9, Jennifer S. Nelson10, Kathleen Berfield11,
John Lazar12, William Stein14, Samuel J. Youssef15, Vakhtang
Tchantchaleishvili13 1University of Texas-Houston, Houston, TX;
2
University of Pittsburgh Medical Center, Pittsburgh, PA; 3Columbia
University, New York City, NY; 4University of Minnesota, Minneapolis,
MN; 5University of Virginia, Charlottesville, VA; 6Medical University of
South Carolina, Charleston, SC; 7University of Alabama, Birmingham,
AL; 8Texas Heart Institute/Baylor, Houston, TX; 9University of
Wisconsin, Madison, WI; 10University of North Carolina, Chapel Hill,
NC; 11University of Washington, Seattle, WA; 12Lenox Hill, New York
City, NY; 13University of Rochester, Rochester, NY; 14Emory University,
Atlanta, GA; 15Swedish Hospital, Seattle, WA
Discussant: *William A. Baumgartner, Johns Hopkins University
School of Medicine, Baltimore, MD
10:00 am – 10:30 am
Tucson Ballroom A-E
SCHEDULE OF EVENTS
GENERAL SESSION (All attendees and guests welcome)
10:30 am – 12:00 pm
10:30 am – 10:50 am
Kent Trinkle Education Lectureship: The University of Louisville
and the Mason Dixon Line: Re-establishing Ties With the STSA
DMark S. Slaughter
10:50 am – 11:20 am
President’s Invited Lecturer: Codman’s Legacy: Data, Reporting,
and Professional Responsibility
David M. Shahian
Massachusetts General Hospital, Boston, MA
11:20 am – 12:00 pm
Presidential Address: Art and the Human Condition
*Richard L. Prager
University of Michigan, Ann Arbor, MI
12:00 pm
All Attendee Lunch
Ania Terrace
12:00 pm – 4:00 pm
EXHIBITS OPEN
Dessert served in the Exhibit Hall at 1:00 pm
Tucson Ballroom A-E
THIRD SCIENTIFIC SESSION A
2:00 pm – 3:30 pm
Simultaneous Cardiac, General Thoracic, and Congenital Breakout
Sessions
Attendees select to participate in one of the following three breakout
sessions:
ADULT CARDIAC BREAKOUT Arizona Ballroom 6–7
Moderators: D*Gorav Ailawadi and D*Himanshu J. Patel
2:00 pm – 2:15 pm (page 108)
19. Retrograde Ascending Aortic Dissection After TEVAR for Distal
Aortic Dissection and Zone 0 Landing: Association, Risk Factors,
and True Incidence
Andrea Garcia2, D*Ourania Preventza1, *Denton Cooley1, Lorena
Gonzales2, D*Joseph Coselli1
1
Texas Heart Institute at Baylor St. Luke's Medical Center, Houston,
TX; 2Baylor College of Medicine, Houston, TX
Discussant: *Edward P. Chen, Emory University School of Medicine, Atlanta, GA
2:15 pm – 2:30 pm (page 110)
20. Short- and Mid-term Outcomes in Transcatheter Aortic Valve
Replacement in Ninety-five Nonagenarians: Comparison of
Transfemoral and Alternative Access Procedures
Michael O. Kayatta, Vasilis Babaliaros, Eric Sarin, Patrick Kilgo, Chun
Li, Chandan Devireddy, Bradley G. Leshnower, Kreton Mavromatis,
Amanda Maas, Robert A. Guyton, James Stewart, Peter Block, Stam
Lerakis, D*Vinod Thourani
Discussant: *Thomas M. Beaver, University of Florida,
Gainesville, FL
2:30 pm – 2:45 pm (page 112)
21. E
arly and Late Outcomes After Complete Aortic Replacement
*Anthony L. Estrera, Harleen Sandhu, Tom C. Nguyen, Ali Azizzadeh,
Kristofer Charlton-Ouw, Charles C. Miller, *Hazim J. Safi
University of Texas Medical School at Houston, Memorial Hermann
Heart and Vascular Institute, Houston, TX
Discussant: *John A. Kern, University of Virginia Health System,
Charlottesville, VA
SCHEDULE OF EVENTS
2:45 pm – 3:00 pm (page 114)
22.Long-term Survival Following Bovine Pericardial Versus Porcine
Stented Bioprosthetic Aortic Valve Replacement: Does Valve Choice
Matter?
Asvin M. Ganapathi, Brian R. Englum, Jeffrey Keenan, *Hanghang
Wang, Matthew A. Schechter, *Donald D. Glower, *G. Chad Hughes
Discussant: D*William H. Ryan, Cardiac Surgery Specialists,
Plano, TX
3:00 pm – 3:15 pm (page 116)
23. R
ed Blood Cells and Mortality After Coronary Artery Bypass
Surgery: Are We Really Transfusing Patients to Death?
Gaetano Paone1, Morley A. Herbert4, Patricia F. Theurer 3, Gail F. Bell3,
Jaelene K. Williams3, Donald S. Likosky2, *Richard Prager2
1
Henry Ford Hospital, Detroit, MI; 2University of Michigan, Ann Arbor,
MI; 3MSTCVS Quality Collaborative, Ann Arbor, MI; 4Southwest Data
Consultants, Dallas, TX
Discussant: D*Alan M. Speir, INOVA Heart and Vascular Institute,
Falls Church, VA
3:15 pm – 3:30 pm (page 118)
24. Transcatheter Aortic Valve Replacement (TAVR) vs. Off Pump Aortic Valve Bypass (AVB) With an Apico-Aortic Conduit: A Comparison of Outcomes and Hospital Economics
*John Brown, Jack H. Boyd, Parth Patel, Amjad Syed, Joe Ladowski,
Joel Corvera
Indiana University, Indianapolis, IN
Discussant: D*Faisal G. Bakaeen, Texas Heart Institute/Baylor
College of Medicine, Houston, TX
(Presentations are limited to seven minutes, followed by eight minutes
of discussion.)
Moderators: D*Traves D. Crabtree and *Mitchell J. Magee
2:00 pm – 2:15 pm (page 120)
25. A
n Assessment of the Optimal Time for Removal of Esophageal
Stents Used in the Treatment of an Esophageal Anastomotic Leak
or Perforation
*Richard K. Freeman, *Anthony J. Ascioti, Megan Dake, Raja S.
Mahidhara
St. Vincent Hospital, Indianapolis, IN
2:15 pm – 2:30 pm (page 122)
26. Electromagnetic Navigation Bronchoscopy Guided Methylene
Blue Pleural Dye Marking for the Thoracoscopic Localization and
Resection of Small Pulmonary Nodules
Omar Awais1, Michael Reidy1, *Arjun Pennathur1, Valentino J.
Bianco1, William E. Gooding2, James D. Luketich1
1
University of Pittsburgh Medical Center, Pittsburgh, PA; 2University
of Pittsburgh Cancer Institute, Pittsburgh, PA
2:30 pm – 2:45 pm (page 124)
27. Efficacy of Portable Ultrasound to Detect Pneumothorax Post Lung
Resection
Farah Mohammad, Arielle Hodari, Ilan Rubinfeld, Karen Byers, Keith
Killu, *Zane Hammoud
Henry Ford Hospital, Detroit, MI
2:45 pm – 3:00 pm (page 126)
28. Resection for Primary and Metastatic Tumors of the Sternum: An
Analysis of Prognostic Variables
Usman Ahmad1, Haoxian Yang1, Daniel H. Buitrago1, Manjit S. Bains1,
Nabil P. Rizk1, James Huang1, Prasad Adusumilli1, Gaetano Rocco2,
*David R. Jones1
1
Memorial Sloan-Kettering Cancer Center, New York, NY; 2National
Cancer Institute, Naples, Italy
3:00 pm – 3:15 pm (page 128)
29. L
ung Function Predicts Pulmonary Complications After Minimally
Invasive Lobectomy
Mark K. Ferguson, Ruoyu Zhang, Sang Mee Lee, Chris Wigfield,
Wickii T. Vigneswaran
University of Chicago, Chicago, IL
3:15 pm – 3:30 pm (page 130)
30. S
urvival After Sublobar Resection vs. Lobectomy for Clinical
Stage IA Lung Cancer: An Analysis of Over 5,000 Patients from the
National Cancer Database
Onkar V. Khullar, Theresa Gillespie, Dana Nickleach, Yuan Liu, Kristin
Higgins, Suresh Ramalingam, Joseph Lipscomb, *Felix G. Fernandez
Moderators: *Lauren C. Kane and *Jorge D. Salazar
2:00 pm – 2:15 pm (page 132)
31. R
esults of Palliation With an Initial Modified Blalock-Taussig
Shunt in Infants With Single Ventricle Associated With Restrictive
Pulmonary Blood Flow
Bahaaldin Alsoufi, *Brian Kogon, Ritu Sachdeva, Brian Schlosser,
Martha Clabby, William Mahle, Dennis Kim, *Kirk Kanter
Discussant: *Pirooz Eghtesady, St. Louis Children's Hospital, St.
Louis, MO
2:15 pm – 2:30 pm (page 134)
32. A
rterioplasty for Right Ventricular Outflow Tract Obstruction
Following Arterial Switch Is a Durable Procedure
Luke M. Wiggins, S. Ram Kumar, *Vaughn A. Starnes, *Winfield J.
Wells
Children's Hospital Los Angeles, Los Angeles, CA
Discussant: *E. Dean McKenzie, Texas Children's Hospital,
Houston, TX
SCHEDULE OF EVENTS
2:30 pm – 2:45 pm (page 136)
33. O
utcomes of ECMO in Children With Single Ventricle Physiology
S. Ram Kumar, Antonio J. Escobar, *Vaughn A. Starnes, *Winfield J.
Wells
Children's Hospital Los Angeles, Los Angeles, CA
Discussant: Gordon A. Cohen, University of California, San
Francisco, CA
2:45 pm – 3:00 pm (page 138)
34. Intermediate Results of Hybrid vs. Primary Norwood Operation in
Risk Stratified Cohorts
Daniel J. Dibardino, Juliana Gomez-Arostegui, Aaron Kemp, Raveen
Raviendran, Sanjeet Hegde, Eric Devaney, John Lamberti, Howaida
El-Said
University of California San Diego/Rady Children's Heart Institute,
San Diego, CA
Discussant: Christian Pizarro, Nemours Cardiac Center, Alfred I.
duPont Hospital for Children, Wilmington, DE
3:00 pm – 3:15 pm (page 140)
35. C
ontemporary Outcomes of Surgical Repair of Total Anomalous
Pulmonary Venous Connection in Patients With Heterotaxy
Syndrome: An Analysis of The Society of Thoracic Surgeons (STS)
Roosevelt Bryant1, Muhammad S. Khan1, Sunghee Kim2, Kevin D.
Hill2, Jeffrey P. Jacobs2, Marshall L. Jacobs2, Sara K. Pasquali2, David
L. Morales1
1
Cincinnati Children's Hospital Medical Center, Cincinnati, OH; 2Duke
Clinical Research Institute, Durham, NC
Discussant: *Robert D.B. Jaquiss, Duke Children's Hospital, Durham,
NC
3:15 pm – 3:30 pm (page 142)
36. Long-term Outcome of Aortic Implantation for Patients With
Anomalous Origin of the Left Coronary Artery From the Pulmonary
Artery
Michael C. Monge, Osama Eltayeb, John M. Costello, Anne E.
Sarwark, Michael R. Carr, *Carl L. Backer
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
Discussant: *James Jaggers, Children’s Hospital Colorado, Aurora,
CO
3:30 pm – 4:00 pm
Tucson Ballroom A-E
THIRD SCIENTIFIC SESSION B
4:00 pm – 5:00 pm
Simultaneous Cardiac, General Thoracic, and Congenital Breakout
Sessions
Attendees select to participate in one of the following three breakout
sessions:
Moderators: D*Faisal G. Bakaeen and *Jennifer S. Lawton
4:00 pm – 4:15 pm (page 144)
37. Nadir Hematocrit on Bypass and Rates of Acute Kidney Injury: Does
Gender Matter?
Michelle C. Ellis3, Theron A. Paugh3, Timothy A. Dickinson4, John
Fuller2, Jeffrey Chores2, *Gaetano Paone5, *Himanshu J. Patel3,
*Richard Prager 3, Donald S. Likosky 3, on behalf of the Michigan
Society of Thoracic and Cardiovascular Surgeons Perfusion
Measures and Outcomes (PERForm) Registry1
1
Michigan Society of Thoracic and Cardiovascular Surgeons
Perfusion Measures and Outcomes (PERForm) Registry, Ann Arbor,
MI; 2St. John Providence Health System, Detroit, MI; 3University of
Michigan, Ann Arbor, MI; 4Specialty Care, Nashville, TN; 5Henry Ford
Hospital, Detroit, MI
Discussant: D*Gorav Ailawadi, University of Virginia, Charlottesville,
VA
4:15 pm – 4:30 pm (page 146)
38. Severe Aortic Valve Stenosis in Rural Community Practice: Under
Treated and Under Referred for Definitive Management
Michael Kayatta2, Julio C. Vasquez1, *Jacob DeLaRosa1
1
Idaho State University, Pocatello, ID; 2Emory University, Atlanta, GA
Discussant: D*Himanshu J. Patel, University of Michigan, Ann Arbor,
MI
4:30 pm – 4:45 pm (page 148)
39. C
ardiac Myxomas: A 50-year Experience With Resection
and Recurrence
Ishan Shah, *Joseph Dearani, *Richard Daly, *Rakesh Suri, *Soon
Park, *Lyle Joyce, Zhuo Li, *Hartzell Schaff
Mayo Clinic, Rochester, MN
Discussant: *Curtis G. Tribble, University of Virginia, Charlottesville,
VA
SCHEDULE OF EVENTS
4:45 pm – 5:00 pm (page 150)
40. A
New Surgical Approach to Exclude the Left Atrial Appendage
Through Right Minithoracotomy and the Transverse Sinus During a
Minimally Invasive CryoCox-Maze Procedure
DNiv Ad, Paul S. Massimiano, Graciela Pritchard, Sari D. Holmes
INOVA Heart and Vascular Institute, Falls Church, VA
Discussant: *James S. Gammie, University of Maryland Medical
Center, Maryland, MD
of discussion.)
Moderators: *Mark J. Krasna and *Theresa D. Luu
4:00 pm – 4:15 pm (page 152)
41. Modifications to the Robotic Esophageal to Gastric Anastomosis
*Benjamin Wei, *Douglas J. Minnich, Ayesha S. Bryant,
*Robert Cerfolio
University of Alabama, Birmingham, AL
4:15 pm – 4:30 pm (page 154)
42. T
imely Discharge and Outpatient Management of Prolonged Air
Leaks Following Lobectomy: Utilization and Cost Containment
Ryan K. Schmocker, Ryan A. Macke, *Shahab A. Akhter, James D.
Maloney, Justin D. Blasberg
University of Wisconsin School of Medicine and Public Health,
Madison, WI
4:30 pm – 4:45 pm (page 156)
43. S
urgery for Benign Esophageal Disease: Does Surgeon Specialty
Matter?
Michael Kent, Thomas Wang, Thomas Curran, Sidhu Gangadharan,
Richard Whyte
Beth Israel Deaconess Medical Center, Boston, MA
4:45 pm – 5:00 pm (page 158)
44. E
ndobronchial Valves in the Treatment of Persistent Air Leaks
John M. Hance, *Jeremiah Martin, *Timothy W. Mullett
University of Kentucky, Lexington, KY
Moderators: Jennifer C. Hirsch-Romano and *Jeffrey P. Jacobs
4:00 pm – 4:15 pm (page 160)
45. Concomitant Procedures Performed During Adult Congenital Heart
Surgery: An Unclear Risk/Benefit Ratio?
*Brian E. Kogon2, Bahaaldin Alsoufi2, Wendy Book 2, Matthew Oster1,
Alexandra Ehrlich1
1
Children's Healthcare of Atlanta, Atlanta, GA; 2Emory University
School of Medicine, Atlanta, GA
Discussant: Harold M. Burkhart, Mayo Clinic, Rochester, MN
4:15 pm – 4:30 pm (page 162)
46. T
he Outcome of Right Ventricle to Pulmonary Artery Conduit for
Biventricular Repair
Takeshi Shinkawa, Carl Chipman, Tom Bozzay, Xinyu Tang, Jeffery
Gossett, Michiaki Imamura
Arkansas Children's Hospital, Little Rock, AR
Discussant: *Paul J. Chai, Columbia University Medical Center, New
York, NY
4:30 pm – 4:45 pm (page 164)
47. E
arly Outcomes of Pulmonary Valve Replacement With the
Mitroflow Bovine Pericardial Bioprosthesis
Sarah A. Schubert, *Joseph B. Clark, John L. Myers
Penn State College of Medicine, Hershey, PA
Discussant: George M. Alfieris, University Surgical Associates, L.L.P.,
SUNY Health Science Center, Syracuse, NY
4:45 pm – 5:00 pm (page 166)
48. M
oderate Tricuspid Valve Regurgitation at the Time of Pulmonary
Valve Replacement: Annuloplasty or Not?
*Brian E. Kogon1, Makoto Mori1, Bahaaldin Alsoufi1, *Kirk Kanter1,
Wendy Book1, Matthew Oster2
1
Emory University School of Medicine, Atlanta, GA; 2Children's
Healthcare of Atlanta, Atlanta, GA
Discussant: *Charles B. Huddleston, Saint Louis University School of
5:00 pm – 6:00 pm
STSA ANNUAL BUSINESS MEETING (Members Only)
6:00 pm – 7:00 pm
Residents Reception
San Luis 1-2
7:00 pm – 9:00 pm
President’s Mixer
Ania Terrace
SCHEDULE OF EVENTS
CODING UPDATE
CODING UPDATE Arizona Ballroom 6–7
7:00 am – 8:00 am
Educational Objective: Upon completion of this program participants
will be able to understand typical and challenging issues in coding and
reimbursement of cardiothoracic surgery procedures.
Update on CPT and Physician Payment Issues for 2015
Moderator: *Peter K. Smith, Duke University Medical Center,
Durham, NC
FOURTH SCIENTIFIC SESSION A
8:00 am – 9:00 am
Simultaneous Cardiac, General Thoracic, Congenital, and Transplant
Breakout Sessions
Attendees select to participate in one of the following four breakout
sessions:
Moderators: *Anthony L. Estrera and *Charles Patrick Murrah
8:00 am – 8:15 am (page 168)
49. I nstitutional Variation in Mortality After Stroke Following Cardiac
Surgery: An Opportunity for Improvement
*Damien J. LaPar1, *Mohammed A. Quader2, *Jeffrey B. Rich3,
*Irving L. Kron1, *Ivan K. Crosby1, *John A. Kern1, *Alan M. Speir4,
*Gorav Ailawadi1
1
University of Virginia, Charlottesville, VA; 2Virginia Commonwealth
University, Richmond, VA; 3Sentara Heart Hospital, Norfolk, VA;
4
INOVA Heart and Vascular Center, Falls Church, VA
Discussant: *Andrea J. Carpenter, University of Texas, Health
Science Center at San Antonio, San Antonio, TX
8:15 am – 8:30 am (page 170)
50. Cost Analysis of Physician Assistant Home Visit Program to Reduce
Hospital Readmission
John Nabagiez, Masood A. Shariff, Robert Carlucci, Joseph DiNatale,
William Molloy, DJoseph T. McGinn
Staten Island University Hospital, Staten Island, NY
Discussant: D*Kevin D. Accola, Cardiovascular Surgical PA, Orlando,
FL
8:30 am – 8:45 am (page 172)
51. O
n-pump Versus Off-pump Coronary Artery Bypass Graft Surgery Among Patients With Type 2 Diabetes
*Edward Sako4, Ashima Singh1, *Hartzell Schaff 2, Maria M. Brooks1,
Mark Hlatky 3, Robert Frye2
1
University of Pittsburgh, Pittsburgh, PA; 2Mayo Clinic, Rochester,
MN; 3Stanford University, Palo Alto, CA; 4University of Texas Health
Science Center at San Antonio, San Antonio, TX
Discussant: *Jennifer S. Lawton, Washington University School of
Medicine, St. Louis, MO
8:45 am – 9:00 am (page 174)
52. Surgical Embolectomy for Acute Massive and Submassive
Pulmonary Embolism in a Series of 115 Patients
Robert C. Neely, *John G. Byrne, Igor Gosev, *Lawrence H. Cohn,
Quratulain Javed, James D. Rawn, *Sary F. Aranki, Samuel Z.
Goldhaber, Gregory Piazza, Marzia Leacche
Brigham and Women's Hospital, Boston, MA
Discussant: D*Neal D. Kon, Wake Forest University School of
Medicine, Winston-Salem, NC
SCHEDULE OF EVENTS
of discussion.)
Moderators: D*Min P. Kim and D*Daniel L. Miller
8:00 am – 8:15 am (page 176)
53. R
e-evaluation of the Modified Ravitch Repair for Pectus Defects:
Forgotten Advantages?
*Michael H. Hines
University of Texas Medical School at Houston, Houston, TX
8:15 am – 8:30 am (page 178)
54. Does Thoracoscopic Surgery Decrease the Morbidity of Combined
Lung and Chest Wall Resection?
Mark Hennon, Elisabeth Dexter, Miriam Huang, John Kane,
Chukwumere Nwogu, Anthony Picone, Sai Yendamuri, *Todd Demmy
Roswell Park Cancer Institute, Buffalo, NY
8:30 am – 8:45 am (page 180)
55. A
Prospective Clinical Trial of Telecytopathology for Rapid
Interpretation of Specimens Obtained During Endobronchial
Ultrasound (EBUS)
Matthew Bott, Bryce James, Brian Collins, *Varun Puri, *Daniel
Kreisel, *Alexander S. Krupnick, *George A. Patterson, *Stephen R.
Broderick, *Bryan F. Meyers, *Traves Crabtree
8:45 am – 9:00 am (page 182)
56. Does Surgical Upstaging in Resected Lung Cancer Depend on the
Surgical Approach?
*Jeremiah Martin, Eric B. Durbin, Li Chen, Tamas Gal, Angela Mahan,
*Victor Ferraris, *Joseph B. Zwischenberger
University of Kentucky, Lexington, KY
TRANSPLANT BREAKOUT Arizona Ballroom 1
of discussion.)
Moderators: *Shahab A. Akhter and *Allan Pickens
8:00 am – 8:15 am (page 184)
57. Should Single Lung Transplantation Continue to be Performed in
Patients With Chronic Obstructive Pulmonary Disease (COPD)?
Daine T. Bennett, Martin R. Zamora, *Thomas B. Reece, John
D. Mitchell, Joseph C. Cleveland, *Frederick L. Grover, David A.
Fullerton, Ashok Babu, Robert A. Meguid, Michael J. Weyant
University of Colorado Denver School of Medicine, Aurora, CO
8:15 am – 8:30 am (page 186)
58. Prior Sterntomy and Ventricular Assist Device Implant Do Not
Adversely Impact Survival or Allograft Function Following Heart
Transplant
Ann C. Gaffey, Emily Phillips, Jessica Howard, Robert Emery, Dale
Korbin, Lee Goldberg, Micheal Acker, *Y. Joseph Woo, *Pavan Atluri
Hospital of the University of Pennsylvania, Philadelphia, PA
8:30 am – 8:45 am (page 188)
59. Stroke After Left Ventricular Assist Device Implantation: Outcomes
in the Continuous Flow Era
Laura Harvey, Christopher Holley, Samit Roy, Peter Eckman, Monica
Colvin-Adams, Kenneth Liao, Ranjit John
University of Minnesota, Minneapolis, MN
8:45 am – 9:00 am (page 190)
60. Is There an Age Limit to Lung Transplantation?
Sreeja Biswas Roy1, Diana Alarcon2, Rajat Walia2, Kristina M.
Chapple2, Ross Bremner2, Michael A. Smith2
1
Providence Hospital and Medical Center, Southfield, MI; 2St.
Joseph's Hospital and Medical Center, Phoenix, AZ
Moderators: *Paul J. Chai and *Charles B. Huddleston
8:00 am – 8:15 am (page 192)
61. Left Ventricular Re-training and Late Arterial Switch for
D-transposition of the Great Arteries
Naruhito Watanabe, *Richard D. Mainwaring, Sergio Carrillo, V.
Mohan Reddy, Frank Hanley
Stanford University School of Medicine, Stanford, CA
Discussant: Jennifer Hirsch-Romano, University of Michigan, Ann
Arbor, MI
8:15 am – 8:30 am (page 194)
62. Equivalent Outcomes for Early and Late Complete Atrioventricular
Canal Repair in the Modern Era
Elizabeth H. Stephens, Ali N. Ibrahimiye, Halit Yerebakan, Tuba
Gencol, Matthew Lippel, Betul Yilmaz, Wyman Lai, Anjali Chelliah,
Amee Shah, Stephanie Levasseur, *Paul Chai, Jan Quaegebeur,
Emile Bacha
Columbia University Medical Center, New York, NY
Discussant: *Carl L. Backer, Ann & Robert H. Lurie Children's
Hospital, Chicago, IL
8:30 am – 8:45 am (page 196)
63. A
ortic Valve Leaflet Morphology Is Associated With the Patterns
of Aortic Dilation and Valve Dysfunction in Young Patients With
Bicuspid Aortic Valves
Mark Ruzmetov, Jitendra J. Shah, *Randall S. Fortuna, *Karl F. Welke
Children's Hospital of Illinois, Peoria, IL
Discussant: *Luca A. Vricella, Johns Hopkins University School of
8:45 am – 9:00 am (page 198)
64. The Supported (Ross Ungerleider) Modified Ross Operation: Early
Outcomes and Intermediate Follow Up
Roni Jacobsen, Michael Earing, Garrick Hill, Michael Barnes, *James
Tweddell
Medical College of Wisconsin/Children's Hospital of Wisconsin,
Milwaukee, WI
Winston-Salem, NC
SCHEDULE OF EVENTS
9:00 am – 9:30 am
Break
HAROLD URSCHEL HISTORY LECTURESHIP Arizona Ballroom 6–7
Moderator: *John W. Hammon
9:30 am – 9:50 am (page 200)
65. O
sler Almon Abbott: The Man, The Award and His Legacy
D*Daniel L. Miller, *Joseph I. Miller, Jr., *Kamal A. Mansour
FOURTH SCIENTIFIC SESSION B
FOURTH SCIENTIFIC SESSION B Arizona Ballroom 6–7
9:50 am – 11:50 am
Moderators: *John H. Calhoon and D*Robert J. Cerfolio
9:50 am – 10:05 am (page 202)
66. O
ne Hundred Safe Transports on Extracorporeal Life Support to a
Regional Extracorporeal Membrane Oxygenation Center
Mauer Biscotti1, Darryl Abrams1, Cara Agerstrand1, *Joshua Sonett1,
Linda Mongero2, *Hiroo Takayama1, DDaniel Brodie1, *Matthew
Bacchetta1
1
Columbia University Medical Center, New York, NY; 2New York
Presbyterian Hospital, New York, NY
Discussant: D*Joseph B. Zwischenberger, University of Kentucky,
Lexington, KY
10:05 am – 10:20 am (page 204)
67. S
urvival in Patients With Continuous-flow Left Ventricular
Assist Devices on the Waiting List and Marginal Donor Heart
Transplantation Recipients: A UNOS Database Analysis
Erin Schumer, Mickey Ising, Jaimin Trivedi, *Mark Slaughter, Allen
Cheng
Discussant: *James K. Kirklin, University of Alabama, Birmingham,
AL
10:20 am – 10:35 am (page 206)
68. M
odified Single Patch: Are We Still Worried About Subaortic
Stenosis?
*Carl L. Backer, Osama Eltayeb, Michael C. Monge, Katherine
Wurlitzer, Lindsay H. Boles, Anne E. Sarwark, Joshua D. Robinson
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
Discussant: *Jorge D. Salazar, University of Mississippi School of
Medicine, Jackson, MS
10:35 am – 10:50 am (page 208)
69. Outcomes of Heart Transplantation in Children With Congenital Heart Disease
Bahaaldin Alsoufi, Shriprasad Deshpande, *Brian Kogon, William
Mahle, Robert Vincent, *Kirk Kanter
Discussant: *Kristine J. Guleserian, Children's Medical Center/UT
Southwestern Medical Center, Dallas, TX
10:50 am – 11:05 am (page 210)
70. Is Interest in a Cardiothoracic Surgical Career Maintained After
Scholarship Awards to Medical Students? Long-term Results From
a Single Institution
Kanika Trehan, Xun Zhou, *Stephen C. Yang
Johns Hopkins Medical Institutions, Baltimore, MD
Discussant: *Curtis G. Tribble, University of Virginia, Charlottesville,
VA
11:05 am – 11:20 am (page 212)
71. Functional Tricuspid Regurgitation Repair Solved: Undersized Rigid
Annuloplasty Insertion Assures Effective and Durable Repair
Mehrdad Ghoreishi, Faisal H. Cheema, Mary Laschinger, Murtaza Y.
Dawood, Charlie Evans, Nathaniel Foster, Xiayang Diao, Bradley S.
Taylor, *Bartley P. Griffith, *James S. Gammie
University of Maryland School of Medicine, Baltimore, MD
Discussant: *John M. Stulak, Mayo Clinic, Rochester, MN
11:20 am – 11:35 am (page 214)
72. S
uper-charged Pedicled Jejunal Interposition Performance
Compares Favorably to a Gastric Conduit After Esophagectomy
Elizabeth Stephens1, Puja Gaur 3, Kathleen Hotze3, Arlene Correa4,
Min Kim3, Shanda Blackmon2
1
Columbia University, New York, NY; 2Mayo Clinic, Rochester, MN;
3
The Methodist Hospital, Houston, TX; 4MD Anderson Cancer Center,
Houston, TX
11:35 am – 11:50 am (page 216)
73. Age-related Outcomes of the Ross Procedure over Twenty Years
Neeraj Bansal1, S. Ram Kumar1, Craig J. Baker1, Ruth Lemus2,
*Winfield J. Wells1, *Vaughn A. Starnes1
1
University of Southern California, Los Angeles, CA; 2Children's
Hospital Los Angeles, Los Angeles, CA
Discussant: *Edward L. Bove, University of Michigan,
Ann Arbor, MI
11:50 am
PROGRAM ADJOURNS
SCIENTIFIC
PAPERS
WEDNESDAY - SCIENTIFIC PAPERS
1V. Repair of Simple Bicuspid Valve Defects Using Geometric
Ring Annuloplasty
Unless otherwise noted in this program book or verbally by the speakers, speakers have
no relevant financial relationship to disclose and will only be presenting information on
devices, products, or drugs that are FDA approved for the purposes they are discussing.
Authors listed with a D next to their name have indicated that they have a financial or
other relationship with a healthcare-related business or other entity to disclose.
Authors: DDomenico Mazzitelli1, Steffen Pfeiffer2, D*J. Scott Rankin3,
Christian Nöbauer1, Christian Schreiber1, Theodor Fischlein2, Rüdiger
Lange1
Author Institution(s): 1Deutsches Herzzentrum Muenchen, Munich,
Germany; 2Klinikum Nürnberg, Nürnberg, Germany; 3Vanderbilt
University, Nashville, TN
COMMERCIAL RELATIONSHIPS: Domenico Mazzitelli: Consultant/Advisory Board:
BioStable Science and Engineering Inc.; J. Scott Rankin: Consultant/Advisory Board:
BioStable Science and Engineering Inc.
REGULATORY DISCLOSURE: This presentation describes the HAART 200 Bicuspid
Aortic Annuloplasty Ring, which has an FDA approval status of Investigational
Objectives: Repair of bicuspid valves with aortic insufficiency has
become routine, and leaflet reconstruction techniques are now
standardized. Long-term results are good, but some patients experience
late repair failure due to progressive annular dilatation. This video
illustrates bicuspid annular stabilization during repair, using a geometric
annuloplasty ring.
Methods: An internal bicuspid annuloplasty ring was developed
with circular base geometry, and two 10-degree outwardly flaring
subcommissural posts, positioned 180 degrees opposite on the
circumference. This video shows the technique of surgical ring
placement into the valve annulus, and bicuspid leaflet repair, in two
patients with simple bicuspid defects. The first patient had a Sievers
Type 0 valve with R-L fusion, no cleft, and only moderate aortic
insufficiency. The valve was repaired during grafting of an ascending
aortic aneurysm. The second patient had a Sievers Type I valve with
R-L fusion, a moderate cleft, and severe aortic insufficiency. Both
were repaired with #23 ring annuloplasties and standard leaflet
reconstruction techniques.
Results: In both patients, ring annuloplasty was performed initially,
which moved the sinus-to-sinus dimension toward the midline, and
facilitated leaflet coaptation. Patient 1 required only minor leaflet
plication, and patient 2 had closure of a moderate fused leaflet cleft,
in addition to leaflet plication. Both patients achieved complete
competence after repair and exhibited low trans-valvular gradients.
Conclusion: Bicuspid ring annuloplasty is a simple and expeditious
method of annular stabilization during valve repair and does not require
deep aortic root dissection. Major annular remodeling converts the
valve to 50%-50% annular geometry and contributes to improved
leaflet coaptation. Geometric ring annuloplasty could improve the early
and late results of simple bicuspid valve repair associated with aortic
insufficiency. *STSA Member D Relationship Disclosure
NOTES:
2V. Endoluminal Suturing
Authors: *Shanda H. Blackmon
Author Institution(s): Mayo Clinic, Rochester, MN
Objectives: The objectives of this video are to review indications,
equipment, and training for endoluminal suturing. Outcomes after an
individual case will also be reviewed.
Methods: A 76 year-old man with end-stage renal disease, diabetes,
congestive heart failure, anemia, hypertension, an aortic aneurysm,
benign prostatic hypertrophy, with a history of rheumatic heart disease
and left ventricular thrombus, who previously underwent an aortic valve
replacement, presented to an outside hospital for trans-esophageal
echocardiography in December of 2013 resulting in an esophageal
tear. He immediately underwent surgical repair with a left thoracotomy
and intercostal muscle flap. He developed persistent leaking from
the esophagus after the repair, which was drained by a chest tube.
Surgical side diversion was performed. With continued leakage, he was
transferred for a persistent leaking intrathoracic esophagus.
Results: A partially covered self-expanding metal stent was placed
initially, but endoscopic evaluation upon stent removal revealed
persistent drainage from the intrathoracic esophagus. Using an
Olympus 190 dual-lumen endoscope with through an overtube,
the fistula was easily identified endoscopically and fluroscopically
with contrast injection. After coagulating the surface of the fistula,
endoscopic suturing using the Apollo Endostitch device was used to
close the hole with a figure-eight suture technique. Endoscopic and
fluroscopic confirmation of closure was achieved. The patient was
discharged on post-procedure day 30. His contrast swallow performed
one month after closure confirmed complete healing without stricture
or narrowing. The patient is scheduled to have the side diversion closed
electively.
Conclusion: Endoscopic closure of complex esophageal perforations in
poor surgical candidates can be performed safely.
NOTES:
3V. Minimally Invasive Transhiatal Esophagogastrectomy With
Mediastinal Anatomosis: Technique and Avoidance of Pitfalls
Authors: Allison Linden, Young Hong, Lorenzo De Marchi, Nadime
Haddad, *M. Blair Marshall
Author Institution(s): MedStar Georgetown University Hospital,
Washington, DC
Objectives: This video demonstrates the technical aspects of an
esophagogastrectomy through the hiatus with the creation of a
mediastinal anastomosis using the trans-oral stapler. We have found
the technique useful in the management of patients with end-staged
benign obstruction at the gastroesophageal junction as well as specific
malignant pathologies, including very early stages esophageal cancer
or cardia cancers suited to a limited resection. However there are
particular pitfalls associated with the use of this device. Technical
aspects and avoidance of pitfalls will be highlighted.
Methods: Indications, patient positioning, and port placement are
reviewed. The technique for intra-abdominal and mediastinal dissection
is demonstrated. Methods for placement of the trans-oral device by the
anesthesia team, specific challenges and techniques to overcome these
challenges are highlighted. The technique for mating of the stapler,
pitfalls and means of avoidance are as well demonstrated.
Results: The trans-oral end-to-end stapler is a useful tool for the
creation of mediastinal esophagogastric anastomosis and avoids
the need for repositioning or additional incisions, common to
esophagectomy surgery. However, thoracic lymphadenectomy is
limited with this approach.
Conclusion: The successful use of this instrument is dependent upon
placement of the anvil through the esophageal staple line as well as the
correct mating of the stapling device when performing the anastomosis.
Critical steps and technique facilitate the successful use of this device.
NOTES:
4V. Neonatal Surgical Repair of Aortico-Left Ventricular Tunnel
Authors: Vijay Sadasivam, Vijayakumar Raju, John N. Kheir, Gerald R.
Marx, Sitaram M. Emani
Author Institution(s): Boston Children Hospital, Boston, MA
Objectives: Aortico-left ventricular tunnel is an extremely rare
congenital heart lesion. It represents a paravalvar communication
between the aorta and left ventricle (LV). The continuous run off of
blood into the LV through the tunnel leads to volume overload with
congestive heart failure. Early surgical closure is essential for survival.
Methods: A full term, newborn baby was diagnosed to have aortic
regurgitation of unclear etiology on prenatal echocardiogram,
developed increased work of breathing shortly after birth. Postnatal
echo confirmed the diagnosis of large aortico–LV tunnel through with
continuous regurgitation and severe LV dilatation. Right coronary artery
(RCA) was arising directly from the tunnel. Echo also demonstrated
a dysplastic aortic valve with mild central aortic regurgitation and
holodiastolic flow reversal in the abdominal aorta.
Results: Surgical repair was performed on the fourth day of life via
midline sternotomy. Cardiopulmonary bypass was established with
aortic and bicaval cannulation. An LV vent was placed through the right
superior pulmonary vein. Cardiac arrest was achieved with antegrade
cardioplegia delivered through the root. The aorta was transected just
above the tunnel. The tunnel was opened longitudinally throughout its
length, terminating in the left ventricular cavity just below the aortic
valve. The RCA was harvested as button from the roof of the tunnel. The
LV aspect of the tunnel was closed with a Dacron patch. The RCA was
reimplanted directly onto the margins of the aortic aspect of the tunnel.
Post-operative echocardiogram showed complete repair of the tunnel
with good flow in the RCA. Patient was weaned from cardiopulmonary
bypass successfully. The patient had an uneventful postoperative
course, and has normal growth and development at six month
follow-up.
Conclusion: Neonatal surgical closure can be achieved with low surgical
risk and it is recommended to prevent worsening of heart failure.
NOTES:
5V. SVC Resection for Germ Cell Tumor
Authors: *Shanda H. Blackmon1, *Michael J. Reardon2
Author Institution(s): 1Mayo Clinic, Rochester, MN; 2Houston Methodist
Hospital, Houston, TX
Objectives: The objective of this video is to describe a successful case
of off-pump superior vena cava (SVC) resection and reconstruction for a
germ cell tumor.
Methods: A 33 year-old man presented with chest pain, head swelling,
and shortness of breath. He was diagnosed with SVC syndrome. He
had no prior medical history. His CT scan of the chest revealed SVC
obstruction, a pericardial effusion, a 16-centimeter anterior mediastinal
mass, and a left-sided pulmonary embolus. His alpha fetoprotein (AFP)
level was 1800, but the hCG level was less than one. He had a core
needle biopsy diagnosis of yolk sac differentiated germ cell tumor. He
had a surgical pericardial window created. He underwent emergent
radiation therapy followed by neoadjuvant chemotherapy. His AFP was
reduced to 13. He had a residual mass on CT scan. Six months after
initial presentation, he underwent surgical resection of the mass and
reconstruction of the SVC.
Results: The patient underwent off-pump SVC resection and
reconstruction with bovine pericardium through a median sternotomy.
The clamp time for the reconstruction was 28 minutes. An endoscopic
stapler was used to seal the folded bovine pericardium into a tube for
reconstruction. The innominate vein was also reconstructed with bovine
pericardium and connected to the SVC reconstruction. Estimated blood
loss was less than 100ml. The patient stayed in the intensive care unit
for one night, and his chest tube was removed one day after surgery. He
was discharged to home six days after surgery. The tumor was entirely
necrotic.
Conclusion: Venous reconstruction of large great vessels can be
successfully performed off-pump. The novel use of a folded bovine
pericardium stapled into a tube allows the surgeon to tailor and taper
the graft to fit veins of differing caliber. Resection of a residual germ cell
tumor after normalization of tumor markers is indicated to determine if
viable tumor is present and to reconstitute great vessel patency.
CT scan of anterior mediastinal mass and PE on presentation
NOTES:
6V. Augmentation of Aorta in Repair of Hemitruncus
Authors: *Inder D. Mehta1, Julie Park1, Victor S. Lucas1, *Ross M.
Ungerleider2
Author Institution(s): 1Ochsner Clinic Foundation/Medical Center, New
Orleans, LA; 2Wake Forest Baptist Medical Center, Winston-Salem, NC
Objectives: Anomalous origin of right pulmonary artery from ascending
aorta (AOPA), often referred to as hemitruncus, is a rare congenital
heart defect that requires repair in early infancy. Compression and
stenosis of the right pulmonary artery (RPA) following anastomosis
to the main pulmonary artery (MPA) is a commonly reported
occurrence following repair. In order to prevent this, previous authors
have suggested techniques for creating a tensionless RPA to MPA
anastomosis. Our video displays demonstrates a new technique to
prevent RPA compression using homograft augmentation of the
ascending aorta.
Methods: Patient is a five week-old female infant who presented
with failure to thrive, tachypnea, and murmur. Echocardiogram
confirmed diagnosis of AOPA. Surgical repair was performed using
cardiopulmonary bypass with moderate hypothermia and a single
dose of antegrade cardioplegia. The aorta was transected and the
RPA was harvested as a large button resulting in a sizeable deficiency
of the posterior aortic wall. The RPA was anastomosed to the MPA
using previously described flap techniques. The posterior aorta was
augmented with a large patch of homograft and then repaired, which
effectively reduced tension and compression on the posterior RPA.
Results: Post-operative echo showed a large, non-compressed RPA
anastomosis.
Conclusion: We describe a new technique for repair of AOPA
(hemitruncus) that focuses on augmentation of the aorta posteriorly
(similar to techniques of neo-pulmonary artery repair in arterial switch)
to prevent compression of the posterior vessels.
NOTES:
Authors: D*Daniel L. Miller
Author Institution(s): WellStar Healthcare, Marietta, GA
COMMERCIAL RELATIONSHIPS: Daniel L. Miller: Consultant/Advisory Board: Ethicon
Endo-Surgery, Inc., Davol-Bard, Inc.
Objectives: Increasing number of patients are referred for lung
resection that are on clopidogrel, an oral antiplatelet agent. Lung
resections have been reported on clopidogrel via a thoracotomy with
acceptable morbidity and mortality. Today a significant number of
patients are undergoing VATS lung resections. We report the first
case of a patient who underwent a VATS lobectomy, while on full dose
clopidogrel for prevention of cerebrovascular ischemic events.
Methods: A 74 year-old woman, former smoker, was found to have
an asymptomatic indeterminate pulmonary nodule (IPN). CT scan
showed a 1.9-centimeter nodule in the right lower lobe without
lymphadenopathy. Integrated CT/PET scan showed a maxSUV of
9.5 of the IPN and no metastasis. Past medical history included
cerebrovascular disease with multiple TIAs. Prior surgery included a
carotid endartectomy. Patient developed recurrent TIAs and underwent
a carotid stent with resolution of TIAs. Medication included clopidogrel
and ASA. CT-guided biopsy of the IPN was performed after cessation of
the clopidogrel. The patient experienced a TIA the night of the biopsy,
but resolved with restarting the clopidogrel. Tissue biopsy was positive
for small cell lung cancer. Further testing included a FEV1 – 1.9 L (68%),
DLCO – 58%, a negative DSE with EF – 55%, and a negative EBUS for N1
or N2 disease.
Results: Patient underwent a VATS right lower lobectomy and energyassisted complete lymph node dissection on full dose clopidogrel,
but no ASA. Operative blood loss was 195 cc; operative time was 95
minutes. Pain management included oral narcotics and local injectable
liposome bupivacaine. The patient was discharged on the fourth
postoperative day. Final stage was a stage IA (T1N0M0) small cell lung
cancer.
Conclusion: VATS lobectomy with complete lymph node dissection can
be performed safely in patients on full dose clopidogrel with no increase
in intra- or post-operative complications; potential ischemic events
were prevented.
NOTES:
8V. Ventricular Embolization of the Valve Prosthesis During Transapical
Transcatheter Aortic Valve Implantation
Authors: Muhammad Aftab, Magdy M. El-Sayed Ahmed, Neil E.
Strickman, *Ross M. Reul
Author Institution(s): Texas Heart Institute at Baylor St. Luke’s Medical
Center, Houston, TX
Objectives: We describe a technique for the management of ventricular
embolization of the valve prosthesis following Transapical Transcatheter
Aortic Valve Implantation (TA-TAVI), a life threatening complication
requiring immediate intervention.
Methods: A 64 year-old female with diabetes mellitus, coronary artery
disease, prior CABG, and morbid obesity (BMI 43.2) presented with
profound dyspnea, angina and New York Heart Association class IV
heart failure. Transthoracic echocardiogram demonstrated severe aortic
stenosis (0.9cm2 valve area, mean transvalvular gradient 42.5mmHg),
calcified trileaflet aortic valve, annulus diameter 24mm and left
ventricular (LV) ejection fraction 50%. Cardiac catheterization revealed
patent bypass grafts. Severe deconditioning, frailty, prior CABG, and
co-morbidities (STS score 6.8, EuroScore II 12.8) made her high risk for
redo-sternotomy for conventional aortic valve replacement.
Results: Due to small iliac arteries, she underwent TA-TAVI. Immediately
after implantation of 26mm Transapical Transcatheter Aortic Valve,
she developed ventricular embolization of the prosthesis resulting in
severe aortic insufficiency and hemodynamic compromise. The wire
and transapical sheath were maintained through the embolized valve
annulus. Femoral cannulation and cardiopulmonary bypass were
established. A second transcatheter valve was deployed transapically.
The embolized valve was grasped with two clamps, crushed, and
directly extracted through the LV apex. She was discharged home on
post-operative day six. Patient was seen in the clinic three weeks after
surgery and found to be recovering well.
Conclusion: Transapical valve extraction obviated the need for
emergent redo sternotomy. In case of LV embolization after TA-TAVI,
maintaining the wire across the annulus is critical to prevent overturning
of the valve in the LV. A second prosthesis can be implanted. Retrieving
the migrated valve directly from the LV apex can be considered to avoid
sternotomy.
NOTES:
9V. Percutaneous Transfemoral Closure of a Pseudoaneurysm at the
Implantation
Authors: Ashkan Karimi1, James C. Fudge1, Anthony A. Bavry1, David
Anderson1, D*Charles T. Klodell1, John W. Petersen1, Marc Litt2, Floyd W.
Burke1, D*Thomas M. Beaver1
Author Institution(s): 1University of Florida, Gainesville, FL;
2
Jacksonville Heart Center, Jacksonville, FL
COMMERCIAL RELATIONSHIPS: Charles T. Klodell: Principal Investigator Edwards
Partner III Trial: Edwards Lifesciences; Thomas M. Beaver: Investigator and Research
Support for Edwards PARTNER II Clinical Trial: Edwards Lifesciences
REGULATORY DISCLOSURE: This presentation illustrates an off-label use of
Amplatzer™ muscular VSD occluder (St. Jude Medical, St. Paul, MN) for closure of a
left ventricular pseudoaneurysm.
Objectives: The reported incidence of left ventricular apical access site
pseudoaneurysm is 1-7% after transapical aortic valve implantation.
In general left ventricular pseudoaneurysms carry 30-45% risk of free
rupture and are traditionally repaired surgically; however, patients who
undergo transcatheter aortic valve implantation are elderly, frail, high
operative risk patients and the risk of a surgical repair is substantial.
We illustrate percutaneous closure of a left ventricular apical
pseudoaneurysm through a femoral approach as a minimally invasive
alternative to open surgical repair.
Methods: This case illustrates a left ventricular apical pseudoaneurysm
that developed at the transapical access site for transcatheter aortic
valve implantation and was successfully excluded percutaneously with
an Amplatzer™ muscular VSD occluder (St. Jude Medical, St. Paul, MN).
Results: The patient is an 86 year-old Caucasian male who presented
with pre-syncope and was found to have severe aortic stenosis. He
underwent transapical aortic valve implantation with a 26 mm Edwards
Sapien valve. He presented three months later with visible pulsations
through skin at the site of the anterolateral mini-thoracotomy incision
and was found to have a left ventricular pseudoaneurysm at the site
of transapical access. He underwent minimally invasive percutaneous
closure of the pseudoaneurysm through a femoral approach without
any complication.
Conclusion: Minimally invasive percutaneous technique is a viable
alternative to open surgical repair for closure of left ventricular apical
access site pseudoaneurysm after transapical aortic valve implantation.
NOTES:
1. Fifteen-year Experience With Aortic Valve Sparing - Aortic Root
Replacement With the Reimplantation Technique
Authors: Stefano Mastrobuoni1, Laurent De Kerchove1, Munir
Boodhwani2, Parla Astarci1, Jean Rubay1, Robert Verhelst1, Philippe
Noirhomme1, Gebrine El Khoury1
Author Institution(s): 1St. Luc’s Hospital, Brussels, Belgium; 2University
of Ottawa Heart Institute, Ottawa ON, Canada
THURSDAY - SCIENTIFIC PAPERS
Discussant: *Duke E. Cameron, Johns Hopkins University School of
Objectives: Aortic valve (AV) sparing aortic root replacement has been
performed for over twenty years in selected centers. However, the
surgical complexity and the concern for the durability of the AV repair
compared to valve replacement have prevented its wide diffusion. In
this study we present our overall experience with the AV reimplantation
technique across 15 years and over 250 patients.
Methods: From 1999 to 2014, 279 consecutive adult patients underwent
elective AV sparing-aortic root replacement with reimplantation
technique. The mean age of this cohort was 48+15 years and 89.6% of
patients were male. Ten percent of patients had Marfan syndrome and a
bicuspid aortic valve was present in 41.6%. Mean duration of follow-up
was 4.7+3.2 years.
Results: Sixty-day mortality was 0.72% (n=2). One patient experienced
early repair failure and underwent re-repair. At discharge from
hospital 97% of patients had <1+ AI. Seven patients (2.8%) required
late AV reoperation. Freedom from AV reoperation was 99.6+0.4%
and 94.7+1.9% at 1 and 5 years respectively. Freedom from recurrent
AI (>2+) was 99.6+0.4% and 93.4+2.2% at 1 and 5 years respectively.
Twelve patients died during follow-up. Therefore postoperative
survival was 99.2+0.6%, 96.3+1.4 and 84.4+5.2% at 1, 5 and 10 years
respectively. Long-term survival and freedom from AV reoperation were
not significantly different in patients with BAV compared to patients
with tricuspid AV after adjusting for age.
Conclusions: Aortic valve repair with the reimplantation technique
has showed a low perioperative mortality and excellent long-term
durability. Reimplantation of the aortic valve into a Dacron graft stabilize
the AV annulus and prevent AI recurrence. Patients with BAV have not
had significantly different outcomes with this technique compared to
patients with tricuspid AV.
NOTES:
2. Effects of Delayed Surgical Resection on Short- and Long-term
Outcomes in Clinical Stage I Non-small Cell Lung Cancer
Authors: Pamela Samson, Aalok Patel, *Matthew Bott, *Traves Crabtree,
*Daniel Kreisel, *Alexander S. Krupnick, *George A. Patterson,
*Stephen Broderick, *Bryan Meyers, *Varun Puri
Author Institution(s): Washington University School of Medicine, Saint
Louis, MO
Discussant: *Melanie A. Edwards, Saint Louis University School of
Objectives: Conflicting evidence currently exists regarding the causes
and effects of delay of care in non-small cell lung cancer (NSCLC). We
hypothesized that delayed surgery in early-stage NSCLC is associated
with worse short- and long-term outcomes.
Methods: Treatment data of clinical stage I NSCLC patients undergoing
surgical resection was obtained from the National Cancer Database
(NCDB). Treatment delay was defined as resection eight weeks or
more after diagnosis. Propensity score matching for patient and tumor
characteristics was performed to create comparable groups of patients
receiving early (less than eight weeks from diagnosis) and delayed
surgery. Multivariable regression models were fitted to evaluate
variables influencing delay of surgery.
Results: From 1998-2010, 39,995 patients with clinical stage I NSCLC
received early surgery, while 15,658 patients received delayed surgery.
27,022 propensity-matched patients were identified. Those with a delay
in care were more likely to be pathologically upstaged (18.3% stage 2 or
higher vs. 16.6%, p<0.001), have an increased 30-day mortality (2.9% vs.
2.4%, p = 0.01), and have decreased median survival (57.7 ± 1.0 months
versus 69.2 ± 1.3 months, p <0.001). Delay in surgery was associated
with increasing age, non-Caucasian race, treatment at an academic
center, urban location, income less than $35,000 and increasing
Charlson comorbidity score (p<0.0001 for all). Delayed patients were
more likely to receive a sublobar resection (17.2% vs. 13.1%, p <0.001).
Conclusions: Patients receiving delayed resection for clinical stage
I NSCLC have higher comorbidity scores that may affect ability to
perform lobectomy and result in higher peri-operative mortality.
However, delay in resection is independently associated with increased
rates of upstaging and decreased median survival. Strategies to
minimize delay while medically optimizing higher risk patients are
needed.
Propensity-matched clinical stage I NSCLC patients from the National
Cancer Data Base, divided into early and delayed resection groups.
Table 1. Patients with clinical stage I NSCLC that underwent propensity matching based
on age, gender, race, income, facility, Charlson/Deyo score, tumor size, clinical T stage,
surgical margins, and type of resection.
Kaplan-Meier curve for propensity-matched clinical stage I NSCLC patients with early
(less than 8 weeks from time of diagnosis) and delayed (8 weeks or greater) resection. STSA 61st Annual Meeting 63
3. Long-term Outcomes After the Ross Procedure in Children Vary by
Age at Operation
Authors: Jennifer S. Nelson1, Clayton N. Pratt2, Sara K. Pasquali2, Janet
E. Donohue2, Sunkyung Yu2, Richard G. Ohye2, Edward L. Bove2, Jennifer
C. Hirsch-Romano2
Author Institution(s): 1University of North Carolina, Chapel Hill, NC;
2
University of Michigan, Ann Arbor, MI
Winston-Salem, NC
Objectives: There are limited data regarding longitudinal outcomes
following the Ross procedure in children. We evaluated longitudinal
mortality and reintervention after the Ross procedure in a large
pediatric cohort and assessed the impact of age at surgery on outcome.
Methods: A retrospective review of all patients <18 years-old who
underwent a Ross operation at our institution (1991-2012) was
conducted. In-hospital and longitudinal outcomes including morbidity,
mortality, and re-intervention were evaluated.
Results: The overall cohort included 224 patients who underwent a
Ross or Ross-Konno operation: 40 infants (<1 yr), 109 children (1-12
yrs) and 75 adolescents (>12 yrs). Infants were more likely to have
complex left heart disease compared with children/adolescents (60% vs
34%; p=0.002). In-hospital mortality was 4% and major complications
occurred in 17%, with the highest rates in neonates/infants (20%
and 45% respectively; Table). Median follow up for the 84 subjects
followed at our institution was 8.5 years (range, 0-21 years). Mortality
during the study period was 19%, and was highest in infants (45%)
vs. children (8%) and adolescents (14%), p<0.0001. Actuarial 10-year
survival was 84% and freedom from left ventricular outflow tract (LVOT)
reintervention was 73% at 10 years (Figure). All LVOT reinterventions
occurred in subjects >1 year at the time of the Ross. Freedom from right
ventricular outflow tract (RVOT) reintervention was 75% at 10 years.
RVOT reintervention rates were significantly higher in subjects <1 year
at the time of the Ross.
Conclusions: Outcomes after the Ross operation in children vary by
age at operation. Infants more commonly have complex left heart
disease and experience substantial morbidity and mortality. Children
and adolescents have higher rates of LVOT reintervention, while infants
are at higher risk of RVOT reintervention. These age delimited data will
allow for improved parental counseling.
Morbidity, Mortality, And Reintervention By Age Group
Abbreviations: LVOT, left ventricular outflow tract; RVOT, right ventricular outflow tract.
* Data are presented as N (column %).
† Comparisons were made as infant (< 1yr) vs. child or adolescent ( 1 yr) and p-value
came from Chi-square test or Fisher’s exact test for total cohort and Log-rank test for
patients followed at surgical site.
Survival and Freedom from Reintervention after Ross
NOTES:
4. When the Ross Is Not an Option: Systemic Semilunar Valve
Replacement in the Pediatric/Young Adult Population Using a Porcine
Full-root Bioprosthesis
Authors: *Jorge D. Salazar2, Bhawna Gupta2, *Charles D. Fraser, Jr.1,
*John H. Calhoon3, *Makram R. Ebeid2, *Mary B. Taylor2, *Ali DodgeKhatami2
Author Institution(s): 1Baylor College of Medicine, Houston, TX; 2The
University of Mississippi Medical Center, Jackson, MS; 3University of
Texas Health Science Center San Antonio, San Antonio, TX
Discussant: D*John W. Brown, Indiana University School of Medicine,
Indianapolis, IN
COMMERCIAL RELATIONSHIPS: DISCUSSANT: John W. Brown: Ownership Interest/
Board of Directors: Correx, Inc.; Speakers Bureau/Honoraria: Cryolife, Inc., Medtronic,
Inc.
Objectives: Management of systemic semilunar valve disease in
growing, young patients is challenging. When replacement is necessary,
use of a pulmonary autograft is sometimes not possible for anatomic
reasons or due to parental/patient preference. We employed a porcine,
full-root bioprosthesis in this setting and report outcomes for the first
such series.
Methods: Over nine years (2005-2013), 24 patients of mean age
13.1 years (range 3 months – 20.34 years) underwent operation for
the indication of: mixed stenosis and insufficiency in 16/24 (67%),
pure insufficiency in 7/24 (29%), and pure stenosis in 1/24 (4%).
Eight patients had multiple prior cardiac operations, nine had prior
repair or replacement of the systemic semilunar valve, and two
had prior percutaneous balloon intervention. Survival, follow-up
echocardiographic findings, and outcomes were documented. All
patients were maintained on daily aspirin.
Results: There were no hospital deaths, and no early or late deaths.
The mean survival for 23 patients was 40.3 months (range 7 – 97), with
one patient moving abroad and lost to follow-up. Echocardiographic
follow-up (mean 28.0 months) demonstrated that no patient developed
more than mild insufficiency or mild-moderate stenosis (mean ≤2.8 m/
sec). 20/24 (83.3%) showed no insufficiency and 14/24 patients (58.3%)
showed no stenosis. Near or complete normalization of left ventricular
mass and dimension was demonstrated (Table 1). There were no
explants and no thromboembolic or bleeding events.
Conclusions: When use of a pulmonary autograft is not an option, the
porcine full-root bioprosthesis appears to be favorable for systemic
semilunar valve replacement in the pediatric/young adult population. Of
note, when prosthetic degeneration does occur, stenosis predominates
rather than insufficiency. Longer-term studies are warranted.
Table 1. Echocardiographic Findings at Last Follow-up.
NOTES:
Authors: DThomas J. Watson1, DJiejing Qiu2
Author Institution(s): 1University of Rochester, Rochester, NY;
2
Covidien, Inc., Mansfield, MA
Discussant: D*Betty C. Tong, Duke University Medical Center, Durham,
NC
COMMERCIAL RELATIONSHIPS: Thomas J. Watson: Consultant/Advisory Board:
Covidien; Jiejing Qiu: Employment/Senior Research Associate: Covidien, Inc
Discussant: Betty C. Tong: Consultant/Advisory Board: W.L. Gore & Associates, Inc.
Objectives: Lung resection via video-assisted thoracoscopic surgery
(VATS) has been increasing in prevalence, with the benefits of
decreased pain and quicker recovery compared to thoracotomy (OPEN).
Less is known about reimbursements, costs, and resource use with each
approach. This study examined differences between VATS and OPEN
lung resections in payment, healthcare utilization, and estimated days
off work for healthcare visits from a commercial insurance database.
Methods: All adult inpatient discharges with an ICD-9-CM code for
VATS (lobectomy 32.41, wedge 32.41) or OPEN (lobectomy 32.49, wedge
32.29) lung resection in 2010 were identified from the Truven Health
Analytics MarketScan® Commercial Claims and Encounters Database.
Results: A total of 2,611 patients undergoing lobectomy (VATS=270,
OPEN=669) or wedge resection (VATS=1,332, OPEN=340) were
identified. OPEN lobectomies had a longer length of stay (mean
difference=1.79 days, p<0.0001), and higher net payment to
hospitals (mean difference=$3,497, p=0.009) and physicians (mean
difference=$433, p=0.01) compared to VATS. Similar findings were
noted after wedge resections. The number of postoperative outpatient
visits within 90 days increased 24% (95% CI: 1.03-1.49) for OPEN
compared to VATS lobectomies. OPEN lobectomies had 1.28 times (95%
CI: 1.12-1.46) and 1.14 times (95% CI: 1.01-1.28) increased healthcare
utilization days within 90 days and 365 days after surgery, respectively,
compared to VATS (Table). No significant differences in healthcare
utilization were noted between OPEN and VATS wedge resections,
except for fewer hospital outpatient visits within 90 days in the OPEN
group.
Conclusions: Compared to an OPEN approach, lobectomy via VATS
is associated with lower hospital and physician payments, and less
healthcare utilization both in the early postoperative period as well as
during the first year after surgery. These reductions are important in an
era of value-based purchasing.
Healthcare utilization for lobectomy and wedge resection within 90
and 365 days
1: VATS is the reference group. 2: Statistically significant, p 0.05 NOTES:
AVR in Michigan
Authors: *Himanshu Patel1, Morley A. Herbert 3, Patricia F. Theurer2, Gail
F. Bell2, Jaelene Williams2, *Richard Prager1
Author Institution(s): 1University of Michigan, Ann Arbor, MI; 2MSTCVS
Quality Collaborative, Ann Arbor, MI; 3Southwest Data Consultants,
Dallas, TX
Discussant: D*Michael J. Reardon, Methodist DeBaket Heart & Vascular
Center, Houston, TX
COMMERCIAL RELATIONSHIPS: Discussant: Michael J. Reardon: Consultant/Advisory
Board: Medtronic, Inc.
Objectives: Transcatheter aortic valve replacement (TAVR) has
emerged as an important option for the treatment of aortic stenosis.
We characterize its early impact on surgical aortic valve replacement
(SAVR) in Michigan.
Methods: We analyzed data obtained following AVR (n=7107) or
AVR/CABG (n=5491) and TAVR (n=640) using a statewide cardiac
surgical quality collaborative from 2006-2013. Hospitals were stratified
based upon local TAVR availability to determine its impact on patient
profiles, SAVR volumes and outcomes. During this period, 13 hospitals
developed TAVR programs.
Results: From 2006-2013, SAVR volume increased by 33.5% at TAVR
hospitals, and 25.1% at non-TAVR hospitals, (p (trend) < 0.001) (Figure
1). When accounting for TAVR volume, overall AVR volume increased
116.2% at TAVR Hospitals (p(trend) < 0.001). In TAVR Hospitals,
patient characteristics in SAVR as assessed by the STS predicted risk
of mortality (PROM) were comparable before (3.8±3.7%) and after
(3.6±3.7%) initiation of TAVR (p=0.06). 30-day mortality was also
similar (pre 2.5% vs. post 2.4%, p=0.83). Rates of major complications
including stroke (pre 1.5% vs. post 1.4%, p=0.84), and renal failure (pre
4.1% vs. post 3.1%, p= 0.09) were similar. Length of stay decreased
slightly from 8.8 d to 8.4 d (p=0.05). When analyzing high risk SAVR
patients (i.e. PROM>8%), again neither mortality, stroke nor renal failure
were significantly different (all p>0.15). Similar results were identified in
nonTAVR Hospitals before and after initiation of TAVR within the state.
(Table).
Conclusions: TAVR implementation in Michigan has dramatically
increased overall surgical AVR volume. This phenomenon has occurred
with little change in preoperative risk profile, and surprisingly, without
improving early SAVR outcomes. As TAVR utilization increases, these
issues may be further clarified and elucidated.
NOTES:
7. Thoracoscopy vs. Thoracotomy for Diaphragm Plication: A Value
Based Comparison
Authors: Onkar V. Khullar, Srini Tridandapani, *Felix G. Fernandez,
*Seth D. Force, *Allan Pickens
Author Institution(s): Emory University School of Medicine, Atlanta, GA
Discussant: *Theolyn N. Price, Cardiac & Thoracic Surgery Associates,
Colorado Springs, CO
Objectives: Diaphragm plication remains an infrequently used
treatment for diaphragm paralysis/eventration. There has been
little data comparing cost and radiographic improvement following
thoracoscopic versus open diaphragm plication. We hypothesized
that thoracoscopy would result in decreased length of stay (LOS) and
cost, with no difference in radiographic improvement or postoperative
outcomes.
Methods: We performed a retrospective case series of all thoracoscopic
and open diaphragm plications at a single institution from 2009 to 2013.
Operative duration, chest tube duration, postoperative LOS, ICU stay,
ventilator days, degree of radiographic improvement, and total hospital
cost were determined. Radiographic improvement was measured as
percent increase in distance from chest apex to diaphragm normalized
to the non-operative side in order to control for inspiratory effort. Cost
data was available from 2010 forward. Group differences were assessed
using two-sample t- and chi-square tests for numerical and categorical
variables, respectively.
Results: Forty-seven total patients were identified, 18 repaired via
thoracotomy and 29 via thoracoscopy. One thoracoscopy case was
converted to thoracotomy for a ruptured diaphragm. No difference
was found in radiographic improvement (42.3% vs 38.5%, p = 0.7).
Postoperative LOS was significantly shorter after thoracoscopy (4.1 vs
6.7 days, p = 0.005), although no difference in operative time or chest
tube duration was seen (Table 1). Total hospital cost trended in favor of
thoracoscopy ($11,701 vs $14,773, p = 0.12), but did not reach statistical
significance.
Conclusions: Thoracoscopic plication can be performed with decreased
LOS and equivalent radiographic improvement when compared with
open plication. Overall cost seems to be lower with a VATS approach
but did not reach statistical significance. Thoracoscopic plication should
be considered when treating patients with diaphragm paralysis.
Postoperative Outcomes and Cost Comparison of Thoracoscopy vs
Thoracotomy for Diaphragm Plication
*Hospital cost reported as median and compared with Wilcoxon test.
NOTES:
8. Learning Habits of the Current Cardiothoracic Resident: Analysis of
the In-training Examination Survey
Authors: David D. Odell1, Damien La Par12, Ryan A. Macke 4, Gabe Loor 3,
Walter F. DeNino11, Bill Stein7, Jennifer S. Nelson5, Kathleen Berfield9,
John Lazar 8, Vakhtang Tchantchaleishvili10, Samuel Youssef 6, Tom C.
Nguyen2
Author Institution(s): 1University of Pittsburgh School of Medicine,
Pittsburgh, PA; 2University of Texas Houston, Houston, TX; 3University
of Minnesota, Minneapolis, MN; 4University of Wisconsin, Madison, WI;
5
University of North Carolina, Chapel Hill, NC; 6Swedish Medical Center,
Seattle, WA; 7Emory University School of Medicine, Atlanta, GA; 8Lenox
Hill Hospital, New York, NY; 9University of Washington, Seattle, WA;
1
0University of Rochester, Rochester, NY; 11Medical University of South
Carolina, Charleston, SC; 12University of Virginia, Charlottesville, VA
Objectives: The educational curriculum in cardiothoracic (CT) surgery is
undergoing extensive revision including development of new curricula,
learning assessment tools and educational milestones. Accurately
understanding learning behavior is key in curriculum development,
yet little information is available regarding the way in which current
CT residents learn. We examine educational resource utilization by CT
residents.
Methods: A pre-exam 30 question survey is required in order to sit for
the In-Training Exam (ITE). Questions were constructed utilizing Likert
Scale responses to examine learning behavior and curricular resources
utilization patterns. Learning patterns among all residents and within
specific training pathways (2-year versus 3-year traditional programs
and 6-year integrated programs (I-6)) were assessed.
Results: 314 residents were surveyed (n=122 2-yr, n=96 3-yr, n=96
I-6). Study time periods were typically less than one hour (25.4% <30
min per session; 56.8% 30-60 min). A majority of residents study in
the hospital during the work day opposed to on independent time at
home or elsewhere. Greater than 50% of study is done online, with 17%
learning exclusively online. 78% of residents believe online education
will increase in the next five years. A minority (22%) primarily used
textbooks, whereas 72% primarily used online resources. When asked
about curriculum needs, residents overwhelmingly (95%) favor further
development of web-based resources (guided curriculum 57%; video
instruction 20%). Incorporation of simulation was favored by the
majority of residents and was felt to be more valuable in cardiac surgery
than thoracic surgery.
Conclusions: CT residents choose to learn in truncated periods
of time (<1 hour) and often in point-of care settings. Online and
electronic resource usage is increasing common. Ongoing curriculum
development should focus on the creation of resources that correspond
to the learning style of the intended audience.
Resident study location and educational resources used
NOTES:
9. Bilateral IMA Use for Coronary Artery Bypass Grafting Remains
Underutilized: A Propensity Matched Multi-Institution Analysis
Authors: *Damien J. LaPar1, *Ivan K. Crosby1, *Jeffrey B. Rich2,
*Mohammed A. Quader 3, *Alan M. Speir4, *John A. Kern1, *Irving L.
Kron1, *Gorav Ailawadi1
Author Institution(s): 1University of Virginia, Charlottesville, VA;
2
Sentara Heart Hospital, Norfolk, VA; 3Virginia Commonwealth
University, Richmond, VA; 4INOVA Heart and Vascular Center, Falls
Church, VA
Discussant: *Michael R. Petracek, Vanderbilt University, Nashville, TN
Objectives: Bilateral internal mammary arterial (BIMA) grafts have
repeatedly demonstrated superior outcomes compared to single IMA
(SIMA) following coronary artery bypass grafting (CABG). Despite
known survival benefits with BIMA use, perceived perioperative
challenges often preclude BIMA use. We hypothesized that the use of
BIMA remains underutilized, even in low risk patients.
Methods: All 43,823 patients undergoing isolated CABG with ≥ 2 vessel
grafting over the previous 12 years in a regional STS database were
evaluated. Patients were stratified by BIMA versus SIMA use. Surgical
candidates considered low risk for BIMA use included: age<70, no or
mild chronic lung disease, BMI < 30, and absence of diabetes. BIMA
patients (n=1,333) were 1:1 propensity-matched to SIMA patients
(n=1,333) and outcomes were compared.
Results: Overall, BIMA use was 3% (n=1,333), while 24% (n=10,327)
of patients met low risk criteria for BIMA use. Furthermore, among
patients meeting low risk criteria, BIMA utilization was 6% (n=615).
Risk-adjusted, propensity-matched comparisons revealed similar
preoperative risk profiles between BIMA and SIMA patients (PROM 1.1%
vs. 1.1%, P>0.05). BIMA use was associated with longer cross clamp
time (71 v 62 min, P<0.05). Importantly, BIMA use was not associated
with increased postoperative mortality, morbidity, or hospital length
of stay (all P>0.05, Table). However, hospital readmission within 30
days was 41% greater for BIMA patients compared to SIMA patients
(P=0.01,Table).
Conclusions: The use of bilateral internal mammary arterial grafts
appears to remain underutilized in the modern surgical era even in low
surgical risk patients. BIMA use does not appear to increase the risk of
postoperative morbidity, although requires longer operative times and a
higher risk for readmission. Efforts to more clearly understand surgeon
motivators for the use of BIMA grafting are needed.
Outcomes for 1:1 Propensity Matched Patient Cohorts Undergoing
CABG Operations
NOTES:
10. Contemporary Results of Open Surgical Repair in Patients With
Marfan Syndrome and Distal Aortic Dissection in the Endovascular Era
Authors: D*Joseph Coselli, Ourania Preventza, Kim I. de la Cruz, Susan
Y. Green, Matt D. Price, *Scott A. LeMaire
Author Institution(s): Baylor College of Medicine/Texas Heart Institute,
Houston, TX
Discussant: D*G. Chad Hughes, Duke University Medical Center,
Durham, NC
COMMERCIAL RELATIONSHIPS: Joseph S. Coselli: Royalties/Consultant/Advisory
Board: Vascutek Ltd., a Terumo Company
DISCUSSANT: G. Chad Hughes: Consultant/Advisory Board: W.L. Gore & Associates,
Inc., Medtronic, Inc., Vascutek Terumo; Speakers Bureau/Honoraria: W.L. Gore &
Associates, Inc., Medtronic Vascular, Vascutek Terumo
Objectives: Treatment paradigms for aortic dissection include
endovascular repair of the distal aorta in patients with complicated
acute dissection or progressive expansion of chronic dissection. Such
repair is generally contraindicated in patients with Marfan syndrome
(MFS); open repair remains the gold standard. We examined outcomes
of surgical repair of thoracoabdominal aortic aneurysm (TAAA) in a
contemporary series of MFS patients with distal aortic dissection.
Methods: Data were collected prospectively for 119 consecutive MFS
patients with aortic dissection (69 male [58%]; mean age 43±13 y, range
17-76 y) who underwent open TAAA repair between January 1, 2004 and
December 31, 2013; 28 of these repairs (24%) were emergent or urgent.
The types of dissection comprised DeBakey type I aortic dissections
in 55 patients (46%), retrograde type I in 5 patients (4%), type IIIA in 7
patients (6%), type IIIB in 49 patients (41%), and localized dissection in
3 (3%). Dissection was chronic in 110 patients (92%). Symptoms were
present in 95 patients (80%). Repairs included 87 extensive repairs
(73%; extent I=26; extent II=61). Left heart bypass was used in 81
patients (68%), hypothermic circulatory arrest in 6 patients (5%), and
cerebrospinal fluid drainage in 106 (89%).
Results: There were 4 early deaths (3%). There were no cases of stroke
or permanent paraplegia; 1 patient (1%) had permanent paraparesis,
and 5 (4%) had permanent renal failure. Actuarial survival was
87.2%±3.2% at 2 years and 73.9%±5.7% at 8 years (Figure).
Conclusions: Contemporary open TAAA repair in MFS patients with
aortic dissection had excellent outcomes in this series the largest to
focus on MFS, dissection, and open TAAA repair. It is questionable
whether these results could be improved upon by expanding current
endovascular approaches to include MFS patients; the premise and
durability of such applications in MFS remain uncertain.
NOTES:
FRIDAY - SCIENTIFIC PAPERS
BASIC SCIENCE FORUM
1B. Pulsatile Flow Does Not Improve Function During Prolonged Ex
Vivo Lung Perfusion
Authors: Erin Schumer, Keith Zoeller, Paul Linsky, Gretel Monreal,
Michael Sobieski, Steven Koenig, *Mark Slaughter, Victor van Berkel
Author Institution(s): University of Louisville, Louisville, KY
Discussant: DMichael J. Weyant, University of Colorado, Aurora, CO
COMMERCIAL RELATIONSHIPS: DISCUSSANT: Michael J. Weyant: Principal
Investigator: XVIVO, Inc.
Objectives: Ex vivo lung perfusion (EVLP) has the potential to increase
the donor pool for lung transplantation by facilitating resuscitation and
extended evaluation of marginal organs. Current methodology employs
continuous flow pumps. In vivo, continuous flow has been shown to
increase pulmonary vascular resistance (PVR). Thus, pulsatile flow
EVLP may reduce PVR and improve organ preservation by restoring
physiologic flow.
Methods: Lung blocks harvested from male pigs were randomly
allocated into continuous flow (CF, n=3) or pulsatile flow (PF, n=4)
groups. CF and PF were provided by a centrifugal and pulsatile
ventricular assist device, respectively. Mean arterial pressure for
CF and PF was maintained at 11.14±0.25 and 14.04±0.35 mmHg,
respectively. The PF group had a pulse pressure of 24.44±1.14 mmHg.
Lungs were ventilated at 4-5 mL/kg, 21% FiO2 and perfused with an
acellular, albumin-based solution corrected for osmolarity, acid/base
balance, and CO2 concentration (≤20 hours at 30°C). Prostaglandin
E1 and 30% albumin were infused continuously at 250 υg/hr and
100 mL/hr, respectively. Hemodynamic, respiratory, and blood gas
parameters were recorded hourly. Parenchymal biopsies were used for
quantification of wet:dry ratio and IL-6, IL-8, and TNF-α using ELISA.
Results: CF and PF results for PVR and ΔPO2/FiO2 are shown in Figure
1. Wet:dry ratio was 5.53±0.56 and 5.32±0.16 at baseline and 5.27±0.48
and 4.70±0.25 at hour 12 for CF and PF, respectively. Peak airway
pressure (PAWP) in cm H2O was 17.0±1.2, 18.5±2.5 at baseline and
20.7±1.7 and 23.3±3.1 at hour 12 for CF and PF, respectively. There were
no significant differences in TNF-α, IL-6, and IL-8 concentrations, PVR,
ΔPO2/FiO2, wet:dry ratio, and PAWP between CF and PF.
Conclusions: The EVLP system successfully maintained lungs up to
20 hours using a modified Steen perfusate. These data suggest PF
does not offer immediate benefits over CF for prolonged ex vivo lung
preservation.
NOTES:
BASIC SCIENCE FORUM
2B. Circulating Tumor Cells From 4D Model Has Increased Activator
Protein-1 Expression Compared to Primary Tumor
Authors: D*Min P. Kim3, Dhruva K. Mishra1, Chad Creighton2, Fengju
Chen2, Michael J. Thrall3, Jonathan M. Kurie 4
Author Institution(s): 1Houston Methodist Research Institute, Houston,
TX; 2Baylor College of Medicine, Houston, TX; 3Houston Methodist
Hospital, Houston, TX; 4University of Texas MD Anderson Cancer
Center, Houston, TX
Discussant: *Chadrick E. Denlinger, Medical University of South
Carolina, Charleston, SC
COMMERCIAL RELATIONSHIPS: Min P. Kim: Speaker Bureau/Honoraria: Ethicon EndoSurgery, Inc.
Objectives: To determine the transcription factor that is important in
formation of CTC in the 4D lung cancer model.
Methods: The ex vivo 4D metastatic lung cancer model was seeded
with H1299 cells. We performed lobectomy of the primary tumor on day
2 and day 25 and metastatic lesion on day 10 and day 25 and isolated
CTCs on day 10 and day 25. Total RNA was extracted and OneArray
microarray was used to determine the gene expression profile for the
tumor cells in each of these three phases and the two time points. We
analyzed for the transcription factor that was elevated in CTC but not in
primary tumor or metastatic lesion. Furthermore, these transcription
factors were analyzed in the primary tumor, CTCs and metastatic lesion
from the 4D model seeded with A549 or H460 cells.
Results: Microarray analysis of the primary tumor and metastatic lesion
between two time points showed differences in gene expression due
to tumor growth while in CTC the difference was due to difference in
metabolic condition at two time points. We then analyzed all of the
microarray data to look at the difference among primary tumor, CTC
and metastatic lesion. We found that 59 genes were up regulated and
20 genes were downregulated in the CTCs as compared to the primary
tumor and metastatic lesion. When we analyzed for transcription
factors, we found that both c-Fos and c-Jun, the components of
activator protein-1, were significantly elevated in the CTCs compared
to the primary tumor and metastatic lesion. We then analyzed the
specimen from 4D model seeded with A549 and H460. In both cell lines,
there was consistent elevation of c-Fos and c-Jun in CTCs as compared
to the primary tumor.
Conclusions: Activator Protein-1, a transcription factor, is elevated in the
circulating tumor cells of the 4D model compared to the primary tumor.
This transcription factor may play an important role in the formation of
circulating tumor cells and lung cancer progression.
NOTES:
BASIC SCIENCE FORUM
3B. Are Histologic Abnormalities More Severe in Bicuspid Aortopathy?
Authors: Elbert Heng, James Stone, Thomas MacGillivray, Jennifer
Walker, Joshua Baker, Gus Vlahakes, Hang Lee, *Thoralf Sundt
Author Institution(s): Massachusetts General Hospital, Boston, MA
Objectives: A more aggressive approach to aortic resection for dilation
has been advocated in the setting of a bicuspid aortic valve (BAV). The
clinical implications of such recommendations are enormous given the
population frequency of BAV, despite scarce literature to substantiate or
refute the notion that aortic material properties are inherently weaker
in BAV aortopathy. We therefore compared the degree of histologic
abnormality in dilated aortas associated with bicuspid versus trileaflet
aortic valve (TAV).
Methods: Aortic specimens resected from patients with BAV (n=61,
age 57±10 years) and TAV (n=34, age 69±12 years) and normal diameter
aortas from patients undergoing cardiac transplantation (n=16, age
58±6 years) were compared for elastic fiber loss (EFL graded 0-4),
smooth muscle cell loss (SMCL graded 0-4), medial proteoglycan
deposition (MPD graded 0-3), medial fibrosis (MF graded 0-3) and
atherosclerosis (0-3). Patients with known connective tissue disorders,
systemic inflammatory conditions, or dissection were excluded.
Results: When specimens were considered across all diameters, EFL,
SMCL, MF and Atherosclerosis were more severe in aorta associated
with TAV than BAV. When stratified to compare only those aortas
within the 4-5cm range, the same trend persists although statistical
significance was lost for EFL and MF; SMCL and atherosclerosis
remained statistically significantly worse for TAV. When histologic
abnormality was graded against diameter, the only correlation was EFL
for TAV patients.
Conclusions: These data do not support more severe medial
abnormality for aneurysms associated with BAV compared with TAV,
nor by inference, a more aggressive approach to surgical intervention
for aortic dilatation associated with BAV; indeed these findings arguably
support the converse. The lack of correlation between aortic diameter
and histological abnormality highlights the inadequacy of diameter
alone as a criterion for aortic resection.
Spearman’s correlations for histologic abnormality versus diameter
NOTES:
BASIC SCIENCE FORUM
4B. Pediatric End-stage Failing Hearts Demonstrate Increased Cardiac
Stem Cells
Authors: Brody Wehman, Sudhish Sharma, Rachana Mishra, David L.
Simpson, Savitha Deshmukh, *Sunjay Kaushal
Author Institution(s): University of Maryland Medical Center, Baltimore,
MD
Discussant: D*John E. Mayer, Boston Children’s Hospital, Boston, MA
COMMERCIAL RELATIONSHIPS: DISCUSSANT: John E. Mayer: Consultant/Advisory
Objectives: Cardiac stem cell (CSC) therapy has shown promise in
the treatment of adults following myocardial infarction and may hold
a similar benefit for children with end-stage heart failure (ESHF). We
sought to determine the location and expression of CSCs in children
with ESHF, which has not been described. We hypothesized that the
ESHF myocardium reverses to not only a fetal gene program but also
a developmental program by increasing the number of CSCs when
compared to congenital heart disease (CHD) patients with normal
myocardium.
Methods: Tissue samples were obtained from the explanted hearts
of children undergoing heart transplantation with ESHF, defined
as NYHA class III or IV and ejection fraction <20%, and from agematched patients undergoing routine congenital cardiac surgery. The
expression profile of cardiac-specific stem cell markers, including
c-kit and Islet-1 (ISL-1), was determined using quantitative RT-PCR and
immunofluorescence. Data are presented as mean +/- standard error
and analyzed by Mann-Whitney t-test.
Results: ESHF myocardium (n=15) had a 2-fold increase in expression
of c-kit and a 3-fold increase in the expression of ISL-1 when compared
to age-matched controls (n=15) (Fig. 1a, b). There was no difference
in the expression of c-kit+ cells between infants and children in ESHF
myocardium, which is in contrast to our previously reported finding
that showed an age-dependent decrease in c-kit+ cells in CHD patients
with normal myocardium (Fig. 1d). ESHF myocardium had a reduction
of αα-myosin heavy chain (MHC) mRNA expression by 4.5-fold and
upregulated βß-MHC and atrial natriuretic factor by 7.5-fold and 8-fold,
respectively (Fig. e-g), consistent with the previously described switch
to the fetal gene program.
Conclusions: Compared to CHD with normal myocardium, ESHF
myocardium demonstrates increased CSCs and evidence of reversal to
a fetal gene program. The exact role of these ESHF-derived CSCs within
the myocardium is not yet defined.
Figure 1. Quantitative RT-PCR in the right atrium of ESHF vs. CHD for mRNA expression
of (a) c-kit (CHD, n=4, 5.3±0.3 vs ESHF, n=4, 10.8±1.3, P= 0.03) and (b) ISL-1 (CHD,
n=4, 1.7±0.1 vs ESHF, n=4, 4.3±0.4, P= 0.03) (c) ISL-1 expression as determined by
immunofluorescence showed increased expression in right sided structures (d) Unlike
CHD-derived CDCs, c-kit expression in ESHF-derived CDCs is age independent and
shows high expression with increasing age. Quantitative RT-PCR of ESHF vs. CHD for
mRNA expression of (e) αß-MHC (CHD, n=5, 0.82±0.1%, vs. ESHF, n=5, 0.34±0.7%, P
=0.015), (f) βß-MHC (CHD n=5, 0.05±0.01% vs. ESHF, n=4, 0.37±0.05%, P=0.015), and (g)
ANF (CHD, n=5, 6.0±0.63% vs. ESHF n=4, 47.7±13.7%, P=0.015). Data are represented as
mean ± S.E.M. analyzed by t-test (Mann-Whitney test) followed by Dunns post hoc test.
*P<0.05, **P<0.001.
NOTES:
BASIC SCIENCE FORUM
5B. Timing of Adding Blood to Prime Affects Inflammatory Response to
Neonatal Cardiopulmonary Bypass
Authors: DBenjamin S.Schmidt, DMagan R.Lane,
DVanessa M.DiPasquale, DLori P.Graf, D*Yoshio Ootaki,
DJames E.Jordan, D*Ross M.Ungerleider
Author Institution(s): Wake Forest Baptist Health, Winston Salem, NC
Discussant:*E. Dean McKenzie, Texas Children’s Hospital, Houston, TX
COMMERCIAL RELATIONSHIPS: Benjamin S. Schmidt: Research Support: Medtronic,
Inc.; Magan R. Lane: Research Support: Medtronic, Inc.; Vanessa M. DiPasquale:
Research Support: Medtronic, Inc.; Lori P. Graf: Research Support: Medtronic, Inc.;
Yoshio Ootaki: Research Support: Medtronic, Inc.; James E. Jordan: Research
Support:Medtronic, Inc.; Ross M. Ungerleider: Research Support: Medtronic, Inc.
Objectives: Complications from systemic inflammation are reported
in neonates following exposure to cardiopulmonary bypass (CPB).
Previous work has demonstrated a significant advantage to the use
of asanguinous prime (AP) versus blood prime (BP) in reducing these
complications. However, use of AP in neonates can result in significant
hemodilution requiring addition of blood at some point. This study
investigates whether the addition of blood after institution of CPB
alters the inflammatory response compared to a BP at the time CPB is
instituted.
Methods: Neonatal swine (3.96±0.25kg, n=19) were randomized into
four groups: BP (n=5); APBC (blood after CPB but before cooling)
(n=3); APEC (blood after cooling, prior to low flow (LF)) (n=5); and
APER (blood after rewarming) (n=6). CPB strategy (all groups) involved
cooling to 18°C, 30 minutes of 50ml/kg LF and rewarming to 36°C. Total
CPB exposure for each group was 2 hours. Endpoints measured were
cytokines, lactic acid, perioperative animal weight gain, hematocrit, and
volume requirements during CPB.
Results: While the hematocrit between groups varied throughout CPB,
all groups ended with a similar value. Although they spent some portion
of CPB with a lower hematocrit, AP groups did not have elevated lactic
acid levels at the end of CPB compared to BP. AP groups released less
IL-8 than BP, with the EC group producing the least (33±20pg/ml vs
148±43pg/ml, p<0.05). All AP groups exhibited less edema than the BP
group, with the least body weight gain noted in the EC group (29±55g vs
727±135g, p<0.05).
Conclusions: This study suggests that using an AP for neonates being
cooled to deep hypothermia is practical. Adding blood to the circuit at
the end of cooling elevates hematocrit to target levels prior to exposure
to low flow without deleterious effects. Exposure to CPB with an AP
followed by later addition of blood reduces inflammation compared to
CPB with a BP.
NOTES:
BASIC SCIENCE FORUM
6B. Spinal Cord Ischemia Reperfusion Injury Induces Erythropoietin
Receptor Expression
Authors: Lisa S. Foley, Daine T. Bennett, Kirsten A. Freeman, Marshall
Bell, Joshua Mares, Xiangzhong Meng, *David A. Fullerton, *Thomas B.
Reece
Author Institution(s): University of Colorado, Aurora, CO
Discussant: *John W. Hammon, Wake Forest University Medical Center,
Winston-Salem, NC
Objectives: Paraplegia remains a devastating complication of
thoracoabdominal aortic surgery, occurring in up to 20% of complex
cases. Erythropoietin (EPO) attenuates this injury in models of spinal
cord ischemia. Upregulation of the ßcR subunit of the EPO receptor is
associated with reduced damage in murine models of neural injury.
This receptor activates anti-apoptotic pathways including STAT3. We
hypothesized that spinal cord ischemia reperfusion injury upregulates
the ßcR receptor subunit with a subsequent increase in activated STAT3.
Methods: Adult male C57/BL6 mice received an IP injection of 0.5mLs
of EPO (10U/kg) or 0.9% saline following induction of anesthesia. Spinal
cord ischemia was induced via sternotomy and 4-minute thoracic aortic
cross-clamp. Sham mice underwent sternotomy without cross-clamp
placement. Following four hours of reperfusion, spinal cords were
harvested and homogenized. ßcR receptor subunit expression and
STAT3 activation was evaluated by Western blot.
Results: Ischemia reperfusion (IR) increased ßcR subunit expression
in spinal cords of IR/control and IR+EPO mice compared to shams
(1.35 ± 0.14 vs 1.09 ± 0.07, p=0.01 and 1.66 ± 0.35 vs 1.08 ± 0.17, p=0.02).
Additionally, both IR injury and IR+EPO administration demonstrated
increased STAT3 activation compared to shams (3.4 ± 1.39 vs 1.31 ± 0.3,
p=0.01 and 3.80 ± 0.58 vs 1.56 ± 0.32 p=0.01, respectively).
Conclusions: Ischemia reperfusion injury induces the ßcR subunit of the
EPO receptor and initiates early downstream anti-apoptotic signaling
through STAT3 activation. Further investigation into the role of the ßcR
receptor subunit is warranted to determine tissue protective functions
of EPO. Elucidation of mechanisms involved in spinal cord protection is
essential for reducing delayed paraplegia.
ßcR receptor subunit expression and STAT3 activation are increased in all ischemic
groups compared with shams. NOTES:
11. Surgical Therapy Is an Important Multimodality Component in
Patients With Distal Esophageal Adenocarcinoma Independent of
Regional Lymph Node Location
Authors: Boris Sepesi1, Henner M. Schmidt2, Michal Lada3, *Garrett
L. Walsh1, *Reza J. Mehran1, *David C. Rice1, *Jack A. Roth1, *Ara A.
Vaporciyan1, Jaffer A. Ajani1, Thomas J. Watson3, *Stephen G. Swisher1,
Donald E. Low 2, *Wayne L. Hofstetter1
Author Institution(s): 1University of Texas MD Anderson Cancer Center,
Houston, TX; 2Virginia Mason Medical Center, Seattle, WA; 3University
of Rochester Medical Center, Rochester, NY
Discussant: *Mark J. Krasna, Jersey Shore University Medical Center,
Neptune, NJ
Objectives: The AJCC 7th edition esophageal cancer staging was
based on outcomes of surgical therapy alone eliminating nodal
location from its schema. This system has not been validated in the
multimodality clinical setting and location of regional nodal disease
continues to influence treatment decisions. The aim of our study was
to evaluate outcomes based on the clinical nodal disease location,
following tri-modality therapy of distal/gastroesophageal junction (GEJ)
adenocarcinoma.
Methods: This was a multi-institutional retrospective study, involving
distal esophageal/GEJ adenocarcinoma clinically node positive (cN+)
patients treated with tri-modality therapy between 01/2002 and 12/2011.
Nodal stations were classified as individual variables; paratracheal,
subcarinal, celiac, lower esophageal, paraaortic, supraclavicular, and
perigastric/perihepatic. Overall survival (OS) was estimated with
the Kaplan Meier method. Univariate and multivariate analyses were
performed to identify variables associated with OS.
Results: A total of 196 cN+ patients met the study criteria. The most
prevalent nodal disease was in the perigastric region 72% (141/196);
paratracheal nodal involvement was present in 19/196 (10%) of patients.
None of the nodal disease locations was significantly associated with
OS on univariable analysis. Multivariable analysis identified age (HR
1.036, p=0.001), male sex (HR 2.39, p=0.003), pathologic T3 (HR 1.81,
p=0.048) and N3 (HR 2.93, p=0.003) to be significantly associated with
survival.
Conclusions: Location of cN+ regional node disease relative to the
primary esophageal adenocarcinoma is not predictive of survival
following trimodality therapy. Rather age, sex, pathologic depth and
number of involved nodes were independent predictors of survival.
Surgery continues to play an important role in survival outcomes
irrespective of nodal distribution in the chest and abdomen.
NOTES:
12. The STS Adult Cardiac Surgery Database Version 2.73:
More is better!
Authors: Terry Shih1, Gaetano Paone2, Patricia F. Theurer 3, Donna
McDonald5, Gail F. Bell3, Jaelene K. Williams3, *David M. Shahian4,
*Richard Prager1
Author Institution(s): 1University of Michigan, Ann Arbor, MI; 2Henry
Ford Hospital, Detroit, MI; 3MSTCVS Quality Collaborative, Ann Arbor,
MI; 4Massachusetts General Hospital, Boston, MA; 5The Society of
Thoracic Surgery, Chicago, IL
Discussant: David M. Shahian, Massachusetts General Hospital, Boston,
MA
Objectives: With the introduction of Version 2.73, a number of new
patient risk factors are now captured in The Society of Thoracic
Surgeons’ (STS) Adult Cardiac Surgery Database. We sought to
evaluate the potential association of these new risk factors with
operative mortality.
Methods: We reviewed all patients with a STS Predicted Risk of
Mortality (PROM) in our statewide quality collaborative database from
July 2011 to December 2013 (N=19,743). Univariate analyses were used
to determine significant associations between mortality and the new
risk factors in version 2.73 (Table). We then performed multivariable
analysis, incorporating the STS PROM into our regression.
Results: In the univariate model, patients with recent smoking history,
other tobacco use, sleep apnea, altered neurologic status, syncope,
illicit drug use, and cancer within five years had no significant
difference in mortality (p>0.05). Patients with an elevated MELD
score, abnormal pulmonary function tests (PFTs), home oxygen use,
inhaled medications or bronchodilator therapy, history of liver disease,
, recent pneumonia, mediastinal radiation, and prolonged five-meter
walk tests had significant increases in operative mortality (p<0.05).
Alcohol use was inversely associated with mortality. In multivariable
analysis incorporating the STS Predicted Risk models, elevated MELD
score, abnormal PFTs, home oxygen use, inhaled medications or
bronchodilator therapy, liver disease, and prolonged five-meter walk
testing were independently predictive of mortality.
Conclusions: In this analysis, several of the new STS data variables were
significantly associated with operative mortality after cardiac surgery.
The addition of these patient factors improves our understanding of
evolving patient demographics and comorbid conditions and their
impact on perioperative risk. This will improve both shared decisionmaking and assessments of provider performance.
Univariate and Multivariable Analysis for New Patient Risk Factors and
Associations with Mortality
*Valve procedures include aortic valve replacement, mitral valve replacement, and
mitral valve repair
NOTES:
13. A Community-based Multi-disciplinary CT Screening Program
Authors: D*Daniel L. Miller, William D. Mayfield, Theresa D. Luu, Gerald
A. Helms, Allan R. Muster, Vickie J. Beckler, Aaron Caan
Author Institution(s): WellStar Healthcare, Marietta, GA
Discussant: *John A. Howington, NorthShore University HealthSystem,
Evanston, IL
COMMERCIAL RELATIONSHIPS: Daniel L. Miller: Consultant/Advisory Board: Ethicon
Endo-Surgery, Inc., Bard-Davol, Inc.
Objectives: Lung cancer is the most common cause of cancer deaths in
the US. Overall survival is less than 17% with the majority of patients
presenting with advanced disease. The NLST showed that cancer
mortality can be reduced with CT screening of high risk patients.
Unfortunately, that study completed enrollment in 2004; results
published in 2011. Today, no formal lung screening is offered. We
report our results of a community-based multi-disciplinary lung cancer
screening program.
Methods: In 2008, we started a self-pay lung cancer CT screening
program within our Healthcare System (HCS). Our HCS consist of five
Hospitals, four health parks and 12 imaging centers and provides care in
a five county area of approximately 1.4 million people.
Results: A total of 1267 patients have undergone self-pay CT lung cancer
screening within our HCS from 2008 through 2013; 25 lung cancers
(1.9%) were diagnosed with 13 (52%) of these in the NLST criteria.
During that same time period 2688 patients were treated for lung
cancer within our HCS that were not Screened. There was a significant
difference in Stage presentation between the two groups. Screened
patients were stage I or II in 64% versus 36% in No screened patients,
while 36% were stage III or IV in Screened patients versus 64% in the No
screened patients. Five-year survival was also significantly increased
for the Screened patients versus the No screened patients with a 17%
increase for the Stage I patients and 15% increase for Stage II patients.
There was no difference in survival between the groups for stage III or
Stage IV patients.
Conclusions: A community-based multi-disciplinary lung cancer CT
screening program can improve survival of patients with lung cancer.
This improvement was caused by a complete stage-shift and in the
care of patients with early stage disease (VATS lobectomy and adjuvant
chemotherapy). Lung cancer CT screening needs to expand to patients
outside of NLST criteria who are also at risk.
NOTES:
14. Moderate vs. Deep Hypothermia With Antegrade Cerebral Perfusion
for Acute Type A Aortic Dissection
Authors: Bradley G. Leshnower, *Vinoud Thourani, *Michael Halkos,
Eric Sarin, William B. Keeling, *Robert A. Guyton, *Edward P. Chen
Discussant: *Anthony L. Estrera, University of Texas Houston Medical
School, Houston, TX
Objectives: Moderate hypothermic circulatory arrest (MHCA) and
unilateral selective antegrade cerebral perfusion (USACP) is an
accepted method of cerebral protection in elective aortic surgery.
This study evaluates the safety of MHCA vs the gold standard of deep
hypothermic circulatory arrest (DHCA) in patients undergoing emergent
repair of acute Type A aortic dissection (Type A).
Methods: A retrospective review of a US aortic surgical database from
2004-2013 identified 243 patients who underwent Type A with right
axillary artery cannulation, USACP and hypothermic circulatory arrest.
Seventy-seven patients underwent DHCA at ≤ 24°C and 185 patients
underwent MHCA at >24°C. Propensity scores were used to model
adverse outcomes as a function of MHCA vs DHCA.
Results: The mean age was 55 years-old in each group. The number
of root replacements (MHCA 27.2% vs. DHCA 29.6%, p=0.71) and
total arch replacements (MHCA 8.3% vs DHCA 10.7%, p=0.58) were
equivalent between the two groups. DHCA patients underwent
circulatory arrest at significantly lower temperatures (DHCA 21.5 ± 2.1°C
vs MHCA 27.3 ± 1.7°C, p <0.001). There were no significant differences
in cardiopulmonary bypass, cross clamp or circulatory arrest times
between the two groups. Mortality was 16.9% in DHCA patients, and
10.6% in MHCA patients (p>0.05). There was no significant difference
in stroke (MHCA 8.4% vs DHCA 10.1%, p=0.68), temporary neurologic
dysfunction (MHCA 5.4% vs DHCA 7.3%, p= 0.58), or renal failure
(MHCA 7.8% vs DHCA 13.4%, p=0.19) between the two groups. The
incidence of respiratory failure requiring tracheostomy was significantly
less in MHCA patients (MHCA 5.4% vs DHCA 15.9%, p <0.001).
Temperature was not found to be a predictor of adverse outcome in
patients undergoing Type A with uSACP (Table)
Conclusions: MHCA+uSACP produces equivalent outcomes to
DHCA+uSACP in patients undergoing emergent Type A repair. This
obviates the need for DHCA in the surgical treatment of Type A.
Adjusted Multivariate Analysis of Temperature as a Predictor of
Adverse Outcomes during Acute Type A
MHCA: Moderate Hypothermic Circulatory Arrest
DHCA: Deep Hypothermic Circulatory Arrest
AOR: Adjusted Odds Ratio
NOTES:
15. Establishing Contemporary Benchmarks for Surgical Pulmonary
Valve Replacement: Analysis of The Society of Thoracic Surgeons
Authors: Amber D. Khanna1, Kevin Hill2, Sara K. Pasquali6, Amelia S.
Wallace2, Joseph D. Kay1, Frederick A. Masoudi1, Marshall L. Jacobs3,
*Jeffrey P. Jacobs 4, Tara Karamlou5
Author Institution(s): 1University of Colorado Anschutz Medical
Campus, Aurora, CO; 2Duke University School of Medicine, Durham,
NC; 3Johns Hopkins University School of Medicine, Baltimore, MD; 4
Johns Hopkins All Children’s Hospital, St. Petersburg, FL; 5University of
California, San Francisco, San Francisco, CA; 6University of Michigan,
Ann Arbor, MI
Discussant: *Brian E. Kogon, Emory University, Children’s Hospital at
Egleston, Atlanta, GA
Objectives: Trans-catheter pulmonary valve replacement (PVR) is
becoming more widely available. We sought to establish benchmark
data for surgical PVR.
Methods: We examined in-Hospital outcomes from surgical PVR in
The Society of Thoracic Surgeons Congenital Heart Surgery Database
(2007-2013), with focus on patients likely to be eligible for trans-catheter
PVR (i.e., ≥ 5 years age, ≥ 30 kg). The cohort was divided into three
procedural groups: isolated PVR, isolated right ventricle to pulmonary
artery (RV-PA) conduit, and remaining patients with concomitant
procedures or endocarditis. Patient characteristics, morbidity and
mortality were described.
Results: Of 5233 eligible patients, median age was 17 years-old (IQR
14, 25 yrs). Age was ≥ 40 years-old in 8.4%. BMI was ≥ 30 in 13.7%.
Pre-operative factors (potential risk factors) are shown in table 1.
As the number of prior cardiopulmonary bypass operations (CPBs)
increased, preoperative factors increased (1.9%, 3.0%, 5.3%, 4.9%, 10%
for 0, 1, 2, 3, and 4 or more prior CPBs respectively). As age increased,
preoperative factors increased (2.4%, 4.8%, and 8.0% for ages < 20,
20-39, 40+). In-Hospital mortality was 0.9% for the entire cohort; 0.2%
for isolated PVR group, 1.1% for isolated RV-PA group and 1.1% for
the concomitant procedure group. Overall, 2.8% experienced one or
more of six major complications (1.6%, 0.0%, and 3.4% in isolated
PVR, isolated RV-PA conduit, and concomitant procedure groups
respectively). Unadjusted mortality increased with increasing number
of prior CPBs (0.6%, 0.6%, 1.2%, 2.3%, and 2.9% for 0, 1, 2, 3, and 4 or
more prior CPBs respectively.) Unadjusted mortality also increased with
increasing age (0.7%, 0.8% and 3.0%, for ages < 20, 20-39, and 40+).
Conclusions: In the modern era, surgical pulmonary valve replacement
is associated with a low risk of mortality or major complications. As age
and number of prior CPBs increases, risk of PVR increases.
Pre-operative Factors and Surgical Outcomes for Pulmonary Valve
Replacement
NOTES:
16. Longitudinal Trends in Morbidity and Mortality With Introduction
of Robotic Assisted Thoracic Surgical Procedures at a Major Academic
Cancer Center
Authors: Inderpal Sarkaria, Amanda A. Ghanie, Joe Dycoco, Rachel
Grosser, David J. Finley, Nabil P. Rizk, James Huang, Prasad Adusumilli,
Robert J. Downey, Manjit S. Bains, Valerie W. Rusch, *David R. Jones
Author Institution(s): Memorial Sloan-Kettering Cancer Center, New
York, NY
Discussant: DMark W. Onaitis, Duke University Medical Center, Durham,
NC
COMMERCIAL RELATIONSHIPS: DISCUSSANT: Mark W. Onaitis: Speakers Bureau/
Honoraria: Intuitive Surgical, Inc.
Objectives: Robotic assisted video assisted thoracic surgical (RAVATS) lobectomy, thymectomy, and robotic assisted minimally invasive
esophagectomy (RAMIE) were introduced at a high volume institution in
2002, 2009, and 2011, respectively. Practice penetration and comparative
measures of quality for these procedures were examined over time.
Methods: All robotic assisted thoracic surgical procedures performed
during the study period were retrospectively identified from a
prospectively maintained database. Data comparing open, VATS, and
robotic assisted procedures were assessed, including robotic utilization
trends, morbidity, mortality, and length of Hospital stay (LOS), for
lobectomy, esophagectomy, and thymectomy.
Results: Between 2002 and 2013, a total 731 robotic thoracic procedures
were performed. Robotic assisted lobectomies, thymectomies, and
esophagectomies grew annually from 3% to 22%, 13% to 47%, and 20%
to 37% from introduction year to 2013 (Figure 1). RAMIE and RA-VATS
lobectomy morbidity and RA-VATS lobectomy mortality were higher
than VATS or open cases, with program inception and with staff and/
or procedure change, and rapidly decreased to service norms (Table 1).
There was no difference in LOS between RA-VATS and VATS lobectomy
over time. RAMIE and RA-VATS thymectomy LOS were decreased
compared with open procedures.
Conclusions: Use of robotics for major thoracic procedures increased
annually over the past decade. Procedure-specific morbidity and/or
mortality rates were higher than service norms but normalized rapidly.
While these procedures may be introduced into practice without
enduring deviations in quality indicators, standardized protocols for
Introduction of new technology should be considered to minimize risks
associated with initial phases of utilization and learning.
Morbidity and mortality rates in year of procedure inception and final
year of study
*2002-2007 **2011-2012
Figure 1. Trends in annual rates of open, VATS, and robotic assisted procedures for
lobectomy, esophagectomy, and thymectomy from 2002 to 2013 at a major academic
cancer center.
NOTES:
17. Variation in Outcomes for Risk-adjusted Pediatric and Congenital
Cardiac Operations: An Analysis of The Society of Thoracic Surgeons
Authors: *Jeffrey P. Jacobs1, Sean M. O’Brien2, Sara K. Pasquali3, *J.
William Gaynor4, Tara Karamlou7, Karl F. Welke5, Giovanni Filardo6, Jane
M. Han8, Sunghee Kim2, David M. Shahian9, Marshall L. Jacobs10
Author Institution(s): 1Johns Hopkins All Children’s Heart Institute,
St. Petersburg, FL; 2Duke University School of Medicine, Durham,
NC; 3University of Michigan, Ann Arbor, MI; 4Children’s Hospital of
Philadelphia, Philadelphia, PA; 5Children’s Hospital of Illinois, Peoria,
IL; 6Institute for Health Care Research and Improvement, Dallas, TX;
7
University of California San Francisco, San Francisco, CA; 8The Society
of Thoracic Surgeons, Chicago, IL; 9Massachusetts General Hospital,
Harvard Medical School, Boston, MA; 10Johns Hopkins University,
Baltimore, MD
Discussant: D*Frederick L. Grover, University of Colorado Denver,
Aurora, CO
COMMERCIAL RELATIONSHIPS: DISCUSSANT: Frederick L. Grover: Consultant/
Advisory Board: Somalution
Objectives: The empirically derived 2014 STS Congenital Heart
Surgery Database (STS-CHSD) Mortality Risk Model incorporates
both procedural stratification by STAT Mortality Category and patient
factors. The purpose of this analysis is to assess variation in pediatric
and congenital cardiac surgical outcomes across centers using this new
risk model.
Methods: All index cardiac operations in the STS-CHSD (January 1,
2010–June 30, 2013) were eligible for inclusion. Isolated PDA closures
in patients <2.5kg were excluded, as were centers with >10% missing
data and patients with missing data for key variables. The risk model
includes the following covariates: STAT Mortality Category, age,
previous cardiovascular operation(s), any non‐cardiac abnormality,
any chromosomal abnormality or syndrome, important preoperative
factors (mechanical circulatory support, shock persisting at time of
surgery, mechanical ventilation, and renal dysfunction), prematurity (for
neonates only), weight (for neonates only), and weight‐for‐age‐and‐sex
Z‐score (for infants only).
Results: 40,835 operations from 80 centers were included. Overall
discharge mortality was 3.7% (1508/40,835). Discharge mortality by age
category was: neonates (10.0% [900/9015]), infants (3.0% [449/15,107]),
children (0.9% [126/14,639]), and adults (1.6% [33/2074]).
Variation across centers was assessed for all patients and within age
categories. Centers for which the 95% confidence interval for observedto-expected mortality ratio does not include unity (does not overlap
with the number 1) are identified as one star (low performing) or three
star (high performing) programs with respect to discharge mortality for
that age category (see Table).
Conclusions: The 2014 STS-CHSD Mortality Risk Model can be used to
describe center-level performance. Identification of low performing and
high performing programs may facilitate quality improvement.
The 2014 STS Congenital Heart Surgery Database (STS-CHSD)
Mortality Risk Model NOTES:
18. Residents’ Perceptions of Two- vs. Three-year Cardiothoracic
Training Programs (2013 and 2014 TSRA/TSDA In-training Exam
Survey)
Authors: Tom C. Nguyen1, David Odell2, Elizabeth H. Stephens3,
Gabriel Loor4, Damien J. LaPar5, Walter F. DeNino6, Benjamin Wei7,
Muhammad Aftab8, Ryan A. Macke9, Jennifer S. Nelson10, Kathleen
Berfield11, John Lazar12, William Stein14, Samuel J. Youssef15, Vakhtang
Tchantchaleishvili13
Author Institution(s): 1University of Texas-Houston, Houston, TX;
2
University of Pittsburgh Medical Center, Pittsburgh, PA; 3Columbia
University, New York City, NY; 4University of Minnesota, Minneapolis,
MN; 5University of Virginia, Charlottesville, VA; 6Medical University of
South Carolina, Charleston, SC; 7University of Alabama, Birmingham,
AL; 8Texas Heart Institute/Baylor, Houston, TX; 9University of Wisconsin,
Madison, WI; 10University of North Carolina, Chapel Hill, NC; 11University
of Washington, Seattle, WA; 12Lenox Hill, New York City, NY; 13University
of Rochester, New York, NY; 14Emory University, Atlanta, GA; 15Swedish
Hospital, Seattle, WA
Discussant: *William A. Baumgartner, Johns Hopkins University School
of Medicine, Baltimore, MD
Objectives: Resident perception of 2 vs. 3-year programs has never
been characterized. The objective of this study was to use the
mandatory TSRA/TSDA In-Training Examination (ITE) survey to
compare 2 vs. 3-year cardiothoracic training programs from graduating
residents.
Methods: Each year ACGME cardiothoracic residents are required to
take a 30-question survey designed by the Thoracic Surgery Residents
Association (TSRA) and Thoracic Surgery Directors Association (TSDA)
prior to taking the ITE. The survey, thus, has a 100% response rate.
2013 and 2014 ITE responses from graduating residents in 2 vs. 3-year
training programs were compared quantitatively. Wilcoxon Signed-Rank
Test was used to analyze ordinal and interval data. Nominal data was
analyzed as contingency tables using Fisher’s exact test.
Results: 416 ITE surveys were collected of which 167 were from
graduating residents (2-year, n=96; 3-year n=71). There was no
difference in perception of being prepared for the ABTS Exams or
amount of debt between 2 vs. 3-year respondents. Respondents
expressed similar interests in terms of specialization, however interest
in cardiac predominated in 3-year while interest in thoracic dominated
in 2-year respondents. There was no difference in intended practice
type (i.e. academic vs. private practice). More residents from 2-year
programs expressed difficulty meeting case requirements and planned
on additional training, while more residents from 3-year programs felt
adequately trained and prepared for independent practice. (TABLE)
Conclusions: There was no difference in field of interest, practice type,
and amount of debt between 2 vs. 3-year programs. Respondents
from 2-year programs expressed more difficulty in meeting case
requirements, while residents from 3-year programs felt more prepared
for independent practice. The TSRA/TSDA ITE survey results may have
important implications in developing 2 vs. 3-year training programs.
NOTES:
19. Retrograde Ascending Aortic Dissection After TEVAR for Distal
Aortic Dissection and Zone 0 Landing: Association, Risk Factors, and
True Incidence
Authors: D*Ourania Preventza1, Andrea Garcia2, *Denton Cooley1,
Lorena Gonzales2, D*Joseph Coselli1
Author Institution(s): 1Texas Heart Institute at Baylor St. Luke’s Medical
Center, Houston, TX; 2Baylor College of Medicine, Houston, TX
Discussant: D*Edward P. Chen, Emory University School of Medicine,
Atlanta, GA
COMMERICAL RELATIONSHIPS: Ourania Preventza: Consultant: Medtronic, Inc.;
Speaker Bureau/Honoraria: Cook Medical, Inc., W.L. Gore & Associates, Inc.; Joseph
S. Coselli: Consultant/Advisory Board: Medtronic, Inc., St. Jude Medical, Inc. Terumo,
Vascutek, W.L. Gore & Associates, Inc.; Speakers Bureau/Honoraria: Terumo, Vascutek
REGULATORY DISCLOSURES: This presentation describes the off-label use of Gore
Thoracic Stent graft for various thoracic aortic pathologies of the arch and of the
descending thoracic aorta. This stent graft is approved by the FDA for some of the
pathologies described in the abstract. This presentation describes the off-label use of
Cook TX-2 Thoracic Stent graft for various thoracic aortic pathologies of the arch and of
the descending thoracic aorta. This stent graft is approved by the FDA for some of the
pathologies described in the abstract. This presentation describes the off-label use of
the Medtronic Thoracic Endograft, which is FDA approved.
Objectives: Thoracic endovascular aortic repair (TEVAR) for distal
aortic dissection and zone 0 deployment are associated with retrograde
ascending aortic dissection (rAAD), yet few data exist regarding rAAD’s
true incidence. The aim of our study was to determine the true incidence
of rAAD, to contribute to the sparse literature, and to challenge this
reported association.
Methods: From January 2005 to March 2014, 300 patients underwent
TEVAR and were at at risk for rAAD. We excluded patients who had prior
ascending or hemiarch grafts, had traditional or frozen elephant trunk
grafts, or required concomitant ascending graft placement. Patients
in Group A (n=106, 35.3%) had distal aortic dissection (n=71, 67.0%) or
required landing of the endograft in zone 0 of the native ascending aorta
(n=35, 33.0%). Patients in Group B (n=194, 64.7%) had non-dissected
descending or distal arch aneurysm (n=172), penetrating ulcer (n=10),
coarctation (n=5), endoleak (n=4), aortobronchial fistula (n=2), or
transection (n=1).
Results: The incidence of rAAD was 1.3% overall (n=4), 0.9% in
Group A (n=1, Gore TAG device), and 1.5% in Group B (n=3; 1 Talent
Captivia, 2 Cook Zenith TX2). No zone 0-treated patient had rAAD. The
Group A patient required aortic arch debranching and endovascular
exclusion of the arch. Of the Group B patients, 2 died and 1 was treated
nonoperatively. The median interval between TEVAR and rAAD was 11
days. Aggressive balloon dilatation (n=1) and stent graft manipulation
(n=3) were the causes of rAAD.
Conclusions: Post-TEVAR rAAD is a rare but lethal complication, so
contributing to the literature is extremely important. Prompt recognition
and prevention by experienced operators is crucial. rAAD is not
device specific and does not appear to be associated with distal aortic
dissection or landing in zone 0. To our knowledge, this is one of the few
studies to report the true incidence of rAAD in patients who are at risk.
ADULT CARDIAC BREAKOUT
NOTES:
Authors: Michael O. Kayatta, Vasilis Babaliaros, Eric Sarin, Patrick
Kilgo, Chun Li, Chandan Devireddy, Bradley G. Leshnower, Kreton
Mavromatis, Amanda Maas, Robert A. Guyton, James Stewart, Peter
Block, Stam Lerakis, D*Vinod Thourani
Discussant: *Thomas M. Beaver, University of Florida, Gainesville, FL
COMMERICAL RELATIONSHIPS: Vinod Thourani: Consultant/Advisory Board: Edwards
Lifesciences, Sorin, St. Jude Medical, Inc., DirectFlow; Co-founder/Ownership Interest:
Apica
Objectives: There has been increasing scrutiny on the outcomes for
aortic valve replacement (AVR) performed in the extreme age groups
resulting in hesitancy to refer for surgery. Consequently, transcatheter
aortic valve replacement (TAVR) may offer these patients a treatment
alternative. The objective of this study was to describe outcomes in
nonagenarians using transfemoral and alternative access techniques.
Methods: A retrospective review was performed on patients who
underwent TAVR from 09/2007 through 02/2014 in an US academic
institution. Ninety-five TAVR procedures were performed in
nonagenarians using a balloon expandable valve: transfemoral (TF,
n=66), transapical (TA, n=14), transaortic (TAo, n=14), and transcarotid
(TC, n=1). Morbidity and 30-day and mid-term mortality were assessed.
Kaplan-Meier plots were used to determine 5-year survival rates.
Results: The mean age was 91.8±1.8 years and 49 (52%) were female.
Postoperative morbidity (Table 1) included one patient (1%) each of
stroke, MI, pneumonia, and renal failure. The mean postoperative
length of stay was 7.0±5.3 days for all patients. Overall 30-day mortality
was 3.2%, much less than the STS PROM of 14.5±7.3%. There were no
deaths in the TF patients, but there were 2 (14.3%) TA and 1 (7.1%) TAo
deaths. The Kaplan-Meier estimate of median survival was 3.2 years.
Conclusions: A tailored approach in these extreme aged, high-risk
patients leads to excellent outcomes in both the short and medium
term. Improvements in alternative access TAVR is required to minimize
morbidity and mortality. Referral for TAVR in nonagenarians should not
be precluded based on age alone.
Short-term Postoperative Outcomes NOTES:
21. Early and Late Outcomes After Complete Aortic Replacement
Authors: *Anthony L. Estrera, Harleen Sandhu, Tom C. Nguyen, Ali
Azizzadeh, Kristofer Charlton-Ouw, Charles C. Miller, *Hazim J. Safi
Author Institution(s): University of Texas Medical School at Houston,
Memorial Hermann Heart and Vascular Institute, Houston, TX
Discussant: *John A. Kern, University of Virginia Health System,
Charlottesville, VA
Objectives: Repair of aneurysms and dissection involving the entire
thoracoabdominal aorta (aortic root to the iliac bifurcation) remains a
surgical challenge often requiring multiple procedures. We describe our
experience with complete aortic replacement.
Methods: Between 1991 and 2013, 3012 repairs of the aortic root,
ascending, transverse arch or thoracoabdominal aorta have been
performed. Of these, we treated 37 patients with total aortic
replacement. Staged repair of the aortic root/ascending/arch and
thoracoabdominal segments was utilized when feasible. Median age
was 54.4 +/- 14.1 years, and 14/37 patients (38%) were women.
Results: We performed 71 operations (31 ascending and 37
thoracoabdominal repairs) in 37 patients; one patient had three
and another had four procedures. Six patients had their ascending/
aortic root operations performed outside our institution, with
thoracoabdominal completion performed in our center. 11/37 (29.8%)
had Marfan syndrome or other connective tissue abnormalities.
Acute dissection was present in 2/37 (5.4%), and chronic dissection in
23/37 (62.2%). History of coronary artery disease was present in 9/37
(24.3%), hypertension in 26/37 (70.3%). Median preoperative GFR was
86.7 ml/min 1.75 mm3 (interquartile range 65-118). Median interval
between stages of repair was 2.5 months. Early mortality after stage 1
was 0%, with all patients in this series progressing to complete aortic
replacement. Mortality following stage completion was 2.7% at 30 days,
8.1% at 45 days, 27% at one year, and 39% at 5 years. Median follow-up
time was 49.9 months (interquartile range 9-113). See Figure 1.
Conclusions: Complete aortic replacement can be performed with
acceptable morbidity and mortality. Most of these patients were
younger, have associated dissection, and require multiple stages for
completion. Even with thorough surveillance, further study is required
to determine the reasons for marginal late survival.
Late Survival After Complete Aortic Replacement (by Kaplan-Meier Estimate)
NOTES:
22. Long-term Survival Following Bovine Pericardial Versus Porcine
Matter?
Authors: Asvin M. Ganapathi, Brian R. Englum, Jeffrey Keenan,
*Hanghang Wang, Matthew A. Schechter, *Donald D. Glower, *G. Chad
Hughes
Author Institution(s): Duke University Medical Center, Durham, NC
Discussant: D*William H. Ryan, Cardiac Surgery Specialists, Plano, TX
COMMERICAL RELATIONSHIPS: DISCUSSANT: William H. Ryan: Consultant/Advisory
Board: Edwards Lifesciences, Medtronic, Inc.
Objectives: Bioprosthetic options are increasingly used for aortic valve
replacement (AVR). Previous research has not assessed differences
in long-term outcomes after stented bovine pericardial (BAVR) versus
porcine (PAVR) AVR. We aimed to examine the effect of bioprosthetic
valve choice on long-term survival after AVR.
Methods: Retrospective analysis of all isolated stented bioprosthetic
AVR ± coronary artery bypass grafting (CABG) procedures at a single
tertiary referral institution from 1975-2013 was conducted using a
prospectively maintained IRB-approved database. Multiple valve/nonCABG cardiac procedures were excluded. AVR was classified as BAVR or
PAVR. The effect of valve type on long-term survival was assessed with
Kaplan-Meier (KM) analysis and Cox proportional hazard model (CPH).
Sub-analyses with a CPH, stratifying by valve size (19 & 21 mm; 23 & 25
mm; 27 & 29 mm), as well as age (18-55; >55 years), assessing mortality
and reoperation were also conducted.
Results: N=2,063 total stented bioprosthetic AVR patients were
identified, and 56.8% (n=1,171) had concomitant CABG. There were
n=1,463 BAVR (70.9%) and n=600 PAVR (29.1%). Differences between
the groups were found in race and type of valvular disease (Table).
KM analysis (Figure; p=0.58) and CPH modeling (hazard ratio BAVR
vs PAVR=1.06, p=0.59) did not reveal a significant overall long-term
survival or need for reoperation difference following BAVR vs PAVR.
Sub-analyses of valve size and patient age failed to show an association
between valve choice and long-term survival and need for reoperation.
Conclusions: For patients undergoing AVR +/- CABG with a stented
bioprosthetic valve, the choice of porcine versus bovine pericardial
bioprosthesis does not appear to impact long-term survival or need
for reoperation, regardless of valve size or patient age. As such, valve
choice for stented bioprosthetic AVR would appear to be best guided by
surgeon preference.
Patient Characteristics in Bovine vs. Porcine Stented Bioprosthetic AVR
23. Red Blood Cells and Mortality After Coronary Artery Bypass
Surgery: Are We Really Transfusing Patients to Death?
Authors: Gaetano Paone1, Morley A. Herbert4, Patricia F. Theurer 3, Gail F.
Bell3, Jaelene K. Williams3, Donald S. Likosky2, *Richard Prager2
Author Institution(s): 1Henry Ford Hospital, Detroit, MI; 2University of
Michigan, Ann Arbor, MI; 3MSTCVS Quality Collaborative, Ann Arbor,
MI; 4Southwest Data Consultants, Dallas, TX
Discussant: D*Alan M. Speir, INOVA Heart and Vascular Institute, Falls
Church, VA
COMMERICAL RELATIONSHIPS: DISCUSSANT: Alan M. Speir: Consultant Advisory
Objectives: Prior studies have implicated transfusion as a risk factor for
mortality in coronary artery surgery (CABG). However, as these reports
routinely demonstrate significant demographic differences between
transfused and non-transfused groups, the true association between
transfusion and outcome remains uncertain. In an attempt to further
our understanding of the manner in which transfusion may be related
to mortality, in this study we specifically analyzed the sub-group of
patients who died following CABG.
Methods: 34,362 patients underwent isolated CABG between
January 2008 and September 2013 and were entered into a statewide
collaborative database. A total of 672 patients (2.0%) expired and form
the basis for this study. Univariate analysis compared pre- and intraoperative variables, as well as post-operative outcomes between those
with and without transfusion.
Results: Of the 672 deaths, 573 patients (85.3%) were transfused.
Predicted risk of mortality (PROM) was 7.6% for the transfused patients
vs. 3.7% for those not transfused, (p<0.001). Transfused patients were
older, more often female, had more emergency, off-pump and re-do
procedures and lower pre-op and on-bypass nadir hematocrit. Most
other demographics were similar between the groups (TABLE). Postoperatively, transfused patients were ventilated longer, had more renal
and multi-system organ failure, and were more likely to die of cardiac,
infectious and pulmonary causes after longer ICU and overall lengths
of stay.
Conclusions: While a majority of patients who expired after CABG
received blood transfusion, significant differences in PROM and the
post-op course leading to death between those with and without
transfusion suggest the role of transfusion may be secondary to other
patient-related factors. Recognizing that the relationship between
transfusion and outcome after CABG remains incompletely understood,
these findings are suggestive of a complex interaction of many
variables.
Pre- and Intra-operative Variables
NOTES:
24. Transcatheter Aortic Valve Replacement (TAVR) vs. Off Pump Aortic
Valve Bypass (AVB) With an Apico-Aortic Conduit: A Comparison of
Outcomes and Hospital Economics
Authors: *John Brown, Jack H. Boyd, Parth Patel, Amjad Syed, Joe
Ladowski, Joel Corvera
Author Institution(s): Indiana University, Indianapolis, IN
Discussant: D*Faisal G. Bakaeen, Texas Heart Institute/Baylor College of
Medicine, Houston, TX
COMMERICAL RELATIONSHIPS: DISCUSSANT: Faisal G. Bakaeen: Principal
Investigator: VA Cooperative Studies Program, NHLBI; Speakers Bureau/Honoraria:
AstraZenca
Objectives: TAVR is currently offered to patients who are high risk for
surgical aortic valve replacement. For the past 37 years off pump AVB
has been utilized in elderly patients at our center for similarly high risk
patients. Although TAVR and AVB are offered to such high-risk patients,
comparisons of outcomes and Hospital economics for both strategies
have not been reported.
Methods: We reviewed the database of 52 AVB patients performed
since 2008 with 51 TAVR cases performed since 2012. Data included
demographics, hemodynamics, STS risk score, extent of coronary
disease, ventricular function and follow up. Follow up was 100% in both
groups. Hospital economics for both cohorts were obtained. Mean STS
score for the TAVR group was 7.0% versus 17.6% for AVB group. (p <
0.001)
Results: Kaplin-Meier Hospital, 3-, 6-month and 1-year survival was 88,
85, 80 and 54% and 89, 77, 77 and 67% for TAVR and AVB respectively
(p=0.924). Two TAVR patients and one AVB patient suffered from stroke.
At discharge mild and moderate perivalvar and central AI were present
in 31% and 16% of TAVR patients respectively; no AVB valve leaked.
Trans-valvar gradients were reduced to less than 10mm Hg in both
groups. Mean ICU and Hospital stay was 4.3 and 8.3 days respectively
for TAVR and 6.7 and 15.6 days respectively for AVB. Median Hospital
charges were $239,000 vs. $123,000 TAVR and AVB respectively. Mean
payment to the Hospital was $65,000 (TAVR) vs. $64,000 (AVB) and the
mean contribution margin (profit) to the Hospital was $5,000 vs. $16,000
for TAVR and AVB respectively.
Conclusions: TAVR and AVB relieve aortic stenosis and have similar and
acceptable procedural mortality. AVB patients had 2.5 times the STS risk
score when compared to the TAVR cohort. Hospital charges for TAVR
were nearly two-fold that of AVB. Hospital reimbursement was similar
but AVB had 3x the profit of TAVR. Longer follow up for the TAVR cohort
will determine if survival is comparable to AVB at 1, 3 and 5 years.
NOTES:
25. An Assessment of the Optimal Time for Removal of Esophageal
Stents Used in the Treatment of an Esophageal Anastomotic Leak or
Perforation
Authors: *Richard K. Freeman, *Anthony J. Ascioti, Megan Dake, Raja S.
Mahidhara
Author Institution(s): St. Vincent Hospital, Indianapolis, IN
REGULATORY DISCLOSURE: This presentation describes the off-label use of an
esophageal stent for the treatment of an esophageal perforation or intrathoracic
esophageal anastomotic leak.
Objectives: The use of an esophageal stent for the treatment of a
perforation or anastomotic leak has been shown to be effective and safe
in selected patients. However the optimal timing for stent removal is in
question as reports of complications such as migration, hemorrhage
or airway occlusion are predominantly derived from long term stent
use for malignant dysphagia. This purpose of this investigation was
to identify a time for stent removal in patients treated for an acute
perforation or anastomotic leak that resulted in sealing of the leak while
minimizing the incidence of stent related complications.
Methods: Patients undergoing esophageal stent placement for the
treatment of an acute perforation or intrathoracic anastomotic leak were
identified from a single institution’s prospectively collected database
which included patients initially treated at other facilities. Excluded
were patients whose leak or perforation was associated with an
untreated malignancy. Patient outcomes were recorded and analyzed.
Complications were segregated by stent dwell time.
Results: Over an eight year period, 162 patients underwent esophageal
stent placement for an acute perforation (117) or anastomotic leak (45)
at the study institution. Excluding stent migration within the first 72
hours, stent dwell times of less than two weeks for an anastomotic leak
and less than four weeks for an acute perforation were associated with
significantly lower complication rates (table).
Conclusions: Endoluminal esophageal stent placement is a safe and
effective treatment for patients with an acute esophageal perforation or
intrathoracic anastomotic leak following esophagectomy. Removal of
stents at two weeks for anastomotic leak or four weeks for perforation
has the potential to decrease the incidence of complications associated
with stent use.
GENERAL THORACIC BREAKOUT
Complications of Esophageal Stent Use Segregated
by Stent Dwell Time NOTES:
26. Electromagnetic Navigation Bronchoscopy Guided Methylene Blue
Pleural Dye Marking for the Thoracoscopic Localization and Resection
of Small Pulmonary Nodules
Authors: Michael Reidy1, *Arjun Pennathur1, Valentino J. Bianco1,
William E. Gooding2, James D. Luketich1, Omar Awais1
Author Institution(s): 1University of Pittsburgh Medical Center,
Pittsburgh, PA; 2University of Pittsburgh Cancer Institute, Pittsburgh, PA
Objectives: The National Lung Screening Trial using computed
tomography (CT) has shown a decreased mortality for lung cancer
and we are already seeing thoracic surgeons being referred increasing
numbers of patients with pulmonary nodules, many of which are
subcentimeter lesions. Obtaining definitive diagnosis in some of these
small lesions is difficult. Electromagnetic navigational bronchoscopy
(ENB) guided pleural methylene blue dye marking of the lesion,
followed by videothoracoscopic (VATS) resection is a new technique
for definitive diagnosis. The main objective of this study is to evaluate
our initial experience with the ENB guided dye localization and VATS
resection for diagnosis of lung lesions
Methods: Patients with newly diagnosed lung lesions underwent ENB,
and the nodule with the nearest overlying pleural surface was marked
with Methylene blue dye, followed by VATS resection. The primary
endpoint was the rate of resection of the nodule and definitive diagnosis
Results: Thirty-one patients (men 15; women 16; median age 66 years)
with 36 lesions, underwent ENB localization followed by resection
(VATS 23;robotic 13) .The median size was 1 cm and the median
distance from pleural surface to the center of the lesion was 1.4 cms.
The index nodule was resected in all patients, and a definitive diagnosis
was rendered by the pathologist in all patients (100%). There were a
total of 19 malignant lesions and notably, the stage was T1N0 in 15
patients (42%). Among patients with malignant lesions, 62% underwent
surgical resection with mediastinal node dissection at the same setting.
The operative mortality was 0%. The median Hospital stay was three
days.
Conclusions: ENB Methylene blue dye localization and VATS resection
is feasible, safe and successful in the diagnosis of small lung lesions
and has the potential for definitive treatment of the lung lesion. Thoracic
surgeons should further investigate this modality, and incorporate this
in their armamentarium.
NOTES:
27. Efficacy of Portable Ultrasound to Detect Pneumothorax Post Lung
Resection
Authors: Farah Mohammad, Arielle Hodari, Ilan Rubinfeld, Karen Byers,
Keith Killu, *Zane Hammoud
Author Institution(s): Henry Ford Hospital, Detroit, MI
Objectives: The role of bedside ultrasonography in detection of
pneumothorax in the acute care setting is well established. However,
its role in the diagnosis of pneumothorax following chest tube removal
post lung resection has yet to be elucidated. Our aim was to assess the
efficacy of portable ultrasound in detection of pneumothorax following
chest tube removal post lung resection.
Methods: The study was approved by the institutional review board
and all patients gave informed consent prior to enrollement. A
total of 76 patients were included in the study. Patients underwent
bedside transthoracicultrasonography and chest radiography after an
intraoperatively placed chest tube for lung resection was removed.
Chest radiography was the standard in diagnosis pneumothorax post
chest tube removal. Data were analyzed in R (R Development Core
Team, 2013).
Results: Chest radiography detected pneumothorax in 35 out of 76
patients (46%). Ultrasonography detected pneumothorax in 32 of
these patients. The sensitivity and specificity were 91% and 63%
respectively. The positive and negative predictive values were 0.68 and
0.90 respectively. Only 3 patients were “false negative”, i.e. negative
ultrasound but ultimately positive CXR, none of whom required further
intervention.
Conclusions: Our study demonstrates that portable sonography is
efficacious in the detection of pneumothorax after chest tube removal
post lung resection. This suggests that sonography may replace routine
CXR, thus leading to reduced overall costs and radiation exposure.
Further studies are required to further refine the role of portable
ultrasound post lung resection.
NOTES:
28. Resection for Primary and Metastatic Tumors of the Sternum: An
Analysis of Prognostic Variables
Authors: Usman Ahmad1, Haoxian Yang1, Daniel H. Buitrago1, Manjit
S. Bains1, Nabil P. Rizk1, James Huang1, Prasad Adusumilli1, Gaetano
Rocco2, *David R. Jones1
Author Institution(s): 1Memorial Sloan-Kettering Cancer Center, New
York, NY; 2National Cancer Institute, Naples, Italy
Objectives: Sternal tumors are rare and often require challenging
surgical resections. We sought to evaluate the clinical outcomes and
determine prognostic variables in patients with sternal tumors who
underwent surgical resection.
Methods: A retrospective analysis of sternal resections for primary
or secondary (metastatic or locally invasive) sternal tumors was
performed for patients treated in two large cancer institutes between
1995 and 2013. Overall survival (OS) was estimated using the KaplanMeier method and predictors of OS were analyzed using the Cox
proportional hazards model.
Results: Seventy-eight patients underwent sternal resection. Seventy
patients (90%) had malignant tumors of which 26 (37%) were primary
sternal, 37 (53%) were metastatic, and seven (10%) were locally
invasive non-breast cancer malignancies. Isolated metastatic breast
cancer was the most common sternal tumor (24, 30%), followed by
primary sternal chondrosarcoma (16, 21%). Thirteen patients (17%)
underwent complete, and 65 (83%) underwent partial sternal resection.
Rigid reconstruction was performed in 61 (78%) and major soft tissue
reconstruction in 49 (63%) cases. There were 14 (18%) grade 3 or
4 complications and no peri-operative mortality. The five-year OS
was 67% for primary and 59% for secondary tumors (p=0.69). An R0
resection was associated with prolonged five-year OS (73% vs 20%) on
univariate (p=0.01) as well as multivariate analysis (adjusted HR=2.98;
p=0.045) (see Fig.1). On subgroup analysis, complete resection was
associated with improved OS for primary sternal tumors (p=0.02).
Conclusions: Partial or complete sternal resection can achieve
reasonable OS for both primary and secondary sternal tumors. An R0
resection is associated with an improved five-year OS for primary but
not secondary sternal malignant tumors.
NOTES:
29. Lung Function Predicts Pulmonary Complications After Minimally
Invasive Lobectomy
Authors: Mark K. Ferguson, Ruoyu Zhang, Sang Mee Lee, Chris
Wigfield, Wickii T. Vigneswaran
Author Institution(s): University of Chicago, Chicago, IL
Objectives: Although ppoFEV1% and ppoDLCO% have been identified
as independent predictors of postoperative pulmonary complications
after open lobectomy, it has been suggested that their predictive
abilities may not extend to patients undergoing minimally invasive
lobectomy.
Methods: We evaluated outcomes in 805 patients undergoing
isolated lobectomy via open (1994-2013; 585 patients) or minimally
invasive (2007-2013; 220 patients; VATS or robotic) approaches using
a prospective database. Demographic and physiologic data were
extracted and compared to complications classified as pulmonary,
cardiac, other, mortality, and any.
Results: Patients included 428 women and 377 men; mean age was
65.0 years. Minimally invasive patients were older ( 66.6 vs 64.3;
p=0.006), were recent smokers less often (13.2% vs 29.9%; p<0.001),
had better ppoFEV1% (71.5% vs 65.6%; p<0.001), and less often
underwent induction therapy (0.5% vs 4.8%). Pulmonary and other
complications were less common after minimally invasive lobectomy
(3.6% vs 10.4%, p=0.0034; 8.6% vs 15.8%, p=0.0083). Death occurred
in 1.4% of minimally invasive and 3.9% of open patients (p=0.075).
Pulmonary complication incidence was related to predicted postop lung
function for both minimally invasive and open approaches (Figure).
On multivariate analysis with stratification for stage, ppoFEV1% and
ppoDLCO% were predictive of pulmonary complications for both
minimally invasive and open approaches (Table).
Conclusions: Decreased pain and maintained chest wall mechanics
attributed to use of minimally invasive techniques for lobectomy
may result in preserved lung function in the early postoperative
period; this may alter the predictive ability of lung function for
postoperative complications. Our results suggest that the predictive
abilities of ppoFEV1% and ppoDLCO% are retained for minimally
invasive lobectomy and can be used to estimate the risk of pulmonary
complications.
Odds ratios for lung function related to postoperative complications
after lobectomy.
30. Survival After Sublobar Resection vs. Lobectomy for Clinical Stage
IA Lung Cancer: An Analysis of Over 5,000 Patients from the National
Cancer Database
Authors: Onkar V. Khullar, Theresa Gillespie, Dana Nickleach, Yuan
Liu, Kristin Higgins, Suresh Ramalingam, Joseph Lipscomb, *Felix G.
Fernandez
Objectives: Lobectomy is the current standard of care for early stage
non-small cell lung cancer (NSCLC). Recent data have suggested
possible oncologic equivalence of sublobar resection. Our aim was to
evaluate short and long term mortality for these two surgical treatments
in patients with clinical stage IA NSCLC.
Methods: This retrospective cohort study uses the National Cancer Data
Base, a joint endeavor of the Commission on Cancer of the American
College of Surgeons and the American Cancer Society that includes
clinical and demographic detail on patients treated at approximately
1,500 Hospitals. Patients undergoing lobectomy or sublobar resection
for clinical stage Ia NSCLC from 2003-2006 were identified, as long-term
survival data is available only for patients diagnosed through 2006.
Primary outcomes were overall survival (OS) and 30-day mortality.
To account for confounding variables, multivariable Cox proportional
hazards both with and without propensity score matching approaches
were utilized.
Results: A total of 13,606 patients were identified. The multivariable
analysis of OS before propensity score matching is shown in the
attached table. After propensity score matching, 2754 patients
remained in each group. Sublobar resection was associated with better
30 day mortality (OR 0.45) but significantly worse overall survival
(HR 1.5) (both p<0.001). Median survival was 63.3 and 88.7 months
for sublobar resection and lobectomy (Figure). Additionally, sublobar
resection was associated with increased likelihood of positive surgical
margins (OR 2.6), and significantly lower likelihood of having more than
two lymph nodes examined (OR 0.1) and nodal upstaging (OR 0.39) (all
p<0.001).
Conclusions: In this large national-level, clinically diverse sample of
clinical stage IA NSCLC patients, sublobar resection was shown to have
significantly worse OS compared to lobectomy. Ongoing prospective
study taking into account LN upstaging and margin status is still
needed.
Multivariate Association with Long-Term Mortality in Overall Cohort
Backward selection with an alpha level of removal of .20 was used. The following
variables were removed from the model: Urban/Rural, Year of Diagnosis, and Race:
White. Primary site was included in the model but did not reach statistical significance.
Other variables reaching statistical significance but not shown include histology, grade,
sex, and patient age.
Long-term Survival after Sublobar Resection vs Lobectomy in a Propensity Matched
Cohort
31. Results of Palliation With an Initial Modified Blalock-Taussig Shunt
in Infants With Single Ventricle Associated With Restrictive Pulmonary
Blood Flow
Authors: Bahaaldin Alsoufi, *Brian Kogon, Ritu Sachdeva, Brian
Schlosser, Martha Clabby, William Mahle, Dennis Kim, *Kirk Kanter
Discussant: *Pirooz Eghtesady, St. Louis Children’s Hospital, St. Louis,
MO
Objectives: The modified Blalock-Taussig shunt (BTS) is the 1st
palliative surgery in the multistage palliation strategy of infants with
single ventricle (SV) anomalies associated with restrictive pulmonary
blood flow. We report current era results from our institution.
Methods: Retrospective review of SV patients who’ve undergone 1st
stage BTS was performed (2002-12). Competing risks analyses modeled
events after BTS and subsequently after Glenn and examined risk
factors affecting outcomes.
Results: 173 SV infants, median age 6 days (1-87) underwent BTS. 29
(17%) were ≤ 2.5Kg, 34 (20%) were premature ≤ 36weeks, 25 (15%)
had chromosomal / extra-cardiac anomalies. Underlying pathology
was pulmonary atresia and intact ventricular septum (PAIVS, n=53),
tricuspid atresia (n=47), heterotaxy (n=39), other (n=34). Concomitant
surgery included pulmonary artery augmentation (n=39), total
anomalous pulmonary venous drainage (n=13), other (n=10).
Hospital mortality was 26 (15%). Prior to Glenn, 24 patients (14%)
needed reoperations. Competing-risks analysis showed that one
year after BTS, 25% have died, 71% have undergone Glenn, 4% have
undergone transplantation. 5 years after Glenn, 6% have died, 63%
have undergone Fontan, 31% were alive awaiting Fontan. Overall 8 year
survival was 68%.
On multivariable analysis, risk factors for mortality were PAIVS or
heterotaxy (HR 9.5, p=0.002), unplanned reoperation (HR 7.8, p=0.005),
chromosomal / extra-cardiac anomalies (HR 12.5, p<0001) and ECMO
requirement (HR 22.6, p<0.001).
Conclusions: Palliation outcomes with a BTS in SV patients trail behind
the generally improved results of congenital heart surgery. Patients
with genetic and extra-cardiac malformations, PAIVS or heterotaxy
syndrome continue to be the most challenging and are associated with
higher operative and interim mortality. Efforts to improve survival in
those high risk patients would incorporate stringent perioperative care
and close vigilance after discharge.
CONGENITAL BREAKOUT
NOTES:
32. Arterioplasty for Right Ventricular Outflow Tract Obstruction
Following Arterial Switch Is a Durable Procedure
Authors: Luke M. Wiggins, S. Ram Kumar, *Vaughn A. Starnes,
*Winfield J. Wells
Author Institution(s): Children’s Hospital Los Angeles, Los Angeles, CA
Discussant: *E. Dean McKenzie, Texas Children’s Hospital, Houston, TX
Objectives: Right ventricular outflow tract obstruction (RVOT) is the
most common late complication requiring intervention following
arterial switch operation (ASO). We sought to evaluate the durability of
surgical management of this complication.
Methods: We retrospectively reviewed the charts of 223 consecutive
patients who underwent ASO for transposition of great arteries at
our institution between 2004 and 2013. Thirty-eight (17%) patients
developed RVOT obstruction requiring intervention. Patient
characteristics, site of stenosis, type of intervention and outcomes were
analyzed. Data is presented as median with interquartile ranges.
Results: Children were diagnosed by echocardiography with significant
RVOT obstruction 12.5 months (3-23.7) after ASO. 24 (63%) children
underwent subsequent cardiac catheterization. Obstruction involved
the supravalvar main pulmonary artery (PA) in 26 (68%), branch PA
in 16 (42%), pulmonary valve in four (11%) and sub-valvar area in one
(3%). Ten of 24 patients that underwent catheterization had attempted
percutaneous intervention with four (40%) demonstrating significant
response. Surgical repair included main PA plasty (38), extended to
one or both branch PAs (22), and across the RVOT annulus (7). There
was one post-operative bleeding (3%) and no Hospital or late mortality.
At last follow-up 25.2 months (8.4-54.5) after RVOT reconstruction, all
but three patients demonstrated no significant residual RVOT stenosis.
Four (11%) patients underwent catheterization 26 months after surgery
and all have had branch PA dilation and stents. One patient required reoperation for main PA stenosis.
Conclusions: Surgical management of RVOT obstruction following
ASO is a highly effective and durable intervention. Our results serve as
benchmark for expected outcomes in this disease process. *STSA Member D Relationship Disclosure
CONGENITAL BREAKOUT
NOTES:
33. Outcomes of ECMO in Children With Single Ventricle Physiology
Authors: S. Ram Kumar, Antonio J. Escobar, *Vaughn A. Starnes,
*Winfield J. Wells
Author Institution(s): Children’s Hospital Los Angeles, Los Angeles, CA
Discussant: Gordon A. Cohen, University of California, San Francisco,
CA
Objectives: Patients with single ventricle physiology (SVP) are at high
risk for severe peri-operative cardiovascular compromise. Due in part to
lack of outcome data with use of extracorporeal membrane oxygenation
(ECMO) in this population, there is skepticism to offer ECMO to these
children. We hypothesized that acceptable survival in children with
SVP who require ECMO support justifies the use of ECMO in this subpopulation. We proposed to ascertain clinical variables that can predict
good outcome following ECMO in these patients.
Methods: The charts of children with SVP who required ECMO support
at our institution between November 2000 and December 2013 were
analyzed. Clinical variable and outcome parameters were analyzed
using SAS 9.0. Significance was defined as p<0.05
Results: There were 47 patients in the cohort (40 neonates, 32 boys).
Thirty-five (74%) patients had single right ventricle physiology, 37 (79%)
underwent a Norwood procedure prior to placement on ECMO. Twentyeight (60%) children were placed on ECMO immediately following the
index surgery. Children were maintained on ECMO for a mean of 4±0.4
days (range 1-10 days). Thirty-three (70%) patients were successfully
weaned from ECMO. Need for intervention on pulmonary blood flow
whlle on ECMO was the only predictor of successful weaning from
ECMO. Eight patients died a mean 28 days after successful decanulation
and 25 (53%) were discharged home alive. Median follow-up after
discharge is 2.2 years and 18 (36%) children are alive at last follow-up.
Two (4%) patients died before Glenn, one (2%) after Glenn, 19 (40%)
are proceeding to or reached Fontan circulation, and 3 (6%) were lost to
follow-up.
Conclusions: Outcomes following placement on salvage ECMO in
children with SVP are comparable to ECMO outcomes in children with
any congenital heart defect. Patients requiring ECMO for inadequate
pulmonary blood flow are most likley to be successfully weaned from
ECMO.
CONGENITAL BREAKOUT
NOTES:
34. Intermediate Results of Hybrid vs. Primary Norwood Operation in
Risk Stratified Cohorts
Authors: Daniel J. Dibardino, Juliana Gomez-Arostegui, Aaron Kemp,
Raveen Raviendran, Sanjeet Hegde, Eric Devaney, John Lamberti,
Howaida El-Said
Author Institution(s): University of California San Diego/Rady
Children’s Heart Institute, San Diego, CA
Discussant: Christian Pizarro, Nemours Cardiac Center, Alfred I. duPont
Hospital for Children, Wilmington, DE
Objectives: The primary management of Hypoplastic left heart
syndrome (HLHS) is evolving in the United States. In 2007 we
developed and evolved an algorithm for management of HLHS variants
with the goal of improving outcomes in high risk patients; during
implementation we have offered both hybrid and Norwood approaches
to standard risk and high risk patients. The purpose of this study was
comparative analysis of the intermediate results.
Methods: Newborns are evaluated jointly (cardiology/cardiac surgery)
for high risk characteristics; birth weight <2.5kg, <35 weeks gestation,
CNS abnormalities, multi-organ failure, intact/severely restrictive atrial
septum, severe ventricular dysfunction and/or severe atrioventricular
valve regurgitation. We prefer primary Norwood for standard and
hybrid for high risk but all groups crossed over into all treatment
pathways. We reviewed all consecutive patients from 2007-12, obtained
follow-up and analyzed the results.
Results: Sixty-eight newborns presented (median 2.96 kg, 8 days);
29 (43%) were high-risk and 39 (57%) standard. There were 14 stage I
Hospital deaths strongly associated with risk category; 3/39 standard
risk (7.7%) and 11/29 high risk (38%, p=0.002, Chi-square). Table1
illustrates the five resulting treatment groups; Stage I discharge
mortality and Hospital stay were highest for high risk Norwood and
high risk hybrid/PGE groups while the hybrid/stent group performed
relatively better (p<001, Chi-square). Actuarial survival up to five years
demonstrated much poorer survival for all three high risk groups (figure
1, p=0.003, Log Rank); the high risk hybrid PGE group was equivalent to
high risk Norwood.
Conclusions: While a risk stratified approach to HLHS variants with
selective hybrid use improved overall stage I discharge mortality for
high risk patients (compared to Norwood), the intermediate mortality
of high risk patients remains much higher than those at standard risk
treated by either modality.
CONGENITAL BREAKOUT
Table 1. Stage I Hospital discharge mortality by treatment pathway;
Chi square analysis indicates significant differences between the 5
resulting treatment pathways (p<0.001).
Kaplan-Meier survival curves with 95% confidence bounds for high risk and standard
risk hybrid and Norwood palliation indicating highly significant difference in
intermediate term survival (p=0.00245, Log Rank). Group 1 = standard risk hybrid stent,
group 2 = high risk hybrid stent, group 3 = high risk hybrid PGE, group 4 = standard risk
Norwood, group 5= high risk Norwood.
NOTES:
35. Contemporary Outcomes of Surgical Repair of Total Anomalous
Pulmonary Venous Connection in Patients With Heterotaxy Syndrome:
An Analysis of The Society of Thoracic Surgeons (STS) Congenital
Heart Surgery Database
Authors: Muhammad S. Khan1, Roosevelt Bryant1, Sunghee Kim2, Kevin
D. Hill2, Jeffrey P. Jacobs2, Marshall L. Jacobs2, Sara K. Pasquali2, David
L. Morales1
Author Institution(s): 1Cincinnati Children’s Hospital Medical Center,
Cincinnati, OH; 2Duke Clinical Research Institute, Durham, NC
Discussant: *Robert D.B. Jaquiss, Duke Children’s Hospital, Durham, NC
Objectives: Total anomalous pulmonary venous connection (TAPVC)
is prevalent in patients with atrio-visceral heterotaxy. While single
ventricle (SV) heart defects are common in heterotaxy syndromes, the
extent to which this association influences overall risk is undefined.
Most reports describe small cohorts at single institutions. This study
examines multi-institutional experience with TAPVC repair in infants
with heterotaxy in a large clinical registry.
Methods: Patients in the STS-CHSD (2002-2012) with a diagnosis of
heterotaxy syndrome who underwent TAPVC repair at age ≤ 90 days
were included. Patients with missing data for key variables were
excluded. Pre-operative, operative, and outcome data were described.
Univariate comparisons were performed using a Chi-square test
for categorical variables and Wilcoxon rank sum test for continuous
variables.
Results: The cohort included 261 patients [females: 115 (44%)] from
65 centers. Median (IQR) age and weight at surgery were 7 days (3-19
days) and 3.1kg (2.7-3.5kg). Overall, 180 (69%) patients had asplenia/
right atrial isomerism, 12 (5%) had polysplenia/left atrial isomerism
and 167 (64%) had single ventricle (SV) diagnoses. Discharge mortality
was 38%. Median postoperative length of stay was 18 days (IQR: 7-32
days). Postoperative extracorporeal membrane oxygenator support
was reported for 36 (11%) patients, and 11 (4%) patients had reoperation
for pulmonary vein stenosis during the same Hospital admission.
Mortality was higher for patients with SV defects (SV 43% vs non-SV
30%, p=0.034) but there was no difference in other reported outcomes
between SV and non-SV groups (Table).
Conclusions: TAPVC repair in heterotaxy patients carries a high risk of
morbidity and mortality, particularly among single ventricle patients.
These multi-institutional data serve as an important benchmark and
may be useful for risk stratification and counseling.
CONGENITAL BREAKOUT
Outcomes of repairs of TAPVC in heterotaxy patients.
LOS – length of stay (days); ECMO – extracorporeal membrane oxygenation NOTES:
36. Long-term Outcome of Aortic Implantation for Patients With
Anomalous Origin of the Left Coronary Artery From the Pulmonary
Artery
Authors: Michael C. Monge, Osama Eltayeb, John M. Costello, Anne E.
Sarwark, Michael R. Carr, *Carl L. Backer
Author Institution(s): Ann & Robert H. Lurie Children’s Hospital of
Chicago, Chicago, IL
Discussant: *James Jaggers, Children’s Hospital Colorado, Aurora, CO
Objectives: Since 1989 all patients with anomalous origin of the left
coronary artery from the pulmonary artery (ALCAPA) at our institution
have been treated with aortic implantation. The purpose of this review
was to assess the late outcomes of these patients, especially regarding
left ventricular (LV) function and mitral valve insufficiency.
Methods: Between 1989 and 2014, 36 patients had aortic implantation
of ALCAPA. Mean age at surgery was 2.5±5.1 years, (median, 0.5 years).
Operative strategy included antegrade cold blood cardioplegia, main
pulmonary artery transection, aortic implantation with a large button
of pulmonary artery, pulmonary reconstruction with fresh autologous
pericardium, and prolonged postoperative inotropic and ventilator
support. Mitral regurgitation and LV dysfunction were graded as 0-4
(0=none, 1=trivial, 2=mild, 3=moderate, 4=severe).
Results: Mean mitral regurgitation grade preoperatively was 3.0±0.8.
Mean LV dysfunction score was 3.1±1.3. Mean cross-clamp and
cardiopulmonary bypass times were 49.1±18 min (median, 48.5 min)
and 147.5±45 min (median, 139 min), respectively. There was no
operative or late mortality. Four patients had delayed sternal closure.
Mean duration of ventilator support was 11±6.6 days (median, 9 days).
Two patients required 3 and 6 days of postoperative extracorporeal
mechanical circulatory support. Mean length of stay was 25±18 days
(median 19 days.). No patient has required reoperation for supravalvar
pulmonary stenosis, coronary stenosis, or mitral valve repair or
replacement. Current echocardiographic follow-up shows a mean LV
dysfunction score of 0.74±1.2. Mean mitral regurgitation grade is now
1.48±1.0.
Conclusions: Aortic implantation is our procedure of choice for patients
with ALCAPA. No patient required mitral valve repair or transplant.
There was marked improvement of mitral regurgitation grade, return to
essentially normal LV function, and no mortality over a 25-year period. *STSA Member D Relationship Disclosure
CONGENITAL BREAKOUT
NOTES:
Gender Matter?
Authors: Michelle C. Ellis3, Theron A. Paugh3, Timothy A. Dickinson4,
John Fuller2, Jeffrey Chores2, *Gaetano Paone5, *Himanshu J. Patel3,
*Richard Prager 3, Donald S. Likosky 3, on behalf of the Michigan Society
of Thoracic and Cardiovascular Surgeons Perfusion Measures and
Outcomes (PERForm) Registry1
Author Institution(s): 1Michigan Society of Thoracic and Cardiovascular
Surgeons Perfusion Measures and Outcomes (PERForm) Registry, Ann
Arbor, MI; 2St. John Providence Health System, Detroit, MI; 3University
of Michigan, Ann Arbor, MI; 4Specialty Care, Nashville, TN; 5Henry Ford
Hospital, Detroit, MI
Discussant: D*Gorav Ailawadi, University of Virginia, Charlottesville, VA
COMMERICAL RELATIONSHIPS: DISCUSSANT: Gorav Ailawadi: Consultant/Advisory
Board: Edwards Lifesciences, Abbott Vascular, Mitralign; Speakers Bureau/Honoraria:
St. Jude Medical, Inc., Atricure
Objectives: Reports have associated nadir hematocrit (Hct) on
cardiopulmonary bypass with the occurrence of renal dysfunction.
Recent literature has suggested that women, while more often exposed
to lower nadir Hct, have lower risk of renal dysfunction. We assessed
whether this relationship held across a large multi-center registry.
Methods: We undertook a prospective, observational study of 13,896
patients (9,434 male, 67.9%; 4,462 female, 32.1%) undergoing cardiac
surgery between 2010-2013 across 22 institutions participating in the
PERForm registry. We calculated crude and adjusted (age, diabetes,
vascular disease, acuity, body surface area) odds ratio between nadir
Hct during cardiopulmonary bypass and Stage II or III acute kidney
injury (AKI), and tested the interaction of sex and nadir Hct. The
predicted probability of AKI, along with 95% confidence intervals, was
plotted separately for men and women.
Results: Nadir Hct<21% occurred among 17.3% of patients, although
was less common among males (969, 10.3%) than females (1437,
32.2%), <0.001. AKI occurred among 5.1% of the total cohort (N=704),
with no significant difference between males and females (5.0% vs.
5.3%, p=0.36). There was a significant interaction between sex and
nadir Hct (p<0.001). The effect of nadir Hct on AKI was stronger among
males (OR: crude 0.86, p<0.001; adj: 0.86, p<0.001) than females (OR:
crude 0.96, p=0.02; adj: 0.95, p=0.01), Figure.
Conclusions: Lower nadir hematocrit was associated with an increased
risk of AKI, although the effect appears to be stronger among males
than females. Understanding of the mechanism(s) underlying this
association remains uncertain, although these results suggest the need
to limit exposure to a nadir HCT of <21 across both genders.
NOTES:
Authors: Michael O. Kayatta2, Julio C. Vasquez1, *Jacob DeLaRosa1
Author Institution(s): 1Idaho State University, Pocatello, ID; 2Emory
University, Atlanta, GA
Discussant: D*Himanshu J. Patel, University of Michigan, Ann Arbor, MI
COMMERICAL RELATIONSHIPS: DISCUSSANT: Himanshu J. Patel: Principal
Investigator/Co-Investigator: Medtronic, Inc., Edwards Lifesciences; Principal
Investigator: W. L. Gore & Associates, Inc., Cook Medical; Ownership Interest: W. L.
Gore & Associates, Inc.
Objectives: Surgical aortic valve replacement (AVR) has been shown
to have excellent outcomes; however, many patients are not referred
for surgical evaluation for a number of reasons. The objective of this
study was to determine the management of patients with severe aortic
stenosis (AS) evaluated at a rural Hospital.
Methods: 2,079 consecutive transthoracic echocardiographic
examinations of adults at a rural referral center over one-year were
reviewed for severe AS defined by the American College of Cardiology
and American Heart Association, (ACC/AHA) . Echocardiographic data
in addition to demographics were recorded.
Results: Of the 2,079 patients reviewed, 122 were found to meet criteria
for severe AS (5.9%). Patients with severe AS had a mean age of 73.0
± 15 years compared to the non-severe AS patients 63.7 ± 14 years
p<0.001. Gender did not differ between groups (53.5% female of AS
patients vs 51.6% withoUTp = 0.69). During this same time period, 58
patients were referred for surgical evaluation (47.5% of those with AS).
Of the 58 patients referred for surgical evaluation 47 (81%) underwent
isolated AVR, eight (14%) AVR with a concomitant procedure, three (5%)
where turned down or refused surgical intervention. Overall 30-day
mortality in operative patients was zero.
Conclusions: More than 50% of patients with severe AS by
echocardiography are not referred for surgical evaluation because of
the ordering practitioner’s preference, lost to follow up, and felt to be
to high risk for AVR by the ordering provider. Many of these patients
may have benefited from AVR. In light of this data, this hospital has
begun prospectively reviewing all echocardiograms meeting criteria for
AS by ACC/AHA guidelines monthly, and these patients are evaluated
in an interdisciplinary valve clinic. As technology advances, many of
the patients previously felt to be too sick for surgical referral may gain
significant benefit from transcatheter aortic valve replacement.
NOTES:
39. Cardiac Myxomas: A 50-year Experience With Resection and
Recurrence
Authors: Ishan Shah, *Joseph Dearani, *Richard Daly, *Rakesh Suri,
*Soon Park, *Lyle Joyce, Zhuo Li, *Hartzell Schaff
Author Institution(s): Mayo Clinic, Rochester, MN
Discussant: *Curtis G. Tribble, University of Virginia, Charlottesville, VA
Objectives: Myxomas are the most common cardiac tumors, but there
is insufficient data regarding long term survival. We also attempt to
determine a strategy to monitor for recurrence, as currently there are no
fixed guidelines.
Methods: We performed a retrospective analysis of 194 patients
(57.2±15.6, 62.3% males) undergoing resection of cardiac myxoma from
June 1955 to June 2011. The left atrium (n=155, 80%) was the most
common location, and the mean tumor size was 4.3±2.1 cm by 3.2±1.6
cm by 2.1±1.3 cm. Dyspnea(n=68) and palpitations(n=57) were the most
common complaints.
Results: The tumor was accessed via the atrium in the majority of
patients (n=186), with a bypass and cross clamp time of 59.1±33.4 min
and 35.2 ± 21.7 min respectively. Two-third of the tumors were excised
with an endocardial button (EB), while the rest were resected at the
base of the stalk (BOS). Operative mortality was 0.5% with a ten-year
survival of 77%, which is comparable to the age-matched general
population (p= 0.191). Age was the only significant predictor of mortality
(p<0.001), while there was no significant difference in survival when
gender (p= 0.784), location of tumor (p= 0.087), the largest tumor
dimension (p=0.257) or surgical technique (EB vs BOS, p=0.502) were
considered.
Tumor recurrence was reported in 11 patients, with freedom from
recurrence estimated at 92%, 91% and 86% at 10, 20 and 30 years
respectively. Age at surgery (HR= 0.94, p= 0.002), maximum dimension
(HR=0.58, P=0.011) and tumor localized to the ventricles (HR=7.29,
p=0.013) were predictors of recurrence (Table 1).
Conclusions: Cardiac myxomas can be resected with low early mortality
and excellent late survival. Tumor recurrence is more likely to occur in
the first ten postoperative years especially in patients that are younger,
have a smaller mass or if the tumor is in the ventricle; and these require
closer monitoring.
Overall survival following surgical resection of cardiac myxomas as compared to the
age-matched general population NOTES:
40. A New Surgical Approach to Exclude the Left Atrial Appendage
Authors: DNiv Ad, Paul S. Massimiano, Graciela Pritchard, Sari D.
Holmes
Author Institution(s): INOVA Heart and Vascular Institute, Falls Church,
VA
Discussant: *James S. Gammie, University of Maryland Medical Center,
Maryland, MD
COMMERICAL RELATIONSHIPS: Niv Ad: Consultant/Advisory Board: Atricure, Estech,
Medtronic, Inc.; Speaker Bureau/Honoraria: Atricure, Estech, Medtronic, Inc.
Objectives: Atrial fibrillation (AF) is associated with an increased risk
for embolic stroke originating from the left atrial appendage (LAA).
Recently, a new LAA epicardial clip occluder (AtriClip® by Atricure®)
was introduced to clinical practice that can be applied through
midsternotomy or small thoracotomy. In this report we assess the
safety and efficacy of a new surgical approach to apply the Atriclip®
and exclude the LAA through a right minithoractomy and the transverse
sinus.
Methods: Thirty-three patients were included in this series of which
19 had the Atriclip® placed through a right minithoracotomy and the
transverse sinus. Intraoperative transesophageal echocardiography
(TEE) was used to exclude LAA thrombus at baseline and evaluate LAA
perfusion and residual neck after the procedure. Clinical follow-up was
accomplished in all patients.
Results: Mean age was 68.6±6.4 years, 96% of patients had nonparoxysmal AF with mean AF duration of 50.2±55 months, and mean LA
diameter of 4.8±0.8 cm (range 3.2-6.4). In 19 patients (57%) the Atriclip®
was applied using the new approach. In one of these attempts, the clip
was not deployed due to severe adhesions in the transverse sinus area
resulting in procedural success of 95%. The cases were nine minimally
invasive mitral repairs with CryoCox-Maze III and ten minimally
invasive standalone CryoCox-Maze III. Intraoperative TEE revealed no
communication in all cases and a mean residual neck at the base of
the LAA of 2.3mm (range 0-4). No perioperative complications related
to the device application were documented. In follow-up of 10.1±7.1
months no embolic strokes were documented.
Conclusions: Management of the LAA during a minimally invasive
Cox-Maze procedure performed through right minithoracotomy is
challenging. This new approach is safe, very effective, and should
offer a superior early and long term solution compared to the current
approach of endocardial stitch closure.
NOTES:
41. Modifications to the Robotic Esophageal to Gastric Anastomosis
Authors: *Benjamin Wei, *Douglas J. Minnich, Ayesha S. Bryant,
*Robert Cerfolio
Author Institution(s): University of Alabama, Birmingham, AL
Objectives: The optimal manner to perform a minimally invasive
anastomosis between the gastric conduit and the esophagus is
unknown.
Methods: This is a retrospective review of a prospective database
of 75 consecutive patients who underwent combined robotic and
laparoscopic Ivor-Lewis esophageal resection for esophageal cancer.
Our modified technique avoids grasping the conduit as it is delivered
in the chest, anchoring the conduit to the divided azygos vein/pleural
reflection posteriorly and the divided vagus nerve anteriorly to
reduce tension, and performing a two-layered hand-sewn interrupted
anastomosis that is buttressed by an omental flap.
Results: Between 4/2011 and 4/2014, 75 patients (61 men,median age
62) underwent robotic Ivor-Lewisesophagectomy. All had cancer, had
an R0 resection and had the thoracic portion completed robotically and
71 had the stomach mobilized laparoscopically. Sixty-two patients had
preoperative chemo-radiotherapy. Mean operative time was 5 hours
and 49 minutes. The median number of lymph nodes resected was 24.
Gastric or anastomotic problems occured in three of 16 patients (18.8%)
prior to modifying our technique, compared to one of 59 patients (1.7%)
afterwards. The 30-day mortality rate of our overall cohort was 4/75
(5.3%).
Conclusions: Technical modifications to the robotic two-layered handsewn anastomosis lower the complication rate of esophagectomy. Our
experience in credentialing other surgeons in robotic surgery shows
that these modifications are teachable, reproducible, and improve
patient outcome.
NOTES:
42. Timely Discharge and Outpatient Management of Prolonged Air
Leaks Following Lobectomy: Utilization and Cost Containment
Authors: Ryan K. Schmocker, Ryan A. Macke, *Shahab A. Akhter, James
D. Maloney, Justin D. Blasberg
Author Institution(s): University of Wisconsin School of Medicine and
Public Health, Madison, WI
Objectives: Prolonged air leaks following lobectomy for lung cancer are
associated with increased length of stay (LOS) and protracted resource
utilization. We evaluated the safety and cost efficiency of a model
favoring timely discharge and outpatient management with a portable
drainage system (PDS).
Methods: We retrospectively evaluated all patients who underwent
lobectomy for lung cancer at our institution between 2003 and 2014.
Those discharged with a PDS met inclusion criteria for analysis. This
group was compared to an internally matched lobectomy cohort (age,
comorbidities, and stage) without postoperative air leaks. Study end
points included resource utilization, complications following discharge,
and rates of readmission.
Results: Of the 739 lobectomies performed during the study period, 74
(10%) patients with persistent air leaks were immediately discharged
with a PDS after fulfilling specified postoperative milestones. Shorter
LOS was observed in the study group compared to matched controls,
approaching statistical significance (3.9±2.4 days vs. 4.8±1.9 days; p
= 0.096). Outpatient 30-day readmission rates were similar (14.6% vs.
10.7%, p=0.45). PDS specific complications occurred in 6.9% of patients
(5/74); 4.0% (3/74) required readmission for recurrent pneumothorax.
PDS’s were maintained for 8.9+3.7 days following hospital discharge
until air leak resolution, with 678 fewer cumulative hospital days needed
in the study group. A cost efficiency analysis predicted an overall
savings of 602 hospital days after correction for readmission, cost of
PDS, and outpatient clinic visits.
Conclusions: In patients otherwise meeting criteria for discharge,
outpatient management of prolonged air leaks following timely
Hospital discharge is a safe and effective management strategy, and is
associated with reduced hospital costs. This model may be applicable
to additional thoracic procedures associated with a protracted LOS.
NOTES:
43. Surgery for Benign Esophageal Disease: Does Surgeon Specialty
Matter?
Authors: Michael Kent, Thomas Wang, Thomas Curran, Sidhu
Gangadharan, Richard Whyte
Author Institution(s): Beth Israel Deaconess Medical Center, Boston,
MA
Objectives: No study has examined the proportion of cases for benign
esophageal disease performed by thoracic surgeons compared to
general surgeons, and whether surgeon specialty has an impact on
outcomes.
Methods: Using the National Inpatient Sample and State Inpatient
Database from 2003-2009, we identified patients who underwent
surgery for benign esophageal disease. Surgeons were classified as
general or thoracic surgeons on the basis of annual case volume, using
previously published guidelines. The primary objective of this study was
to document trends in case volume of procedures for achalasia, GERD
and diaphragmatic hernia between thoracic and general surgeons. A
secondary objective was to document the use of laparoscopy among
general and thoracic surgeons.
Results: A total of 33,687 cases were identified. General surgeons
performed 90.8% of these cases. Overall case volume has increased
over the study period, from 4,172 cases in 2003 to 6,735 cases in 2009.
The majority of growth was observed in procedures for diaphragmatic
hernia (see Figure). General surgeons performed an increasing
proportion of diaphragmatic hernia cases over the study period, and
were more likely to perform the operation laparoscopically (46.7% vs.
28.1%, p<.05). Additionally, length of stay for diaphragmatic hernia
cases performed by thoracic surgeons was 5 days versus 2 days for
general surgeons (p<.05)
Conclusions: There has been a significant increase in procedures for
diaphragmatic hernia from 2003-2009, with a increasing proportion
of these operations performed by general surgeons. The increased
utilization of laparoscopy among general surgeons may be an important
factor in determining case distribution among specialties. To address
this we suggest that training programs in general thoracic surgery
should emphasize laparoscopic techniques for benign esophageal
disease.
Diaphragmatic hernia procedures, 2003-2009. Panel A: Annual case volume by specialty,
Panel B: Market share for thoracic surgeons.
NOTES:
44. Endobronchial Valves in the Treatment of Persistent Air Leaks
Authors: John M. Hance, *Jeremiah Martin, *Timothy W. Mullett
Author Institution(s): University of Kentucky, Lexington, KY
Objectives: Endobronchial valves (EBV) are a useful tool in the
management algorithm of patients with persistent air leaks. They are
increasingly used in the management of post-surgical parenchymal air
leaks. We report our experience which also includes the management
of patients with spontaneous pneumothorax and bronchopleural fistula
who are otherwise poor operative candidates.
Methods: An IRB-approved retrospective review was conducted
of our single-center EBV experience. Patients were categorized as
post-surgical versus medical. Data collected included demographics,
indication for and number of valves placed, and chest tube duration
before and after valve placement which correlated with overall
resolution of air leak.
Results: A total of 14 valve placement procedures were performed.
Mean age was 60 and 10 were male. Eight represented prolonged leaks
managed by the surgical service, and six were medical. Indications
for placement of valves in medical patients included persistent leak
secondary to lung biopsy, ruptured bleb disease and pneumothorax
after CPR. Surgical indications included leaks secondary to lung biopsy,
lobectomy, and ruptured bleb disease. A median of two valves were
placed per procedure. A post-procedure length of stay of three days was
observed in the surgical group compared with 16.5 days in the medical
group. Overall success rate was 75% in the surgical group and 33% in
the medical group.
Conclusions: Endobronchial valves are a safe and effective tool in the
management of air leaks particularly in post-surgical patients. EBV
placement is useful when other interventions are contraindicated.
Further studies should address EBV efficacy in non-surgical candidates
given the poor success rate in this population. We suspect this is likely
an indicator of increased overall pre-procedural morbidity and risk for
mortality from other causes.
NOTES:
45. Concomitant Procedures Performed During Adult Congenital Heart
Surgery: An Unclear Risk/Benefit Ratio?
Authors: *Brian E. Kogon2, Bahaaldin Alsoufi2, Wendy Book 2, Matthew
Oster1, Alexandra Ehrlich1
Author Institution(s): 1Children’s Healthcare of Atlanta, Atlanta, GA;
2
Discussant: Harold M. Burkhart, Mayo Clinic, Rochester, MN
Objectives: Patients with congenital heart disease are frequently
surviving into adulthood, and many of them will require surgery. Often
the indications for particular aspects of the operation are unclear. Our
aim is to: 1) characterize the concomitant procedures performed in adult
congenital heart surgery, and 2) better define the risk involved with
performing concomitant procedures during a single operation.
Methods: We retrospectively studied 458 adult patients, who
underwent cardiac surgery for congenital heart disease between
2000 and 2010. Major procedures were characterized as aortic, mitral,
pulmonary, tricuspid, septal defect, single ventricle, transplant, and
other. We constructed logistic regression models to assess the risk for
mortality, major adverse event, and prolonged length of stay.
Results: 362 operations involved a single major procedure, whereas 96
involved two or more concomitant procedures. Performing concomitant
procedures increases mortality (7.3 vs 2.5%), major adverse events
(29 vs 18.2%), and prolonged length of stay (29 vs 17.2%). The overall
adjusted risks of performing a concomitant procedure on mortality,
major adverse event, and prolonged length of stay are 4.1 (95% CI
1.3-12.5, p=0.01), 2.2 (95% CI 1.3-3.9, p=0.006), and 2.0 (95% CI 1.1-3.7,
p=0.02). For those patients undergoing concomitant procedures, 71/96
(74%) involved the pulmonary valve. The adjusted risks of adding any
concomitant procedure to a pulmonary valve procedure on mortality,
major adverse event, and prolonged length of stay are 3.7 (95% CI
0.81-16.7, p=0.09), 2.4 (95% CI 1.1-4.1, p=0.02), and 3.1 (95% CI 1.4-6.8,
p=0.006).
Conclusions: Concomitant procedures performed during adult
congenital heart surgery often add significant risk to the operation.
Often with unclear indications, we should be confident that the benefits
outweigh the additional risk. Awareness of this risk may improve
surgical decision-making and outcomes.
CONGENITAL BREAKOUT
Patient distribution and outcomes
MAE - major adverse event, LOS - length of stay
NOTES:
46. The Outcome of Right Ventricle to Pulmonary Artery Conduit for
Biventricular Repair
Authors: Takeshi Shinkawa, Carl Chipman, Tom Bozzay, Xinyu Tang,
Jeffery Gossett, Michiaki Imamura
Author Institution(s): Arkansas Children’s Hospital, Little Rock, AR
Discussant: *Paul J. Chai, Columbia University Medical Center, New
York, NY
Objectives: The objective of this study was to assess the outcomes of
right ventricle to pulmonary artery conduit.
Methods: This is a retrospective review of all right ventricle to
pulmonary artery conduit operation for biventricular repair of
congenital heart disease between 1982 and 2013 at a single institution.
Major outcomes studied included patient survival and conduit survival.
Results: Four hundred seventy-six physiological right ventricle
to pulmonary artery conduit operations were identified for 345
patients with 195 pulmonary homografts, 105 valved expanded
polytetrafluoroethylene (ePTFE) conduits, 103 bioprosthetic valved
conduit (woven fabric conduit with porcine aortic valve), 38 nonvalved ePTFE tubes, and 35 others. The median age and body weight
at operation were 6.7 years and 20.0kg. There were 17 early deaths, 12
late deaths, and five heart transplants during the median follow-up of
6.3 years. The actuarial survival and freedom from conduit reoperation
were 90.7 % and 33.0 % at 20 years. The freedom from conduit
reoperation was significantly different among conduit materials (76.8%,
92.1%, 81.9%, 80.6% 63.8% for pulmonary homograft, valved ePTFE
conduit, bioprosthetic valved conduit, non-valved ePTFE tube, and
others at 5 years, p=0.0001). The valved ePTFE conduit had significantly
higher freedom from conduit reoperation compared to combined other
materials in short-term (92.1% vs. 85.1% and 92.1% vs. 77.3% at 3 and 5
years, p=0.028). The Cox proportional hazards model also showed the
significant difference in freedom from conduit reoperation between
the valved ePTFE conduit and combined other materials (p=0.02), after
adjusting for the potential confounding effect from era, preoperative
diagnosis, conduit size, and surgical technique.
Conclusions: The valved ePTFE conduit showed excellent early
outcome as right ventricle to pulmonary artery conduit for biventricular
repair. A longer follow-up and a randomized study will be necessary to
explore the advantages of the valved ePTFE conduit.
CONGENITAL BREAKOUT
NOTES:
47. Early Outcomes of Pulmonary Valve Replacement With the
Mitroflow Bovine Pericardial Bioprosthesis
Authors: Sarah A. Schubert, *Joseph B. Clark, John L. Myers
Author Institution(s): Penn State College of Medicine, Hershey, PA
Discussant: George M. Alfieris, University Surgical Associates, L.L.P.,
SUNY Health Science Center, Syracuse, NY
REGULATORY DISCLOSURE: This presentation describes the off-label use of the Sorin
Mitroflow Aortic Pericardial Heart Valve for pulmonary valve replacement.
Objectives: Bovine pericardial valves are often used for pulmonary
valve replacement (PVR) in patients with previously repaired congenital
heart disease. Attention has recently focused on the safety of the
Mitroflow bovine pericardial valve following a national alert describing
several cases of sudden valve failure. In response to this concern, we
report our experience using the Mitroflow bioprosthesis for PVR.
Methods: IRB approval was obtained. Medical records were reviewed
for all patients who underwent PVR using a Mitroflow valve at our
center (2008-13).
Results: The cohort included 84 patients (52 males) with a median
age of 18.3 years (range 0.8-62.1) and weight of 48.4 kg (5.7-167.8);
82 patients (98%) had prior surgical repair at 16.8 years (0.4-54.4)
earlier. The leading congenital diagnoses were tetralogy of Fallot (48),
pulmonary atresia (17), and truncus arteriosus (9). Indications for
surgery included native outflow tract insufficiency (59), valved conduit
failure (20), and isolated prosthetic valve failure (5). PVR was performed
using valve sizes of 19 (12), 21 (9), 23 (11), 25 (7), and 27 mm (45).
Bypass and clamp times were 102 (46-305) and 64 m (0-230). Length
of stay was three days (2-13). There were no Hospital deaths. Median
followup was 1.7 years (0.1-5.0). Pulmonary valve insufficiency and peak
gradient increased with time (Table). At latest followup, freedom from
insufficiency ≥moderate was 85.7% and from peak gradient ≥50 mmHg
was 93.5%. Reintervention was required in two patients: PVR (0.6 y)
for endocarditis, and balloon valvuloplasty (4.0 y) then percutaneous
PVR (4.2 y) for insufficiency/stenosis. Kaplan-Meier freedom from
intervention at five years was 86.2% (Figure).
Conclusions: Early outcomes using the Mitroflow bioprosthesis for PVR
in children and adults with repaired congenital heart disease appear
acceptable and similar to reported outcomes for other tissue valve
options. Valve failure due to premature structural deterioration was not
observed.
CONGENITAL BREAKOUT
Echocardiographic Assessment of Function of the Pulmonary Valve
Bioprosthesis
NOTES:
48. Moderate Tricuspid Valve Regurgitation at the Time of Pulmonary
Valve Replacement: Annuloplasty or Not?
Authors: *Brian E. Kogon1, Makoto Mori1, Bahaaldin Alsoufi1, *Kirk
Kanter1, Wendy Book1, Matthew Oster2
Author Institution(s): 1Emory University School of Medicine, Atlanta,
GA; 2Children’s Healthcare of Atlanta, Atlanta, GA
Discussant: *Charles B. Huddleston, Saint Louis University School of
Objectives: In adult congenital patients who have undergone prior
pulmonary valve disruption, management of moderate functional
tricuspid regurgitation during subsequent pulmonary valve replacement
remains controversial. Our aim is to 1) analyze tricuspid valve function
following pulmonary valve replacement through midterm follow-up,
and 2) evaluate the benefit of concomitant tricuspid annuloplasty.
Methods: Thirty-five patients with tetralogy of Fallot or congenital
pulmonary stenosis were analyzed. Pre-operative and post-operative
pulmonary and tricuspid regurgitation, along with right ventricular
dilation and dysfunction were scored echocardiographically (0–none,
1-mild, 2-moderate, 3-severe). Comparisons were made between those
patients who underwent pulmonary valve replacement alone and those
who underwent concomitant tricuspid valve annuloplasty.
Results: One month following pulmonary valve replacement, there was
a significant reduction in pulmonary valve regurgitation (mean, 3 vs.
0.39, p<0.0001) and tricuspid valve regurgitation (mean, 2.33 vs. 1.3,
p<0.0001), as well as significant reductions in right ventricular dilation,
volume, and area. There was no difference with concomitant tricuspid
annuloplasty (mean, 1.31 vs 1.29, p=0.81). However, at latest followup (mean 7.0 +/- 2.8 years), there was a significantly higher degree of
tricuspid regurgitation in the concomitant annuloplasty group (mean,
1.87 vs 1.12, p=0.005).
Conclusions: In patients with moderate tricuspid valve regurgitation,
significant improvement in tricuspid valve function and right ventricular
size occurs in the first postoperative month following pulmonary valve
replacement, irrespective of concomitant tricuspid valve annuloplasty.
The tricuspid valve maintains competence better over the mid-term if
annuloplasty is not performed.
CONGENITAL BREAKOUT
Serial echocardiographic comparisons (mean +/- standard deviation)
(PVR - pulmonary valve replacement, TV - tricuspid valve, PI - pulmonary insufficiency,
TR - tricuspid regurgitation, RV - right ventricle)
NOTES:
49. Institutional Variation in Mortality After Stroke Following Cardiac
Surgery: An Opportunity for Improvement
Authors: *Damien J. LaPar1, *Mohammed A. Quader2, *Jeffrey B. Rich3,
*Irving L. Kron1, *Ivan K. Crosby1, *John A. Kern1, *Alan M. Speir4,
*Gorav Ailawadi1
SATURDAY - SCIENTIFIC PAPERS
Author Institution(s): 1University of Virginia, Charlottesville, VA;
2
Virginia Commonwealth University, Richmond, VA; 3Sentara Heart
Hospital, Norfolk, VA; 4INOVA Heart and Vascular Center, Falls Church,
VA
Discussant: *Andrea J. Carpenter, University of Texas, Health Science
Center at San Antonio, San Antonio, TX
Objectives: Postoperative stroke remains one of the most devastating
complications following cardiac surgery. Understanding the variations
in stroke rates between surgical centers is unknown. This study
evaluated patient risk and institutional factors on postoperative stroke
following cardiac surgery.
Methods: Patient records from a multi-institutional STS certified
database for cardiac operations (2001-2011) were analyzed. The relative
contribution of patient- and Hospital-related factors to the likelihood
of postoperative stroke was assessed by univariate and multivariate
analyses.
Results: A total of 57,387 patients were included. Postoperative stroke
rate was 1.5% with significant variation across Hospitals (range=0.8-2%,
P<0.001). Stroke patients presented with more co-morbid disease
and higher risk profiles (STS PROM 3.1% vs. 1.2%, P<0.001, Table).
Mortality was expectedly higher after stroke (18% vs. 2%, P<0.001), with
significant variation across Hospitals (0-35%, P<0.001). Importantly,
postoperative stroke was associated with nearly double the total cost
of Hospitalization ($46,395 vs. $25,254, P<0.001). After risk adjustment,
individual Hospital demonstrated a strong association with likelihood
for stroke (P<0.001). Furthermore, high performing Hospitals with low
stroke rates performed less aortic valve operations (5-6% vs. 7-17%),
more CABG operations (83-87% vs. 65-83%) and accrued longer ICU
lengths of stay (48 vs. 32-43 hrs, all P<0.001).
Conclusions: Significant inter-center variation exists in postoperative
stroke following cardiac surgery. Postoperative stroke remains a
significant source of mortality and morbidity. Institutional practice
patterns appear to confer a strong influence on postoperative stroke
independent of case mix. Understanding differences between high and
low performing centers is essential to improving outcomes, costs, and
Hospital quality.
NOTES:
Authors: John Nabagiez, Masood A. Shariff, Robert Carlucci, Joseph
DiNatale, William Molloy, DJoseph T. McGinn
Author Institution(s): Staten Island University Hospital, Staten Island,
NY
Discussant: D*Kevin D. Accola, Cardiovascular Surgical PA, Orlando, FL
COMMERCIAL RELATIONSHIPS: Joseph T. McGinn: Speaker Bureau/Honoraria:
Medtronic, Inc.
DISCUSSANT: Kevin D. Accola: Consultant: Edwards Lifesciences, CorMatrix; Speakers
Bureau/Honoraria: Edwards Lifesciences, Cryolife
Objectives: A physician assistant home care (PAHC) program providing
house calls was initiated to reduce Hospital readmission after adult
cardiac surgery. The purpose of our study was to determine pre-PAHC
and PAHC readmission rates and cost analysis of readmissions within
30 days.
Methods: One thousand seven hundred and thirty-nine consecutive
patients undergoing CABG and/or valve replacement or repair
surgery between September 2008 and August 2012 were reviewed
retrospectively. Pre-PAHC served as a control group. Readmission
diagnoses were reviewed and compared between control and PAHC
group. Readmission costs were compared.
Results: Over a four-year period 1739 underwent cardiac surgery;
69.5% (N=1209) were discharged to home, 156 (12.9%) of whom were
readmitted. The total readmissions of the control group (n=652)
compared to the PAHC group (n=557) was 101 (15.5%) and 55 (9.9%),
respectively (p=0.0044), a 36.1% reduction in readmission rate. The
average cost per readmission was $40,023 in the control group and
$57,441 in the PAHC group. The cost of providing home visits was
calculated to be $100,000 per year. Without a reduction in readmissions
rate from 15.5% to 9.9%, the PAHC group would have incurred over $1.8
million in readmission costs, for that 2 year period, to the healthcare
system.
Conclusions: The PAHC program reduced the 30-day readmission rate.
The cost analysis demonstrated a savings of over $1.8 million for a
two-year period by reducing the readmission rate by 36%, at a cost of
$100,000 per year. Therefore, home visits by a physician assistant are a
cost-effective strategy to reduce post cardiac surgery readmissions. *STSA Member D Relationship Disclosure
NOTES:
51. On-pump Versus Off-pump Coronary Artery Bypass Graft Surgery
Among Patients With Type 2 Diabetes
Authors: Ashima Singh1, *Hartzell Schaff 2, Maria M. Brooks1, Mark
Hlatky 3, Robert Frye2, *Edward Sako4
Author Institution(s): 1University of Pittsburgh, Pittsburgh, PA; 2Mayo
Clinic, Rochester, MN; 3Stanford University, Palo Alto, CA; 4University of
Texas Health Science Center at San Antonio, San Antonio, TX
Discussant: *Jennifer S. Lawton, Washington University School of
Medicine, St. Louis, MO
Objectives: This study aims to compare off-pump versus on-pump
coronary artery bypass graft (CABG) surgery in terms of post procedure
complications and medium-term functional and clinical outcomes in
patients with Type 2 diabetes.
Methods: In the Bypass Angioplasty Revascularization Investigation
2 Diabetes (BARI 2D) trial, management strategies in diabetic patients
with myocardial ischemia and coronary artery disease were studied.
A subset of patients underwent CABG with the cases being done on
or off-pump at the discretion of the individual centers. Data regarding
postoperative complications and medium term clinical results were
recorded. Using a logistic regression model, we computed a propensity
score for each patient and matched those done off-pump with on-pump.
Complications were compared using McNemar’s test, and functional
and clinical outcomes were compared using generalized linear models
and Cox proportional hazard models with robust standard errors,
respectively.
Results: 615 patients underwent CABG with 444 (72%) being done on
pump. We obtained 153 matched pairs. Early mortality (2.6% off-pump
vs 1.3% on-pump, p = 0.41) and risk of any in-Hospital complication
(11.1% off-pump vs 15.7% on-pump, p = 0.25) was similar in the two
groups. At a mean follow up of 4.4 years, the risk of composite outcome
death, MI or stroke was significantly higher among off-pump patients.
In addition, repeat revascularization was performed in 17 (11.1%) of the
off pump group compared to 4 (2.6%) of those done on pump (p=0.005).
There were no significant differences in the functional outcomes
between the two groups.
Conclusions: In this group of patients with type 2 diabetes undergoing
CABG surgery, doing the procedure off pump is associated with
marginally fewer postoperative complications but an increased
incidence of death, MI or stroke and need for repeat revascularization in
the medium term when compared to on pump.
NOTES:
Authors: Robert C. Neely, *John G. Byrne, Igor Gosev, *Lawrence H.
Cohn, Quratulain Javed, James D. Rawn, *Sary F. Aranki, Samuel Z.
Goldhaber, Gregory Piazza, Marzia Leacche
Author Institution(s): Brigham and Women’s Hospital, Boston, MA
Discussant: D*Neal D. Kon, Wake Forest University School of Medicine,
Winston-Salem, NC
COMMERCIAL RELATIONSHIPS: DISCUSSANT: Neal Kon: Advisory Board/Consultant:
Medtronic, Inc.
Objectives: Pulmonary embolectomy is often indicated for central
pulmonary embolism (PE) with hemodynamic instability, but remains
controversial for hemodynamically stable patients with signs of right
ventricular dysfunction. Because lytic therapy is often contraindicated
post-operatively, we reviewed risk factors and outcomes of pulmonary
embolectomy for stable and unstable central PE, particularly in the early
post-operative period.
Methods: Between 10/99-9/13, 115 patients underwent pulmonary
embolectomy for central, hemodynamically unstable PE (49/115,
43%) or hemodynamically stable (56/115, 49%) PE. Ten operations for
alternate indications (right atrial mass, endocarditis) were excluded for
comparison analysis, leaving N = 105 patients. Mean age was 59±13
years. 46/105(44%) had recent surgery (<5 wks): orthopedic (12/46,
25%), neurosurgery (11/46, 24%), general surgery (10/46, 22%).
Results: Preoperative demographics did not differ between groups,
except for the frequency of cardiopulmonary resuscitation (CPR) in
unstable 22% (11/49) vs. stable 0% (0/56)(p<0.001) groups. Operative
mortality for combined groups was 6.6% (7/105); unstable 10.2% (5/49)
vs. stable 3.6% (2/56) (p = 0.247). Of 11 patients requiring pre-operative
CPR, four died. Six-month, one- and three-year actuarial survival for
unstable PE was 75%, 68.4%, 65.8% and 92.6%, 86.7%, 80.4% for stable
PE, respectively (p = 0.018).
Conclusions: This large series of pulmonary embolectomies
demonstrates excellent early and late survival rates for patients
with stable and unstable PE. These findings confirm pulmonary
embolectomy as a successful therapeutic option for central PE,
especially during the post-operative period when lytic therapy is often
contraindicated.
Figure 1. Kaplan Meier survival curves for massive (blue) and submassive (green) PE
groups (N = 105) (p=0.018).
NOTES:
53. Re-evaluation of the Modified Ravitch Repair for Pectus Defects:
Forgotten Advantages?
Authors: *Michael H. Hines
Author Institution(s): University of Texas Medical School at Houston,
Houston, TX
Objectives: The use of minimally invasive surgery does not assure
similar results or less complications than more traditional open surgery.
We examined our series of modified Ravitch repairs and compared the
results to published results of the minimally invasive Nuss operation.
Methods: A retrospective chart review was conducted of 50 sequential
patients undergoing Modified Ravitch repair of pectus excavatum (42)
or carinatum (8), ages 6-40 (mean 16). Mean Haller index (excavatum)
was 5.0 (range 2.9 -17). Two patients had had previous repairs as
young children. Two patients had concurrent cardiac surgery. Thoracic
epidurals were placed in 42 patients, contraindicated in seven, and
declined by one.
Results: There were no deaths or serious complications. Mean
Operative Time was 224 minutes. Length of stay was 3.4 days (2-7). No
patient required transfusion. Three patients had small pneumothoraces,
none requiring treatment. One patient required reoperation for a
flipped bar on post-op day 1. There were no bar infections, hemothorax,
seromas, empyemas or readmissions. Two patients had late mild
incisional cellulitis. Epidurals were discontinued on day two, and pain
controlled with ibuprofen in 49 patients, along with PRN propoxyphene
in 34 and acetaminophen with codeine in four. Only six patients
required hydroxycodone or oxycodone. Patients returned to school
or work at 2-3 weeks, and to normal activities at 6-8 weeks, including
athletics (excluding football). Bars were removed at 9-12 months.
Conclusions: While requiring a larger incision and taking longer, the
modified Ravitch repair has very low morbidity, equal to or better than
published reports for the Nuss, and freuqnetly without transfusion.
Patients experience less pain and require less narcotics. The bar is only
left in place for a year or less, (versus 3-4 years) allowing patients to
return to full athletic activities much sooner, making it a viable option
for many patients.
NOTES:
54. Does Thoracoscopic Surgery Decrease the Morbidity of Combined
Lung and Chest Wall Resection?
Authors: Mark Hennon, Elisabeth Dexter, Miriam Huang, John Kane,
Chukwumere Nwogu, Anthony Picone, Sai Yendamuri, *Todd Demmy
Author Institution(s): Roswell Park Cancer Institute, Buffalo, NY
Objectives: Because of the historical high risk for death or major
morbidity, we studied our combined lung/chest wall resection outcomes
for both thoracoscopic and open approaches.
Methods: All consecutive chest wall resections between 2007 (year of
our first VATS case) and 2013 at a comprehensive cancer center were
tabulated retrospectively. Data were analyzed by approach type and
the largest subset (T3 lung cancers) was analyzed separately. Special
attention was given to the attributed causes for early major morbidity/
mortality. Statistical methods used included the Kruskal-Wallis test for
continuous variables, Chi-Square for categorical analysis, as well as the
Kaplan-Meier method and log rank test.
Results: Of 47 chest wall resections performed, 17 (36%) were
performed by VATS with no conversions. Three cases were for benign
conditions and 11 for sarcoma. Thirty resections performed for primary
NSCLC had VATS (15) or thoracotomy approaches (15). Patients
undergoing a VATS approach were older while operative time, blood
loss, and ribs resected were similar between groups (table). VATS cases
had shorter ICU and Hospital length of stay but both groups had high
Hospital morbidity/mortality largely from postoperative pneumonia/
respiratory SIRS (n=5), CVA (n=2) and postoperative colon ischemia
(n=1). Each group had a 90-day mortality of 26.7%, but the VATS group
ranged in age from 73-90 years (cf. 54-74 open) with OR times from 445720 minutes (cf. 300-428 open). Stage-matched survival curves for both
approaches were superimposable (p=0.88).
Conclusions: Thoracoscopic chest wall resection is feasible, expanded
case selection, and reduced prosthetic reconstruction. It did not reliably
protect frail, elderly patients. Briefer, less traumatic operations may be
needed for this group.
VATS vs. Open for Combined Lung and Chest Wall Resection
NOTES:
55. A Prospective Clinical Trial of Telecytopathology for Rapid
Interpretation of Specimens Obtained During Endobronchial
Ultrasound (EBUS)
Authors: Matthew Bott, Bryce James, Brian Collins, *Varun Puri, *Daniel
Kreisel, *Alexander S. Krupnick, *George A. Patterson, *Stephen R.
Broderick, *Bryan F. Meyers, *Traves Crabtree
Author Institution(s): Washington University School of Medicine, St.
Louis, MO
Objectives: Cytopathologic interpretation of EBUS-FNA samples
by a remote pathologist can be time-consuming and costly and
an onsite cytopathologist may not always be readily available. A
telecytopathology system was instituted and evaluated to examine the
impact on operative time for EBUS.
Methods: A prospective study was performed of sequential
patients undergoing EBUS-FNA for the evaluation of mediastinal
lymphadenopathy. The control group involved transportation of
specimens to the pathology lab followed by cytologic interpretation.
A subsequent cohort utilized a new telecytopathology system with
intra-op transmission of real-time microscopic images to a remote
cytopathologist (TCP group). The primary outcome was time to
confirmation of cytology results.
Results: Of 46 patients entered into the study, 23 underwent
traditional analysis (Control group) while 20 were analyzed using
telecytopathology (TCP group). Lung cancer was the most common
malignancy in both groups (12 TCP, 12 Control). There was no difference
in mean number of lymph node stations sampled (1.3 TCP vs. 1.8
Control, p=0.76) or needle passes made (3.8 TCP vs. 4.0 Control,
p=0.59). (Table 1) Time to result confirmation was significantly shorter
in the TCP group (19.0 vs. 46.7 minutes, p<0.001). A diagnostic specimen
was obtained in 70% of patients in the TCP group compared with 65% in
the control group (p=0.5). False negative rates in patients undergoing
both EBUS-FNA and mediastinoscopy were similar between the two
groups (0 in TCP vs. 2 in Control, p=0.49). Mean procedural costs
(excluding cost of the telecytology system and OR time) were equivalent
between the two groups ($888 TCP vs. $887 Control).
Conclusions: Telecytopathology provides rapid interpretation
of EBUS-FNA samples with diagnostic accuracy comparable to
traditional methods and may be the preferred model when an onsite
cytopathologist is not available.
Table 1: Comparison of telecytopathology (TCP group)
vs. conventional analysis (Control group) for the evaluation
of specimens obtained during EBUS
NOTES:
56. Does Surgical Upstaging in Resected Lung Cancer Depend on the
Surgical Approach?
Authors: *Jeremiah Martin, Eric B. Durbin, Li Chen, Tamas Gal, Angela
Mahan, *Victor Ferraris, *Joseph B. Zwischenberger
Author Institution(s): University of Kentucky, Lexington, KY
Objectives: Recent reports have demonstrated that thoracoscopic
lobectomy for lung cancer may be associated with lower rates of
surgical upstaging. We queried a state-wide cancer registry for
differences in stage migration rates and survival by surgical approach.
Methods: The Kentucky Cancer Registry (KCR) collects data, including
centralized pathology reporting, on cancer patients treated statewide.
We performed a retrospective review from 2010-2012 to examine
clinical and pathologic stage. We assessed rates of stage migration
and whether or not the surgical approach, thoracotomy (THOR) versus
minimally invasive techniques (VATS), had an impact on final pathologic
stage. Statistical significance was determined using Chi-square tests for
binary outcomes and log-rank tests for survival outcomes.
Results: The KCR database from 2010 to 2012 contained information
on 2593 lung cancer cases, 1928 having THOR and 665 having VATS
resections (Table 1). Preoperatively, 58.2% of THOR were clinically stage
1 vs. 66.5 % VATS (p=0.0002). Of these, final pathologic stage remained
stage 1 in 70.3% of THOR and 74.4% of VATS (p=0.14). The overall
upstaging rate for THOR was 21.8% and 18.4% for VATS (p=0.09). A
significantly different upstaging rate was seen for stage I or II tumors to
stage III, occurring in 9.8% of THOR and 5% of VATS (p=0.002). Overall
survival for stage 1 (graph) was better in the VATS group (p=0.047).
Conclusions: Consistent with other reports, we demonstrate a lower
upstaging rate with VATS. Nevertheless, there is a survival advantage
in VATS patients, most of which is realized in the first months after
surgery. Although selection bias may play a role in these observed
differences, the improved quality of life measures associated with VATS,
may explain survival improvement despite lower surgical upstaging.
Comparison of lung cancer patients treated by
thoracotomy and vats in Kentucky, 2010-2012.
Survival of pathologic stage 1 lung cancer patients, stratified by surgical approach.
NOTES:
57. Should Single Lung Transplantation Continue to be Performed in
Patients With Chronic Obstructive Pulmonary Disease (COPD)?
Authors: Daine T. Bennett, Martin R. Zamora, *Thomas B. Reece,
John D. Mitchell, Joseph C. Cleveland, *Frederick L. Grover, David A.
Fullerton, Ashok Babu, Robert A. Meguid, Michael J. Weyant
Author Institution(s): University of Colorado Denver School of
Medicine, Aurora, CO
Objectives: Single lung transplants (SLTx) are viewed as inferior to
bilateral lung transplants (BLTx) due to perceptions that overall survival
is lower for single lung transplant. We believe that subpopulations
of patients exist who exhibit similar survival for SLTx and BLTx.
Identifying these populations will expand the number of usable donor
organs, maximizing patient life-years saved. We hypothesize that in
patients with end-stage lung disease secondary to chronic obstructive
pulmonary disease (COPD), SLTx and BLTx achieve comparable survival
outcomes.
Methods: Based on our institution’s transplant criteria, patients with
COPD 55 years old are offered single lung transplantation. Cohorts
of consecutive patients undergoing lung transplant for COPD between
1992-2012 were identified from our institution and from United Network
of Organ Sharing (UNOS). Patients with diagnosis of alpha-1 antitrypsin
deficiency and re-transplantation were excluded. Five-year survival of
SLTx and BLTx were compared by Kaplan-Meier survival curves.
Results: From our institution, 239 patients with COPD meeting criteria
were identified. 209 underwent SLTx, and 30 underwent BLTx. Fiveyear survival for SLTx (52.9±3.5%) and BLTx (56.7±10.2%) was not
significantly different (p=.722) (Figure 1). The UNOS database contained
7281 patients meeting selection criteria with 4425 undergoing SLTx
and 2856 undergoing BLTx. Five-year survival in the UNOS cohorts was
lower for SLTx (46.4±0.8%) compared to BLTx (55.8±1.1%) (p<.001).
However, five-year survival for SLTx (52.9±3.5%) from our institution
was not significantly different from UNOS BLTx (55.8±1.1%) cohort
(p=.488) (Figure 2).
Conclusions: Based on our institution’s practices, five-year survival
after SLTx for COPD is comparable to BLTx cohorts from our institution
and the UNOS database. SLTx is a viable therapy. Increased utilization of
SLTx may improve overall life-years saved in the COPD population due
to expansion of donor lung availability.
TRANSPLANT BREAKOUT
Figure 1. At our institution, 5-year survival for SLTx (52.9±3.5%) and BLTx (56.7±10.2%)
was not significantly different (p=.722) in patients with COPD. Figure 2. 5-year survival
for SLTx (52.9±3.5%) from our institution was not significantly different from BLTx
(55.8±1.1%) from the UNOS cohort (p=.488).
NOTES:
58. Prior Sterntomy and Ventricular Assist Device Implant Do Not
Adversely Impact Survival or Allograft Function Following Heart
Transplant
Authors: Ann C. Gaffey, Emily Phillips, Jessica Howard, Robert Emery,
Dale Korbin, Lee Goldberg, Micheal Acker, *Y. Joseph Woo, *Pavan
Atluri
Author Institution(s): Hospital of the University of Pennsylvania,
Philadelphia, PA
Objectives: Orthotopic heart transplant (OHT) remains the gold
standard for end-stage heart failure; however, donor availability is
limited. With a median wait time of 6.6 months, the decision is often
made to implant a ventricular assist device (VAD) as bridge to transplant
(BTT) for medical stabilization. Furthermore, the number of patients
who have had at least one prior sternotomy (PS) awaiting transplant
is increasing. Previous studies have indicated reoperative sternotomy
as a risk factor for compromised survival. Concerns are focused on
outcomes following VAD explant or redo-sternotomy prior to OHT due
to increasing operative complexity. We hypothesize that despite the
greater technical difficulty outcomes would not be compromised.
Methods: We retrospectively analyzed patients who underwent OHT at
our center over a five-year period (2008-2013;n=253). All patients who
underwent a BTT VAD (n=72) or PS (n=65) were compared to those
undergoing OHT with a virgin chest (VC, n=116). Peri-operative variables
were analyzed. Short and long-term survival was studied (minimum
follow up=6 mos).
Results: Co-morbidities were similar between the groups (TABLE).
There was no difference in donor ischemic time or cross clamp time; but
cardiopulmonary bypass time was longer in both BTT and PS cohorts
(p<0.00001). The blood transfusion requirement was higher in BTT
and PS groups as compared to the VC cohort (p= 0.0019). For BTT and
PS, both time to extubation (p=0.01) and ICU LOS (p=0.01). There was
no difference in Hospital length of stay (0.19). Overall, there was no
difference in one- or three-year survival among the groups.
Conclusions: PS or VAD as BTT does not adversely impact allograft
function, Hospital length of stay, or long-term outcomes following OHT.
The decision to manage a patient medically while awaiting transplant
versus an LVAD BTT strategy should not be altered by concerns of
subsequent complexity of OHT.
TRANSPLANT BREAKOUT
Table 1. Perioperative Characteristics Stratified by VC, BTT, or PS
* The p values were determined by analysis of variance.
NOTES:
59. Stroke After Left Ventricular Assist Device Implantation: Outcomes
in the Continuous Flow Era
Authors: Laura Harvey, Christopher Holley, Samit Roy, Peter Eckman,
Monica Colvin-Adams, Kenneth Liao, Ranjit John
Author Institution(s): University of Minnesota, Minneapolis, MN
Objectives: Left ventricular assist devices (LVADs) are increasingly
being used in patients with heart failure. We evaluated our single center
experience to study the impact of stroke on clinical outcomes after LVAD
placement.
Methods: From June 2005 to June 2013, 230 patients received a
HeartMate II (HM II) LVAD. Standard statistical methods including
t-tests, chi-square tests and Kaplan-Meier analysis were used.
Results: Of 230 LVAD patients, 185 (80.4%) were bridge to transplant
and 45 (19.6%) were destination therapy. Strokes occurred in a total of
39 patients (17%), an incidence rate of 0.064 strokes per person-year.
19 (48.7%) strokes were embolic and 20 (51.3%) were hemorrhagic.
Median duration of support at the time of stroke was 146 [IQR: 34,
518] days for embolic and 240 [IQR: 76, 1188] days for hemorrhagic
(p=0.23). Freedom from stroke at 6, 12, and 24 months was 92.6%,
89.6%, and 86.1% respectively. There were no significant differences
in baseline demographic variables except that stroke patients had a
lower incidence of coronary artery disease (p=0.004) and prior cardiac
surgery (p=0.001) [Table 1]. There was a trend towards increased risk of
stroke in patients with LVAD-related infections (p=0.05). The 6, 12, and
24 month survival rate in patients with a stroke was 84.6%, 71.8%, and
53.9% compared to 84.2%, 81.6%, and 74.7% respectively in patients
without a stroke (log-rank p=0.0019) [Figure 1]. Over a median follow-up
time of 761 days, patients who had a stroke had a mortality risk that was
2.01 times that of patients without stroke (HR=2.01; p=0.004). 30-day
and 1 year mortality after stroke was 20.5% and 30.8%.
Conclusions: Stroke while on LVAD support is associated with
significant mortality and occurs with increasing incidence over
time. Identification of risk factors and a better understanding of the
interaction between LVAD-related infections and stroke are essential to
reduce the risk of stroke.
TRANSPLANT BREAKOUT
Table 1 – Patient Demographics by Stroke
NOTES:
60. Is There an Age Limit to Lung Transplantation?
Authors: Sreeja Biswas Roy1, Diana Alarcon2, Rajat Walia2, Kristina M.
Chapple2, Ross Bremner2, Michael A. Smith2
Author Institution(s): 1Providence Hospital and Medical Center,
Southfield, MI; 2St. Joseph’s Hospital and Medical Center, Phoenix, AZ
Objectives: Lung transplant in patients age 65+ has become
increasingly common. However, questions remain regarding risk vs.
benefit and procedure choice. We sought to identify short and long
term outcomes in older single (SLT) and bilateral (BLT) lung transplant
recipients.
Methods: A retrospective review of UNOS data on patients who
underwent lung transplant from May 2005 to December 2012 was
done. Patients were allocated into age groups (12-64, 65-69, 70-74, and
75-79). Short term (30 day, 90 day, and 1-year) and long term (3 and
5-year) survival was calculated (Kaplan Meier approach) and survival
distributions compared (log-rank tests).
Results: 11,776 patients (mean age=53.6 +/- 14.1 years) were
transplanted: 9317(79%) 12-64, 1902(16%) 65-69, 486(4%) 70-74, and
71(1%) 75-79 years. While lung allocation scores increased, mean
pulmonary artery pressures decreased with increasing age. The
proportion of males increased from 56% (12-64), to 66% (64-69), 77%
(70-74), and 94% (74-79). The proportion of SLTs increased from 27%
(12-64), to 55% (64-69), 69% (70-74), and 79% (70-79). Short term
survival was similar across all age groups and procedure types except
the 75-79 group, which had lower short term survival for BLT. The 12-64
group had higher five-year survival for SLT and BLT (p<0.001) than all
other groups. There was a long term survival advantage for BLT over
SLT in this group (p< 0.0001). Older age groups trended to better long
term survival for BLT over SLT in 65-69 (p=0.059) and 70-74 (p=0.079).
While data was lacking for 5-year survival for age 75-79, their three-year
survival for BLT was significantly worse.
Conclusions: Lung transplant can be offered to select older patients up
to age 74 with acceptable outcomes. SLT may be preferred in this group
of patients, but BLT offers acceptable long term outcomes without
significant short term risk. While patients age 75+ have acceptable short
term outcomes for SLT, long term outcomes for SLT and BLT are poor.
TRANSPLANT BREAKOUT
Demographics of subjects receiving lung transplantation between May
2005 to December 2012
Cumulative survival rates by age and transplant type. NOTES:
61. Left Ventricular Re-training and Late Arterial Switch for
D-transposition of the Great Arteries
Authors: Naruhito Watanabe, *Richard D. Mainwaring, Sergio Carrillo,
V. Mohan Reddy, Frank Hanley
Author Institution(s): Stanford University School of Medicine, Stanford,
CA
Discussant: Jennifer Hirsch-Romano, University of Michigan, Ann
Arbor, MI
Objectives: For several decades, patients with D-transposition of the
great arteries underwent an atrial switch procedure. While many of
these patients have continued to do well, a subset will develop profound
right ventricular (RV) failure. Some patients may be candidates for left
ventricular (LV) re-training and late arterial switch. The purpose of this
study was to review our experience with LV re-training and late arterial
switch in D-transposition.
Methods: This was a retrospective review of 32 patients with
D-transposition. Thirty patients underwent a previous atrial switch
and subsequently developed RV failure, while two presented late (8
months and 6 years) without prior intervention. The median age at
the time of enrollment in this program was 15 years. Seven patients
proceeded directly to late arterial switch due to systemic LV pressures.
The remaining 25 underwent a pulmonary artery band (PAB) for LV
re-training.
Results: Twenty of the 32 (63%) patients enrolled in this program
were able to undergo a late arterial switch. There were four operative
mortalities (20%), including one of seven who proceeded directly to late
arterial switch and three of 13 who underwent LV re-training. There has
been no late mortality s/p arterial switch with a median follow-up of
five years. During this interval, three patients have required aortic valve
replacement.
Twelve patients underwent one or more PABs without evidence of
effective LV re-training. There have been two early and three late (42%)
deaths in this sub-group.
Conclusions: The data demonstrate that nearly two-thirds of patients
who develop RV failure s/p atrial switch may be candidates for late
arterial switch. However, one-third do not show evidence of adequate
re-training and remain at risk for both early and late mortality. The
outcomes following arterial switch are encouraging and suggest that
LV re-training and late arterial switch provides a viable option for this
complex group of patients.
CONGENITAL BREAKOUT
NOTES:
62. Equivalent Outcomes for Early and Late Complete Atrioventricular
Canal Repair in the Modern Era
other relationship with a healthcare-related business or other entity to discloser.
Authors: Elizabeth H. Stephens, Ali N. Ibrahimiye, Halit Yerebakan, Tuba
Gencol, Matthew Lippel, Betul Yilmaz, Wyman Lai, Anjali Chelliah, Amee
Shah, Stephanie Levasseur, *Paul Chai, Jan Quaegebeur, Emile Bacha
Author Institution(s): Columbia University Medical Center, New York,
NY
Discussant: *Carl L. Backer, Ann & Robert H. Lurie Children’s Hospital,
Chicago, IL
Objectives: Repair of complete atrioventricular canal (CAVC) early
in infancy has traditionally carried greater morbidity and mortality
than repair performed later. However, an individualized anatomybased repair may give young infants outcomes that are equivalent to
older infants. The objective was to test this hypothesis by comparing
outcomes between CAVC patients repaired at <3 months and those >3
months.
Methods: We retrospectively reviewed 140 patients who underwent
CAVC repair at our institution 1/2005-12/2012. Repair was performed
with an individualized approach: two-patch repair (n=101) for large
ventricular septal defects (VSD) and modified single patch (“Australian
technique,” n=39) for “shallow” VSDs. The left atrioventricular (AV)
valve cleft was at least partially closed with interrupted sutures.
Statistics were performed using Student’s t-test, Pearson chi-square
test, and univariate and multivariate analysis.
Results: The average age was 25.5±3.9 weeks and 78% had Trisomy 21.
Mean follow-up was 5.0±0.2 years with 100% completeness of data.
There was 1 (0.7%) in-Hospital and 1 (0.7%) late mortality. The rate for
left AV valve reoperation was 9%. Compared to patients >3 months,
patients <3 months (n=39, 28%) had similar peri-operative courses and
rate of reoperation (Table). Compared to Australian repair patients,
2-patch repair patients (n=102, 73%) were more likely to have Trisomy
21 and had longer bypass and cross-clamp times, but similar outcomes.
On univariate analysis, risk factors for left AV valve reoperation included
ICU stay, reintubation, preoperative kidney disease, degree of pre- and
postoperative left AV valve regurgitation, and pre- and postoperative
right AV regurgitation (all p<0.05); however none of these factors were
significant on multivariate analysis.
Conclusions: Utilizing an individualized surgical approach, repair of
CAVC yields reoperation and early mortality rates similar for younger
infants compared to older infants.
CONGENITAL BREAKOUT
*indicates statistically significant differences. Data is presented as mean ± standard
error. When appropriate the number of patients is listed for each parameter followed by
% of cohort in parentheses. Preop=preoperative, BSA=body surface area, mo=months,
PDA=patent ductus arteriosus, mech=mechanical, PA=pulmonary artery, MR=mitral
regurgitation, TR=tricuspid regurgitation, PR=pulmonic regurgitation, AR=aortic
regurgitation, RV=right ventricle, LV=left ventricle, CPB=cardiopulmonary bypass,
XC=cross clamp, LOS=length of stay, ICU=intensive care unit, periop=perioperative,
trach=tracheostomy, Afib=atrial fibrillation, post op=post-operative, PPM=permanent
pacemaker, reop=reoperation, L AV=left atrioventricular, f/u=follow-up.
NOTES:
63. Aortic Valve Leaflet Morphology Is Associated With the Patterns of
Aortic Dilation and Valve Dysfunction in Young Patients With Bicuspid
Aortic Valves
Authors: Mark Ruzmetov, Jitendra J. Shah, *Randall S. Fortuna, *Karl F.
Welke
Author Institution(s): Children’s Hospital of Illinois, Peoria, IL
Discussant: *Luca A. Vricella, Johns Hopkins University School of
Objectives: Dilation of the aorta is a frequent complication in patients
with bicuspid aortic valve (BAV). The aim of this study was to determine
the relationship between the sub-type of leaflet fusion, right and
non-coronary leaflets (R/N) versus right and left leaflets (R/L) and the
patterns of aortic dilation and valve dysfunction in young patients with
BAV.
Methods: We performed a retrospective review of 511patients who
presented with BAV between 1994 and 2014. Of these patients, 124
(24%) had aortic dilation (Z score >2) by echocardiogram. For each
patient, the most recent study or the last study before intervention was
reviewed.
Results: Median patient age was 15 years (range 0-40) with patients
with R/N being younger (Table). R/N was the most prevalent
subtype (R/N,n=74,60% vs. R/L,n=50,40%). Dilation of the ascending
aorta (AA) was seen more often in patients with R/N (R/N,88% vs.
R/L,68%;p=0.004) whereas the prevalence of dilation of the sinuses
of Valsalva(SV) was significantly higher in patients with R/L (R/L,46%
vs. R/N,20%;p=0.01). The magnitude of dilation differed as well. The Z
value of the SV was significantly higher in patients with R/L (R/L,2.03 vs.
R/N,1.2;p=0.003) while the z values of the AA and sinotubular junction
were similar between the groups (Figure). Patients with R/N were more
likely to have AI and within the R/N group, patients with AI had a greater
degree of AA dilation (p=0.003).
Conclusions: Our study suggests that in young patients with BAV and
aortic dilation, aortic valve morphology may be associated with the
patterns of aortic dilation and valve dysfunction. Patients with R/N
fusion were more likely to have AA dilation, while patients with R/L
fusion were more likely to have dilation of the aortic root. In addition,
patients with R/N fusion presented at a younger age and were more
likely to have AI. Recognition of these differences may eventually be
helpful for patient counseling and the planning of follow-up.
CONGENITAL BREAKOUT
NOTES:
64. The Supported (Ross Ungerleider) Modified Ross Operation: Early
Outcomes and Intermediate Follow Up
Authors: Roni Jacobsen, Michael Earing, Garrick Hill, Michael Barnes,
*James Tweddell
Author Institution(s): Medical College of Wisconsin/Children’s Hospital
of Wisconsin, Milwaukee, WI
Winston-Salem, NC
Objectives: Since 2006 the Supported “Ross Modified” Ross (RMR) has
been the preferred surgical approach for adolescent and adult patients
at our center. A Sinus of Valsalva graft is used to support the neoaortic
root. We compared outcomes following the RMR technique to the Ross
procedure using the aortic root replacement technique (ARR).
Methods: From 1992-2013, 89 patients underwent a Ross procedure. Of
these, based on age and size, 40 patients were considered candidates
for the RMR procedure.
Results: For the 40 patients (75% male), median age at surgery was 15.4
years (range 11-32 years). There were 29 patients (72%) who underwent
the RMR and the remaining 11 patients (28%) underwent the ARR. At
time of Ross, indication for surgery was regurgitation (47.5%), stenosis
(10%), and mixed (42.5%). There was one early death. The mean follow
up was two years (range 1-12 years). At last follow up, patients in the
RMR cohort had a smaller neoaortic root index (p<0.0004), smaller
neoaortic root z-score (p<0.0012), and were less likely to have neoaortic
valve regurgitation (3% vs 30%, p<0.01). Overall, four patients (40%)
in the ARR cohort had required reintervention, including three directed
at the neoaortic root. One patient in the RMR cohort has required
reintervention for revision of the right coronary artery.
Conclusions: At intermediate follow up, patients who underwent the
RMR technique were less likely to have neoaortic root dilation, neoaortic
valve regurgitation, or reintervention compared to patients who
underwent the Ross procedure using the ARR technique.
CONGENITAL BREAKOUT
NOTES:
HAROLD URSCHEL HISTORY LECTURESHIP
65. Osler Almon Abbott: The Man, The Award and His Legacy
Authors: D*Daniel L. Miller, *Joseph I. Miller, Jr., *Kamal A. Mansour
COMMERICAL RELATIONSHIPS: Daniel Miller: Thoracic Surgery Advisory Board:
Ethicon Endo-Surgery, Inc., Davol, A Bard Company
Osler Almon Abbott was born in Hamilton, Ontario on June 6, 1912. He
graduated from Princeton University in 1933 and John Hopkins School
of Medicine in 1937. His internship was at McGill University in Montreal,
Canada in the Department of Medicine. He spent six years in general
surgery residency at Cincinnati General Hospital in Cincinnati, Ohio
and one year in Thoracic Surgery at Washington University in St. Louis
under Dr. Evarts Graham. He served as Captain in the Army and was
Chief of the Orthopedic Surgery at Fort Knox, Kentucky. Dr. Abbott was
recruited to Emory University in Atlanta, Georgia in 1945 to start the
Thoracic and Cardiovascular Surgical Service. Dr. Abbott was one of the
founding members of the Emory Clinic in 1953 and initiated the Thoracic
Surgery residency program at Emory in 1963. Dr. Abbott published 52
papers and wrote three book chapters over his career and retired in
1971. He passed away on November 2, 1976 and is buried in Lexington,
Kentucky. Dr. Abbott was the nephew of Sir William Osler, who was one
of the founders of John Hopkins School of Medicine and Regis professor
of Medicine at Oxford.
The Osler Abbott Award (OAA) was established in 1960 and has been
awarded annually to that member of the STSA who excels in the art of
discussionship. It was named for Dr. Abbott, who in 1960, discussed
26 consecutive papers of 42 that were presented at the 1960 AATS
meeting in Miami Beach, Florida. Because of this incredible academic
accomplishment and showmanship, a Secret committee at the 1960
STSA meeting in Nassau, Bahamas developed the OAA. The first
recipient of the OAA was Dr. Joseph Peabody in 1960. In the early years,
sheer volume of discussion was sufficient to earn at least an honorable
mention, but volume alone never won the award. More important
were factors such as pomposity, arrogance, irrelevancy, and the use of
outdated slides which had been shown on two or more occasions. In
recent years the tactics have ranged from extreme subtlety to blatant
exhibitionism and from apparent indifference to obvious covetousness.
To place this traditional award on a somewhat higher plane of
competition, the Council, in its wisdom, decided to base the decision on
Oslerian principles, and selection would come from evaluation of the
more memorable of discussions during the scientific sessions. Thus,
the reincarnated purposes of the OAA of the STSA are: 1) to focus on
the importance of open, frank, and candid discussion in the spirit and
substance of the STSA and, in this way, to encourage more objective
and active participation by all members attending the annual meeting
and 2) to stimulate a healthy give-and-take among the members and,
thereby, enhance the camaraderie and esprit-de-corps which have
traditionally characterized the STSA. Dr. Abbott, himself, was awarded
the OAA in 1967.
Building on Dr. Abbott’s foundation for Thoracic Surgery excellence
at Emory, Dr. Charles R. Hatcher Jr., former STSA President, hired Dr.
Kamal A. Mansour in 1968, who trained under Dr. Abbott. Dr. Mansour
was the backbone of the General Thoracic Surgery (GTS) at Emory for
over 45 years. Dr. Mansour won the OAA in 1991. Dr. Joseph I. Miller, Jr.
joined Emory in 1974 and became the chief of GTS in 1984. Dr Miller was
STSA President in 2003. In 2002, Dr. Daniel L. Miller joined Emory and
became Chief of GTS in 2006 and was named the first Kamal A. Mansour
Professor of Thoracic Surgery in 2007. Dr. Vinod H. Thourani, current
attending and prior CT Surgery resident at Emory won the OAA in 2010.
Dr. Miller won the OAA in 2013. Dr. Abbott’s legacy is robust at Emory
and in the STSA today. NOTES:
66. One Hundred Safe Transports on Extracorporeal Life Support to a
Authors: Mauer Biscotti1, Darryl Abrams1, Cara Agerstrand1, *Joshua
Sonett1, Linda Mongero2, *Hiroo Takayama1, DDaniel Brodie1, *Matthew
Bacchetta1
Author Institution(s): 1Columbia University Medical Center, New York,
NY; 2New York Presbyterian Hospital, New York, NY
Discussant: D*Joseph B. Zwischenberger, University of Kentucky,
Lexington, KY
COMMERICAL RELATIONSHIPS: Daniel Brodie: Research Support: Maquet
Cardiovascular; Consultant/Advisory Board: ALung Technologies
DISCUSSANT: Joseph B. Zwischenberger: Ownership Interest: Avalon, Maquet t
Objectives: This report characterizes the first 100 consecutive
adult extracorporeal membrane oxygenation (ECMO) transports at
our institution. Extracorporeal life support technology has gained
acceptance as a salvage mode for patients in respiratory or cardiac
failure. Patients who are sick enough to require ECMO support are
often too unstable for transfer to a Hospital with ECMO capabilities.
We highlight the progressive development of an ECMO transport team
and the manner in which it provides reliable transport with excellent
outcomes.
Methods: All data was collected retrospectively from our Hospital’s
electronic medical record. Patient outcomes are reported through April
2, 2014.
Results: Our institution began an ECMO transport program in 2008 with
the initial phase involving transport of highly selected patients over
short distances. With experience we refined our intake and evaluation
process. We also consolidated care for ECMO patients into two intensive
care units and developed a dedicated ECMO intensivist position. As
the program has matured patient selection has become more inclusive
and we have extended our capabilities to include interstate and
international transport. All 100 patients were successfully placed on
ECMO and transported to our center. Seventy-nine patients were placed
on venovenous ECMO, 19 on venoarterial ECMO, and 2 on venovenous
arterial ECMO. There was one complication with no adverse effect to the
patient, and there were no intra-transport power failures or equipment
malfunctions. The median transport distance was 16 miles and ranged
from 2.5 to 7084 miles. Three transports were via fixed wing aircraft
with the remainder via ambulance.
Conclusions: ECMO transport can be performed safely and reliably
with excellent outcomes with a dedicated team that maintains stringent
adherence to well-designed management protocols.
ECMO Patient Outcomes
*Decannulation prior to leaving OSH with successful recannulation
APACHE, Acute Physiology and Chronic Health Evaluation; ECMO, Extracorporeal
Membrane Oxgenation; OSH, Outside Hospital
Figure 1. Transports per year *Through April 2, 2014 NOTES:
67. Survival in Patients With Continuous-flow Left Ventricular Assist
Devices on the Waiting List and Marginal Donor Heart Transplantation
Recipients: A UNOS Database Analysis
Authors: Erin Schumer, Mickey Ising, Jaimin Trivedi, *Mark Slaughter,
Allen Cheng
Author Institution(s): University of Louisville, Louisville, KY
Discussant: *James K. Kirklin, University of Alabama, Birmingham, AL
Objectives: The shortage of donor hearts has limited cardiac
transplantation as a treatment for end-stage heart failure (HF), leading
to the increased use of left ventricular assist devices (LVADs) as bridgeto-transplant (BTT) and marginal donor hearts. While the use of LVADs
and marginal donor hearts has expanded treatment options, outcomes
have been mixed. This study examines differences in wait list survival of
patients with continuous flow LVADs and post-transplantation survival
of marginal donor heart recipients.
Methods: The United Network of Organ Sharing database was
retrospectively queried from January 2005 to June 2013 to identify adult
patients listed for heart transplant. Marginal donor criteria included age
>55 years old, hepatitis C positive, cocaine use, ejection fraction <45%,
and donor:recipient body mass index greater (BMI) mismatch of 20%.
Wait list survival of patients with continuous flow LVADs and posttransplant survival of marginal donor heart recipients were compared
using Kaplan-Meier analysis, and was the primary endpoint.
Results: A total of 20,195 patients were listed for heart transplant during
this time period of which 2561 patients received LVAD support and 4737
patients received a marginal donor heart. At time of LVAD implantation
or marginal donor transplant, groups differed significantly for gender,
BMI, diabetes, and creatinine (Table 1). The 30-day, 1-year, and 2-year
post-transplant survival was 97%, 89%, and 85%, respectively, for
recipients with marginal donor hearts and 96% , 89% and 85%,
respectively, for patients with LVAD support on the waiting list (p=0.2)
(Figure 1).
Conclusions: There was no significant difference in survival between
patients with LVAD support as BTT and recipients with marginal
donor hearts. These results may suggest clinical benefits to using
LVAD support as a bridge to an optimal donor heart as opposed to
transplantation with a marginal heart.
Characteristics of LVAD and marginal donor group
Mean ± standard deviation or N (%). BMI = body mass index, UNOS = United Network of
Organ Sharing, PAP = mean pulmonary arterial pressure
NOTES:
68. Modified Single Patch: Are We Still Worried About Subaortic
Stenosis?
Authors: *Carl L. Backer, Osama Eltayeb, Michael C. Monge, Katherine
Wurlitzer, Lindsay H. Boles, Anne E. Sarwark, Joshua D. Robinson
Author Institution(s): Ann & Robert H. Lurie Children’s Hospital of
Chicago, Chicago, IL
Objectives: When the modified single patch technique for
atrioventricular septal defect (AVSD) repair was introduced by Dr.
Benson Wilcox, there was concern that these patients might be at risk
for late subaortic stenosis and left ventricular outflow tract obstruction
(LVOTO). The purpose of this review was to evaluate our modified single
patch population for LVOTO in the postoperative period.
Methods: Between January 2000 and 2013, 77 infants underwent AVSD
repair with a modified single patch technique. Trisomy 21 was present
in 57 of the 77 patients (74%). Mean age at surgery was 0.4±0.2 years,
median age was 0.37 years, and median weight was 5 kg. Eight patients
had a prior coarctation of the aorta repair via left thoracotomy.
Results: There was one early death at four months post-op (liver
failure). The median Hospital stay was ten days. No patient required
a pacemaker. The mean and median follow-up time is 4.6 and 3.7
years. Only two patients (2.5%) required reoperation for LVOTO; both
had repair of coarctation of the aorta as newborns. The first patient
developed a discrete fibrous subaortic membrane and required
resection at three and seven years post-repair. The other patient had
LVOTO from accessory chordae of the left atrioventricular valve and
required mitral valve replacement 5 months post-repair. Three other
patients (all with prior coarctation repair) have an unchanged LVOTO
gradient of 10-15 mmHg, maximum follow-up is ten years.
Conclusions: At intermediate term follow-up, LVOTO does not appear to
be a significant postoperative issue after modified single patch repair of
AVSD. Coarctation of the aorta was the most significant predictor of late
LVOTO post-repair of atrioventricular septal defect. *STSA Member D Relationship Disclosure
NOTES:
69. Outcomes of Heart Transplantation in Children With Congenital
Heart Disease
Authors: Bahaaldin Alsoufi, Shriprasad Deshpande, *Brian Kogon,
William Mahle, Robert Vincent, *Kirk Kanter
Discussant: *Kristine J. Guleserian, Children’s Medical Center/UT
Southwestern Medical Center, Dallas, TX
Objectives: Heart transplantation (HT) in children with congenital heart
disease (CHD) has been associated with inferior outcomes owing to
several anatomic and physiologic challenges. We report our experience
with pediatric HT for CHD.
Methods: 120 CHD patients underwent HT (1988-2013). Effects of
multiple demographic, clinical, anatomic, operative and donor variables
on outcomes were examined.
Results: There were 74 males (62%). Median age was 3.6years (6days18.7years). 82(68%) had single ventricle and 38(32%) had two ventricle
anomalies. 16(13%) had primary HT while 104(87%) had prior surgical
repair or palliation including Fontan in 30(25%).
On competing risks analysis: 10 years following HT, 42% have died,
17% have undergone retransplantation and 41% were alive free from
retransplantation. There was no survival improvement between earlier
(<2000) and later (>2000) era in CHD patients: 1 year 79% vs. 80%
(p=0.98) and 10 year 49% vs. 54% (p=0.95), unlike contemporaneous
non-CHD patients who had improved outcomes in recent era: 1 year
82% vs. 95% (p=0.02) and 10 year 56% vs. 67% (p=0.12).
Survival was not affected by age groups (p=1.00), gender (p=0.50),
presence of high panel reactive antibody (p=0.40), prior cardiac surgery
(p=0.76), anatomy (p=0.49), Fontan (p=0.90), pulmonary augmentation
(p=0.94). On multi-variable analysis, the only factor affecting survival
was donor/recipient race mismatch (HR 5.8, p=0.016).
Conclusions: Disappointingly, HT outcomes in CHD children have not
improved and survival gap between CHD and non-CHD patients have
increased. Interestingly, survival was not affected by single ventricle,
Fontan, or high PRA. Strategies to improve outcomes in CHD patients
might need to address patient selection criteria, transplantation
timing, pre-transplant and post-transplant care. The effect of donor/
recipient race mismatch on survival warrants further investigation
and might impact organ allocation algorithms or immune-suppression
management.
NOTES:
70. Is Interest in a Cardiothoracic Surgical Career Maintained After
Scholarship Awards to Medical Students? Long-Term Results From a
Single Institution
Authors: Kanika Trehan, Xun Zhou, *Stephen C. Yang
Author Institution(s): Johns Hopkins Medical Institutions, Baltimore,
MD
Discussant: *Curtis G. Tribble, University of Virginia, Charlottesville, VA
Objectives: Several award opportunities currently exist for medical
students to facilitate early experience and exposure to cardiothoracic
surgery (CTS). Our current study reviews long-term interest outcomes
of these students who were given both institutional and national
support to formally participate in CTS clinical and research activities.
Methods: Students who were selected following their first or second
year of medical school for clinical and research support formed the
study cohort. Outcomes are kept in a prospective database from
the Division of Thoracic Surgery. Sources of support came from the
American Association for Thoracic Surgery (AATS), Society of Thoracic
Surgeons (STS), Southern Thoracic Surgical Association (STSA), and a
private family donor. An update on their current status and CTS interest
is performed annually. The clinical and research experience varied from
4-8 weeks, while the national society exposure occurred during the
annual meeting.
Results: Since 1999, 45 students received formal support. Sources
included the AATS (8, 18%), STS (2, 4%), STSA (1, 2%), and private
donation (34, 76%). The median follow-up of graduated students is
seven years. Of the 14 (31%) with current CTS interest, two are faculty,
seven are planning to apply to traditional CTS training, one is in an
integrated six-year program, and the remaining four are still in medical
school but planning a CTS career still. Twelve (27%) have entered
another surgical specialty. Academic productivity included 12 national
presentations, 11 manuscripts, and 2 national awards.
Conclusions: Approximately 1/3 of students who received institutional
or national awards for CTS experience during medical school have
maintained their interest over time. Although long-term data following
these relatively brief CTS experience programs is scarce, it remains
critical to continue these mentoring relationships over time with these
students in guiding their career choices.
NOTES:
71. Functional Tricuspid Regurgitation Repair Solved: Undersized Rigid
Annuloplasty Insertion Assures Effective and Durable Repair
Authors: Mehrdad Ghoreishi, Faisal H. Cheema, Mary Laschinger,
Murtaza Y. Dawood, Charlie Evans, Nathaniel Foster, Xiayang Diao,
Bradley S. Taylor, *Bartley P. Griffith, *James S. Gammie
Author Institution(s): University of Maryland School of Medicine,
Baltimore, MD
Discussant: *John M. Stulak, Mayo Clinic, Rochester, MN
Objectives: Previous clinical experiences have demonstrated high
early and late recurrence rates after repair of functional tricuspid
regurgitation (TR). We investigated the results of functional TR repair
using a systematic approach that emphasized the implantation of
aggressively undersized rigid annuloplasty rings.
Methods: From January 2007 to December 2013, 255 consecutive
patients with functional tricuspid regurgitation underwent
undersized rigid three-dimensional annuloplasty ring (Size 26 or 28
mm) implantation at our institution. All patients had pre-discharge
echocardiography in a core echocardiography laboratory. Follow-up
echocardiography was available for 82% (175/214) of surviving patients.
The mean time to echocardiographic follow-up was 22 months.
Results: Mean age was 65 ± 14 years and 67% were female. 51%
(129/255) had atrial fibrillation and 44% (113/255) were in New York
Heart Association (NYHA) functional class III or IV. Mean left ventricular
ejection fraction was 50±14% and the mean systolic pulmonary artery
pressure (sPAP) was 42±16 mm Hg. There was a history of cardiac
operation in 19.6% (50/255) of patients. Concomitant operations
included coronary artery bypass grafting in 22% (56/255), mitral
valve procedure in 88% (224/255), aortic valve procedure in 11%
(29/255), and CryoMaze procedure in 25% (64/255). Highest grade
of preoperative TR was moderate in 33% (85/255) and > moderate
in 67% (170/255). Perioperative mortality rate was 7.5 % (19/255). On
predischarge echocardiography, TR grade was none or mild in 96%
(245/255), moderate in 2% (6/255), and > moderate in 2% (4/255). The
mean TV gradient at discharge was 3.7 ± 2.1. During follow-up, TR grade
was none or mild in 85.1% (149/175), moderate in 9.7% (17/175), and >
moderate in 5.1 % (9/175).
No patient required TV reoperation.
Conclusions: Undersized rigid annuloplasty rings assure effective and
durable treatment of functional tricuspid regurgitation.
NOTES:
72. Super-charged Pedicled Jejunal Interposition Performance
Compares Favorably to a Gastric Conduit After Esophagectomy
Authors: Elizabeth Stephens1, Puja Gaur 3, Kathleen Hotze3, Arlene
Correa4, *Min Kim3, *Shanda Blackmon2
Author Institution(s): 1Columbia University, New York, NY; 2Mayo Clinic,
Rochester, MN; 3The Methodist Hospital, Houston, TX; 4MD Anderson
Cancer Center, Houston, TX
Objectives: A variety of conduits can be used for esophageal
reconstruction. The objective of this study was to determine the
performance of a super-charged pedicled jejunal (SPJ) interposition
conduit compared to a gastric conduit in terms of postoperative
functional outcome.
Methods: We prospectively evaluated patients who underwent
esophageal reconstruction between 1/1/2009 to 12/31/2013, collecting
demographics, operation, and clinical outcomes. Patients were asked
to rate their outcomes at multiple intervals beginning at least one
month after reconstruction using a 5-point Likert scale for the following
variables: reflux, dumping, dysphagia, stricture, and Zubrod score. A
10-point scale was used to grade postoperative pain. Esophagrams
determined a conduit emptying score. Statistical analysis was
performed using Mann-Whitney utest and Fisher’s Exact Test for
crosstabs.
Results: 45 of the 94 esophageal reconstruction patients (48%) were
alive, had either a gastric conduit or SPJ reconstruction, and consented
to perform the questionnaire. The mean age was 60.6±12.5 years and
69% were male. The majority of patients had cancer (87%). Details
regarding surgical technique and peri-operative complications for
the two groups are shown in the Table. Average time after surgery for
conduit assessment was 15±13 months for the gastric conduit group and
17±12 months for the SPJ group. There were no significant differences
in terms of reflux, dumping, dysphagia, stricture, or Zubrod score,
between the two groups, however SPJ patients had a longer length of
stay and higher pain score. Three patients (10%) in the gastric conduit
group and one patient (7%) in the SPJ group required reoperation.
Conclusions: Super-charged pedicled jejunal (SPJ) interposition
performance compares favorably to a gastric conduit after
esophagectomy. The utility of a standardized conduit assessment to
guide postoperative evaluation and intervention is established.
The number of patients is listed for each parameter followed by % of patients who
answered that particular question is given in parentheses. Mean ± standard deviation
listed where appropriate. For conduit functional status parameters, the scale is listed
in parentheses. Afib=atrial fibrillation, NS=not statistically significant, UTI=urinary
tract infection, DVT=deep vein thrombosis. Average scores included the average of
all patients in the conduit group using the worst score each patient reported during
questionnaire period.
NOTES:
73. Age-related Outcomes of the Ross Procedure over Twenty Years
Authors: Neeraj Bansal1, S. Ram Kumar1, Craig J. Baker1, Ruth Lemus2,
*Winfield J. Wells1, *Vaughn A. Starnes1
Author Institution(s): 1University of Southern California, Los Angeles,
CA; 2Children’s Hospital Los Angeles, Los Angeles, CA
Discussant: *Edward L. Bove, University of Michigan, Ann Arbor, MI
Objectives: The Ross procedure is an alternative in patients with aortic
valve disease not amenable to repair. Long-term follow-up after a
Ross procedure has demonstrated the need for autograft (LVOT) and
homograft (RVOT) re-intervention. We sought to assess the agestratified outcomes of LVOT and RVOT following Ross procedure over a
twenty-year time-period.
Methods: We performed a retrospective review of 304 consecutive
patients operated on between 1992 and 2012, aged 4 days to 70 years,
stratified by age - less than 1 (n=40), 1-10 (n=85), 10-20 (n=84), 20-40
(n=59), and over 40 yrs (n=36). Median follow-up was 8.2 years (3
mos - 19.2 yrs). Primary endpoints were survival, and freedom from reintervention in LVOT and RVOT.
Results: 173 (57%) patients had prior intervention on their aortic valve.
94 (31%) had isolated regurgitation (AI), 90 (30%) stenosis and 120
(39%) mixed lesion. There were 103 concomitant procedures (58 on
LVOT, 25 on aorta, 13 on mitral valve). Thirty-day morbidity was 15.5%,
in-Hospital mortality varied with age (Table 1). Need for emergent
surgery and concomitant mitral valve intervention (p<0.05) predicted
mortality in infants. Age was inversely related to need for LVOT reintervention (p<0.05), but directly related to RVOT re-intervention (p <
0.01, Table 1). Wrapping of autograft in a dacron tube in patients over
ten years of age improved seven-year freedom from re-intervention on
LVOT from 81% to 91% (p<0.001). At last follow-up, AI was mild or less
in 272 (94%) patients, and heart function was normal in 280 (97%).
Conclusions: The Ross Procedure is a safe, effective and coumadin-free
alternative for aortic valve replacement across all age groups. Longterm survival and preservation of heart function are more favorable
compared to published outcomes for prosthetic valves. Autograft
durability can be improved in patients over ten years of age by using a
Dacron wrap.
In-Hospital mortality, survival and freedom from re-intervention at 10
years stratified by age
NOTES:
PAST MEETINGS AND
AWARDS
PAST MEETINGS
PRESIDENTSECRETARY
1954—Hollywood Beach, FL
James D. Murphy*
Hawley H. Seiler*
1955—White Sulphur
Paul W. Sanger*
Hawley H. Seiler*
Springs, WV
1956—Miami Beach, FL
Donald L. Paulson*
Hawley H. Seiler*
1957—New Orleans, LA
Duane Carr*
Hawley H. Seiler*
1958—Miami Beach, FL
John S. Harter*
Hawley H. Seiler*
1959—Edgewater Park, MS
Edward F. Parker* Hawley H. Seiler*
1960—Nassau
Edgar W. Davis*
Hawley H. Seiler*
Bahamas, BVI
1961—Memphis, TN
DeWitt C. Daughtry* Hawley H. Seiler*
1962—Ocho Rios, Jamaica
James E. Dailey*
Hawley H. Seiler*
1963—San Antonio, TX
Lewis H. Bosher*
Hawley H. Seiler*
1964—Atlanta, GA
Robert G. Ellison*
Hawley H. Seiler*
1965—Freeport, Grand Bahama Francis H. Cole*
Hawley H. Seiler*
1966—Asheville, NC
Will C. Sealy*
Hawley H. Seiler*
1967—Dallas, TX
Edward R. Munnell*
Hawley H. Seiler*
1968—San Juan, PR
Milton V. Davis*
Hawley H. Seiler*
1969—Washington, DC
Osler A. Abbott*
James W. Brooks*
1970—Bermuda
Watts R. Webb
James W. Brooks*
1971—Tampa, FL
Hawley H. Seiler*
James W. Brooks*
1972—Port of Spain,
A. Robert Cordell*
James W. Brooks*
Trinidad and Tobago
1973—Louisville, KY
James W. Pate
James W. Brooks*
1974—Williamsburg, VA
Bertram A. Glass*
James W. Brooks*
1975—New Orleans, LA
Frederick H. Taylor*
J. Kent Trinkle*
1976—Acapulco, Mexico
James W. Brooks*
J. Kent Trinkle*
1977—Marco Island, FL
Joseph W. Peabody, Jr.*J. Kent Trinkle*
1978—Marco Island, FL Robert Carr*
J. Kent Trinkle*
Harold C. Urschel, Jr.* Richard B. McElvein
W. Glenn Young, Jr.* Richard B. McElvein
Springs, WV
1981—Palm Beach, FL
Dennis Rosenberg*
Richard B. McElvein
1982—Hilton Head Island, SC
J. Kent Trinkle*
Richard B. McElvein
Francis Robicsek
Harvey W. Bender, Jr.
1984—Hilton Head, SC
Charles R. Hatcher, Jr. Harvey W. Bender, Jr.
1985—Boca Raton, FL
George C. Kaiser
Richard B. McElvein
Springs, WV
1987—Boca Raton, FL
J. Alex Haller, Jr.
Gordon F. Murray
O. Brewster Harrington*Gordon F. Murray
1989—Scottsdale, AZ
Richard E. Clark
Gordon F. Murray
1990—Dorado, PR
Harvey W. Bender, Jr. Gordon F. Murray
1991—Orlando, FL
Robert M. Sade
Hendrick B. Barner
1992—Wesley Chapel, FL
William A. Cook
Hendrick B. Barner
1993—Panama City Beach, FL Gordon F. Murray
Hendrick B. Barner
Ronald C. Elkins
Hendrick B. Barner
Frederick L. Grover
D. Glenn Pennington
1996—Cancun, Mexico
William C. Alford
D. Glenn Pennington
1997—Naples, FL
Kit V. Arom*
D. Glenn Pennington
1998—Orlando, FL
Hendrick B. Barner
D. Glenn Pennington
1999—San Juan, PR
William A. BaumgartnerCarolyn E. Reed*
Donald C. Watson
Carolyn E. Reed*
William F. Sasser
Carolyn E. Reed*
2002—Miami, FL
Constantine Mavroudis Carolyn E. Reed*
2003—Bonita Springs, FL
Joseph I. Miller, Jr.
John H. Calhoon
2004—Cancun, Mexico
D. Glenn Pennington John H. Calhoon
2005—Orlando, FL
Irving L. Kron
John H. Calhoon
2006—Tucson, AZ
Ross Ungerleider
John H. Calhoon
2007—Bonita Springs, FL
Carolyn E. Reed* Robert J. Cerfolio
2008—Austin, TX
John W. Hammon
Robert J. Cerfolio
Michael J. Mack
Robert J. Cerfolio
2010—Orlando, FL
Keith S. Naunheim
Robert J. Cerfolio
Joseph S. Coselli
David R. Jones
2012—Naples, FL
Walter H. Merrill
David R. Jones
2013—Scottsdale, AZ
Robert J. Cerfolio
David R. Jones
2014—Tucson, AZ
Richard L. Prager
David R. Jones
* Deceased
MEETINGS AND AWARDS
AWARDS
CLIFFORD VAN METER PRESIDENT’S AWARD
Formerly known as the President’s Award, the Clifford Van Meter
President’s Award was established in 2008 to recognize the best
scientific paper delivered at the previous Annual Meeting of the
Association. In 2013, this Award was augmented to specifically
recognize the best adult cardiac surgery paper delivered at the Annual
Meeting. The award is given on the basis of originality, content, and
presentation. Previous award recipients have uniformly displayed
excellence in all areas. The selected author receives a certificate
identifying the award and a suitable monetary reward. The recipient is
chosen by the President with assistance from the Council.
CLIFFORD VAN METER PRESIDENT’S AWARD RECIPIENTS
1964—Bertram A. Glass
1965—Harold C. Urschel, Jr.
1966—Thomas J. Yeh
1967—Yale H. Zimberg
1968—J. Alex Haller, Jr.
1969—William H. Sewell
1970—George R. Daicoff
1971—Charles E. Eastridge
1972—J. Kent Trinkle
1973—Donald L. Bricker
1974—Harvey W. Bender, Jr.
1975—Charles E. Martin
1976—Gordon F. Murray
1977—Denis H. Tyras
1978—Joseph I. Miller, Jr.
1979—M. Wayne Flye
1980—Francis Robicsek
1981—Ellis L. Jones
1982—William G. Malette
1983—Robert H. Breyer
1984—Blair A. Keagy
1985—John W. Hammon, Jr.
1986—William H. Frist
1987—Jean-Nicolas Vauthey
1988—Robert A. Gustafson
1989—Harvey I. Pass
1990—Vincent L. Gott
1991—Ross M. Ungerleider
1992—William H. Frist
1993—Kirk R. Kanter
1994—Thomas L. Spray
1995—Constantine Mavroudis
1996—David A. Fullerton
1997—Christopher J. Knott-Craig
1998—James L. Zellner
1999—Thomas D’Amico
2000—Joseph C. Cleveland, Jr.
2001—Neal D. Kon
2002—Joseph S. Coselli
2003—Robert J. Cerfolio
2004—Malcolm DeCamp
2005—Seenu V. Reddy
2006—Andrew W. ElBardissi
2007—John Stulak
2008—G. Chad Hughes
2009—Scott H. Johnson
2010—Kenneth A. Kesler
2011—Robert Stewart
2012—Haritha Reddy
2013—Bartosz Rylski
New Orleans, Louisiana
Dallas, Texas
Savannah, Georgia
Richmond, Virginia
Baltimore, Maryland
Sayre, Pennsylvania
St. Petersburg, Florida
Memphis, Tennessee
San Antonio, Texas
Lubbock, Texas
Nashville, Tennessee
Chapel Hill, North Carolina
St. Louis, Missouri
Atlanta, Georgia
Galveston, Texas
Charlotte, North Carolina
Atlanta, Georgia
Omaha, Nebraska
Springfield, Massachusetts
Morgantown, West Virginia
Bethesda, Maryland
Baltimore, Maryland
Durham, North Carolina
Atlanta, Georgia
St. Louis, Missouri
Chicago, Illinois
Denver, Colorado
Oklahoma City, Oklahoma
Charleston, South Carolina
Denver, Colorado
Winston-Salem, North Carolina
Houston, Texas
Birmingham, Alabama
Boston, Massachusetts
San Antonio, Texas
Rochester, Minnesota
Lansing, Michigan
Indianapolis, Indiana
Cleveland, Ohio
Ann Arbor, Michigan
Freiburg, Germany
CAROLYN REED PRESIDENT’S AWARD
The Carolyn Reed President’s Award was established in 2013 to
recognize the best general thoracic surgery scientific paper delivered
at the STSA Annual Meeting. Named in memory of STSA Past
President, Carolyn E. Reed, MD, (STSA President, 2006-07), this award
will be given on the basis of originality, content, and presentation.
The selected author receives a certificate identifying the award and a
suitable monetary reward. The recipient is chosen by the President with
assistance from the Council.
CAROLYN REED PRESIDENT’S AWARD RECEIPIENTS
2013—R. Douglas Adams
Merrillville, Indiana
CONGENITAL HEART SURGERY PRESIDENT’S AWARD
The Congenital President’s Award was established in 2013 to recognize
the best congenital heart surgery scientific paper delivered at the STSA
Annual Meeting. This award will be given on the basis of originality,
content, and presentation. The selected author receives a certificate
identifying the award and a suitable monetary reward. The recipient is
chosen by the President with assistance from the Council.
CONGENITAL HEART SURGERY PRESIDENT’S AWARD RECEIPIENTS
2013—Vincent K.H. Tam
Fort Worth, Texas
TIKI AWARD
The quality of slides can greatly enhance or detract from a scientific
presentation. In order to emphasize the importance of well-planned and
prepared slides, the Southern Thoracic Surgical Association created the
Tiki Award.
This award is given to the person who presents a slide at the annual
meeting that is judged by a committee appointed by the President to
be the most memorable and noteworthy. This slide can be selected
because it is unintelligible, confusing, cluttered, irrelevant, or
conversely because it is superbly clear, concise, colorful, pertinent,
and/or utilizes state of the art graphics.
TIKI AWARD RECIPIENTS
1964—Watts R. Webb
1966—Richard M. Peters
1967—Myron W. Wheat
1968—Carl H. Almond
1970—William A. Neely
1971—Paul C. Adkins
1972—Panagiotis Symbas
1973—James L. Alexander
1974—Lloyd H. Hudson
1975—Richard E. Clark
1976—William S. Lyons
1977—Maruf A. Razzuk
1979—Maruf A. Razzuk
1981—Robert Sade
1982—Kit V. Arom
1983—Herbert E. Warden
1984—Noel L. Mills
1985—George C. Kaiser
1986—J. G. Selle
Baltimore, Maryland
San Diego, California
Columbia, South Carolina
Jackson, Mississippi
Washington, DC
Atlanta, Georgia
Savannah, Georgia
Flint, Michigan
St. Louis, Missouri
Alexandria, Virginia
Dallas, Texas
Dallas, Texas
Dallas, Texas
Minneapolis, Minnesota
Morgantown, West Virginia
St. Louis, Missouri
MEETINGS AND AWARDS
AWARDS
1987—Steven Gundry
1988—Harvey I. Pass
1989—Duke E. Cameron
1991—William H. Coltharp
1993—Benson R. Wilcox
1994—P. Michael McFadden
1995—Carolyn E. Reed
1996—John L. Ochsner
1997—Clifford H. Van Meter, Jr.
1998—John D. Oswalt
1999—W. Randolph Chitwood
2001—Neal D. Kon
2002—W. Steves Ring
2003—Betsey Urschel
2004—John Puskas
2005—Meredith Scott
2008—Curt Tribble
2009—Jeffrey P. Jacobs
2010—Peter K. Smith
2011—John Calhoon
2012—Vinay Badhwar
2013—Lorraine Cerfolio
Baltimore, Maryland
Bethesda, Maryland
Baltimore, Maryland
Pittsburgh, Pennsylvania
Houston, Texas
Austin, Texas
Greenville, North Carolina
Portland, Oregon
Dallas, Texas
Dallas, Texas
Atlanta, Georgia
Shell, Wyoming
Chicago, Illinois
Birmingham, Alabama
Gainesville, Florida
Houston, Texas
Pittsburgh, Pennsylvania
Birmingham, Alabama
OSLER ABBOTT AWARD
The Osler Abbott Award was first given in 1960 and has been awarded
annually to that member of the Association who excels in the art of
discussionmanship. It was named for Osler Abbott, MD of Atlanta,
Georgia, who, in 1950, somehow managed to discuss 26 papers, no
mean feat since only 25 were presented and one was his own!
In the early years, sheer volume of discussion was sufficient to earn at
least an honorable mention, but volume alone never won the award.
More important were factors such as pomposity, arrogance, irrelevancy,
and the use of outdated slides which had been shown on two or more
occasions. In recent years, the tactics have ranged from extreme
subtlety to blatant exhibitionism and from apparent indifference to
obvious covetousness.
To place this traditional award on a somewhat higher plane of
competition, the Council, in its wisdom, decided to base the decision on
Oslerian principles, and selection would come from evaluation of the
more memorable of discussions during the scientific sessions.
Thus, the reincarnated purposes of the Osler Abbott Award of the
Southern Thoracic Surgical Association are:
1. To focus on the importance of open, frank, and candid discussion
in the spirit and substance of the Southern Thoracic Surgical
Association and, in this way, to encourage more objective and active
participation by all members attending the Annual Meeting.
2. To stimulate a healthy give-and-take among the members and,
thereby, enhance the camaraderie and esprit-de-corps which
have traditionally characterized the Southern Thoracic Surgical
Association.
OSLER ABBOTT AWARD RECIPIENTS
1960—Joseph W. Peabody, Jr.
1961—Milton V. Davis
1962—E. Converse Peirce, II
1963—Lewis H. Bosher, Jr.
1964—Sam E. Stephenson, Jr.
1966—Robert E. Carr
1967—Osler A. Abbott
1968—Watts R. Webb
1969—William A. Cook
1970—Edward F. Parker
1971—Minas Joannides, Jr.
1975—Gilbert S. Campbell
1976—James W. Brooks
1978—Raymond C. Read
1980—Joseph Peabody, Jr.
1981—Robert M. Sade
1982—James S. Donahoo
1988—Ronald C. Elkins
1989—Bradley M. Rodgers
1991—Kamal A. Mansour
1992—Arthur E. Baue
1993—Kit V. Arom
1994—Frederick L. Grover
1996—George Daicoff
1998—Lynn Harrison
1999—William A. Baumgartner
2001—Carolyn E. Reed
2002—John H. Calhoon
2004—Keith S. Naunheim
2005—Irving L. Kron
2006—Thoralf M. Sundt
2008—John W. Hammon
2009—Kevin D. Accola
2010—Vinod Thourani
2011—Jeffrey P. Jacobs
2012—Duke E. Cameron
2013—Daniel L. Miller
Washington, DC
Dallas, Texas
New York, New York
Richmond, Virginia
Jacksonville, Florida
Fort Worth, Texas
Atlanta, Georgia
Andover, Massachusetts
Baltimore, Maryland
Dallas, Texas
Little Rock, Arkansas
Richmond, Virginia
San Antonio, Texas
Little Rock, Arkansas
St. Louis, Missouri
Washington, DC
Philadelphia, Pennsylvania
Kaufman, Texas
St. Louis, Missouri
Kaufman, Texas
Baltimore, Maryland
Oklahoma City, Oklahoma
Charlottesville, Virginia
Atlanta, Georgia
St. Louis, Missouri
Minneapolis, Minnesota
Denver, Colorado
Chicago, Illinois
Baltimore, Maryland
Birmingham, Alabama
San Antonio, Texas
Chicago, Illinois
St. Louis, Missouri
Dallas, Texas
Orlando, Florida
Atlanta, Georgia
Baltimore, Maryland
Marietta, Georgia
MEETINGS AND AWARDS
AWARDS
KENT TRINKLE EDUCATION LECTURESHIP
The Kent Trinkle Educational Lectureship is dedicated to J. Kent Trinkle,
(STSA President, 1981-82) for his contributions to cardiothoracic
surgery and STSA. Each year, in honor of Dr. Trinkle’s remarkable
dedication to student education, an STSA member is selected to present
on his/her training program. Presenters are selected by the STSA
President.
1993—Benson R. Wilcox
St. Louis, Missouri
San Antonio, Texas
1997—William A. Baumgartner
Baltimore, Maryland
1998—Donald C. Watson, Jr.
Memphis, Tennessee
1999—Fred A. Crawford, Jr.
2000—Robert A. Guyton
Atlanta, Georgia
2001—Joel D. Cooper
St. Louis, Missouri
Dallas, Texas
2003—Walter G. Wolfe
2004—Joseph Coselli
Houston, Texas
2005—Neal Kon
2006—Joe B. Putnam, Jr.
2007—Walter H. Merrill
Cincinnati, Ohio
2008—Curt Tribble
Gainesville, Florida
2010—Michael R. Mill
Houston, Texas
2012—Bartley P. Griffith
Baltimore, Maryland
2013—Michael Argenziano
New York, New York
2014—Mark S. Slaughter
Louisville, Kentucky
The Harold Urschel History Lectureship is dedicated to long-time STSA
member and contributor, Harold C. Urschel, Jr., MD (STSA President,
1978-79; STSA Historian, 2001-12). This lectureship was established in
memory of Dr. Urschel in 2013. The lecturer will be selected annually by
the Program Committee as the abstract author who submitted the most
exemplary history abstract.
2014—Daniel L. Miller
Houston, Texas
Marietta, Georgia
HAWLEY H. SEILER RESIDENTS COMPETITION AWARD
The Hawley H. Seiler Residents Competition Award is presented for
an outstanding paper by a cardiothoracic or general surgery resident.
It is bestowed upon the resident excelling in the following categories
regarding their abstract submission: quality of abstract as well as
manuscript and oral presentation. The award is named after STSA Past
President and founding member, Hawley H. Seiler, MD.
Dr. Seiler’s many contributions to STSA included serving as Secretary
for 15 years and presenting on numerous topics at Annual Meetings.
HAWLEY H. SEILER RESIDENTS COMPETITION AWARD WINNERS
1997—Elaine E. Tseng
1998—Stephen Langley
1999—Aron Goldberg
2000—Cullen D. Morris
2001—Sitaram M. Emani
2002—Thomas H. Maxey
2003—Brian T. Bethea
2004—Tara Karamlou
2005—Edward John Hickey
2006—Thomas K. Varghese
2007—Tara Karamlou
2008—David T. Cooke
2009—Jeremiah Geoff Allen
2010—Castigliano M. Bhamidipati
2011—Sameh Said
2012—Timothy George
2013—Rachel L. Medbery
Baltimore, Maryland
Atlanta, Georgia
Baltimore, Maryland
Portland, Oregon
London, England
Seattle, Washington
Portland, Oregon
Sacramento, California
Baltimore, Maryland
Baltimore, Maryland
Atlanta, Georgia
MAVROUDIS-URSCHEL AWARD
The Mavroudis-Urschel Award was established in 2006 to recognize
and honor an STSA member who has not only made important
contributions to the STSA scientific program, but who has also uniquely
personified the social spirit, camaraderie, and fun for which STSA is
famous. The award is named for STSA Past Presidents Constantine
Mavroudis and Harold Urschel, who both contributed significantly not
only to the scientific value of the STSA Annual Meeting but also, and
just as importantly, to the organization’s high spirits (and high-jinx).
There is more to an organization than its bylaws, and there is more to
its Annual Meeting than the slides and presentations. To many, STSA
meetings are as much about social interactions as they are about new
research findings in cardiothoracic surgery. Meeting highlights also
happen at social events, such as the president’s mixer, receptions,
sports events, and during the exhibit hall breaks. The Award goes to a
member who has enhanced both aspects of the organization, scientific
and social, and done so with a distinctive, even flamboyant, personal
style – in the manner of its namesakes.
The Mavroudis-Urschel Award is made at the discretion of the President
with input and recommendation from the double-secret Tiki and OslerAbbot committee chairs. When given, the award is announced at the
Annual Awards Dinner & Dance.
MAVROUDIS-URSCHEL AWARD RECIPIENTS
2007—Kit V. Arom
2010—Keith S. Naunheim
2013—Kevin D. Accola
Bangkok, Thailand
San Antonio, Texas
St. Louis, Missouri
Dallas, Texas
Orlando, Florida
AWARDS
STSA INSPIRATION AWARD
The STSA Inspiration Award was established in 2007 to recognize
the important contribution of mentorship to the specialty and the
organization, and to encourage upcoming generations of CT surgeons
by helping to cultivate mentors worthy of emulation.
The future of cardiothoracic surgery is in the hands and hearts of its
medical students and residents. Inspiring a resident or medical student
to become a CT surgeon – to become a great CT surgeon – is among
the most far-reaching and important contributions one can make to the
specialty and ultimately to the Southern Thoracic Surgical Association.
The residency program directors and faculty at teaching programs
affiliated with the STSA are developing and inspiring future
cardiothoracic surgeons every day – teaching them to become
leaders in their future institutions, practices, and communities. And
mentorship is not limited to program directors and faculty. Surgeons in
private practice hire young graduates and become influential mentors
providing career guidance and support often for years to come.
To acknowledge the crucial importance of mentorship in developing CT
surgeons and to recognize and positively reinforce STSA members who
have excelled in their mentorship roles, STSA established its Inspiration
Award in 2007. The Inspiration Award is given to the STSA member
who has demonstrated exceptional efforts in motivating, inspiring,
and cultivating the clinical and research talents of medical students,
residents and/or early career CT surgeons.
Nominations must be submitted in writing by September 1 to the
sitting STSA President to be considered for possible presentation
at the subsequent STSA Annual Meeting. Recommendation letters
should outline the specific merits of the nominee and his or her positive
influences for the ‘mentee(s).’ Recipient must be a member of STSA in
good standing. The award is given at the discretion of the President in
consultation with the Council.
STSA INSPIRATION AWARD RECIPIENTS
2007— R
obert J. Cerfolio
Hooshang Bolooki
2010— K
amal A. Mansour
Francis Robicsek
Frederick L. Grover
Ara A. Vaporciyan
2013—James Robert Headrick
Birmingham, Alabama
Miami, Florida
Atlanta, Georgia
Aurora, Colorado
Houston, Texas
Chattanooga, Tennessee
JAMES W. BROOKS MEDICAL STUDENT SCHOLARSHIP
The STSA James W. Brooks Medical Student Scholarship was
established in 2010 to pay tribute to Jim Brooks, MD, past President
of STSA and a great mentor to countless residents and students. The
Brooks Scholarship seeks to identify 2nd, 3rd, and 4th year medical
students in the STSA region who are interested in cardiothoracic
surgery. The recipient, selected annually by a committee of STSA
leaders, receives funding to attend the STSA Annual Meeting and the
unique opportunity to benefit from the guidance of STSA members,
thus extending Dr. Brooks’ legacy as a great mentor. It has become
increasingly important to begin mentoring future CT surgeons at the
medical student level. In establishing the Brooks Scholarship and
providing first-rate mentorship, STSA hopes to annually inspire a
promising medical student to become a great CT surgeon, thus making
a far-reaching and important contribution to the future of the specialty
and ultimately to the STSA.
2010—Elizabeth A. Spradlin
2011—Carlo Bartoli
2012—Vernissia Tam
2013—Sahar Saddoughi
2014—Mickey Ising
Xiaoying Lou
Richmond, Virginia
Baltimore, Maryland
Chicago, Illinois
STSA RESIDENT SCHOLARHIP
The STSA Resident Scholarship was established in 2014 and seeks
to identify a general surgery or thoracic surgery resident who is
committed to CT surgery. Each year a scholarship recipient will be
invited to attend the STSA Annual Meeting where they will be mentored
by an STSA surgeon leader.
2014—Zachary Kon, MD
Baltimore, Maryland
GENERAL INFORMATION
EXHIBITORS*
*CONFIRMED AS
13,24,
2012
*CONFIRMED
ASOF
OFSEPTEMBER
SEPTEMBER
2014
EXHIBIT HOURS AND FLOOR PLAN
EXHIBIT HOURS
THURSDAY, NOVEMBER 6
Exhibits Open
12:00 pm – 4:00 pm
FRIDAY, NOVEMBER 7
Exhibits Open
6:45 am – 11:30 am
1:00 pm – 4:00 pm
• Exhibit Hall is located in the in Tucson Ballroom A–E
• All coffee breaks scheduled during exhibit hours are in the exhibit
area
• Complimentary coffee and pastries will be served
ENTRANCE
EXHIBITORS
EXHIBITORS
Acute Innovations
Booth: 204
21421 NW Jacobson Rd – Suite 700
Hillsboro, OR 97124
ACUTE Innovations® provides innovative solutions for challenging
thoracic procedures. Come learn about our new launch products:
AcuTie® II sternum closure system and the RibLoc® U Plus chest wall
plating system.
Admedus Corp.
Booth 405
8400 Normandale Lake Blvd, Ste 920
Minneapolis, MN 55437
Admedus, a global healthcare group, is working with renowned medical
leaders to bring new medical technologies to market. CardioCel™, a
cardiovascular scaffold, is the first of our ADAPT™ tissue engineered
bio-implants and is being used by surgeons to repair simple and
complex cardiac defects.
ATMOS, Inc.
Booth: 208
3717 Huckleberry Rd
Allentown, PA 18104
Atmos offers the S201 Digital Chest Drainage System. Our advanced
system allows for patient mobility while maintaining suction, quantifies
the flow in L/min, records the patient’s therapy up to 12 days, requires
less nursing intervention and ultimately a reduction in length of stay for
the patient.
AtriCure, Inc.
Booth: 112
6217 Centre Park Drive
West Chester, OH 45069
AtriCure is intent on reducing the Afib epidemic. We’re a leading Afib
solutions partner with the only FDA–approved surgical treatment for Afib
and significant investment in science, education and innovation.
CryoLife
Booth: 401
1655 Roberts Blvd
Kennesaw, GA 30144
CryoLife ® is a leader in the advancement of allograft processing and
cryopreservation technologies. CryoLife also offers solutions for patients
with Refractory Angina utilizing Transmyocardial Revascularization or
TMR with the Cardiogenesis Holmium:YAG system.
Davol, Inc., a BARD Company
Booth: 403
100 Crossings Blvd
Warwick, RI 02886
BARD is the market leader in comprehensive soft tissue reconstruction.
In addition to this extensive suite of products, our BioSurgery
franchise is delivering a growing line of enhanced sealants and
hemostatic products to complement surgical techniques across
thoracic, cardiovascular, and other surgical specialties. This franchise
is committed to serving our surgeons and clinicians by leveraging
unique & proprietary materials science and continuing BARD’s focus on
improving clinical outcomes.
Domain Surgical
Booth: 210
1370 S. 2100 E.
Salt Lake City, UT 84018
The FMwand is an intelligent surgical platform that uses pure thermal
energy to cut and coagulate soft tissue; without passing electrical
current through the patient.
Edwards Lifesciences
Booth: 104
1 Edwards Way
Irvine, CA 92614
Edwards Lifesciences is the global leader in the science of heart valves
and hemodynamic monitoring. Driven by a passion to help patients, the
company partners with clinicians to develop innovative technologies.
Additional company information can be found at www.edwards.com.
Genesee BioMedical, Inc.
Booth: 207
700 W Mississippi Ave Unit D5
Denver, CO 80223
Genesee BioMedical, Inc. provides unique devices for cardiothoracic
surgery including sternal/thoracic valve retractors for adult, adult
congenital/pediatric surgery and aortic valve repair. Denver, CO USA
www.geneseebiomedical.com
HeartWare, Inc.
Booth: 305
500 Old Connecticut Path
Framingham, MA 01701
HeartWare, Inc. designs and develops miniaturized mechanical
circulatory support systems for the treatment of advanced heart failure.
The HeartWare® Ventricular Assist System is commercially available in
Europe and is the subject of a US IDE trial.
Intuitive Surgical
Booth: 209–211
1020 Kifer Road
Sunnyvale, CA 94086
Intuitive Surgical, Inc. designs, manufactures and distributes the da
Vinci® Surgical System – technology designed to allow surgeons to
perform many complex procedures minimally invasively.
KLS–Martin
Booth: 212
PO Box 16369
Jacksonville, FL 32245
KLS–Martin, a responsive company, is focused on the development of
innovative products for oral, plastic and craniomaxillofacial surgery.
New product developments in our titanium osteosynthesis plating
systems allow these products to be used for rapid sternal fixation and
reconstruction.
LifeNet Health
Booth: 407
1864 Concert Drive
Virginia Beach, VA 23453
LifeNet Health helps save lives and restore health for thousands
of patients each year. We are the world’s most trusted provider of
transplant solutions, from organ procurement to new innovations in
bio–implant technologies and cellular therapies—a leader in the field of
regenerative medicine, while always honoring the donors and healthcare
professionals that allow the healing process.
EXHIBITORS
EXHIBITORS
Medistim
Booth: 101
14000 25th Ave N – Ste 108
Plymouth, MN 55447
Medistim offers technologies proven to reduce post–CABG MACCE. The
VeriQ C™ combines transit time flow and a 15 MHz ultrasound probe,
specifically designed for epiaortic and epicardial imaging.
Medtronic, Inc.
Booth: L01
710 Medtronic Pkwy
Minneapolis, MN 55432
At Medtronic, we’re committed to Innovating for Life. Find Opportunity in
Change and consider Medtronic’s intuitive solutions for the treatment of
structural heart disease including: tissue, mechanical and transcatheter
valves; irrigated RF and cryo surgical ablation devices; and OPCAB, MICS
CABG, cannulae and perfusion products.
Myriad Genetics
Booth: 409
320 Wakara Way
Salt Lake City, UT 84018
Myriad Genetics is a leading molecular diagnostic company dedicated
to making a difference in patient’s lives through the discovery and
commercialization of transformative tests to assess a person’s risk of
developing disease.
On–X Life Technologies
Booth: 106
1300 E Anderson Lane, Bldg. B
Austin, TX 78752
On–X® Heart Valves: Patented natural design and On–X® Carbon
offer reduced turbulence in a mechanical valve to rival the clinical
and hemodynamic performance of bioprostheses. FDA IDE approved
PROACT (Prospective Randomized On–X® Anticoagulation Clinical Trial)
is in process. Chord– X PTFE suture is available for mitral valve repair.
rEVO Biological
Booth: 303
175 Crossing Blvd
Framingham, MA 01702
rEVO Biologics is a commercial-stage biopharmaceutical company
focused on developing and commercializing of therapeutics for unmet
medical needs. rEVO’s lead product, ATryn, is the first and only
plasma-free antithrombin concentrate.
Scanlan International, Inc.
Booth: 109
One Scanlan Plaza
St. Paul, MN 55107
Highest quality surgical products designed and manufactured by the
Scanlan family since 1921. Over 3,000 stainless steel and titanium
precision instrumentation designs. New VATS/MICS instruments,
single–use and instrument care products.
Sorin Group
Booth: 109
14401 W 65th Way
Arvada, CO 80004
Sorin Group is a world leader in the treatment of cardiovascular
diseases. Our innovative product portfolio includes aortic and mitral
valve replacement and repair, perfusion equipment, cannulae and MICS
instruments. For more information visit our web site at www.sorin.com.
Spiration
Booth: 307
6675 185 Avenue N.E.
Redmond, WA 98052
The Spiration® Valve System has a humanitarian device approval in the
U.S. to control specific postoperative air leaks of the lung and has CE
mark approval for the treatment of diseased lung in emphysematous
patients and for damaged lung resulting in air leaks by limiting air flow
to selected areas.
St. Jude Medical, Inc. Booth: L02
6300 Bee Cave Rd, Bldg 2 – Ste 100
Austin, TX 78746
St. Jude Medical is dedicated to transforming the treatment of some
of the world’s most expensive, epidemic diseases by creating cost–
effective medical technologies that save and improve lives of patients
around the world.
SynCardia Systems, Inc.
Booth: 110
1992 E Silverlake Rd
Tucson, AZ 85713
The SynCardia temporary Total Artificial Heart is the only FDA, Health
Canada and CE approved TAH–t. It is approved as a bridge to transplant
for patients dying from end–stage biventricular failure.
Terumo Cardiovascular Systems
Booth: 205
6200 Jackson Rd
Ann Arbor, MI 48103
Whether surgical or interventional, disposable, or implantable,
common–place or custom, Terumo products are used daily in a wide
range of cardiac and vascular procedures. Terumo Cardiovascular Group
develops, manufactures and distributes products for surgical teams,
including cardiopulmonary bypass and intraoperative monitoring,
endoscopic vein harvesting, and vascular grafts.
Thoratec
Booth: 203
6035 Stoneridge Dr
Pleasanton, CA 94588
Thoratec is the world leader in mechanical circulatory support with the
broadest product portfolio to treat the full range of clinical needs for
patients suffering from advanced heart failure.
Vitalcor, Inc.
Booth: 108
100 E. Chestnut Ave
Westmont, IL 60559
Gemini Plus headlight & Camera with LED light source. Latex Free
Coronary Artery Balloon Canulae with self-inflating Balloon. Axiom
Wound Drains. Reusable Bulldog Clamp. Titanium and stainless steel
specialty instruments and retractors.
Wexler Surgical Booth: 105
11333 Chimney Rock Rd – #110
Houston, TX 77035
Wexler Surgical designs and manufactures titanium and stainless steel
specialty surgical instruments and products for Cardiovascular, Thoracic,
and Micro Surgery. Visit us at www.wexlersurgical.com.
GENERAL INFORMATION
MEMBERSHIP
ROSTER*
If you have updates or corrections to your contact
information, please e-mail [email protected].
* MEMBERSHIP INFORMATION AS OF AUGUST 18, 2014
NECROLOGY REPORT
Dr. Page W. Acree
Baton Rouge, Louisiana
Dr. Theodore L. Batchelder
Jacksonville, Florida
Dr. Arthur E. Baue
Fishers Island, New York
Dr. Martin Bergmann
St. Louis, Missouri
Dr. Richard L. Cassady
Lake Junakuska, North Carolina
Dr. William L. Cox
Houston, Texas
Dr. James E. Davis
North Liberty, Iowa
Dr. Oscar Brewster Harrington (STSA Past President, 1988)
Memphis, Tennessee
Dr. Philip J. Hess, Jr.
Dr. Gerard A. Kaiser
Miami, Florida
Dr. James D. Moody
Orlando, Florida
Dr. John W. Overstreet
Houston, Texas
Dr. Herbert T. Ransdell
Dr. William K. Rogers
Knoxville, Tennessee
Dr. Donald N. Ross
London, England
Dr. Harold C. Spear
Miami Beach, Florida
Dr. William Z. Yahr
Tallahassee, Florida
MEMBERSHIP ROSTER – A
HONORARY MEMBERS
BOVE, Edward L. (Linda)
University of Michigan, F7830 Mott Hospital, Ann Arbor, MI 48109
Phone: (734) 936-4980 Fax: (734) 763-7353
E-mail: [email protected]
COOLEY, Denton (Louise Goldborough Thomas)
PO Box 20345, 1101 Bates Avenue, Houston, TX 77225
Phone: (832) 355-4932
DAVID, Tirone E. (Jacqueline)
Toronto General Hospital,
200 Elizabeth St – 4N457, Toronto, ON M5G 2C4 Canada
Phone: (416) 340-5062 Fax: (416)-340-4020
EDMUNDS, L. Henry, Jr. (Martha Mel)
The Annals Thoracic Surgery,
3440 Market Street, Suite 306, Philadelphia, PA 19104
Phone: (215) 662-2092 Fax: (215) 614-0416
HAVERICH, Axel E.
Hannover Medical School, Carl-Neuberg
Str. 1, Hannover, D30625, Germany
Phone: 0049-511-532-6580 Fax: 0049-511-532-5404
MOHR, Friedrich Wilhelm (Anita)
Klinik fur Herzchirurgie, Strumpellstrasse 39, Leipzig 04289, Germany
Phone: 49 341 865-1421
NAEF, Andreas P.
12 Avenue Villardin, Pully-Lausanne, CH1009, Switzerland
Phone: 41 21 729 52 08 Fax: 41 212 38596
TURINA, Marko I.
Clinic for Cardiovascular Surgery University Hospital
Ramistrasse 100, Zurich, 8091, Switzerland
Phone: 12553298 Fax: 12554446
URSCHEL, Betsey Bradley, MED
4930 Manson Court, Dallas, TX 75229
Phone: (214) 363-6952 Fax: (214) 824-2503
MEMBERSHIP ROSTER
‡ABARBANELL, Aaron
*1858 Westminster Way NE, Atlanta, GA 30307
Phone: (317) 408-6008
Email: [email protected]
**ABELSON, Donald S. (Imogene)
2085 Canyon Lakes Drive, San Ramon, CA 94583
**ABRAHAM, Ralph E. (Mary)
415 South 28th Avenue, Hattiesburg, MS 39401
Phone: (601) 268-5660 Fax: (601) 268-5759
ABRISHAMCHIAN, Ahmad Reza (Farnaz)
400 Holiday Drive, Suite 101, Pittsburgh, PA 15220
Phone: (412) 444-0098
ACCOLA, Kevin D. (Carolyn)
217 Hillcrest Street, Orlando, FL 32801
Phone: (407) 425-1566 Fax: (407) 422-0166
AHMAD, Umraan Saeed (Homaa)
*6033 Camp St, New Orleans, LA 70118
Phone: (504) 842-3966 Fax: (504) 842-2278
AILAWADI, Gorav (Aarti)
TCV Surgery, P.O. Box 800679, Charlottesville, VA 22908
Phone: (434) 924-5052 Fax: (434) 982-3885
AKHTER, Shahab A. (Pamela)
H4/340 Clinical Science Center, 600 Highland Avenue, Madison, WI 53792
Phone: (608) 263-6551 Fax: (608) 263-0547
**ALEGRE, Cesar A.
7707 North University Drive, Suite 204, Fort Lauderdale, FL 33321
Phone: (954) 721-3399 Fax: (954) 721-8289
**ALESSI, Francis J. M. (Pamela Jeanne)
760 Marlene Dr., Gretna, LA 70056
Phone: (504) 340-5226 Fax: (504) 340-5227
ALEXANDER, Pendleton
6 Weems Creek Dr., Annapolis, MD 21401
Phone: (202) 745-8626
**ALEXANDER, James A. (Ann)
*6200 Southwest 36th Way, Gainesville, FL 32601
Phone: (352) 846-0341 Fax: (352) 846-0356
**ALEXANDER, John C. (Carol)
*5 Wicker Sham Court W, Pinehurst, NC 28374
Phone: (201) 953-1452
**Senior Member +New Member ‡Resident Member *Home Address
MEMBERSHIP ROSTER – A
MEMBERSHIP ROSTER
ALEXANDER, George L. (Nancy)
17200 Due West Drive, Charlotte, NC 28278
Phone: (704) 582-1401 Fax: (915) 331-9959
**ALFORD, William C.
*402 Ellendale Ave., Nashville, TN 37205
Phone: (615) 385-1395 Fax: (615) 385-1396
ALLEN, William B. (Melinda)
2750 Laurel Street, Suite 305, Columbia, SC 29204
Phone: (803) 254-5140 Fax: (803) 779-1279
ALLEN, Gary S. (Yvette)
3120 Waterman Way, Tavares, FL 32778
Phone: (352) 343-1216 Fax: (352) 343-1582
**ALLUMS James A. (Dee)
*2012 County Road 260, Nacogdoches, TX 75965
**ALMOND, Carl H.
Richland Medical Park, Two Medical Park, Suite 300, Columbia, SC 29203
Phone: (803) 256-2657 Fax: (803) 434-7349
‡ALNAJJAR, Raed M. (Hanady)
*158 Cedar Hills Dr., Pikeville, KY 41501
Phone: (248) 686-4238 Fax: (606) 218-4540
ALZEERAH, Masoud A. (Jennifer)
1301 S. Coulter Drive,#103, Amarillo, TX 79106
Phone: (806) 463-1712
AMEIKA, James A. (Karin)
4802 E. Johnson Avenue, Jonesboro, AK 72401
Phone: (870) 972-8030 Fax: (870) 972-0826
**ANDERSON, Carl E. (Maryanne)
*16 Woodland Way, Greenville, SC 29601
Phone: (864) 232-6200 Fax: (864) 232-7793
**ANDERSON, N. James, Sr. (Jane)
1722 Pine Street, Suite 703, Montgomery, AL 36106
Phone: (334) 832-4161 Fax: (334) 832-4162
ANDERSON, Robert J. (Nancy Ann)
600 University Blvd., Suite 101, Jupiter, FL 33458
Phone: (561) 626-9801 Fax: (561) 626-9804
ANDERSON, Richard C.
1001 Main Street, 3rd Floor Peoria, IL 61606
Phone: (309) 495-0200 Fax: (309) 676-6545
**ANDERSON, Robert L.
14 Woodward Blvd., Tulsa, OK 74114
Phone: (918) 584-7322
ANDREWS, David Scott (Julia)
301 Hawthorne Lane, Charlotte, NC 28204
Phone: (704) 316-5100
**ANGEL, Robert T. (Sue)
*7301 Westover Road, Waco, TX 76710
Phone: (254) 772-2300 Fax: (254) 772-5514
ANSTADT, Mark Peter
30 E. Apple Street, Suite 6252, Dayton, OH 45409
Phone: (937) 208-6060 Fax: (937) 208-6061
ANSWINI, Geoffrey A. (Vanessa)
2123 Auburn Avenue, Suite 238, Cincinnati, OH 45140
Phone: (513) 651-1180 Fax: (513) 651-2175
APPLEBY, Douglas C. (Gayle)
1720 Nicholasville Rd, Suite 502, Lexington, KY 40503
Phone: (859) 277-7129 Fax: (859) 277-9613
**ARAGON, Guillermo E. (Maria)
2 Polo Club Drive, Denver, CO 80209
Phone: (303) 778-6032 Fax: (303) 765-0776
ARCIDI, M. Joseph, Jr. (Janette)
13286 Haddon St., Fenton, MI 48430
Phone: (810) 208-0060 Fax: (810) 232-2591
ARMITAGE, John M. (Lee Ann)
*4325 Spring Blvd, Eugene, OR 97405
Phone: (540) 847-0992 Fax: (541) 744-6102
**ARNOLD, Homer S. (Helen)
1010 West 40th, Austin, TX 78756
Phone: (512) 459-8753 Fax: (512) 483-6807
ARNOLD, Scott W.
2001 Crystal Spring Avenue, SW, Suite 201, Roanoke, VA 24014
Phone: (540) 344-5781 Fax: (540) 342-9308
**ARRANTS, Jack E. (Lillian)
311 John Anderson Dr., Ormond Beach, FL 32176
Phone: (386) 673-9327
ARU, Giorgio M. (Jan)
2500 North State Street, Jackson, MS 39216
Phone: (601) 984-5170 Fax: (601) 984-5198
MEMBERSHIP ROSTER
ASCIOTI, Anthony J. (Tara)
8433 Harcourt Rd, Suite 100, Indianapolis, IN 46260
Phone: (317) 566-1104 Fax: (317) 583-7628
**ASHE, William M.
618 N. Magnolia Street, Rockport, TX 78382
MEMBERSHIP ROSTER – B
ATKINS, Broadus Zane (Kimberly)
*540 Rodante Way, Sacramento, CA 95684
Phone: (707) 423-2300 Fax: (707) 423-7496
**ATTAR, Safuh (Vera)
22 South Green Street, Baltimore, MD 21201
Phone: (410) 321-1281 Fax: (410) 828-4746
**AUSTIN, John C. (Michelle)
2010 Church Street, Suite 736, Nashville, TN 37203
Phone: (615) 329-7878 Fax: (615) 284-3460
AUSTIN,Erle H., III
201 Abraham Flexner Way, Suite 1200, Louisville, KY 40202
Phone: (502) 583-8383 Fax: (502) 561-2190
**AVERY, Joel E. (Nannette)
*15 Hidden Brook Lane, Signal Mountain, TN 37377
Phone: (423) 624-0862 Fax: (615) 624-5520
**AVES, Fred H. (Alice)
*6143 Willers Way, Decatur, GA 30030
**AYLWARD, Theodore D. (Kathleen)
*4900 Marlin Drive, New Port Richey, FL 34652
Phone:Fax: (727) 842-9605
BACKER, Carl L. (Julia)
1106 Sunset Road, Winnetka, IL 60093
Phone: (312) 227-4240 Fax: (312) 227-9643
BADHWAR, Vinay
UPMC Presbyterian, 200 Lothrup Street, C-711, Pittsburgh, PA 15213
Phone: (412) 648-6314 Fax: (412) 648-6358
BAIRD, Christopher W.
*416 Common Wealth Ave, Unit 711, Boston, MA 02115
Phone: (617) 355-2765
**BAISDEN, Clinton E. (Rena)
*11 Arnold Palmer, San Antonio, TX 78257
Phone: (210) 268-7522 Fax: (210) 567-2877
BAKAEEN, Faisal G. (Lori)
*2403 N. Mystic MDW, Houston, TX 77021
Phone: (713) 794-7892 Fax: (713) 794-7352
BAKER, Joseph W. (Tracy)
Phone: (540) 345-4132 Fax: (540) 342-9308
**BALLENGER, James F. (Sandra)
206 Discovery Way, Mauldin, SC 29662
Phone: (864) 242-9915 Fax: (864) 233-3732
BANKER, Michael C. (Gretchen)
11411 Chivarly Chase Lane, Spotsylvania, VA 22551
Phone: (540) 972-5802
BAPTISTE, Reginald C. (Hope)
6500 N. Mopac #2207, Austin, TX 78731
Phone: (512) 494-9985 Fax: (512) 494-9986
**BARNER, Hendrick B. (Mechthild)
Cardiothoracic Surgery, 3635 Vista Avenue, St. Louis, MO 63110
Phone: (314) 577-8359 Fax: (314) 577-8315
**BARNES, Robert P. (Jean)
333 North First, Suite 280, Boise, ID 83702
Phone: (208) 345-6545 Fax: (208) 345-1213
BARNETT, Mark G. (Robin)
202 10th Street SE, Cedar Rapids, IA 2403
Phone: (319) 362-5118 Fax: (319) 364-0574
BARTON, Ben R. (Mary)
1802 Braeburn Drive, Suite 1310, Salem, VA 24153
Phone: (540) 776-2020 Fax: (540) 776-2017
BATES, Michael John (Amanda)
Department of Surgery, 1514 Jefferson Hwy, New Orleans, LA 70121
Phone: (504) 842-4070
BAUMGARTNER, William A. (Betsy)
Miller Research Building, Suite115,
733 N. Broadway, Baltimore, MD 21205
Phone: (410) 955-2411 Fax: (410) 502-5228
BAXTER, Tammy M.
2410 Patterson Street, Suite 212, Nashville, TN 37203
Phone: (615) 342-7345 Fax: (615) 342-7346
MEMBERSHIP ROSTER
**BEASLEY, Walter E., III
*944 Timberlake Drive, Virginia Beach, VA 23464
Phone: (740) 383-7950
BEAVER, Thomas M.
PO Box 100129, Gainesville, FL 32610
Phone: (352) 273-5501 Fax: (352) 273-5513
**BEGELMAN, Kenneth M. (Helen)
PO Box 764, Jackson, WY 83001
Phone: (561) 499-7707
BENDER, Edward Michael (Penny)
11 Dumaine St., Cape Girardeau, MO 63701
Phone: (573) 331-3155 Fax: (573) 331-5096
**BENDER, W. Harvey, Jr. (Doris)
1801 Laurel Ridge Drive, Nashville, TN 37215
Phone: (615) 322-0064 Fax: (615) 343-9194
**BERGEN, Frederick D. (Margaret Ann)
11701 Johnson Road, Petersburg, VA 23803
Phone: (804) 732-1011 Fax: (804) 861-2128
**BERGMAN, Donald R. (Carole)
PO Box 35185, Tulsa, OK 74153
Phone: (918) 494-3827
**BERRY, Eugene B. (Jolie)
7777 Hennessy Boulevard, Suite 1008, Baton Rouge, LA 70808
Phone: (225) 766-0416 Fax: (225) 769-9212
BERRY, Mark F. (Yuet)
DUMC 3652, Duke South White Zone, Room 3589, Durham, NC 27710
Phone: (919) 668-5061 Fax: (919) 684-8508
**BESSONE, Luis N. (Viviana)
5137 San Jose, Tampa, FL 33629
Phone: (813) 875-8988 Fax: (813) 876-9827
+BETHEA, Brian T. (Amber)
5909 Harry Hines Blvd., Dallas, TX 75390
BHAMA, Jay Kumar
Suite C-900, 200 Lothrop Street, Pittsburgh, PA 15213
Phone: (412) 692-2779 Fax: (412) 692-2948
BHATIA, Devinder S. (Gina)
8901 FM 1960 Bypass Rd, Suite 303, Humble, TX 77338
Phone: (281) 397-7000 Fax: (281) 397-7061
BICHELL, David P. (Terry Jo)
5247 Doctor’s Office Tower, 2200 Children’s Way Nashville, TN 37232
Phone: (615) 936-5500
**BILBREY, George M. (Diana)
257 McDowell Street, Asheville, NC 28803
Phone: (704) 258-1121 Fax: (704) 252-6114
BINFORD, Robert S. (Julia)
1135 116th Ave NE, Suite 605, Bellevue, WA 98004
Phone: (425) 698-1805 Fax: (615) 376-9116
BLACKMON, Shanda H. (Matt)
*2498 Hawk Hill Lane SW, Rochester, MN 55902
Phone: (713) 494-9871
BLACKWELL, Ray A. (Wanda)
4755 Ogletown-Stanton Rd, Suite 1E50, Newark, DE 19718
Phone: (302) 733-1980 Fax: (302) 733-1986
**BLAND, Ralph W.
Burlington, NC
BLANKENSHIP, Robert C. (Mary Anne)
1919 S. Wheeling Avenue, Suite 602, Tulsa, OK 74104
Phone: (918) 749-6400 Fax: (918) 748-7505
BLEIWEIS, Mark S. (Jennifer)
UF Health Congenital Heart Center, 1600 SW Archer Road, P.O. Box
100297, Gainesville, FL 32610
Phone: (352) 273-5422 Fax: (352) 273-5927
BLOCK, Mark I. (Debora)
1150 N 35th Ave, Ste 660, Hollywood, FL 33021
Phone: (954) 265-1125
**BLOODWELL, Robert D.
1907 South Dr, #105, Natchitoches, LA 71457
Phone: (318) 476-4020 Fax: (318) 476-4022
BLUCHER, Mark L. (Jodi)
625 S. New Ballas Road, Suite R7040, St. Louis, MO 63141
Phone: (314) 569-6970 Fax: (314) 251-1053
BODENHAMER, Mark R. (Judy)
4050 W. Memorial Rd., Oklahoma City, OK 73120
Phone: (405) 285-5211
BOEDEFELD, William Michael, II (Robyn)
7777 Hennessy Blvd, Suite 1008, Baton Rouge, LA 70808
Phone: (225) 324-2175
MEMBERSHIP ROSTER
BOLAN, Peter James (Kristy)
688 Walnut Street, Suite 200, Macon, GA 31201
Phone: (478) 742-7566 Fax: (478) 746-9944
‡BOLANOS, Michael D.
740 S. Limestone Street, Room A301, Lexington, KY 40536
BOLLING, Steven F. (Cheryl)
1500 E. Medical Center Drive, SPC 5864,
Cardiovascular Center 5144, Ann Arbor, MI 48109
Phone: (734) 936-4981 Fax: (734) 764-2255
BOLMAN, Morton R., III (Ceeya)
75 Francis St., Boston, MA 02115
Phone: (617) 732-6964 Fax: (617) 264-6319
BOLTON, William (Jennifer)
701 Grove Rd, Greenville, SC 29605
Phone: (864) 884-1384 Fax: (864) 455-1485
BOLTON, Randolph J.W. (Valerie)
2865 Siena Heights, Ste 131, Henderson, NV 89052
Phone: (702) 616-6580 Fax: (702) 616-6584
BORCHELT, Bret D. (Ann)
4622 Country Club Rd, Suite 180, Winston-Salem, NC 27104
Phone: (336) 768-9535 Fax: (336) 768-4155
BORDERS, Blaine M. (Carla)
102 Thomas Rd, Ste 205, West Monroe, LA 71291
Phone: (318) 329-1900 Fax: (318) 396-6163
BORKON, Michael A. (Margaret)
Medical Plaza II - Suite 50, 4320 Wornall Road, Kansas City, MO 64111
Phone: (816) 931-3312 Fax: (816) 531-9862
BORSODY, Karl J. (Jaleh)
3533 Southern Blvd, Suite 5650, Kettering, OH 45429
Phone: (937) 789-8280 Fax: (937) 294-3611
BOSTON, Umar Sekou-Toure
St. Louis Children’s Hospital One Children’s Place, Suite 5S, St. Louis, MO
63110
Phone: (314) 454-6156 Fax: (314) 454-2381
BOTT, Jeffrey N. (Kelly)
1222 South Orange Ave, MP #25, 4th Floor Orlando, FL 32806
Phone: (321) 841-7700 Fax: (321) 841-7799
**BOWLIN, John W. (Linda)
2661 Columbine Place, Tupelo, MS 38801
Phone: (662) 842-8193
BOWLING, Roy G. (Ann)
Phone: (502) 425-3205 Fax: (502) 589-6751
BOYCE, Steven W. (Amy)
106 Irving St NW, Suite 2200 North, Washington, DC 20010
Phone: (202) 877-7464 Fax: (202) 877-3503
BRADFORD, Darien W.
515 West Mayfield, Suite 404, Arlington, TX 76014
Phone: (817) 465-5311 Fax: (817) 465-8569
BRADLEY, Scott M. (Robyn)
96 Jonathan Lucas Street, 424 CSB, Charleston, SC 29425
Phone: (843) 792-3361 Fax: (843) 792-9783
BRAUNSTEIN, Paul W. (Linda)
1417 Battlefield Blvd N 180, Chesapeake, VA 23320
Phone: (757) 491-6467 Fax: (757) 428-1630
**BREA, A. Cesar, Jr. (Greggie)
*6460 SW 94th Street, Miami, FL 33156
Phone: (305) 665-6993 Fax: (305) 665-6994
BREITKREUTZ, Lawrence R.
4228 Houma Blvd., Suite 300, Metairie, LA 70005
BROCK, Malcolm V. (Ronae)
600 North Wolfe Street, 240 Blalock Baltimore, MD 21287
Phone: (410) 614-3891 Fax: (410) 614-9428
**BROWN, John W. (Susandale)
*121 Headwater Circle, Irmo, SC 29063
Phone: (803) 276-7172 Fax: (803) 276-7175
BROWN, Paul S., Jr.
*625 Northfield Road, Lititz, PA 17543
Phone: (717) 735-3920 Fax: (717) 735-3923
BROWN, John W. (Carol)
545 Barnhill Drive, Emerson Hall #215, Indianapolis, IN 46202
Phone: (317) 274-7150 Fax: (317) 274-2940
**BROWN, Brooks J. (Helen)
3599 University Blvd. South, Suite C, Jacksonville, FL 32216
Phone: (904) 858-7471 Fax: (904) 858-7480
MEMBERSHIP ROSTER
BROWN, Randy G. (Twila)
3050 Spring Lake Trail, Jackson, MO 63755
Phone: (513) 587-9208 Fax: (573) 331-7879
BROWN, Lyle L.
1023 N. Mound Street, Suite B, Nacogdoches, TX 75961
Phone: (936) 559-0800 Fax: (936) 559-0803
BRUNSTING, Louis A., III (Kim)
THT 712, 1900 University Boulevard, Birmingham, AL 35294
Phone: (205) 934-7019 Fax: (205) 996-2555
BRYAN, Curtis F., II (Lynda)
6006 49th Street North, Suite 310, St. Petersburg, FL 33709
Phone: (727) 527-9779
BUCHANAN, Scott A.
818 Congress Street, Suite 300, Portland, ME 04102
Phone: (207) 773-8161 Fax: (207) 878-8472
MEMBERSHIP ROSTER – C
BUDDE, Jason M. (Laura)
162 Blount Memorial POB, Maryville, TN 37804
Phone: (865) 238-6181 Fax: (865) 681-3387
BUFKIN, Bradley Lance
Phone: (813) 571-9988
**BUKER, Robert H. (Ethel)
11706 Oakmont Court, Fort Meyers, FL 33908
Phone: (404) 365-4152
BURCH, Phillip Todd (Tamara)
100 North Mario Capecchi Dr., Suite 2800, Salt Lake City, UT 84113
Phone: (801) 662-5566 Fax: (801) 662-551
BURFEIND, William R., Jr. (Julia)
701 Ostrum Street, Suite 603, Bethlehem, PA 18015
Phone: (610) 954-3990
BURKE, James Ryan (Jenna)
8 Richland Medical Park, #400, Columbia, SC 29203
Phone: (803) 765-0871 Fax: (803) 765-9215
BURNETT, Clay M. (Angela)
930 Carondelet Drive Building C, Suite 200, Kansas City, MO 64114
Phone: (816) 268-2155
BURNEY, Patrick D. (Charlotte)
*1805 Tiffany Place, Greensboro, NC 27408
Phone: (336) 621-3777 Fax: (336) 621-8374
BURTON, Nelson A. (Amy)
2921 Telestar Court, Ste 140, Falls Church, VA 22042
Phone: (703) 280-5858 Fax: (703) 849-0874
**BYERS, Frank M. (Patricia)
4940 60 Ave. So., St. Petersburg, FL 33715
Phone: (727) 867-3451 Fax: (727) 866-0346
CABLE, David G. (Anne)
6333 Brigantine Lane, Rockford, IL 61114
Phone: (815) 639-1353
CAI, Tung H. (Dana)
3341 Unicorn Lake Boulevard, Denton, TX 76210
Phone: (940) 381-2003 Fax: (940) 483-1221
CALHOON, John H. (Sarah)
Dept of Cardiothoracic Surgery, MC 7841,
7703 Floyd Curl Drive, San Antonio, TX 78229
Phone: (210) 567-2878 Fax: (210) 567-2877
**CALLARD, George M. (Linda)
2345 Bedford Avenue, Cincinnati, OH 45208
Phone: (513) 871-9452 Fax: (513) 871-8321
CAMERON, Duke E. (Claudia)
Zayed 7107, 1800 Orleans Street, Baltimore, MD 21287
Phone: (410) 955-2698 Fax: (410) 955-3809
CAMP, Phillip C. (Mary)
Division of Thoracic Surgery, 75 Francis Street, Boston, MA 02115
Phone: (617) 732-8148
**CAMPBELL, Daniel C., Jr. (Jean)
690 Springcreek Drive, Ashland, OR 97520
Phone: (541) 582-3424
**CAMPBELL, Gilbert S. (Joan)
66 River Ridge Rd, Little Rock, AR 72207
Phone: (501) 225-8116
CANNON, Michael Bruce
2604 Saint Michaels Drive, Suite 425, Texarkana, TX 75503
Phone: (903) 614-5600 Fax: (903) 614-5630
MEMBERSHIP ROSTER
CAPALLO, David V.
11805 Mercy Blvd, Savannah, GA 31419
Phone: (912) 354-4179 Fax: (912) 351-9748
CARLSON, David E. (Claire)
1680 Antilley RoadSuite 260, Abilene, TX 79606
Phone: (915) 691-5590 Fax: (915) 691-1231
**CARLSON, Robert Gerald (Lois Marie)
Coral Cay Condo 207, 1419 11th Street, Port Aransas, TX 78373
Phone: (361) 749-3188 Fax: (763) 427-1370
CARLTON, Richard A. (Lynn)
420 North Center Street, Hickory, NC 28601
Phone: (704) 323-1100 Fax: (704) 324-9189
CARMICHAEL, Michael J. (Becki)
2815 S. Seacrest Blvd, Boynton Beach, FL 33435
Phone: (561) 374-5720 Fax: (561) 374-5717
**CARNEY, Edward K. (Charlene)
*10 Edinborough Court, Salisbury, MD 21801
Phone: (410) 749-1561 Fax: (410) 749-3941
CARPENTER, Andrea J.
7703 Floyd Curl Drive, MC 7841, San Antonio, TX 78229
Phone: (210) 567-2878 Fax: (210) 567-2877
CARRILLO, Roger G. (Migdalia)
1295 NW 14th Street, Suite H, Miami, FL 33125
Phone: (305) 674-2780 Fax: (305) 674-2865
**CARTER, Robert L. (Mary Loy)
1111 Avenue ‘D’ – Suite 713, Marrero, LA 70072
Phone: (504) 349-6713 Fax: (504) 349-6733
**CARTER, James S. (Sharon)
6053 West Victoria Place, Chandler, AZ 85226
Phone: (480) 545-6097
‡CARTER, R. Neal
1053 Rotherwood Dr., Kingsport, TN 37660
**CARVER, Gordon M., Jr.
32 Denada Path, Roxboro, NC 27573
CASPI, Joseph (Tali)
200 Henry Clay Avenue, New Orleans, LA 70118
Phone: (504) 896-3928 Fax: (504) 896-3952
CASSANO, Anthony D. (Angela)
1200 East Broad St, West Hospital PO BOX 980068, Richomond, VA 23298
Phone: (804) 828-4628 Fax: (804) 628-0537
CASSIVI, Stephen D. (Kathy)
Mayo Clinic, 200 First Street SW, Rochester, MN 55905
Phone: (507) 266-0911 Fax: (507) 284-0058
+CASTILLO-SANG, Mario (Natalie)
25 Courtenay Drive Suite 7018, MSC 295, Charleston, SC 29425
Phone: (843) 876-4843 Fax: (843) 876-4866
CATINELLA, Frank P.
5601 North Dixie Highway, Suite 209, Fort Lauderdale, FL 33334
Phone: (954) 9468289 Fax: (954) 491-2628
CEITHAML, Eric L. (Susan)
820 Prudential Dr, Suite 202, Jacksonville, FL 32207
Phone: (904) 244-3418 Fax: (904) 244-6347
CERFOLIO, Robert J.
703 19th Street, SZRB 739, Birmingham, AL 35294
Phone: (205) 995-7561 Fax: (205) 934-6218
CHAI, Paul Jubeong (Suzanne)
3959 Broadway, CHN 275, New York, NY 10032
Phone: (212) 305-5975
CHANG, Albert S.Y. (Catherine)
11300 April Moon Lane, Raleigh, NC 27614
CHAPMAN, Gerald Todd
1371 Frisbie Lane, Cookeville, TN 38501
Phone: (931) 526-4349 Fax: (931) 372-0401
CHATTERJEE, Subhasis (Archana)
1506 S. Oneida Street, Appleton, WI 54914
Phone: (920) 730-7690 Fax: (920) 730-2655
**CHAVEZ, Carlos M. (Carmen)
P. O. Box 3847, Brownsville, TX 78523
Phone: (956) 350-6121 Fax: (956) 350-6125
CHEN, Edward Po-Chung (Suephy)
1365 Clifton Road, Suite A2236, Atlanta, GA 30302
Phone: (404) 778-3484 Fax: (404) 778-4346
MEMBERSHIP ROSTER
CHEUNG, Edson H K. (Anita)
3409 Worth St Ste 720, Dallas, TX 75246
Phone: (214) 8213603 Fax: (214) 823-1317
**CHISCANO, Alfonso (Mary-Alice)
*15243 Pebble Cove, San Antonio, TX 78232
Phone: (210) 260-3132 Fax: (210) 494-6629
CHITWOOD, Randolph W. (Tamara)
115 Heart Drive, Room 3107, Greenville, NC 27834
Phone: (252) 744-4822 Fax: (252) 744-3051
CHOONG, Cliff (Vivien)
*3, Lydia Court, Deepdene, Victoria 3103, Australia
Phone: 61-3-98177328
CHRISTIAN, Karla G.
2200 Children’s Way, 5247 Doctor’s Office Tower, Nashville, TN 37232
Phone: (615) 936-5500 Fax: (615) 343-0042
CHRISTOPHER, Thomas D. (Mary)
7107 Jahnke Road, Suite 500, PO Box 13110, Richmond, VA 23225
Phone: (804) 320-2751 Fax: (804) 330-3831
CHU, Danny (Kim)
UPMC, 200 Lothrop Street, Suite C700, Pittsburgh, PA 15213
Phone: (412) 648-6259 Fax: (713) 794-7352
CHUNG, Byung H.
2301 S. Clear Creek, Suite 212, Killeen, TX 76542
**CIARAVELLA, James M., Jr.
7717 Creswell Rd #31, Shreveport, LA 71106
Phone: (318) 469-6298 Fax: (318) 222-8855
**CLARK, Richard E. (Nancy)
*408 Maple Ln., Sewickley, PA 15143
Fax: (412) 741-7258
CLARK, Joseph Brian (Carol)
500 University Drive, H085, Hershey, PA 17033
Phone: (717) 533-5847 Fax: (737) 531-2052
**CLARKE, John P. (Joyce)
Virginia Beach Surgery, 1020 First Colonial Road Virginia Beach, VA 23454
Phone: (757) 481-4879
**CLAUSE, Harry P., Jr. (Mary Anne)
1709 Kingston Circle, Bedford, VA 24523
Phone: (434) 245-4080
**CLAXTON, Calvin P., Jr. (Martha Ann)
240 Upper Flat Creek, Weaverville, NC 28787
Phone: (828) 645-9127 Fax: (825) 658-1147
CLAY, Richard L. (Susan)
201 Sivley Road, Suite 300, Huntsville, AL 35801
Phone: (256) 533-1077 Fax: (256) 533-3379
**CLAYTON, Orville W. (Dorothy)
3133 Ryecraft Road, Birmingham, AL 35223
Phone: (205) 599-3700
**CLINE, Robert E. (Kathy)
5601 North Dixie Highway, Fort Lauderdale, FL 33334
Phone: (954) 491-7523 Fax: (954) 491-2620
**CODD, John E. (Dorothy)
126 Southarm Dr., St. Louis, MO 63122
Phone: (314) 355-3003 Fax: (314) 355-0515
COFFEY, Arthur C.
1801 N. Senate Boulevard, Suite 755, Indianapolis, IN 46202
Phone: (317) 923-1787 Fax: (317) 923-1787
COHEN, Neri M. (Ilene)
GBMC Healthcare, 6569 North Charles Street,
Suite 701, Baltimore, MD 21204
Phone: (443) 849-3470 Fax: (443) 849-3435
COHEN, Evan S. (Ellen)
201 Sivley Road, Suite 300, Huntsville, AL 35801
Phone: (256) 533-1077 Fax: (256) 533-3379
COHEN, Daniel M. (Marcia)
Brigham & Women’s Hospital CT Surgery,
75 Francis Street, CA 273, Boston, MA 02115
Phone: (617) 763-6290 Fax: (617) 879-2658
COHN, William E. (Mishaun)
Texas Heart Institute, P.O. Box 20345, MC 2-114A,
6770 Bertner Avenue, Ste. C-355M, Houston, TX 77225
Phone: (832) 355-3000 Fax: (832) 355-6798
COLE, Hammond F. , Jr. (Kay)
6195 Boskey Dr., Millington, TN 38053
Phone: (901) 448-5912 Fax: (901) 448-7588
**COLE, Fred N., Jr. (Nancy)
7322 Brightside Road, Baltimore, MD 21212
Phone: (410) 377-4344
MEMBERSHIP ROSTER
COLLAZO, Lucas R. (Karen)
Phone: (703) 280-5858 Fax: (703) 849-0874
**CONKLE, David M. (Babs)
3080 Blackshear Ave, Pensacola, FL 32503
Phone: (904) 474-8344
CONNORS, Rafe C. (Jennifer)
4403 Harrison Blvd, Suite 3835, Ogden, UT 84403
Phone: (801) 387-3475 Fax: (801) 387-3480
**CONNORS, John P. (Ruth Anne)
Missouri Baptist Hospital 3015 North Ballas Road, St. Louis, MO 63131
Phone: (314) 996-5287 Fax: (314) 432-6068
CONTE, John V.
600 N. Wolfe Street, Blalock 618, Baltimore, MD 21287
Phone: (410) 955-1753 Fax: (410) 328-2750
**CONTI, Vincent R. (Andrea)
6.120 John Sealy Annex, Galveston, TX 77555
Phone: (409) 772-1203 Fax: (409) 772-1421
**COOK, William A. (Cynthia)
198 Massachusetts Avenue, Suite 102, North Andover, MA 01845
Phone: (978) 686-1311 Fax: (978) 682-4756
**COOK, Joseph W. (Kathryn)
2071 Hopedale Ave, Charlotte, NC 28207
Phone: (704) 373-0212 Fax: (704) 372-1249
COOK, William H. (Shelley)
4030 Smith Road, Suite 300, Cincinnati, OH 45209
Phone: (513) 984-0904 Fax: (513) 345-2606
COOPER, William A.
61 Whitcher St, Suite 4100, Marietta, GA 30060
Phone: (404) 778-8340 Fax: (404) 778-5358
**COOPER, Joel D.
3400 Spruce St., 6 Silverstein Philadelphia, PA 19104
Phone: (215) 662-2022 Fax: (215) 349-5798
COORDES, Cordie C. (Kathleen)
222 South Woods Mill Road, #550, Chesterfield, MO 63017
Phone: (314) 434-3049 Fax: (314) 205-6916
COPE, Jeffrey Todd (Beth)
540 North Duke St., Ste 110, Lancaster, PA 17602
Phone: (717) 544-4995 Fax: (717) 299-6577
CORCORAN, Philip C. (Maria)
8600 Old Georgetown Road, Bethesda, MD 20814
Phone: (301) 896-7610 Fax: (301) 896-7626
**CORRELL, Noble
221 Tressler Drive SE, Stuart, FL 34994
Phone: (772) 220-6981
CORVERA, Joel S. (Mary Lester)
1801 N. Senate Blvd., Suite 3300, Indianapolis, IN 46202
Phone: (317) 923-1787 Fax: (317) 962-6259
COSELLI, Joseph Stapleton (Kelly)
Baylor College of Medicine, One Baylor Plaza,
BCM 390, Houston, TX 77030
Phone: (832) 355-9929 Fax: (832) 355-9920
**COX, Clyde B. (Carolyn)
*101 Landline Road, Selma, AL 36701
Phone: (205) 872-2306 Fax: (205) 872-2308
CRABTREE, Traves D. (Felicia)
660 S. Euclid Ave, CB 8234, St. Louis, MO 63110
Phone: (314) 362-8089 Fax: (314) 362-6288
**CRAVER, Joseph M. (Missy)
*3456 Knollwood Drive, Atlanta, GA 30305
Phone:Fax: (404) 261-6250
CRAWFORD, Fred A., Jr. (Mary Jane)
25 Courtenay Dr., Suite 7018, MSC 295, Charleston, SC 29425
Phone: (843) 876-4840 Fax: (843) 876-4866
CRESWELL, Lawrence L.
2500 North State Street, Division of CT Surgery, Jackson, MS 39216
Phone: (601) 984-5171 Fax: (601) 984-5198
CROCKER, Edward F. (Trudy)
255 Baptist Blvd, Suite 401, Columbus, MS 39705
Phone: (662) 244-2288 Fax: (662) 244-2289
**CROMARTIE, Samuel R., III (Elaine)
588 Sterthaus Avenue, Ormond Beach, FL 32174
Phone: (386) 672-9501 Fax: (386) 673-0308
CROUCH, Michael F. (Karen)
524 SE Osceola St., Suite 100, Stuart, FL 34996
Phone: (772) 419-2379
MEMBERSHIP ROSTER
CROUCH, John David
2901 W. Kinnickinnic River Pkwy, Suite 511, Milwaukee, WI 53215
Phone: (414) 649-3990 Fax: (414) 649-3969
CROYLE, Philip H. (Edana)
*4924 Cobbs Dr. 8A, Waco,TX 76710
Phone: (254) 722-0929 Fax: (254) 751-4243
**CRUZE, Kenneth (Jean)
919 Brickmanor Circle, Silver Spring, MD 20905
Phone: (301) 774-3999
CUMMINGS, Steven Paul (Reann)
12383 N. Via Tuscania, Clovis, CA 93619
Phone: (540) 678-1780
**CUMMINGS, Robin G. (Rebecca)
360 Tall Timber Drive, Pinehurst, NC 28374
Phone: (910) 315-4242
**CURTIS, Jack J. (Thi)
3702 Woodrail On The Green, Columbia, MO 65203
Phone: (573) 268-1412
**CYRUS, Richard J. (June)
2730 Fernway Dr., Montgomery, AL 36111
Phone: (334) 263-6876
DABAL Robert J. (Jamie)
176F STE 9100, 619 19TH ST S, Birmingham, AL 35294
Phone: (205) 934-2419 Fax: (205) 996-6551
MEMBERSHIP ROSTER – D
D’AGOSTINO, Harry J. , Jr. (Carman)
653 West Eighth Street, Jacksonville, FL 32209
Phone: (904) 388-5815 Fax: (904) 244-6347
**DAICOFF, George R. (Mary)
4950 28th Avenue N, St. Petersburg, FL 33710
Phone: (727) 322-3040 Fax: (727) 322-1332
DAMIANO, Ralph J. (Marci)
660 South Euclid, Campus Box 8234, St. Louis, MO 63110
Phone: (314) 362-7327 Fax: (314) 367-8459
D’AMICO, Thomas A. (Lisa)
Box 3496, Durham, NC 27710
Phone: (919) 489-1463 Fax: (919) 684-8508
**DANIEL, Thomas M. (Margery)
826 Colridge Drive, Charlottesville, VA 22903
Phone: (434) 295-1875 Fax: (434) 295-9104
DANIELS, Larkin J. (Kimberly)
1855 Springhill Avenue, Mobile, AL 36607
Phone: (251) 471-3544 Fax: (251) 476-7254
DANS, Nestor F. (Ann Marie)
P. O. Box 4586, Suite 304, Charleston, WV 25364
Phone: (304) 352-2112 Fax: (304) 352-2113
DAON, Emmanuel (Kristina)
University of Kansas Medical Center,
3901 Rainbow Blvd, Mailstop 4035, Kansas City, KS 66160
Phone: (913) 588-7743
**DAUGHERTY, Harry K. (Marjorie)
Emeritus, Sanger Clinic, 1245 Wareham Court Charlotte, NC 28207
Phone: (704) 930-7220
‡DAVID, Elizabeth
*3520 Verona Terrace, Davis, CA 95618
Phone: (916) 734-4728 Fax: (916) 734-3066
DAVIES, James Edward (Susan)
1530 3rd Ave South, ZRB 712, Birmingham, AL 35294
Phone: (205) 996-9256 Fax: (205) 996-9385
**DAVIS, Jesse T., Jr. (Barbara)
6027 Walnut Grove Road, #114, Memphis, TN 38120
Phone: (901) 683-4471 Fax: (901) 683-7998
**DAVIS, David J. (Wilda)
7777 Hennessy Boulevard, Suite 108, Baton Rouge, LA 70806
Phone: (504) 766-0416 Fax: (504) 769-9212
DAVIS, Robert D., Jr.
3543 Duke Hospital South, Box 3864, Durham, NC 27710
Phone: (919) 681-4760 Fax: (919) 681-4797
DAVIS, Barry R.
890 W. Faris Road, Suite 550, Greenville, SC 29605
Phone: (864) 455-4921 Fax: (864) 455-1320
**DAWSON, Royce E. (Lucy)
1929 Sussex Place, Owensboro, KY 42301
Phone: (270) 685-1135 Fax: (270) 683-8902
MEMBERSHIP ROSTER
+DE DELVA, Pierre (Heather)
2500 N. State Street, Division of Cardiothoracic Surgery,
Jackson, MS 39157
Phone: (601) 984-5176 Fax: (601) 984-5198
DE OLIVEIRA, Nilto C. (Fernanda)
H4/348 Clinical Science Center, 600 Highland Avenue Madison, WI 53792
Phone: (608) 263-6311 Fax: (608) 262-3858
**DEAL, Thomas E. (Pauline)
800 Eldorado Ave, Clearwater, FL 33767
Phone: (727) 461-0670 Fax: (727) 461-0670
DEANDA, Abe, Jr.
530 1st Avenue, Suite 9V, New York, NY 10016
Phone: (914)231-6458 Fax: (212)263-3842
DEARANI, Joseph A. (Ann)
Mayo Clinic, Dept. of Surgery,
200 First Street, S.W., Rochester, MN 55905
Phone: (507) 281-8976 Fax: (507) 255-7378
**DEATON, Hugo L. (Ruth)
415 North Center Street, Suite 102, Hickory, NC 28601
Phone: (828) 327-9178 Fax: (828) 327-4258
DEEL, John
500 Poplar Street Suite 304, So Charleston, WV 25309
Phone: (304) 767-7770 Fax: (304) 767-7779
DEFRAIN, Michael P. (Stephanie)
Phone: (616) 459-7258
MEMBERSHIP ROSTER – D
DELAROSA, Jacob (Rosabeth)
777 Hospital Way, Pocatello, ID 83201
Phone: (208) 239-2580 Fax: (208) 239-2589
DEMMY, Todd L. (Bridget)
Elm & Carlton Streets, Buffalo, NY 14263
Phone: (716) 845-8675 Fax: (716) 845-7692
DENLINGER, Chadrick E. (Jeannine)
25 Courtenay Dr., Suite 7018 MSC 295 Charleston, SC 29425
Phone: (843) 884-1735 Fax: (843) 876-4866
DENNIS, Hugh M.
317 St. Francis Drive, Suite 120, Greenville, SC 29601
Phone: (305) 942-7083 Fax: (305) 491-2628
DEROSIMO, John F.
7600 SW 174th Street, Palmetto Bay, FL 33157
Phone: 305-807-5171 Fax: (843) 792-8286
DETTERBECK, Frank C.
Yale University School of Medicine,
330 Cedar St., BB 205, New Haven, CT 06520
Phone: (203) 785-4931 Fax: (203) 737-2163
**DEVRIES, William C. (Linda)
*7 Snowmound Court, Rockville, MD 20850
Phone:Fax: (240) 453-0062
DEWAN, Stephen J. (Diane)
1010 West 40th Street, Austin, TX 78756
Phone: (512) 459-8753 Fax: (512) 459-0586
DEWEY, Todd M. (Kim)
7777 Forest Lane, Suite A307, Dallas, TX 75230
Phone: (972) 566-4866 Fax: (972) 566-2469
DEWITT, Robert C. (Lori)
3311 Prescott Road, Suite 202, Alexandria, LA 71301
Phone: (318) 442-0106 Fax: (318) 442-8151
**DEWITT, Paul L. (Patricia)
7894 Lantana Creek Road, Largo, FL 33777
Phone: (727) 393-5141 Fax: (727) 392-4149
DHUDSHIA, Neel V.
5320 S. Rainbow Blvd, Suite 282, Las Vegas, NV 89118
Phone: (702) 737-3808
‡DHUPAR, Rajeev
1515 Holcombe Blvd, Department of CT Surgery, Houston, TX 77030
DICORTE, Charles J. (Helene)
1000 Ochsner Boulevard, Covington, LA 70433
Phone: (985) 875-2825 Fax: (985) 875-2725
DIMAIO, J. Michael
6125 Luther Lane, Dallas, TX 75225
**DIXON, Sewell H., Jr. (Elizabeth)
229 Beauty Berry Court, Cassique, Kiawah Island, SC 29455
Phone: (910) 282-9112 Fax: (910) 282-5121
**DOBBIE, Robert P. (Barbara)
128 Rivershire Lane, Lincolnshire, IL 60069
Phone: (847) 634-1756
MEMBERSHIP ROSTER
DOBRILOVIC, Nikola
520 N. Kinsbury Street, #3105, Chicago, IL 60654
Phone: (401) 421-4200
DODD, David J. (Amy)
*6955 Tiffany Oaks Drive, Lakeland, FL 33813
Phone: (863) 646-7861 Fax: (863) 294-8536
**DONAHOO, James S. (Carol)
Department of Surgery - Rm. G 595, 1
85 South Orange Avenue, Newark, NJ 07103
Phone: (973) 972-5678 Fax: (973) 972-2925
**DONATO, Antonio T. (Marilyn)
1125 South Jefferson Street, Roanoke, VA 24016
Phone: (540) 982-1141 Fax: (540) 982-5802
**DOOLEY, Byron N. (Jo)
8645 Fredricksburg Rd. #456, San Antonio, TX 78240
Phone: (210) 698-9595 Fax: (210) 698-9595
MEMBERSHIP ROSTER – E
DORMAN, Malcolm J.
3375 Burns Road, Suite 101, Palm Beach Gardens, FL 33410
Phone: (561) 622-6550 Fax: (561) 622-6331
DOWNEY, Richard S. (Virginia)
1560 E Sherman Blvd, Suite 309, Muskegon, MI 49444
Phone: (231) 830-8643 Fax: (231) 830-8651
DOWNING, Stephen W. (Amy)
515 Abbott Road, Suite 101, Buffalo, NY 14220
Phone: (716) 923-9650 Fax: (716) 961-4440
DRINKWATER, Davis C. (Donna)
Phone: (615) 342-5812 Fax: (615) 342-5813
**DRUCKER, Morris H. (Louise)
48 Wilers Creek Way, Hilton Head Island, SC 29926
Phone: (843) 686-4316
DUARTE, Ignacio G. (Michelle Diane)
270 S. Moon Avenue, Brandon, FL 33511
Phone: (813) 289-3950 Fax: (813) 571-9922
DUNCAN, J. Michael (Patsy)
Texas Heart Institute, P.O. Box 20345, Houston, TX 77225
Phone: (832) 355-4914 Fax: (832) 355-3770
**DUNN, Ralph J., Jr. (Gail)
*109 Miss Georgia Court, Cary, NC 27511
Phone: (919) 460-9774 Fax: (919) 460-0560
DYLEWSKI, Mark R.
PO Box 431341, South Miami, FL 33243
Phone: (305) 663-5864 Fax: (305) 663-9778
EARLE, Gary F.
1720 Nicholasville Road, Suite 502, Lexington, KY 40503
Phone: (859) 266-4996 Fax: (859) 277-9613
EDGERTON, T. Arthur (Ann)
155 Memorial Drive, Pinehurst, NC 28374
Phone: (910) 986-4229 Fax: (910) 715-4101
EDGERTON, James R. (Linda)
PO Box 190667, Dallas, TX 75219
Phone: (469) 800-6200 Fax: (469) 800-6210
**EDWARDS, William H. (Frances)
50 Concord Park East, Nashville, TN 37205
Phone: (615) 383-9085 Fax: (615) 383-9116
**EDWARDS, Michael L. (Kathy)
9213 University Blvd Suite C, Charleston, SC 29406
Phone: (843) 572-2100 Fax: (843) 572-2163
**EDWARDS, Fred H. (Linda)
Division of Cardiothoracic Surgery,
655 West 8th Street, Jacksonville, FL 32209
Phone: (904) 244-3418 Fax: (904) 244-6347
EDWARDS, Melanie
Saint Louis University Hospital Cardiothoracic Surgery,
3635 Vista Ave, St. Louis, MO 63110
Phone: (617) 817-1934 Fax: (314) 577-8315
**EGAN, Thomas M.
Div. of Cardiothoracic Surgery,
123 Burnett-Womack Bldg CB7065, Chapel Hill, NC 27599
Phone: (919) 966-3381 Fax: (919) 966-3475
EGGERSTEDT, Jane M.
1501 Kings Hwy., P.O. Box 33932, Shreveport, LA 71130
Phone: (318) 675-6108 Fax: (318) 675-4689
MEMBERSHIP ROSTER
EGHTESADY, Pirooz (Kimberly)
St. Louis Children’s Hospital Suite 5 S 50,
1 Children’s Place, St. Louis, MO 63110
Phone: (314) 454-6165 Fax: (314) 454-2381
**EHRENSTEIN Fred I. (Meral)
1110 South Southlake Drive, Hollywood, FL 33019
Phone: (954) 922-5226 Fax: (954) 961-2728
MEMBERSHIP ROSTER – F
‡EILERS, Amanda L.
7703 Floyd Curl Drive, MSC# 7841, San Antonio, TX 78229
Phone: 515-537-9645
**ELBEERY, Joseph R. (Elaine)
600 Moye Boulevard, Greenville, NC 27858
Phone: (252) 816-7452 Fax: (252) 816-3010
**ELKINS, Ronald C. (Lida)
920 Stanton L. Young Blvd., WP 2230, Oklahoma City, OK 73104
Phone: (405) 271-5789 Fax: (405) 271-3288
ELKINS, Louis W. (Terrie)
555 West 6th St., Mountain Home, AR 72653
Phone: (870) 425-3291 Fax: (870) 425-3490
ELKINS, Charles Craig
3433 NW 56th, Bldg B, Suite 670, Oklahoma City, OK 73112
Phone: (405) 951-4345 Fax: (405) 951-4392
ELLMAN, Peter I. (Sarah)
155 Medical Drive, Pinehurst, NC 28374
Phone: (910) 715-4111 Fax: (910) 715-4101
‡ENLOW, Jonathan M. (Kara)
Riverside Methodist Hospital
3525 Olentangy River Road, Suite 5300, Columbus, OH 43214
Phone: (614) 735-9888 Fax: (614) 533-0150
ESTRERA, Anthony L. (Vicky)
6400 Fannin St, Memorial Hermann Plaza, Suite 2850, Houston, TX 77030
Phone: (713) 486-5100 Fax: (713) 512-7200
**EVANGELIST, Felix A. (Paula)
3601 East Independence Blvd., Suite 204, Charlotte, NC 28205
Phone: (704) 563-7788 Fax: (704) 532-1984
FACKTOR, Matthew A. (Marti)
Department of Thoracic Surgery, 100 North Academy Avenue, Danville,
PA 17822
Phone: (570) 214-1991 Fax: (570) 214-1480
FARKAS, Emily A.
8025 Maryland Ave, Suite 2B, Clayton, MO 63105
FARO, Richard S. (Eileen)
3370 Burns Road-Suite 206, Palm Beach Gardens, FL 33410
Phone: (561) 626-9801
**FAULKNER, Scott L. (Katie)
600 Aylesford Ln, Franklin, TN 37069
Phone: (334) 264-3746 Fax: (334) 264-3748
FEINS, Richard H. (Ceil)
3400 Burnett Womack Bldg CB 7065, Chapel Hill, NC 27599
Phone: (919) 966-3383 Fax: (919) 966-3475
FELGER, Jason E. (Suzanne)
120 North Magdalen, Suite 320, San Angelo, TX 76903
Phone: (325) 315-8555 Fax: (325) 658-8645
FELGER, Mark C.
1010 W. 40th Street, Austin, TX 78756
Phone: (512) 459-8753 Fax: (512) 483-6807
FENTON, Kathleen N.
14805 Maydale Court, Silver Spring, MD 20905
Phone: 301-576-4094 Fax: (901) 432-4243
FERGUSON, T. Bruce (Candice)
115 Heart Drive, East Carolina Heart Institute,
East Carolina University, Greenville, NC 27834
Phone: (252) 744-2687 Fax: (252) 744-5233
FERNANDEZ, Felix G. (Christine)
The Emory Clinic, 1365 Clifton Ave, Atlanta, GA 30322
Phone: (404) 683-3596
FERRARIS, Victor A. (Suellen)
740 S. Limestone, Suite A301, Lexington, KY 40536
Phone: (859) 266-7108 Fax: (859) 257-4682
FIORE, Andrew C. (Lee)
1465 South Grand, Glennon Hall A432, St. Louis, MO 63104
Phone: (314) 268-4180 Fax: (314) 577-5313
MEMBERSHIP ROSTER
**FISHER, R. Darryl (Orpha Lou)
7210 Waverly Avenue, Nichols Hills, OK 73120
Phone: (405) 751-8665 Fax: (405) 755-8341
FLEISCHER, Kirk (Richelle)
600 Gresham Dr., Suite 8600, Norfolk, VA 23501
Phone: (757) 388-6010 Fax: (757) 388-6006
**FLEMING, William H. (Pam)
*17850 South Reflection Avenue, Bennington, NE 68007
Phone:Fax: (402) 315-9087
FLOYD, Richard D., IV (Julie)
*4409 Brookridge Dr., Lexington, KY 40515
Phone: (859) 913-2802
**FLOYD, Richard D. (Mary)
*913 The Curtilage, Lexington, KY 40502
MEMBERSHIP ROSTER – G
FORBESS, Joseph M. (Lisa)
1935 Medical District Drive, Mail Stop C3.02, Dallas, TX 75235
Phone: (214) 456-9294 Fax: (214) 456-5015
FORCE, Seth D. (Sara)
1365 Clifton Road, Atlanta, GA 30322
Phone: (404) 607-8106 Fax: (404) 778-4346
FORE, Frank N. (Leigh Ann)
1919 S. Wheeling Ave, STE 602, Tulsa, OK 74104
Phone: (918) 749-6400 Fax: (918) 748-7505
**FRANTZ, Paul T. (Elaine)
Phone: (540) 344-5781 Fax: (540) 342-9308
FRANTZ, David W. (Judith)
2410 Atherholt Road, Lynchburg, VA 24506
Phone: (434) 200-2212 Fax: (434) 200-1506
FRASER, Charles D., Jr. (Helen)
6621 Fannin Street, Suite 19345H, Houston, TX 77030
Phone: (832) 826-1929 Fax: (832) 825-1905
**FRAZIER, Oscar H. (Rachel)
Texas Heart Institute, P.O. Box 20345 MC-2114A, Houston, TX 77225
Phone: (832) 355-3000
**FREANT, Lawrence J. (Sarah Ann)
681 Glen Abbey Drive, Augusta, GA 30907
Phone: (706) 863-7075
**FREEMAN, James M. (Shannon)
*4521 Lacosta Drive, Albany, GA 31721
Phone: (229) 698-5714 Fax: (912) 888-7543
FREEMAN, Richard K. (Kelly)
Corvasc MD’s, PC 8433 Harcourt Road, Indianapolis, IN 46260
Phone: (317) 583-7602 Fax: (317) 583-7628
FUDGE, Tommy L.
604 North Acadia Road, Suite 409, Thibodaux, LA 70301
Phone: (504) 873-7212 Fax: (504) 868-9569
**FULCHER, Thomas M. (Joann)
13792 Charismatic Way, Gainesville, VA 20155
Phone: (703) 743-1013 Fax: (703) 743-1014
**FURST, Alex J. (Elayne)
1201 NW 16th Street, Miami, FL 33125
Phone: (305) 575-3244 Fax: (305) 575-3255
+GACA, Jeffrey (Ana Maria)
DUMC 2816, Durham, NC 27710
Phone: (919) 613-5672 Fax: (919) 613-5674
GAMLIEL, Ziv (Jennifer)
7501 Osler Drive, Suite 203, Towson, MD 21204
Phone: (410) 427-2220 Fax: (410) 427-2221
GAMMIE, James S. (Ann)
110 S. Paca Street, 7th Floor Baltimore, MD 21201
Phone: 410-790-8889 Fax: (410) 328-2750
GANDHI, Sanjiv K. (Elizabeth Ann)
Suite AB207, BC Children’s Hospital Vancouver, BC, V6H 3V4, Canada
Phone: (778) 279-2696 Fax: (604) 875-3159
+GANGEMI, James J. (Bonnie)
PO Box 800679, 1215 Lee Street, Room 4067, Charlottesville, VA 22908
Phone: (434) 243-6828 Fax: (434) 244-7588
**GARCIA, Gustavo (Mary)
Poba InternationAL P.O. Box 52-1308, Miami, FL 33152
GARCIA-COVARRUBIAS, Lisardo (Diana)
8950 N Kendell Dr., Suite 607 West Tower, Miami, FL 33176
Phone: (786) 596-1230 Fax: (786) 596-1239
MEMBERSHIP ROSTER
**GARCIA-RINALDI, Raul F. (Debra)
PO Box 6684, Marina Station, Mayaguez, PR 00681-6684
Phone: (787) 265-3712 Fax: (787) 265-3711
**GARDNER, Timothy J. (Nina)
Suite 1003, 4755 Ogletown-Stanton Rd., Newark, DE 19718
Phone: (302) 733-1241 Fax: (302) 733-1429
**GAY, William A., Jr. (Frances)
One Barnes - Jewish Hospital Plaza, Suite 3108 Queeny Tower, St. Louis, MO 63110
Phone: (314) 747-1315 Fax: (314) 367-8459
GAYNOR, William J.
34th Street & Civic Center Boulevard, Suite 8527, PhiladelphIa, PA 19104
Phone: (215) 590-2708
**GEISLER, Gerald F. (Mary)
4706 N. Lindhurst, Dallas, TX 75229
Phone: (214) 691-0758 Fax: (214) 691-0394
**GENTSCH, Thomas O. (Betty)
100 Timber Ridge Way NW, Unit #6109, Issaquah, WA 98027
Phone: (425) 369-9876 Fax: (425) 369-9877
GEORGE, Kristopher M. (Sarah)
720 West Oak St, Suite 360, Kissimmee, FL 34741
Phone: (407) 704-3918 Fax: (407) 846-0072
GERHARDT, Edward B.
2704 Henry Street, Greensboro, NC 27405
Phone: (336) 621-3777 Fax: (336) 621-8374
+GHANTA, Ravi (Sharmila)
Thoracic & Cardiovascular Surgery,
PO Box 800679 - 1215 Lee Street, Charlottesville, VA 22908
Phone: (434) 924-5052 Fax: (434) 244-7588
GHARAGOZLOO, Farid (Mary)
Section of Thoracic Surgery, 1501 N. Campbell Ave., Room 4302,
P.O. Box 245071, Tuscon, AZ 85724
Phone: (520) 616-6668 Fax: (520) 626-4042
GILBERT, Christian L. (Linda)
*1197 Chapel Park Blvd, Cordovva,TN 38016
Phone: (757) 705-0492 Fax: (901) 754-3176
**GILBERT, Joseph W., Jr. (Estelle)
1000 Vicars Landing Way, Apt. D-103, Ponte Vedra Beach, FL 32082
**GILL, Sarjit S. (Primaljit)
LSU Medical Center Surgery Dep,
1501 Kings Highway, Shreveport, LA 71130
Phone: (318) 675-6108 Fax: (318) 675-6141
GLOWER, Donald D. (Sue Ann)
Department of Surgery, P.O. Box 3851, Durham, NC 27710
Phone: (919) 681-5789 Fax: (919) 681-8912
**GOFF, R. Daley, Jr. (Kathleen)
717 Treys Drive, Winchester, VA 22601
Phone: (540) 665-1868 Fax: (540) 665-1868
**GOLDBERG, Lawrence G. (Carole)
1850 Bluegrass Avenue, Louisville, KY 40215
Phone: (502) 367-3321 Fax: (502) 367-3322
GOLINO, Alessandro
910 Maritime Crt, Bradenton, FL 34212
Phone: (941) 744-2640 Fax: (941) 744-2650
**GOMES, Mario N. (Belinda)
374 R Helena Vieira Da Silva E4-5DN,
Leca Da Palmeira, 4450-590, Portugal
Phone: (302) 623-4530 Fax: (302) 623-4522
**GONZALEZ, Ivan F.
CMMS 476, PO Box 70344, San Juan, PR 00936-8344
Phone: (787) 281-0451 Fax: (787) 281-0450
GORDON, William (Nancy)
44555 Woodward Suite 307, Pontiac, MI 48341
Phone: (248) 858-3939 Fax: (248) 858-3844
**GOTT, Vincent L. (Iveagh)
600 N. Wolfe St., Blalock 618, Baltimore, MD 21287
Phone: (410) 955-3297 Fax: (410) 955-3809
**GOTTSEGEN, Warren L. (Becky)
4320 Houma Boulevard, Suite 300 Metairie, LA 70006
Phone:Fax: (504) 598-9934
GRAEBER, Geoffrey M. (Janet)
UMASS Memoria Health Care, 55 Lake Avenue,
North Worchester, MA 01605
Phone: (508) 334-8996 Fax: (508) 334-7284
MEMBERSHIP ROSTER
**GRAHAM, Walter H. (Sylvia)
501 Piney Point Road, Yorktown, VA 23692
Phone: (757) 890-9580
GRAPER, Peter W. (Rhonda)
1569 Oak Way, Sarasota, FL 34232
Phone: (914) 371-9710 Fax: (914) 371-9713
**GRAY, Laman, Jr.
Phone: (502) 561-2180 Fax: (502) 561-2190
GREELISH, James P. (Susan)
2555 Court Drive, Gastonia, NC 28054
Phone: (615) 343-9195 Fax: (615) 343-5234
GREEN, Gary R. (Meg)
104 Union Ave and Townsend St, Ste 1001, Syracuse, NY 13203
Phone: (315) 423-7192 Fax: (315) 423-7192
GREENFIELD, Tyler D. (Anne)
The Heart Center, 2050 Meadowview Parkway, Kingsport, TN 37660
Phone: (423) 230-5000 Fax: (423) 230-5160
GREENLEE, Joseph Alan, III (Joan)
11108 Parkview Circle, Suite 5100, Fort Wayne, IN 46845
Phone: (260) 266-2800 Fax: (260) 266-2805
GRIFFITH, Bartley P.
22 South Greene Street, N4W94, Baltimore, MD 21201
Phone: (410) 328-3822 Fax: (410) 328-2750
GRIMBALL, Arthur (Rosanne)
329 Coatsland Drive, Jackson, TN 38301
Phone: (901) 424-5080 Fax: (901) 424-4109
**GRINNAN, George L. B. (Karon)
106 Quail Way, Duck, NC 27949
Phone: (757) 460-5400 Fax: (757) 460-5400
GRISHKIN, Brent A. (Betty)
*8918 Hemingway Grove Circle, Knoxville, TN 37922
Phone: (865) 670-9880 Fax: (865) 373-0821
GROGAN, Eric L. (Melanie)
VUMC Thoracic Surgery Dept, 1313 21st Avenue South,
609 Oxford House, Nashville, TN 37232
Phone: (615) 322-0248 Fax: (615) 936-7003
GROH, Mark (Sumandeep)
Att: Cathy, 257 McDowell Street, Asheville, NC 28803
Phone: (828) 628-0425 Fax: (828) 252-6114
GROVER, Frederick L. (Carol)
Academic Office 1, Room 6602,
12631 E. 17th Avenue, C-310, Aurora, CO 80045
Phone: (303) 724-7428 Fax: (303) 724-2806
GRUBER, Peter J. (Diana)
Primary Children’s Medical Center,
100 North Marcio Capecchi Dr., Suite 2800, Salt Lake City, UT 84113
Phone: (801) 662-5566 Fax: (801) 662-5571
GUARESCHI, Claudio (Helene)
303 West Alexander Avenue, Suite E, Greenwood, SC 29646
Phone: (864) 330-7900 Fax: (864) 330-7910
GULESERIAN, Kristine J.
1935 Medical District Drive, Suite C-3211, Dallas, TX 75235
Phone: (214) 456-5010 Fax: (214) 456-5015
GUSTAFSON, Robert A. (Kelly)
West Virginia University School of Medicine, Health Sciences Center
North, Box 9238, Morgantown, WV 26506
Phone: (304) 293-2340 Fax: (304) 293-5845
**GUYNES, W. Allison (Catherine)
#6 Medical Drive, Amarillo, TX 79106
Phone: (806) 353-6604 Fax: (806) 353-3977
**GUYTON, Robert A. (Beth)
1365 Clifton Road NE, Suite 2223, Atlanta, GA 30322
Phone: (404) 778-3836 Fax: (404) 778-5039
MEMBERSHIP ROSTER
**HABAL Salem M. (Sandra)
1940 N.E. 47th Street, Suite 1, Fort Lauderdale, FL 33908
Phone: (954) 771-3220 Fax: (954) 771-8369
HAITHCOCK, Benjamin (Carmen)
3040 Burnett Womack Bldg; CB 7065, Chapel Hill, NC 27599
Phone: (919) 966-3381 Fax: (919) 966-3475
HALKOS, Michael E. (Danielle)
550 Peachtree Street, NE Division of Cardiothoracic Surgery,
6th Floor Medical Office Tower Emory University Hospital Midtown,
Atlanta, GA 30308
Phone: (404) 312-4114
HALL, Timothy S. (Kathryn)
POB 9317, Department of Surgery Stamford Hospital, Stamford, CT 06904
Phone: (203) 276-7470 Fax: (203) 276-7089
HALL, William C. (Stacy Leann)
Suite 380 Physicians Plaza, 988 Oak Ridge Turnpike, Oak Ridge, TN 37830
Phone: (865) 481-0183 Fax: (865) 481-0186
**HALL, David P.
638 Tom Hunt Road, Chickamauga, GA 30707
Phone: (706) 375-5714 Fax: (706) 375-9523
**HALLER, Alex J., Jr. (Emily)
1314 Glencoe Road, Sparks Glencoe, MD 21152
Phone: (410) 472-4241 Fax: (410) 472-3477
**HALLMAN, Grady L. (Martha)
Texas Heart Institute, P.O. Box 20345, Houston, TX 77025
Phone: (832) 355-4129 Fax: (832) 355-3770
MEMBERSHIP ROSTER – H
HAMILTON, Timothy
7703 Floyd Curl Drive, MSC 7841, San Antonio, TX 78229
Phone: 210-243-5072
**HAMMON, John W. (Mary Lisa)
Dept. of Cardiothoracic Surg., Wake Forest University School of Medicine,
Winston-Salem, NC 27157
Phone: (336) 716-6002 Fax: (336) 716-3348
HAMNER, Lawrence R.
4330 Medical Dr, Ste 325, San Antonio, TX 78229
Phone: (210) 615-7700 Fax: (210) 615-1782
HANSEN, Andrew H., II (Kathy)
2803 Earl Rudder Freeway, Suite 100, College Station, TX 77845
Phone: (979) 696-8346 Fax: (979) 764-4013
**HARDIN Robert A. (Jo Ann)
2000 Church Street, Nashville, TN 37236
Phone: (615) 329-5915 Fax: (615) 284-3571
**HARPOLE, David H. (Ann)
9704 Old Dell Trace, Richmond, VA 23233
Phone: (804) 741-5699
HARPOLE, David H., Jr. (Karen)
DUMC 3627, Durham, NC 27710
Phone: (919) 668-8413 Fax: (919) 668-7122
HARR, Charles Dulaney (Debra)
301 Hawthorne Lane, Suite 200, Charlotte, NC 28204
Phone: (704) 316-5100 Fax: (704) 316-5101
**HARRAH, John D. (Phyllis)
1975 Wiltshire Blvd., Huntington, WV 25701
Phone:Fax: (304) 529-7478
HARRIS, William J., III (Cindy)
501 Marshall Street, Suite 100, Jackson, MS 39202
Phone: (601) 969-7047
**HARRIS, Jackson (Gene)
211 Burlington Place, Nashville, TN 37215
Phone: (615) 297-2345
**HARRIS, H. Stuart, Jr. (Marie)
1911 Thomson Drive, Lynchburg, VA 24501
Phone: (804) 947-3901 Fax: (804) 947-3907
**HARRISON, Lynn H. (Lura)
8950 N. Kendall Drive, Suite 607W, Miami, FL 33176
Phone: (786) 220-7440
HART, David (Rochelle)
1575 South Andrew Circle, Bloomington, IN 47401
Phone: (812) 361-6930
**HARTSUCK, James M. (Jean)
6909 NW Grand Boulevard, Oklahoma City, OK 73116
Phone: (405) 659-9802 Fax: (405) 843-7314
HARTWIG, Matthew Galen (Laurie)
*2304 Cranford Rd, Durham, NC 27705
Phone: (919) 451-0834 Fax: (919) 681-8912
MEMBERSHIP ROSTER
**HARVILLE, Lacy E., III (Sandra)
9125 Cross Drive, Suite 200, Knoxville, TN 37923
Phone: (423) 632-5900 Fax: (423) 637-2114
**HATCHER, Charles R., Jr. (Phyllis)
The Emory Clinic Inc., 1365B Clifton Rd. NE, Ste. 6205, Atlanta, GA 30322
Phone: (404) 778-3838 Fax: (404) 778-5130
HAVENS, Dennis L. (Audria)
911 Bypass Road, Pikeville, KY 41501
Phone: 859-221-8186 Fax: (606) 278-0159
HAVENSTRITE, Keith A. (Tanya)
*17108 134th Avenue Ct E, Puyallup, WA 98374
Phone: (253) 224-4914 Fax: (253) 968-0232
**HAWLEY, William D. (Carol)
6900 N.W. Grand Blvd., Oklahoma City, OK 73116
Phone: (405) 946-0900
HAZELRIGG, Stephen R.
PO Box 19638, Springfield, IL 62794
Phone: (217) 545-8875 Fax: (217) 545-7053
HEADRICK, James Robert
2108 East Third, Suite 300, Chattanooga, TN 37404
Phone: (423) 624-5200 Fax: (423) 624-4440
HECK, Herman A., Jr. (Joanie)
1542 Tulane Ave, Room 752, New Orleans, LA 70112
Phone: (504) 903 2392 Fax: (504) 903 2391
HEIDARY, Dariush H. (Farideh)
4750 Waters Avenue, Suite 452, Savannah, GA 31404
Phone: (912) 354-7188 Fax: (912) 354-5208
HEINLE, Jeffrey S. (Sheila)
6621 Fannin WT19345H, Houston, TX 77030
Phone: (832) 826-1929 Fax: (832) 825-1905
+HELSEL, Bryan Scott (Shasta)
*2034 Sauvignon, San Antonio, TX 78258
Phone: (210) 362-1162
HENNINGTON, Mark H. (Deborah)
420 North Center Street, Hickory, NC 28601
Phone: (828) 256-1915 Fax: (828) 324-9189
HENRY, Gavin (Marilyn)
900 Caton Ave, St. Agnes Hospital Baltimore, MD 21229
Phone: (410) 368-2730 Fax: (410) 951-4007
HENRY, Clarke L., Jr.(Mary)
8901 W 74th St STE 1, Shawnee MSN, KS 66204
Phone: 913-341-0120 Fax: (913) 341-6071
HERRBOLD, Francis (Kelly)
425 W. Third Ave., Suite 510 Albany, GA 31701
Phone: (229) 312-7500 Fax: (229) 312-7505
HERRERA, Luis J. (Jeanne)
1400 S. Orange Ave, MP-760, Orlando, FL 32806
Phone: (407) 9499581 Fax: (407) 872-7754
HESS, Philip J. (Pamela)
1600 SW Archer Road, Room NG-33, Gainesville, FL 32610
Phone: (352) 273-5501 Fax: (352) 273-5513
HIGGINS, Robert S.D. (Molly)
Department of Surgery, 395 W. 12th Avenue,
Suite 670, Columbus, OH 43210
Phone: (614) 293-8701 Fax: (614) 293-7221
HIGGS, William R. (Rebecca)
3715 Dauphin St, Bldg. 2, Ste. 600, Mobile, AL 36608
Phone: (251) 990-4836 Fax: (251) 990-4854
**HILL, Ronald C. (Lenora)
12 Sterling Run Dr., Fletcher, NC 28732
Phone: (828) 298-7911 Fax: (828) 299-2567
HILLER, Laurence F. (Olivia)
2751 Albert Bicknell Drive, Shreveport, LA 71103
Phone: (318) 675-6154 Fax: (318) 675-4689
HINES, Michael H. (Leigh)
6431 Fannin Street, MSB 6.264, Houston, TX 77030
Phone: 832-544-9230
**HITCH, William S. (Lucy)
7001 Hodgson Memorial Drive, #5, Savannah, GA 31406
Phone: (912) 356-6361 Fax: (912) 352-9800
**HIX, William R. (Jane)
1079 Burning Tree Drive, Chapel Hill, NC 27517
Phone: (919) 932-7622
MEMBERSHIP ROSTER
HOFF, Steven J.
1215 21st Avenue South, MCE - 5th Floor Suite 5209, Nashville, TN 37232
Phone: (615) 343-9195 Fax: (615) 343-5248
‡HOFFMAN, Aaron Lee (Emily)
*3161 Parthenon Avenue, Unit 104, Nashville, TN 37203
Phone: 205-999-1401
HOFSTETTER, Wayne
1515 Holcombe, Unit 1489, Houston, TX 77030
Fax: (713) 794-4901
HOLDEN, Anthony Austin (Barbara)
*105 Suncrest Terrace, Morgantown, WV 26505
Phone: (304) 282-1733
HOLLEY, Wayne C. (Lori)
425 Third Ave., Suite 510, Albany, GA 31701
Phone: (229) 312-7502 Fax: (229) 312-7505
HOLMAN, William L. (Linda)
ZRB719, 703 19th Street South, Birmingham, AL 35294
Phone: (205) 934-3853 Fax: (205) 975-6618
**HOLMES, Chester L.
P.O. Box 305, Ellison Bay, WI 54210
Phone: (414) 854-2146
HOLT, John B. (Diane)
588 Sterthaus Avenue, Ormond Beach, FL 32174
Phone: (386) 672-9501 Fax: (386) 673-0308
HOOPES, Charles W.
740 South Limestone, Suite A301, Lexington, KY 40536
Phone: (859) 323-6494
HOOTS, Anthony V. (Barbara)
425 Third Avenue Suite 510, Albany, GA 31701
Phone: (912) 432-5633 Fax: (912) 888-7543
**HOPKINS, Richard A. (Jenny)
2401 Gillham Road, 4 West Tower-Cardiac Surgery, Kansas City, MO 64108
Phone: (816) 234-3580 Fax: (816) 983-6380
**HORNEFFER, Peter J. (Barbara)
O’Dea Medical Arts Building,
7505 Osler Drive-Suite 306, Baltimore, MD 21204
Phone: (410) 296-2520 Fax: (410) 821-6860
HOROWITZ, Michael D.
P.O. Box 639, Lebanon, GA 30146
Phone: (678) 469-1154
HORVATH, Keith A. (Catherine)
10 Center Drive – MSC 1550, 10 B1D47, Bethesda, MD 20892
Phone: (301) 896-7610 Fax: (301) 480-1649
**HOTCHKISS, William S. (Virginia)
144 Harvest Drive, Huntington Village, Charlottesville, VA 22903
HOUCK, Ward Vaughn (Caroline)
*915 Hawick Drive NW, Atlanta, GA 30327
Phone: (770) 880-0730
**HOWE, Robin W. (Elaine)
*1 Highland Hills Way, Landrum, SC 29356
Phone: (864) 895-8115
HOWE, Harold R., Jr. (Kathy)
Phone: (704) 316 5100 Fax: (704) 377-8825
HOWINGTON, John A. (Anne)
Evanston Hospital 2650 Ridge Ave,
Suite 3507 Walgreen, Evanston, IL 60201
Phone: (847) 441-4520 Fax: (847) 733-5005
HUANG, Kuo Fon (Kimberly)
2115 South Fremont Avenue, Suite 5000, Springfield, MO 65804
Phone: (417) 820-3960 Fax: (417) 820-3966
**HUBBELL, David S. (Barbara)
100 Beach Drive, NE, #802, St. Petersburg, FL 33701
Phone: (813) 979-3050 Fax: (813) 972-8495
HUDDLESTON, Charles B. (Marye Gleva)
*14 Kingsbury Place, St. Louis, MO 63112
Phone: (314) 268-4183 Fax: (314) 577-5313
‡HUDDLESTON, Stephen J.
930 East First Street, Suite 303, Duluth, MN 55812
Phone: (218) 576-2998
**HUDSON, Loyde H. (Arlene)
P.O. Box 8400, Fayetteville, AR 72703
Phone: (501) 444-0552
**HUDSPETH, Allen S. (Kathryn)
*211 Knollwood Street, Winston-Salem, NC 27104
Phone: (336) 721-1748 Fax: (336) 716-3348
MEMBERSHIP ROSTER
HUGHES, George C., IV (Diane)
Box 3051 DUMC, Durham, NC 27710
Phone: (919) 403-8673 Fax: (919) 613-5674
HUH, Joseph (Sonia)
3701 J Street, Suite 109, Sacramento, CA 95825
Phone: (916) 733-4100
MEMBERSHIP ROSTER – J
HUME, Andrew Tucker
2001 Willow Dr, San Angelo, TX 76904
Phone: (512) 459-8753 Fax: (512) 483-6807
HUMMEL, Brian W. (Kristin)
8010 Summerlin Lakes Dr, STE 100, Fort Myers, FL 33907
Phone: (239) 939-1767 Fax: (239) 939-5895
HUNTER, Merrill R. (Marilyn)
3000 New Bern Avenue, Suite 1100, Raleigh, NC 27610
Phone: (919) 231-6333 Fax: (919) 231-6334
HUSAIN, Adil S. (Rebecca)
7703 Floyd Curl Dr., MC 7841, San Antonio, TX 78229
Phone: (210) 381-5074 Fax: (210) 567-2877
**IBACH, John R., Jr. (Stephanie)
904 Greenridge Road, Jacksonville, FL 32207
Phone: (904) 396-7890 Fax: (904) 396-6065
IKONOMIDIS, John S.
25 Courtenay Drive, Suite 7030, Charleston, SC 29425
Phone: (843) 343-7149 Fax: (843) 876-4866
IRANI, Adel D. (Natasha)
6400 Fannin St. Ste. 2850, Houston, TX 77030
Phone: (713) 486-5100 Fax: (713) 512-7200
**ITKIN, Ernest L. (Toni)
61 Whitcher Street, Suite 4120, Marietta, GA 30060
Phone: (770) 424-9732 Fax: (770) 421-0228
JACOBS, Jeffrey P. (Stacy)
601 5TH ST S, 6TH Floor BOX 70-6610, St. Petersburg, FL 33701
Phone: (727) 767-2620 Fax: (727) 767-8606
JAGGERS, Robert C.
Cardiovascular Surgical Clinic of NW Arkansas, 3276 N. Northhills Blvd,
Fayetteville, AR 72703
Phone: (479) 587-1114
JAGGERS, James
Childrens Hospital Colorado, Cardiac Surgery B200,
13123 East 16th Ave, Aurora, CO 80045
Phone: (720) 777-3376 Fax: (720) 777-7290
**JAHNKE, Edward J. (Betty)
1596 San Leandro Lane, Santa Barbara, CA 93108
Phone: (805) 969-5271
JAQUISS, Robert DB (Cheryl)
Duke University School of Medicine, DUMC Box 3474, Durham, NC 27710
Phone: (919) 448-8225 Fax: (919) 681-4907
JAROSZEWSKI, Dawn E. (Lucas)
5777 E. Mayo Blvd, Phoenix, AZ 85054
Phone: (480) 342-2270 Fax: (480) 342-2269
**JEFFERY, Diane L.
1513 Del Webb Blvd. West, Sun City Center, FL 33573
Phone: (813) 633-2330
**JENKINS, Edward W. (Mary Jane)
7410 Lochness Circle, Tulsa, OK 74132
Phone: (918) 388-4409
JESSEN, Michael E. (Patti)
5323 Harry Hines Blvd., MC 8879, Dallas, TX 75390
Phone: (214) 645-7721 Fax: (214) 645-7701
**JOHNSON, George W., Jr. (Marie)
*901 W. Lamberth Rd., Sherman, TX 75092
Phone: (903) 892-2801
JOHNSON, Scott B. (Andrea)
Department of Surgery, 7703 Floyd Curl Drive,
MC 7841, San Antonio, TX 78229
Phone: (210) 698 8484 Fax: (210) 567-2877
JOHNSON, Joe H. (Jan)
575 First Street, Macon, GA 31201
Phone: (478) 743-9762 Fax: (478) 473-9465
JOHNSON, Scott H. (Suzanne)
890 W. Faris Rd., Suite 550, Greenville, SC 29650
Phone: (864) 455-6800
JOHNSON, William E., III
1855 Spring Hill Ave, Mobile, AL 36607
Phone: (334) 433-0404 Fax: (334) 431-3655
MEMBERSHIP ROSTER
JOHNSON, Carl M.
2601 Kentucky Avenue, Suite 300, Paducah, KY 42003
Phone: (502) 443-5564 Fax: (502) 443-5549
**JOHNSON, Robert G.
3635 Vista At Grand Blvd., St. Louis, MO 63110
**JOHNSTON, Robert H. (Sara)
*303 Pasadena, Victoria , TX 77904
**JOHNSTON, Alan D.
M. D. Anderson Cancer Center Orlando,
1400 S. Orange Avenue, Orlando, FL 32806
Phone: (407) 648-5384 Fax: (407) 872-7754
**JONES, James W. (Joan)
*31 La Costa Drive, Montgomery, TX 77356
Phone: (573) 882-4158 Fax: (573) 884-4585
MEMBERSHIP ROSTER – K
**JONES, Robert H. (Catherine)
P.O. Box 2986, Durham, NC 27710
Phone: (919) 684-6077 Fax: (919) 684-5700
**JONES, James C. (Dianne)
3176 Willow Bend, Lehi, UT 84043
JONES, Gary P. (Elaine)
3311 Prescott Road - Suite 202, Alexandria, LA 71301
Phone: (318) 445-0206 Fax: (318) 443-0441
JONES, David R. (Julie)
1275 York Ave, Box 7, New York, NY 10065
Phone: (212) 639-6428
JONES, Robert N. (Mica)
MidMichigan Medical Center-Midland, 4009 Orchard Drive, Se 3025,
Midland, MI 48640
Phone: (989) 488-5410
JONES, Robert Evans (Mimi)
4700 Waters Avenue, ACI Building, 2nd Floor Savannah, GA 31404
Phone: (912) 350-2299 Fax: (912) 350-2298
**JUDD, Donald R. (Carolyn)
10162 Tanbridge Rd, St. Louis, MO 63128
Phone: (314) 647-5525 Fax: (314) 645-5713
**JUDE, James R.
200 Edgewater Drive, Coral Gables, FL 33133
Phone: (305) 854-7374 Fax: (305) 859-7269
**JUST, Jorge O. (Sonia)
*2120 Redding Road, Birmingham, AL 48009
JUSTICZ, Alexander G.
4725 N Federal Hwy, Fort Lauderdale, FL 33308
Phone: (954) 494-0590
KABAS, Scott J. (Danette)
2000 E. Greenville Street, Suite 3100, Anderson, SC 29621
Phone: (864) 455-6800 Fax: (864) 455-6825
**KAHN, Donald R. (Shirley)
2012 Magnolia Avenue, Birmingham, AL 35205
Phone: (205) 933-7794 Fax: (205) 933-7952
**KAISER, George C.
10 Jefferson Rd#1D, Webster Groves, MO 63119
Phone: (314) 962-0446
KAMATH, Vinayak M. (Sheila)
Georgia Regents University, Cardiac and Thoracic Surgery-BA 4300,
1120 15th Street, Augusta, GA 30912
Phone: (706) 722-8242 Fax: (706) 722-0831
KANALY, Paul J. (Beverly)
3433 NW 56, Suite 670, Oklahoma City, OK 73112
Phone: (405) 951-4345 Fax: (405) 951-4392
KANE, Lauren (Timothy)
*9007 Powhatan Dr., San Antonio, TX 78230
Phone: (210) 567-5621 Fax: (210) 567-2877
KANTER, Kirk R.
Pediatric Cardiac Surgery, 1405 Clifton Road, Atlanta, GA 30322
Phone: (404) 785-6330 Fax: (404) 785-6266
KAPPELMAN, Mark D. (Susan)
120 Meadowcrest Street, Suite 450, Gretna, LA 70056
Phone: (504) 391-7660 Fax: (504) 393-2407
KARTIS, Thomas
2595 Harbor Blvd., Suite 102, Port Charlotte, FL 33952
Phone: (941) 235-4400 Fax: (941) 505-5563
MEMBERSHIP ROSTER
KASIRAJAN, Vigneshwar (Sucharitha)
1200 E. Board Street, 7 South, P.O. Box 980068, Richmond, VA 23219
Phone: (804) 827-1255 Fax: (804) 828-4620
KAUSHAL, Sunjay (Avni)
110 S Paca St, 7th Floor Baltimore, MD 21201
Phone: (443) 826-0206
KAUTEN, James R. (Deanna)
95 Collier Road, Suite 5015, Atlanta, GA 30309
Phone: (404) 233-9700 Fax: (404) 355-4235
KAVARANA, Minoo Naozer (Zarin)
96 Jonathan Lucas Street, CSB 424/MSC 613, Charleston, SC 29425
Phone: (843) 792-5882
‡KAYATTA, Michael O.
1365 Clifton Road NE, Atlanta, GA 30322
**KEELEY, Robert L. A.
1234 Franklin Road SW, Roanoke, VA 24016
Phone: (540) 345-1561 Fax: (540) 345-2112
KEELING, Brent W. (Maggie)
49 Jesse Hill Jr Dr SE, Atlanta, GA 30303
Phone: (404) 550-4741
KELEMEN, John J., III (Sara)
721 American Avenue, Suite 510, Waukesha, WI 53188
Phone: (262) 928-5300 Fax: (262) 928-2689
KELLER, Antoine V. (Ali)
5560 Clipper Ct, New Port Richey, FL 34652
Phone: (225) 333-8228
**KELLEY, Henry G., Jr. (Marilyn)
853 N. Church Street, Suite 500, Spartanburg, SC 29303
Phone: (864) 560-1582 Fax: (864) 560-1590
KELLY, James P. (Christine)
17022 Shandwick lane, Granger, IN 46530
Phone: (574) 647 6542 Fax: (574) 647-6518
KERN, John A. (Catherine)
TCV Surgery, PO Box 800679, Charlottesville, VA 22908
Phone: (434) 982-4301 Fax: (804) 243-5781
KESLER, Kenneth A.
545 Barnhill Drive, EH 215, Indianapolis, IN 46202
Phone: (317) 274-2394 Fax: (317) 274-2940
**KESSINGER, John M.
2514 Country Club Drive, Lynn Haven, FL 32444
Phone: (850) 785-9559
KHALAFI, Reza S. (Kathy)
1650 W. Rosedale, #201, Fort Worth, TX 76104
Phone: (817) 885-7442 Fax: (817) 885-7443
+KHALIL, Kamal G. (Samia)
6400 Fannin Suite 2850, Houston, TX 77030
Phone: (713) 486-5100 Fax: (783) 512-7200
KHANDHAR, Sandeep (Seema)
2921 Telestar Court, Suite 140, Falls Church, VA 22042
Phone: (703) 280-5858
KHANSARINIA, Saeid
95 Collier Road NW, Suite 5015, Atlanta, GA 30309
Phone: (404) 605-5699 Fax: (404) 355-4235
+KHAWAJA, Fawad Naeem (Amna)
2016 S.W 66th Drive, Gainesville, FL 32607
Phone: 352-872-5057 Fax: (904) 244-6347
‡KIANKHOOY, Armin
*1830 Candlewood Court, #208, Charlottesville, VA 22903
Phone: (434) 260-4444
KIERNAN, Paul D. (Carol)
Phone: (703) 280-5858 Fax: (703) 849-0876
+KILIC, Ahmet (Gwen)
N-831 Doan Hall, 410 West 10th Ave., Columbus, OH 43210
Phone: (614) 505-6908 Fax: (614) 293-7221
**KILLEN, Duncan A. (Lucy)
12542 West 123rd Terrace, Overland Park, KS 66213
Phone: (913) 681-9471
MEMBERSHIP ROSTER
KIM, Jae Hyun (Jin Hee)
Dalsung-ro 56, Jung-gu, Daegu, 700-712, South Korea
Phone: 82532508387 Fax: 82532507307
+KIM, Min Peter (Maria)
6550 Fannin Street, SM1661, Houston, TX 77030
Phone: (713) 441-5177 Fax: (713) 790-5030
KIM, Peter Y.
5098 SW 41st St, Ocala, FL 34474
Phone: (352) 867-8311
KINCAID, Edward H. (Shiva)
Department of Cardiothoracic Surgery, Wake Forest University School of
Medicine, Medical Center Boulevard, Winston-Salem, NC 27157
Phone: (336) 716-4359 Fax: (336) 716-3348
KING, Lewis G. (Cheryl)
6500 N. Mopac, Bldg 2, Suite 2207, Austin, TX 78731
Phone: (512) 494-9985 Fax: (512) 494-9986
**KINGRY, Roy L., Jr. (Julia)
8704 Paluxy Drive, Tyler, TX 75703
Phone: (903) 509-9503
**KIPHART, Ridlon J. (June)
*107 Caprock Circle, Boerne, TX 78006
Phone: (830) 229-5406
KIRKLIN, James K.
1900 University Blvd # 760, Birmingham, AL 35294
Phone: (205) 934-3368 Fax: (205) 975-2553
KIRSHBOM, Paul M.
Yale University School of Medicine, Department of Surgery, PO Box
208039, New Haven, CT 06520
Phone: (203) 785-2702 Fax: (203) 785-3346
KISER, Andy Christopher
UNC at Chapel Hill, Division of CT Surgery, 3040 Burnett Womack Bldg,
CB 7065, Chapel Hill, NC 27599
Phone: (919) 966-3381 Fax: (919) 966-3475
KITCHENS, William Clifford (Heather)
1348 Walton Way, Suite 5700, Augusta, GA 30901
Phone: (706) 737-6922 Fax: (706) 722-8351
KITCHENS, William R. (Scotta)
1348 Walton Way, Suite 5700, Augusta, GA 30901
Phone: (706) 722-8242 Fax: (706) 722-8351
KLENA, James W. (Leah)
100 Fairfield Avenue, Seneca, PA 16346
Phone: (814) 676-7900 Fax: (814) 676-7887
KLINE, Elizabeth M. (Richard)
125 Doughty St., #690, Charleston, SC 29401
Phone: (843) 720-8490 Fax: (843) 727-3602
KLODELL, Charles T. (Cindy)
PO Box 100129, Gainesville, FL 32610
Phone: (352) 273-5501 Fax: (352) 273-5513
**KNIGHT, Wade L. (Linda)
2401 South 31st Street, Temple, TX 76508
Phone: (254) 724-4910 Fax: (254) 724-6213
KNOTT-CRAIG, Christopher J.
50 N. Dunlap, 3rd Floor Heart Institute, Memphis, TN 38103
Phone: (901) 287-5995 Fax: (901) 287-5970
KOGON, Brian E.
1405 Clifton Road, Suite 2100, Atlanta, GA 30322
Phone: (404) 785-6330
KON, Neal D.
Wake Forest School of Medicine, Medical Center Boulevard,
Winston-Salem, NC 27157
Phone: (336) 716-4338 Fax: (336) 716-3348
**KOSTER, Kenneth J., Jr. (Lesley)
836 Prudential Drive, Suite 1804, Jacksonville, FL 32207
Phone: (904) 398-3888 Fax: (904) 346-3026
**KOUCHOUKOS, Nicholas T. (Judith)
3009 N. Ballas, Suite 360C, St. Louis, MO 63131
Phone: (314) 996-5287 Fax: (314) 432-6068
KOURETAS, Peter C. (Niki)
Rainbow Babies & Children’s Hospital 11100 Euclid Avenue, Suite 380,
Mailstop RBC 6021, Cleveland, OH 44106
Phone: (216) 844-3058 Fax: (216) 844-3517
KOURLIS, Harry
30 Quail Ridge Drive, Bentleyville, OH 44022
Phone: (214) 403-8006
MEMBERSHIP ROSTER
KOURY, Michael A. (Kathryn)
501 Marshall Street, Suite 100, Jackson, MS 39202
Phone: (601) 594-4766 Fax: (601) 355-8563
KOUTLAS, Theodore C.
2003 Kootenai Health Way, Suite 300, Coeur d’Alene, ID 83814
Phone: (208) 449-6414 Fax: (208) 666-2556
KOZOWER, Benjamin D. (Nicole)
P.O. Box 800679, 1215 Lee Street, HEP 4th, Charlottesville, VA 22908
Phone: (434) 924-2145 Fax: (434) 243-6131
**KRAEFT, Nelson H. (Bobbie)
2397 Troland Road, Tallahassee, FL 32312
Phone: (904) 386-8164
**KRAEGER, Russell R. (Betty)
129 North Bemiston Ave, St. Louis, MO 63105
Phone: (314) 965-9660 Fax: (314) 965-9670
KRAHNERT, John F. (Anne)
155 Memorial Drive, PO Box 3000, Pinehurst, NC 28374
Phone: (910) 715-4111 Fax: (910) 715-4101
KRASNA, Mark J. (Diane)
1945 Route 33, Neptune, NJ, 07753
Phone: (732) 776-4724 Fax: (732) 776-4417
KRATZ, John M.
Department of Surgery, 171 Ashley Avenue, Charleston, SC 29425
Phone: (843) 792-3363 Fax: (843) 792-8286
MEMBERSHIP ROSTER – L
KRAUT, Jonathan David (Arlene)
4003 Kresge Way, Suite 224, Louisville, KY 40207
Phone: (502) 895-2295 Fax: (502) 895-2296
KREISEL, Daniel (Friederke)
660 S. EuclID Campus Box 8234, St. Louis, MO 63110
Phone: (314) 362-6021 Fax: (314) 367-8459
KRON, Irving L.
1215 Lee Street, HEP Bldg, Room 4066,
Box 800679, Charlottesville, VA 22908
Phone: (434) 924-2158 Fax: (434) 982-3885
KRUPNICK, Alexander Sasha (Shauna)
660 S. Euclid, Campus Box 8234, St. Louis, MO 63110
Phone: (314) 362-9181 Fax: (314) 367-8459
KUCHLER, Joseph A. (Patricia)
1935 Route 70 East, Cherry Hill, NJ 08003
Phone: (856) 428-7700 Fax: (856) 772-0788
KWONG, King F. (Andrea)
Bldg 10, 4-3940, 10 Center Drive, MSC 1201, Bethesda, MD 20892
Phone: 443-622-3518 Fax: (301) 480-8600
KYPSON, Alan P. (Kristal)
ECHI At ECU, 115 Heart Drive, Greenville, NC 27834
Phone: (252) 744-3570 Fax: (252) 744-2687
LADDEN, David A. (Shelly)
*1680 Brentwood Drive, Lufkin,TX 75901
Phone: (936) 671-2135 Fax: (936) 631-6778
LAFUENTE, Javier A. (Priscilla)
18400 Katy Fwy, Ste 690, Houston, TX 77094
Phone: (832) 522-8600 Fax: (832) 522-8601
**LAMBERTH, Wade C. (Frances)
2018 Brookwood Medical Ctr. Drive, POB Suite 215,
Birmingham, AL 35209
Phone: (205) 877-2627 Fax: (205) 871-7602
LAMBRIGHT, Eric S. (Julia)
1313 21st Ave. So., 609 Oxford House Nashville, TN 37232
Phone: (615) 322-0248 Fax: (615) 936-7003
LANCASTER, Lee L. (Terri)
3443 Dickerson Pike, Suite 400, Nashville, TN 37207
Phone: (615) 860-1772 Fax: (615) 870-1070
**LANCASTER, Joseph R.
4787 Oak Circle, Boynton Beach, FL 33436
Phone: (407) 734-7914
LANDOLFO, Kevin P. (Carolyn)
4500 San Pablo Road, Davis Building, 3 North, Jacksonville, FL 32224
Phone: (904) 953-1491 Fax: (904) 953-7368
LANDRENEAU, Rodney J. (Sandra)
1514 Jefferson Hwy, Gayle & Tom Benson Cancer Center,
New Orleans, LA 70121
Phone: (412) 427-4233 Fax: (504) 842-0224
LANDVATER, Lance E. (Cynthia)
2800 Blue Ridge Rd, Suite 403, Raleigh, NC 27607
Phone: (919) 805-1062 Fax: (919) 231-6334
MEMBERSHIP ROSTER
**LANE, Carl E. (Martha)
688 Walnut Street, Suite 200, Macon, GA 31201
Phone: (478) 742-7566 Fax: (912) 743-2804
‡LAPAR, Damien J.
*829 Rainier Rd, Charlottesville, VA 22908
‡LARSON, Sharon
1200 Brickell Bay Drive, #3904, Miami, FL 33131
LASCHINGER, John C. (Elizabeth)
*14 Selsed Garth, Lutherville, MD 21093
Phone: (301)796-1210
**LASLEY, Charles H. (Jan)
#4 Pelican Place, Belleair, FL 33756
Phone: (727) 584-1039
LATTOUF, Omar M.
550 Peachtree Street, 6th Floor Atlanta, GA 30308
Phone: (404) 686-2513 Fax: (404) 686-4959
LAU, Christine L. (Adam)
UVA PO Box 800679, Charlottesville, VA 22908
Phone: (434) 924-8016 Fax: (434) 244-9429
LAUDITO, Antonio Laudito
*311 East Superior Street, Unit # 803, Duluth, MN 55802
Phone: (218) 464-7619
MEMBERSHIP ROSTER – L
**LAWLER, R. Marion, Jr. (Nan)
2601 Clifford Drive, Harlingen, TX 78550
Phone: (956) 423-0043 Fax: (956) 440-9063
LAWS, Kenneth H. (Ava)
Mid State Medical Center, 2010 Church Street,
Suite 626, Nashville, TN 37203
Phone: (615) 329-7878 Fax: (615) 329-7899
LAWTON, Jennifer S.
Queeny Tower, Suite 3108, St. Louis, MO 63110
Phone: (314) 362-2821 Fax: (314) 747-4216
LEE, Robert B. (Scottye)
*1112 Pigskin Court, Franklin, TN 37064
Phone: (615) 875-4325
LEE, Richard (Michelle)
St. Louis University Hospital Center for Comprehensive Cardiovascular
Care, 3635 Vista Ave., 13th Floor DT, St. Louis, MO 63110
Phone: (314) 577-8877 Fax: (314) 268-5410
LEMAIRE, Scott A. (Brenda)
One Baylor Plaza, BCM 390, Houston, TX 77030
Phone: (832) 355-9910 Fax: (832) 355-9948
**LEPERE, Robert H. (Vicky)
2211 Camelback Drive, San Antonio, TX 78209
LEPPARD, Edward M., Jr. (Constance)
2750 Laurel Street-Suite 305, Columbia, SC 29204
Phone: (803) 254-5140 Fax: (803) 779-1279
LEVETT, James M. (Paula)
202 10th Street SE, Cedar Rapids, LA 52403
Phone: (319) 247-3010
LEVIN, Barry J. (Joanne)
Camalier Building, 10215 Fernwood Road, Suite 405, Bethesda, MD 20817
Phone: (301) 897-5620 Fax: (301) 897-3679
LEWIS, Clifton T.P., Sr. (Anne)
833 Princeton Avenue SW, POB III, Suite 200A, Birmingham, AL 35211
Phone: (205) 786-2776 Fax: (205) 786-6227
LICK, Scott D. (Michele)
301 University Blvd., Galveston, TX 77555
Phone: (409) 772-1203 Fax: (409) 772-1421
LIN, Shu S. (Michelle)
DUMC - 3392, Durham, NC 27710
Phone: (919) 812-4950 Fax: (919) 681-7524
LINDBERG, Harald L. (Jorunn)
*Hjemliveien 14, Oslo, 667, Norway
Phone: 90119527 Fax: 23073741
**LINDSEY, Edward S. (Margaret Ann)
#4 Rosa Park Place, New Orleans, LA 70115
Phone: (504) 897-4440
LINKER, Robert W., III (Margaret)
Phone: (502) 895-0569 Fax: (502) 589-5629
MEMBERSHIP ROSTER – M
MEMBERSHIP ROSTER
LIVESAY, James J. (Robin)
3670 Inwood Dr, Houston, TX 77019
Phone: (832) 355-4976 Fax: (832) 355-3770
LOBDELL, Kevin W. (Maureen)
1000 Blythe Blvd, 3rd Floor SHVI Administration, Charlotte, NC 28232
Phone: (704) 355-1582 Fax: (704) 355-6227
LOCHER, James P., Jr.(Amanda)
MMG Cardiovascular Services, 112 NE Crescent Ave, Peoria, IL 61606
Phone: (309) 672-4670
LOCHRIDGE, Stanley K. (Tracy)
2871 Acton Road, Suite 100, Birmingham, AL 35243
Phone: (205) 838-3835 Fax: (205) 838-3976
**LOCICERO, Joseph, III (Martha)
1158 Church St., Mobile, AL 36604
Phone: (251) 591-0061 Fax: (251) 432-4142
LODGE, Andrew J. (Barbara)
Box 3340, DUMC, Durham, NC 27710
Phone: (919) 681-2343 Fax: (919) 681-4907
**LOGAN, William D., Jr. (Pat)
305 Ellis Street, Carthage, MS 39051
Phone: (601) 267-5114 Fax: (601) 267-1381
**LONG, Graydon A. (Virginia)
812 Hildeen Road, Lexington, KY 40502
**LONGAKER, Dail W. (Mary Lou)
1850 Laurel Street, Columbia, SC 29201
Phone: (803) 256-3400 Fax: (803) 256-2039
LONQUIST, James L. (Lauralyn)
1717 North E Street, Suite 333, Pensacola, FL 32501
Phone: (850) 484-6600 Fax: (850) 479-1697
LOPEZ, Nicholas M. (Cara)
2601 Kentucky Ave, Paducah, KY 42003
**LOUGHRIDGE, Billy Paul (Linda)
2100 South Utica Suite 204, Tulsa, OK 74114
Phone: (918) 744-7213 Fax: (918) 744-7214
**LOWE, James E. (Lorraine)
P.O. Box 3954, Room 4537 Blue Zone, Durham, NC 27710
Phone: (919) 684-3235 Fax: (919) 681-7524
LOWRY, Terry S. (Paula)
2936 North Elm Street, Lumberton, NC 28359
Phone: (910) 671-6619 Fax: (910) 608-0487
**LUCAS, Aaron E. (Betty)
4402 Churchman Ave., Suite 205, Louisville, KY 40215
Phone: (502) 366-8825 Fax: (502) 366-0044
LUCKE, John C. (Barbara)
1100 Tunnel Road, Asheville VAMC #112, Asheville, NC 28805
Phone: (828) 299-2540 Fax: (828) 299-2567
+LUU, Theresa Duyen
1199 Prince Avenue, 2nd Floor Athens, GA 30606
+LY, Truc Trung
*828 Dublin Dr., Mishawaka, IN 46545
Phone: (541) 602-3549 Fax: (574) 335-0738
LYDA, Tim S. (Virginia)
4330 Medical Drive, Suite 325, San Antonio, TX 78229
Phone: (210) 615-7700 Fax: (210) 615-1958
LYONS, Jefferson M. (Ellen)
3525 Olentangy River Rd, Suite 5300, Columbus, OH 43214
Phone: (614) 566-3500
**LYONS, William S. (Dorothy)
5601 Seminary Road, Suite 6, Falls Church, VA 22041
Phone: (703) 998-8600 Fax: (703) 998-8600
MACK, Michael J. (Barbara)
1100 Allied Drive, Plano, TX 75093
Phone: (469) 814-4105 Fax: (469) 814-4388
MACK, John W., Jr. (Diane)
1940 Alcoa Highway, E-110, Knoxville, TN 37920
Phone: (865) 637-6392 Fax: (865) 637-5216
**MACKENZIE, James W. (Melinda)
Dept. of Surgery, PO Box 19, New Brunswick, NJ 08903
Phone: (732) 235-7802 Fax: (732) 235-8150
MACRIS, Michael P. (Donna)
1631 North Loop W., Suite 240, Houston, TX 77008
Phone: (713) 465-7979 Fax: (713) 465-5278
MEMBERSHIP ROSTER
**MACRIS, Allen G. (Eftichia)
6375 Blackwater Trail, Atlanta, GA 30328
Phone: (404) 255-2600
MAGEE, Mitchell J. (Karen)
7777 Forest Lane, Suite A307, Dallas, TX 75230
Phone: (214) 363-9339
MAGGART, Michael L.
9125 Cross Park Drive, Suite 200, Knoxville, TN 37923
Phone: (423) 632-5900 Fax: (423) 637-2114
MAGOVERN, George J., Jr. (Jamie)
14th Floor South Tower, 320 East North Avenue, Pittsburgh, PA 15212
Phone: (412) 359-3715 Fax: (412) 359-3878
MAINWARING, Richard D.
300 Pasteur Drive, Falk CVRC, Stanford, CA 94305
Phone: (650) 723-0190 Fax: (916) 733-7112
MALIAS, Mark A. (Victoria)
1040 37th Place, Suite 101, Vero Beach, FL 32960
Phone: (772) 563-4580 Fax: (772) 563-4690
+MALLIDI, Hari (Susmitha)
One Baylor Plaza, BCM390, Houston, TX 77030
Phone: (832) 355-9304 Fax: (832) 355-9004
+MALTAIS, Simon (Manon)
1215 21st Avenue, MCE 5025, Nashville, TN 37232
Phone: (615) 343-9195 Fax: (615) 343-5248
MANIAR, Hersh (Purvi)
1 Barnes Jewish Hospital Pl, St. Louis, MO 63110
Phone: (314) 362-7431
**MANLY, Isaac V. (Peggy)
725 Lakestone Drive, Raleigh, NC 27609
Phone: (919) 787-0371
MANNING, Peter B. (Kathryn)
Box 8234, One Children’s Place St. Louis, MO 63110
Phone: (314) 454-6165 Fax: (314) 454-2381
**MANSOUR, Kamal A. (Cleo)
1365 Clifton Road NE, Suite A2242, Atlanta, GA 30322
Phone: (404) 778-3554 Fax: (404) 778-4346
MARBARGER, John P. (Sharon)
*1 Brentmoor Park, St. Louis, MO 63105
Phone: (314) 251-6970 Fax: (314) 251-1053
MARGOLIS, Marc (Sheryl)
2175 K Street, NW, 3rd Floor Suite 300, Washington, DC 20037
Phone: (202) 444-6985 Fax: (202) 775-1599
‡MARKS, Jenifer L.
525 N Foote Ave, Suite 302, Thoracic Surgery,
Colorado Springs, CO 80909
**MARSHALL, William G. (Marsha)
University of South Florida College of Medicine, 3500 E. Fletcher Ave.,
Ste. 530, MDC 62 Tampa, FL 33613
Phone: (813) 974-7663 Fax: (813) 974-8487
MARSHALL, M. Blair
3800 Reservoir Road, NW, Washington, DC 20007
Phone: (202) 444-5045 Fax: 1 (877) 376-2421
MARTIN, Linda W. (Stephen)
Dept of Surgery, 510 Upper Chesapeake Dr, #515, Bel Air, MD 21204
Phone: 410-531-1451 Fax: (443) 643-3231
MARTIN, Jeffery S. (Susan)
Eight Richland Medical Park, Suite 400, Columbia, SC 29203
Phone: (803) 765-0871 Fax: (803) 765-9215
MARTIN, J.E. ‘Rick’ (Suzie)
5320 S. Rainbow Blvd, Suite 282, Las Vegas, NV 89118
Phone: (702) 737-3808 Fax: (702) 737-7364
MARTIN, Tomas D.
1600 SW Archer Road, Room M602, Gainesville, FL 32610
Phone: (352) 846-0360 Fax: (352) 846-0356
+MARTIN, Jeremiah Thomas
740 South Limestone St., A301, Lexington, KY 40536
Phone: (859) 323-6494 Fax: (859) 257-4682
MASCIO, Christopher E. (Beth)
Phone: (502) 561-2180 Fax: (502) 561-2190
MEMBERSHIP ROSTER
MASROOR, Saqib (Aisha)
111760 SW 40 Street, Suite 722 Miami, FL 33175
Phone: (201) 790-0793 Fax: (786) 428-1062
**MATTHEWS, John T.
329 Coatsland Drive, Jackson, TN 38301
Phone: (901) 424-5080 Fax: (901) 424-4109
**MATTINGLY, William T. (Sally)
*8 North Hill Rd., Wausau, WI 54403
**MATTOX, Kenneth L. (June)
One Baylor Plaza, Houston, TX 77030
Phone: (713) 798-4557 Fax: (713) 796-9605
MAUNEY, Michael C. (Cheryl)
3009 North Ballas Road, Suite 360C, St. Louis, MO 63131
Phone: (314) 996-5287 Fax: (314) 996-5287
MAVROUDIS, Constantine (Martha)
*315 E. New England Avenue, #2, Winter Park, FL 32789
Phone: (407) 303-3697
MAXEY, Thomas S.
1001 Blythe Blvd, Suite 300, Charlotte, NC 28203
Phone: (704) 381-3916
MAYER, John E. (Christine)
Cardiac Surgery, 300 Longwood Ave, Boston, MA 02115
Phone: (617) 355-8258 Fax: (617) 730-0214
MAYFIELD, William R. (Shirley)
61 Whitcher St NE, Suite 4120, Marietta, GA 30060
Phone: (770) 424-9732 Fax: (770) 421-0228
**MCCARDLE, Robert J. (Sally)
Phone: (803) 739-6301 Fax: (803) 78202732
MCCOY, Daniel W. (Dana)
PO Box 5564, Johnson City, TN 37602
Phone: (423) 676-8088 Fax: (423) 282-8911
**MCCRACKEN, Robert L.
MCCURDY, James R. (Sherri)
500 East Robinson, Suite 2300, Norman, OK 73071
Phone: (405) 329-4102 Fax: (405) 364-3476
**MCCUTCHEON, Benson W., Jr. (Lou)
2014 Wilshire Drive, Durham, NC 27707
**MCDOWELL, Donald E. (Amada)
West Virginia University Medical Center,
Department of Surgery, Morgantown, WV 26506
Phone: (304) 293-2367 Fax: (304) 293-4711
‡MCELVEEN, Russell L.
53 Northtown Drive, Apt. 35 G, Jackson, MS 39211
Phone: (843) 453-7639
**MCELVEIN, Richard B.
97 Carey Lane, Falmouth, MA 02540
Phone: (508) 548-3850
**MCGEE, Lawrence S. (Evelina)
15 Midtown Park Dr. West, Suite C, Mobile, AL 36606
Phone: (251) 432-2701 Fax: (251) 432-0469
+MCKENZIE, Emmett Dean (Laurie)
6621 Fannin Street,WT19345H, Houston, TX 77030
Phone: (832) 826-1929 Fax: (832) 825-1904
**MCLAUGHLIN, Joseph S. (Irene)
10 East Lee Street, #2507, Baltimore, MD 21202
Phone: (410) 328-3218 Fax: (410) 328-2750
**MCMULLAN, Martin H. (Lyllian)
Clinical Affairs - Box 9283, 2500 N. State Street, Jackson, MS 39216
Phone: (601) 815-9292 Fax: (601) 815-5474
MCNEIL, Jeffrey D. (Shannon)
*15 Serena, San Antonio, TX 78248
Phone: (210) 916-2412
MEADORS, Frederick A. (Carol)
5 St. Vincent Cir., Suite 501, Little Rock, AR 72205
Phone: (501) 666-2894 Fax: (501) 666-9017
**MEADOWS, Charles T. (Helen)
*136 North Bay Drive, Bullard, TX 75757
MEHRAN, Reza J.
1515 Holcombe, Unit 1489, Houston, TX 77030
Phone: (713) 563-3908 Fax: (713) 794-4901
MEHTA, Inder (Neeta)
1514 Jefferson Hwy., New Orleans, LA 70121
Phone: (504) 842-3966
MEMBERSHIP ROSTER
MELDRUM, Daniel R. (Kirstan)
14045 NW 173rd Street, Alachua, FL 32615
Phone: (352) 273-5501 Fax: (352) 273-5513
MENDELOFF, Eric N.
7777 Forest Lane, Suite B 115, Dallas, TX 75230
Phone: (972) 566-2525 Fax: (972) 566-2032
MENDES, O. C. (Judith)
1601 South Apollo Boulevard, Melbourne, FL 32901
Phone: (407) 768-2816 Fax: (407) 952-2607
**MENTZER, Robert M., Jr. (Monika)
540 East Canfield, Rm 1241, Detroit, MI 48201
Phone: (313) 577-1335 Fax: (313) 577-8777
MERRILL, Walter H. (Morgan)
AA 1214 Medical Center North, 1161 21st Ave South, Nashville, TN 37232
Phone: (615) 343-2959
‡MERRITT, Helen Mari
3611 Stonhaven, San Antonio, TX 78230
Phone: (210) 863-8289
+MERY, Carlos M. (Marissa)
6621 Fannin WT-19345, Houston, TX 77030
Phone: (617) 281-0090 Fax: (832) 825-1904
MESSERSCHMIDT, William H. (Bonnie)
One Medical Park Blvd., Suite 458-W, Bristol, TN 37620
Phone: (423) 230-5005 Fax: (423) 230-5170
METTLER, Bret Allen (Kelly)
5247 Doctor’s Office Tower, 2200 Children’s Way Nashville, TN 37232
Phone: (615) 936-5500
MEYER, Dan M. (Peggy)
5323 Harry Hines Boulevard, Dallas, TX 75390
Phone: (214) 645-7716 Fax: (214) 645-9708
MEYERS, Cary H. (Laura)
*2216 Valley Falls Court, Kingsport, TN 37664
Phone: (423) 480-9633
MEYERS, Bryan F. (Julie)
Queeny Tower, Suite 3108,
Barnes-Jewish Hospital Plaza, St. Louis, MO 63110
Phone: (314) 362-8598 Fax: (314) 367-8459
MILANO, Carmelo A.
DUMC Box 3043, Durham, NC 27710
Phone: (919) 684-3243 Fax: (919) 684-8563
MILL, Michael R.
Division of Cardiothoracic Surgery, 3040 Burnett Womack Bldg, UNC-CH
CB #7065, Chapel Hill, NC 27599
Phone: (919) 966-3381 Fax: (919) 966-3475
**MILLER, Joseph I. (Louise)
*1858 Breckenridge Drive NE, Atlanta, GA 30345
Phone: (404) 634-3498
MILLER, Daniel L. (Pamela)
Section of Thoracic Surgery, 1365 Clifton Road NE, Atlanta, GA 30322
Phone: (404) 778-3755 Fax: (404) 778-4346
MILLER, LaWayne O., Jr. (Rita)
2501 Jimmy Johnson Blvd, Suite 201, Port Arthur, TX 77640
Phone: (409) 722-4001 Fax: (409) 722-4010
MILLER, James E. (Sarah)
835 W. 55th St, Kansas City, MO 64113
Phone: (913) 390-8050 Fax: (913) 390-8049
**MILLS, Mitchell (Betty)
7442 Spring Village Dr., Apt. PV-118, Springfield, VA 22150
MILLS, Stephen A.
306 Westwood Ave, Suite 505, High Point, NC 27262
Phone: (336) 889-7700 Fax: (336) 889-7701
MINNICH, Douglas (Heather)
703 19th Street South, 716 Zeigler Research Building,
Birmingham, AL 35294
Phone: (205) 940-6258 Fax: (205) 996-9500
MITCHELL, Michael E. (Aoy)
9000 W. Wisconsin Ave, MS B730, Milwaukee, WI 53226
Phone: (414) 266-2491 Fax: (414) 266-2075
MEMBERSHIP ROSTER
**MITTS, Donald L. (Elizabeth)
2123 Auburn Avenue-Suite 238, Cincinnati, OH 45219
Phone: (513) 651-1180 Fax: (513) 651-2175
‡MONFRE, Joseph M.
*8830 Fernbrook, San Antonio, TX 78250
Phone: (210) 567-6158
MEMBERSHIP ROSTER – N
**MONTAGUE, Norton T., III (Cynthia)
9 Innisbrook Lane, Birmingham, AL 35242
MOON, Marc R.
One Barnes-Jewish Hospital Plaza, Queeny Tower,
Suite 3108, St. Louis, MO 63110
Phone: (314) 362-0993 Fax: (314) 362-0328
MOORE, Wistar, III
700 Doctors Court, Leesburg, FL 34748
Phone: (352) 787-9838 Fax: (352) 728-8705
MORA, Bassem N.
PO Box 6162, Chicago, IL 60680
Phone: (773) 484-3778 Fax: (773) 245-5220
MORACA, Robert J. (Holly)
320 E. North Avenue, 14th Floor South Tower Pittsburgh, PA 15212
Phone: (412) 359-8820 Fax: (412) 359-3878
MORELL, Victor O. (Amy)
Children’s Hospital of Pittsburgh of UPMC, Faculty Pavilion, 5th Floor
45th and Penn Avenue, Pittsburgh, PA 15201
Phone: (412) 692-7625 Fax: (412) 692-5817
MORGAN, Joel C.
4622 Country Club Road, Suite 180, Winston-Salem, NC 27104
Phone: (919) 768-9510 Fax: (919) 768-4155
MORRIS, Cullen D. (Leigh)
Medical Services Building, 1199 Prince Ave., 2nd Floor Athens, GA 30606
Phone: (706) 475-1950 Fax: (706) 208-1526
**MORRIS, Robert J. (Mary)
MORTMAN, Keith D. (Kristy)
2150 Pennsylvania Avenue, NW, Washington, DC, 20037
Phone: (202) 741-3220 Fax: (202) 741-3488
**MOSELEY, Patterson W. (Sherry)
*630 Dunmar Cicrle, Winter Springs, FL 32708
Fax: (407) 422-0166
MOTTA, Joseph
3370 Burns Road-Suite 206, Palm Beach Gardens, FL 33140
Phone: (561) 626-9801 Fax: (561) 626-9804
MOULTON, Michael J. (Mary Lee)
*2035 181st Circle, Omaha, NE, 68150
Phone: (402) 559-4424 Fax: (402) 559-6913
MOY, Peter M. (Barbara)
3000 Coliseum Dr., Ste 200, Hampton, VA 23666
Phone: (757) 736-7250 Fax: (757) 262-1444
**MULLEN, Donald C. (Patricia)
18 Westbrook Drive, Newnan, GA 30263
Phone: (770) 683-4528
MULLENIX, Philip S. (Cristina)
*2700 Spencer Rd, Chevy Chase, MD 20815
Phone: (919) 806-9688
MULLETT, Timothy W.
Phone: (859) 323-6494 Fax: (859) 257-4682
MULLIGAN, Charles Ray, Jr.(Sharon)
*1211 Running Cedar Way, Lynchburg, VA 24503
Phone: (434) 200-6262 Fax: (434) 200-5307
MUMTAZ, Muhammad (Farhana)
Baylor College of Medicine, 315 N. San Saba St.
Suite 1135, San Antonio, TX 78207
Phone: (210) 704-4275 Fax: (210) 704-4520
MUNDINGER, Gerhard H. (Sue)
1860 Chadwick Drive, Suite 256, Jackson, MS 39204
Phone: (601) 376-1394 Fax: (601) 376-2005
MUNFAKH, Nabil A. (Paula)
11155 Dunn Road, Suite 209 East, St. Louis, MO 63136
Phone: (314) 355-3003 Fax: (314) 355-0515
MEMBERSHIP ROSTER
+MURPHY, Edward T. (Sally )
100 Michigan Street NE, MC 103, Grand Rapids, MI 49503
Phone: (616) 459-7258 Fax: (616) 459-5215
MURPHY, Douglas A. (Susan)
5665 Peachtree-Dunwoody Road, Suite 200, Atlanta, GA 30342
Phone: (404) 778-7200
MURPHY, Michael C.
3009 North Ballas Road, Suite 360C, St. Louis, MO 63131
Phone: (314) 996-5287 Fax: (314) 432-6068
MURRAH, Charles Patrick (Alison)
Emory Clinic Athens, 1199 Prince Avenue
MSB 2nd Floor Athens, GA 30606
Phone: (706) 475-1950 Fax: (706) 475-1955
MEMBERSHIP ROSTER – O
**MURRAY, Gordon F. (Sharon)
4217 Skeffington Court, Southport, NC 28461
Phone: (910) 448-0048 Fax: (910) 457-6365
‡MURTHY, Raghav A.
*5215 Belmont Ave., Apt. 2206, Dallax, TX 75206
Phone: (313) 319-9227
MYERS, John C. (Pauline)
1340 Charles St, Suite 300, Rockford, IL 61104
Phone: (779) 696-8800 Fax: (815) 315-6026
NACHBAUER, Craig A. (Sharalyn)
North Country Thoracic and Vascular, PC,
12 Healey Avenue, Plattsburgh, NY 12901
Phone: (518) 314-1520 Fax: (518) 314-1178
‡NASIR, Basil Saad
1560 rue Sherbrooke est, 8e CD - Pavillon Lachapelle, bureau D-8051,
MontreAL QC, H2L 4M1, Canada
Phone: (514) 890-8000
NAUNHEIM, Keith S. (Rosanne)
3635 Vista Avenue at Grand, St. Louis, MO 63110
Phone: (314) 577-8360 Fax: (314) 577-8315
**NELSON, Ken (Sharon)
*609 Purdue, Tyler, TX 75703
Phone: (903) 877-7460 Fax: (903) 877-5548
‡NERAVETLA, Soumya R.
*19 Rio Rd, Savannah, GA 31419
NESBITT, Jonathan C. (Sally )
1710 The Vanderbilt Clinic, 1301 Medical Center Drive Nashville, TN 37232
Phone: (615) 322-0248 Fax: (615) 343-5993
**NESMITH, M. A., Jr. (Carolyn)
1121 NW 64th Terrace, Gainesville, FL 32605
Fax: (352) 332-6098
**NEVILLE, Edwin C. (Diane)
1021 Park Street, Scranton, PA 18509
Phone: (717) 344-1231 Fax: (717) 344-1255
NEW, Brent R. (Sharon)
1010 W. 40th, Austin, TX 78756
Phone: (512) 459-8753 Fax: (512) 483-6807
**NEWMAN, William H. (Ernestine)
1205 Longleaf Drive, Fayetteville, NC 28305
Phone: (910) 485-6464
NEWSOM, Barry D. (Nancy)
Suite 808, 701 University Blvd. East, Tuscaloosa, AL 35401
Phone: (205) 759-4228 Fax: (205) 345-0841
NEWTON, Joseph R. (Jill)
600 Gresham Drive, Suite 8600, Norfolk, VA 23507
Phone: (757) 388-6005 Fax: (757) 388-6006
NIELSEN, James L. (Jody)
5151 North 9th Ave., Suite 200, Pensacola, FL 32504
Phone: (850) 937-0717 Fax: (850) 857-1745
NIFONG, Wiley L. (Daphne)
East Carolina Heart Institute, 115 Heart Drive, Greenville, NC 27834
Phone: (252) 744-2187 Fax: (252) 744-3542
**NIGHTINGALE, David S. (Patricia)
6900 U.S. Highway 42, Louisville, KY 40241
Phone: (502) 339-9901 Fax: (502) 339-8858
NORCROSS, James F. (Shirley)
902 West Randol Mill Road, Suite 200, Arlington, TX 76012
Phone: (817) 461-8327 Fax: (817) 275-2525
**NORENBERG, Richard G. (Arlene)
Baypines VA Medical Center, DEPT of Surgery,
P.O. Box 5005, Bay Pines, FL 33744
Phone: (727) 385-5650 Fax: (727) 398-9584
MEMBERSHIP ROSTER
**NORRIS, Franklin G. (Sara)
1801 Bimini Drive, Orlando, FL 32806
Phone: (407) 425-7555 Fax: (407) 894-4977
NOVICK, William M.
80 Monroe Avenue, Suite G1, Memphis, TN 38103
Phone: (901) 869-4243 Fax: (901) 432-4243
**NUNN, Daniel B. (Gloria)
5125 Yacht Club Road, Jacksonville, FL 32210
Phone: (904) 384-0176 Fax: (904) 387-4597
**NUNNALLY, Lester C. (Jeanne)
5538 Jessamine Lane, Orlando, FL 32839
Phone: (407) 851-2529
OAKS, Timothy E. (Ann)
Ely Surgical Associates, 3940 Arrowhead Blvd,
Suite 230, Mebane, NC 27302
Phone: (336) 712-0460 Fax: (336) 716-3348
O’BRIEN, James E., Jr. (Lina)
2401 Gillham Road, Kansas City, MO 64108
Phone: (816) 234-3580 Fax: (816) 802-1245
**OCHSNER, John L. (Mary Lou)
1514 Jefferson Highway, New Orleans, LA 70121
Phone: (504) 842-4070 Fax: (504) 842-6767
**ODYNIEC, Norman A. (Mary)
*9208 Le Velle Drive, Chevy Chase, MD 20815
Phone: (301) 906-3900 Fax: (301) 656-9632
MEMBERSHIP ROSTER – P
OFENLOCH, John C. (Tiffany)
455 Pinellas St, Ste 320, Clearwater, FL 33756
Phone: (727) 446-2273 Fax: (727) 441-4966
OGLE, William (Jeanne)
*618 N New Ballas Rd, 405, St. Louis, MO 63141
Phone: (573) 270-2861
**OKANO, Takeshi (Betty)
2313 Lanai Avenue, Bellair Bluffs, FL 33770
Phone: (727) 584-7295
OKUM, Eric J. (Bess)
10506 Montgomery Road, Suite G103, Cincinnati, OH 45242
Phone: (513) 865-5120 Fax: (513) 865-5121
**OLCOTT, Eugene D.
6013 Merrymount Rd., Fort Worth, TX 76107
Phone: (817) 732-1900
**OLINDE, Henry D. H. (Diane)
*7225 Barford Ave, Baton Rouge, LA 70808
Phone: (504) 924-5396 Fax: (504) 924-5590
**OLIVET, Ronald T. (Linda)
*1814 Northridge Road, Tuscaloosa, AL 35406
Fax: (205) 349-4114
OSWALT, John D. (Karen)
1010 West 40th Street, Austin, TX 78756
Phone: (512) 459-8753 Fax: (512) 483-0586
+OTAKI, Yoshio (Chiyo)
Medical Center Boulevard, Winston-Salem, NC 27157
Phone: (336) 793-9226 Fax: (336) 716-1295
OTERO, Carmelo (Carmen)
225 E. Sonterra Blvd., Ste 201, San Antonio, TX 78258
Phone: (210) 615-6626 Fax: (210) 615-1318
**OTHERSEN, Biemann H., Jr. (Janelle)
Department of Surgery, 171 Ashley Avenue, Charleston, SC 29425
Phone: (843) 792-3851 Fax: (843) 792-3858
OWEN, Edmond W., Jr. (Kathryn)
3980 New Covington Pike, Suite 101, Memphis, TN 38128
Phone: (901) 383-8232 Fax: (901) 383-8277
**OWENS, Joseph L., Jr. (Emily)
156 Hampton Point Drive, St. Simons Island, GA 31522
Phone: (912) 638-6479
PAGNI, Sebastian (Jennifer)
Phone: (502) 899-3858 Fax: (502) 899-3878
**PAI, Ganesh M. (Sharada)
209 Timber Ridge Drive, West Columbia, SC 29169
Phone: (803) 794-5307 Fax: (803) 926-0328
+PAL, Jay D. (Angela)
1959 NE Pacific Street, Box 356310, Seattle, WA 98195
Phone: (206) 598-3636
**PALATCHI, Albert S. (Donna)
2500 Gulf Blvd., 203 A, Belleair Beach, FL 33786
Phone: (727) 595-2530
PALATIANOS, George M. (Elisabeth)
*Zamanou 40A, Glyfada, 166 74, Greece
Phone: 306944474280 Fax: (210) 968-1000
MEMBERSHIP ROSTER
PALAZZO, Anthony J.
310 N State of Franklin Road, Suite 101, Johnson City, TN 37604
Phone: (423) 929-7393
PALIOTTA, Marco A.
920 Stanton L Young Blvd., WP 2230, Oklahoma City, OK 73104
Phone: (405) 271-5789 Fax: (405) 271-3288
PALMER, George J., III (Sheila)
Phone: (407) 425-1566 Fax: (407) 422-0166
‡PAN, Hao
7703 Floyd Curl Drive, MC7841, San Antonio, TX 78229
**PARKS, William E., Jr. (Susan)
4402 Churchman Avenue, Caritas Medical Bldg. #1,
Suite 20S, Louisville, KY 40215
Phone: (502) 366-8825 Fax: (502) 366-0044
PARRINO, Patrick Eugene (Charlotte)
1514 Jefferson Highway, New Orleans, LA 70121
Phone: (504) 842-3966 Fax: (504) 842-2278
PARSA, Cyrus J. (Suzanne)
504 Redmond Road, Rome, GA 30165
Phone: (706) 290-2360
MEMBERSHIP ROSTER – P
PARSONS, Alden (Stephen)
Rex Thoracic Specialists, 2800 Blue Ridge Road,
Suite 201, Raleigh, NC 27607
Phone: (919) 306-2164 Fax: (713) 794-4901
PARSONS, Billy D. (Terri Lynn)
611 Alcorn Drive, Suite 200, Corinth, MS 38834
Phone: (903)278-0007 Fax: (662) 665-4645
**PASCOTTO, Robert D. (Joan)
8010 Summerlin Lakes Drive, STE 100, Fort Myers, FL 33907
Phone: (941) 939-1767 Fax: (941) 939-5895
PASS, Lawrence J. (Jan)
Phone: (615) 340-0070 Fax: (615) 340-9379
PASTUSZKO, Peter (Wendy)
3030 Children’s Way, Suite 202, San Diego, CA 92123
Fax: (858) 966-8032
**PATE, James W. (Anne)
910 Madison Ave, 2nd Floor Rm 208, Memphis, TN 38163
Phone: (901) 448-5912 Fax: (901) 448-7588
PATEL, Vijay S. (Lina)
3945 Hammonds Ferry, Evans, GA 30809
Phone: (706) 721-3226 Fax: (706) 721-7508
PATEL, Himanshu Jagdish (Heena)
1500 East Medical Center Drive, 5144 Cardiovascular Center,
Ann Arbor MI 48109
Phone: (734) 615-9129 Fax: (734) 764-2255
PATTERSON, Alexander (Susan)
660 South Euclid Ave, Box 8234, St. Louis, MO 63110
Phone: (314) 362-6025 Fax: (314) 747-4087
**PECORA, David V. (Dorothy)
7202 Evans Mill Road, Mc Lean, VA 22101
PEELER, Benjamin Banks
1001 Blythe Blvd, Suite 300, Charlotte, NC 28203
Phone: (704) 373-1813
**PEIRCE, Converse E., II (Esther)
HC 77 Box 618, Hancock, ME, 04640
Phone: (207) 422-8247
PENNATHUR, Arjun (Revathi)
200 Lothrop St., C-800, Pittsburgh, PA 15213
Phone: (412) 647-7556
PENNINGTON, Glenn D. (Dottie)
East Tennessee State University, PO Box 75075, Johnson City, TN 37614
Phone: (423) 439-6771 Fax: (423) 439-6259
PEPER, William A.
300 Richland West, Suite 2, Waco, TX 76712
Phone: (254) 772-2300 Fax: (254) 772-5514
PEREIRA, Sara Jane (Keith)
425 Patterson Rd., Suite 403, Grand Junction, CO 81506
Phone: (970) 298-7675 Fax: (970) 245-2984
MEMBERSHIP ROSTER – R
MEMBERSHIP ROSTER
**PERRYMAN, Richard A.
1150 North 35th Avenue, Suite 440, Hollywood, FL 33021
Phone: (954) 962-5000 Fax: (954) 961-7027
PETERSEIM, David Scott
125 Doughty Street, Suite 690, Charleston, SC 29403
Phone: (843) 720-8490 Fax: (843) 727-3602
PETIT, Scott J. (Barbara)
8 Richland Medical Park, Suite 400, Columbia, SC 29203
Phone: (803) 765-0871 Fax: (803) 765-9215
PETRACEK, Michael R. (Constance)
1215 - 21st Avenue So, Suite 5209 MCE South Tower, Nashville, TN 37205
Phone: (615) 343-9185 Fax: (615) 343-5248
PETRIK, Pavel V. (Linda)
1331 West Avenue J, #203, Lancaster, CA 93534
Phone: (661) 733-0181 Fax: (661) 718-2472
PETTITT, Timothy W. (Deborah)
200 Henry Clay Avenue, New Orleans, LA 70118
Phone: (504) 896-9868 Fax: (504) 896-3952
PEYTON, Robert B. (Christy)
3000 New Bern Avenue, Suite 1100, Raleigh, NC 27610
Phone: (919) 784-7110 Fax: (919) 870-7599
PEYTON, Marvin D.
920 Stanton Young Boulevard, WP2230, Oklahoma City, OK 73104
Phone: (405) 271-5789 Fax: (405) 271-3288
**PICKARD, Laurens R. (Julie)
6560 Fannin Suite 1846, Houston, TX 77030
Phone: (713) 797-1211 Fax: (713) 795-9805
PICKENS, Allan (Abraxas)
Emory Crawford Long Medical Tower Thoracic Surgery, 6th Floor 550
Peachtree St. N.E. Atlanta, GA 30308
Phone: (404) 686-2515 Fax: (404) 686-4788
PIERSON, Richard Norris, III (Allene)
22 South Greene Street, N4W94, Baltimore, MD 21201
Phone: (410) 328-5842 Fax: (410) 328-2750
**PINCKLEY, James N. (Peggy)
1900 S. National Avenue, Suite 3400, Springfield, MO 65809
Phone: (417) 841-3960 Fax: (417) 841-3967
**PITMAN, John M., Jr. (Helene)
326 Monticello Drive, Williamsburg, VA 23185
Phone: (804) 229-4958 Fax: (804) 229-3118
**PLAYFORTH, Herman R. (Elizabeth)
6105 Sulphur Well Rd, Lexington, KY 40509
Fax: (859) 264-7784
PLUNKETT, Mark D. (Connie)
2450 Riverside Ave, E. Bldg MB 544, Minneapolis, MN 55454
Phone: (612) 625-7132 Fax: (859) 257-4682
PLUSCHT, Peter, III
1855 Spring Hill Avenue, Mobile, AL 36607
Phone: (334) 633-2314 Fax: (334) 633-3135
POLIMENAKOS, Anastasios C. (Maria)
Geisinger Clinic, Pediatric Cardiothoracic Surgery,
100 N Academy Ave, Danville, PA 17822
Phone: (708) 363-5040
POLLARD, Thomas R. (Camy)
Phone: (865) 659-2110 Fax: (865) 637-2114
POLLOCK, Samuel B. (Laura)
Phone: (502) 899-3858 Fax: (502) 899-3878
POSTON, Robert S. (Susan)
1501 N. Campbell Avenue, P.O. Box 245071, Tucson, AZ 85724
Phone: (520) 626-7951 Fax: (520) 626-7955
**PRADHAN, Duleep J. (Gale)
6722 Milani Street, Lake Worth, FL 33467
Phone: (561) 968-3238 Fax: (561) 968-3238
PRAGER, Richard L. (Lauren)
5144 Cardiovascular Center, 1500 East Medical Center Drive,
Ann Arbor, MI 48109
Phone: (734) 936-4974 Fax: (734) 764-2255
**PRATHER, Richard J. (Evelyn)
*6758 Tangleberry Lane, Memphis, TN 38138
Phone: (901) 523-8990
+PREVENTZA, Ourania
6770 Bertner Street, C350, Houston, TX 77030
Phone: (832) 355-9910 Fax: (832) 255-9920
MEMBERSHIP ROSTER
+PRICE, Theolyn
*1165 Charles Grove, Colorado Springs, CO 80906
Phone: (507) 269-9463 Fax: (407) 473-3553
**PRILLAMAN, Paul E., Jr. (Ginger)
1311 70th Street NW, Bradenton, FL 34209
PUSKAS, John D. (Jane)
550 Peachtree Street, 6th Floor M.O.T., Atlanta, GA 30308
Phone: (404) 686-2513 Fax: (404) 686-4959
PUTNAM, Joe B., Jr. (Jacqueline)
609 Oxford House, 1313 21st Avenue South, Nashville, TN 37232
Phone: (615) 343-9202 Fax: (615) 322-3079
QUINTESSENZA, James A.
601 5TH ST S, 6TH Floor BOX 70-6610, St. Petersburg, FL 33701
Phone: (727) 767-6666 Fax: (727) 767-8606
RAHBAR, Ahmad (Marylon)
1021 Mount De Chantal Road, Wheeling, WV 26003
Phone: (304) 243-1000 Fax: (304) 243-1523
RAMLAWI, Basel (Nasrin)
6550 Fannin St, Suite 1401, Houston, TX 77030
Phone: (713) 441-5200 Fax: (713) 793-7428
**RAMS, James J. (Jan)
112 Yorkshire Dr., Pittsburgh, PA 15238
Phone: (412) 963-7984
**RANDOLPH, Judson G. (Comfort)
3800 Whitland Avenue, Nashville, TN 37205
RANKIN, Scott J. (Sue)
320 Lynnwood Blvd, Nashville, TN 37205
Phone: (615) 969-1543
**RAWITSCHER, Robert E. (Carol)
2812 Fenwich Lane, Plano, TX 75093
Fax: (972) 867-9464
RAYBURN, Thomas S., III
10100 Kanis Road, Little Rock, AR 72205
Phone: (501) 223-5757 Fax: (501) 223-5758
**RAYL, John E. (Billie)
Veterans Admin. Hospital Suite 151, Lake City, FL 32055
**READ, Raymond C. (Lillian)
*304 Potomac St., Rockville, MD 20850
Phone: (501) 660-2038 Fax: (501) 671-2523
READE, Clifton (Erin)
ACTVS 2108 E 3rd St, Suite 300, Chattanooga, TN 37404
Phone: (423) 624-5200 Fax: (423) 624-4440
REAMES, Mark K. (Gay)
1001 Blythe Boulevard, Suite 300, Charlotte, NC 28203
Phone: (704) 373-0212 Fax: (704) 372-1249
REARDON, Michael J. (Robin)
6550 Fannin Street, Suite 1401, Houston, TX 77030
Phone: (713) 441-5200 Fax: (713) 390-3370
REDA, Hassan K.
Phone: (859) 323-6494 Fax: (859) 257-4682
REDDY, Seenu V. (Meera)
*3513 Woodmont Boulevard, Nashville, TN 37215
Phone: (615) 342-6900 Fax: (615) 342-6899
REDMOND, Clyde (Susan)
Warren Clinic, 6151 South Yale Ave, Ste 1301, Tulsa, OK 74136
Phone: (918) 502-3200 Fax: (918) 502-3200
REECE, Brett T. (Leena)
12631 East 17th Avenue, Room 6602, MS C310, Aurora, CO 80045
Phone: (303) 724-7428 Fax: (303) 724-2806
REGO, Alfredo (Molly Anne)
3650 NW 82 Ave, Suite 207-208, Doral, FL 33166
Phone: (305) 935-9883 Fax: (305) 792-9901
**REINHARDT, Robert J. (Nora)
19921 Downing Road, Holt, MO 64048
**REUL, George J. (Susan)
P.O. Box 20345, Houston, TX 77025
Phone: (832) 355-4929 Fax: (832) 355-3424
REUL, Ross M. (Terri)
1101 Bates, P514, Houston, TX 77030
Phone: (832) 355-5884 Fax: (832) 355-3770
MEMBERSHIP ROSTER
**RHEA, Gardner W., Jr. (Joan)
109 Stoney Creek Loop, 3329 Land Harbor Newland, NC 28657
Phone: (828) 733-3382 Fax: (828) 733-3382
RHEE, John W. (Barbara)
1625 North George Mason Drive, Ste 288, Arlington, VA 22205
Phone: (703) 558-6491 Fax: (703) 524-4365
RICCI, Marco (Michelle)
1 University of New Mexico, MSC10 5610, Albuquerque, NM 87131
Phone: (505) 272-6901 Fax: (505) 272-6909
RICE, David C.
1400 Pressler, Suite 19.6000, Houston, TX 77030
Phone: (713) 794-1477 Fax: (713) 794-4901
RICHARDSON, John B.
2871 Acton Road, Suite 100, Birmingham, AL 35243
Phone: (205) 879-5733 Fax: (205) 969-3513
RIGBY, Swayze (Joni)
7777 Hennessey Boulevard, Suite 1008, Baton Rouge, LA 70808
Phone: (225) 766-0416 Fax: (225) 766-6941
**RIGGS, Orval E. (Inez)
1300 North Hughes, Little Rock, AR 72207
Phone: (501) 666-1315
**RILEY, Stancel M. (Kerri)
21 Chauncy Street Apt 3, Cambridge, MA 02138
Phone: (617) 945-2402 Fax: (617) 945-2403
RING, W. Steves (Denise)
5323 Harry Hines Boulevard, Dallas, TX 75390
Phone: (214) 645-7706 Fax: (214) 645-9708
ROACH, Harry A. (Maria)
4228 Houma Blvd, Suite 300, Metairie, LA 70006
Phone: (504) 454-2222 Fax: (504) 454-2388
ROBACZEWSKI, David L. (Susan)
818 Congress Street, Portland, ME 04102
Phone: (207) 773-8161
+ROBERTS, Harold G. (Angelica)
4725 N Federal Highway, Fort Lauderdale, FL 33308
Phone: (954) 267-6770 Fax: (954) 267-6768
ROBERTS, John Robert (Katherine)
Phone: (615) 390-9075 Fax: (615) 340-3547
**ROBERTS, Arthur J.
Jersey Shore Cardiac & Thoracic Surgery Assoc., 1944 Corliss Avenue,
Suite 204 Neptune, NJ 07753
Phone: (732) 776-4610 Fax: (732) 776-4647
**ROBERTSON, William A.
*Oak Knoll Farm 1185 Millers Lane, Manakin Sabot, VA 23103
Phone: (804) 282-2227 Fax: (804) 282-2228
**ROBICSEK, Francis (Livia)
Suite 300, 1001 Blythe Boulevard, Charlotte, NC 28203
Phone: (704) 444-3901 Fax: (704) 373-0781
ROBINSON, Lary A. (Susannah)
12902 Magnolia Drive, Thoracic Oncology Program, Tampa, FL 33612
Phone: (813) 745-6895 Fax: (813) 745-3027
ROBINSON, John R. (Sue)
3311 Ivy Hills Blvd, Cincinnati, OH 45244
Phone: (513) 421-3494 Fax: (513) 345-2606
RODGERS, Bradley M. (Martha)
University of Virginia Department of Surgery Box 800709,
Charlottesville, VA 22908
Phone: (804) 924-2673 Fax: (804) 924-2656
RODRIGUEZ, Jose Rafael (Amber)
30 E. Apple St., Suite 1480, Dayton, OH 45409
Phone: (937) 208-3220
RODRIGUEZ, Evelio (Lisa)
4230 Harding Road, Suite 430, Nashville, TN 37205
Phone: (615) 222-5500 Fax: (615) 222-5601
RODRIGUEZ AGUERO, Jesus (Joan Lois)
620 South 12th Street, McAllen, TX 78501
**RODRIGUEZ-RAMOS, Ernest R. (Deboarah)
700 S. Sycamore St., Ste 6, Petersburg, VA 23803
Phone: (804) 861-8600 Fax: (804) 861-8610
RONSON, Russell S.
2018 Brookwood Medical Center Dr., POB
Suite 215, Birmingham, AL 35209
Phone: (205) 877-2627 Fax: (205) 802-6590
MEMBERSHIP ROSTER
ROSENBLOOM, Michael (Carol)
3 Cooper Plaza, Suite 411, Camden, NJ 08103
Phone: (856) 342-2141
+ROSENGART, Todd (Debra)
One Baylor Plaza, Mailstop BCM390, Houston, TX 77030
Phone: (713) 798-1317 Fax: (713) 798-6609
MEMBERSHIP ROSTER – S
ROSS, Scott D. (Alesia)
Phone: (843) 720-8490 Fax: (843) 727-3602
ROUSE, Richard G. (Veronica)
4330 Medical Drive, Suite 325, San Antonio, TX 78229
Phone: (210) 615-7700 Fax: (210) 496-3342
ROVIN, Joshua (Peggy)
455 Pinellas St, Suite 320, Clearwater, FL 33756
Phone: (727) 446-2273 Fax: (727) 441-4966
ROWE, Joseph Franklin, III (Anne)
2001 Crystal Spring Avenue, Suite 201, Roanoke, VA 24014
Phone: (540) 344-5781 Fax: (540) 342-9308
RUBENSTEIN, Forrest
160 Country Road, Fairfield, CT 06824
Phone: (504) 782-3367 Fax: (504) 412-1777
**RUBIN, Joseph W. (Edith)
22 River Reach Way, Charleston, SC 29407
Phone: (843) 225-2946 Fax: (843) 225-2948
RUIZ, Victor H. (Colleen)
*573 Twin Fawns, St. Louis, MO 63131
Phone: (314) 909-7371 Fax: (314) 434-2454
RUSSO, Pierantonio (JoAnne)
Biotechnology Ctr - Temple University,
1762 Teresa Court, Downingtown, PA 19335
Phone: (215) 910-0503 Fax: (888) 268-3470 #2
RYAN, William H.
Cardiac Surgery Specialists, 4716 Alliance Blvd, Ste 310, Plano, TX 75093
Phone: (972) 596-6676 Fax: (214) 692-6265
SADE, Robert M. (Rinne)
25 Courtenay Drive, Suite 7028, MSC 295, Charleston, SC 29425
Phone: (843) 556-1848
SADOFF, John D. (Judith)
9 Park Place, Swansea, IL 62226
Phone: (618) 233-5722
**SADOW, Samuel H. (Bruna)
529 S. Flagler Drive, Ste. 18G, West Palm Beach, FL 33401
Phone: (772) 335-9800 Fax: (772) 335-9090
SAFI, Hazim J.
University of Texas Medical School, 6400 Fannin
Suite 2850, Houston, TX 77030
Phone: (713) 661-8056 Fax: (713) 512-7200
SAHA, Sibu P. (Becky)
740 S. Limestone St., A301, Lexington, KY 40536
Phone: (859) 260-6370 Fax: (859) 278-4836
SAINT, David L. (Rhonda)
1405 Centerville Road, Suite 5000, Tallahassee, FL 32308
Phone: (850) 878-6164 Fax: (850) 656-5575
SAKO, Edward Y. (Jennifer)
7703 Floyd Curl Drive, San Antonio, TX 78229
Phone: (210) 567-5617 Fax: (210) 567-2877
SALAZAR, Jorge D.
2500 N. State Street, Jackson, MS 39216
Phone: (713) 376-9344
SALERNO, Tomas A. (Helen)
1611 NW 12 Ave, R-114, Miami, FL 33139
Phone: (305) 585-5271 Fax: (305) 672-6027
‡SANCHETI, Manu Suraj
*1420 Markan Drive NE, Atlanta, GA 30306
Phone: (646) 467-055
SANCHEZ, Juan A. (Lise)
900 Caton Ave, Baltimore, MD 21229
Phone: (410) 368-2748 Fax: (410) 951-4007
SAND, Mark E. (Leslie)
Phone: (404) 425-1566 Fax: (404) 422-0166
MEMBERSHIP ROSTER
**SANFELIPPO, Peter M. (Cecelia)
1817 Raveneaux Lane, Tyler, TX 75703
Phone: (903) 877-7468 Fax: (903) 877-5892
**SANFORD, Marshall C.
Coosaw Plantation, Dale, SC 29914
**SASSER, William F. (Molly)
5 Woodbridge Manor Road, St. Louis, MO 63141
Phone: (314) 577-8351 Fax: (314) 567-5082
SAULS, Clark F.
901 W. Maple, Suite 201, Enid, OK 73701
Phone: (580) 237-3608
SAVAGE, Edward B. (Susan)
2950 Cleveland Clinic Blvd, Weston, FL 33331
Phone: (954) 659-5320
**SAWYERS, John L. (Julia)
Vanderbilt University Hospital 1001 Oxford House, Nashville, TN 37232
Phone: (615) 936-1290 Fax: (615) 936-0982
SCHAFF, Hartzell V. (Voni)
200 First Street SW, Rochester, MN 55905
Phone: (507) 285-9881 Fax: (507) 255-7378
SCHARFF, James Rowe (Tiffany)
3009 N. Ballas Road, Suite 360 C, St. Louis, MO 63131
Phone: (314) 996-5287
**SCHEERER, Rudolph P. (Joanne)
808 North Olive Avenue, West Palm Beach, FL 33401
Phone: (561) 832-1378 Fax: (561) 832-6771
+SCHENA, Stefano
11155 Dunn Road, Professional Building 1,
Suite 209E, St. Louis, MO 63136
Phone: (314) 355-3003 Fax: (314) 355-0515
SCHIPPER, Paul (Elizabeth)
3181 Southwest Sam Jackson Park Road, L353, Portland, OR 97239
Phone: (503) 494-7820 Fax: (503) 494-7829
**SCHMIDT, Frank E. (Sidonie)
*1137 Jefferson Avenue, New Orleans, LA 70115
Phone: (504) 568-4576 Fax: (504) 568-4633
SCHMIDT, Frank Ernest, Jr.
*13494 E. 600 Rd., Inola, OK 74036
Phone: (918) 502-3200 Fax: (918) 502-3205
**SCHMIDT, Ivan C.
5200 North Flagler Drive, #1701, West Palm Beach, FL 33407
Phone: (561) 842-2398
SCHOETTLE, Glenn Phillip (Lynn)
Thoracic and Cardiovascular Surgery Associates, 6005 Park Avenue,
Suite 802, Memphis, TN 38119
Phone: (901) 725-9450 Fax: (901) 274-0741
SCHULTZ, Scot C.
101 South Ravenel Street, Suite 270, Florence, SC 29502
Phone: (843) 777-7020
**SCHUMACHER, Paul D.
*81 Oakleigh Drive, Maitland, FL 32751
‡SCHWARTZ, Gary
1800 Orleans Street, Suite 7107, Baltimore, MD 21287
Phone: (443) 660-9954
‡SCIORTINO, Christopher (Vanessa)
*8004 Silver Fox Dr., Glen Burnie, MD 21061
Phone: (410) 955-2800
**SCOTT, Meredith L. (Susan)
2051 Beaver Creek Rd., Shell, WY 82441
Phone: (307) 765-9516 Fax: (307) 765-9561
SEARS, Nicholas J. (Michelle Marie)
450 Knights Run Ave, Suite 1406, Tampa, FL 33602
Phone: (813) 972-5030 Fax: (813) 977-6173
+SEBASTIAN, Vinod A.
1935 Medical Drive District, Suite C3211, Dallas, TX 75235
Phone: (214) 456-5000 Fax: (214) 456-5015
SEE, Mike W. (Joni)
University of Missouri, MA 312, 1 Hospital Drive, Columbia, MO 65212
Phone: (573) 442-2320 Fax: (573) 442-8503
SEGUROLA, Romualdo Jose
3650 NW 82nd Ave, Suite 207, Doral, FL 33166
Phone: (305) 858-7505 Fax: (305) 858-7721
MEMBERSHIP ROSTER
**SELBY, John H., Jr. (Kay)
4117 Hillsboro Pike, Ste 103-266, Nashville, TN 37215
Phone: (615) 463-8096
SELL, Jeffrey Edward
1540 S. Tamiami Trail, Suite 503, Sarasota, FL 34239
Phone: (941) 917-8791
**SELLE, Jay G. (Sheila)
The Sanger Clinic, 1001 Blythe Blvd-Suite 300, Charlotte, NC 28203
Phone: (704) 373-1500 Fax: (704) 372-1249
**SEREMETIS, Michael G. (Anastasia)
5142 Nebraska Avenue NW, Washington, DC 20008
Phone: (202) 244-6553 Fax: (202) 244-7264
**SETHI, Gulshan K. (Neelam)
University Medical Center, Tucson, AZ 85724
Fax: (520) 626-4042
**SEWELL, David H. (Mary)
1723 Orchard Ct, Kingsport, TN 37660
Phone: (423) 378-5558 Fax: (423) 378-5298
‡SHAH, Asad A.
*7 Kilary Drive, Durham, NC 27713
**SHAH, Hasmukh H. (Indira)
3600 Gaston Avenue, Suite 404, Dallas, TX 75246
Phone: (214) 824-0881 Fax: (214) 821-3760
SHAH, Ashish S.
600 N. Wolfe St., Blalock 618, Baltimore, MD 21287
Phone: (410) 502-3900 Fax: (410) 955-3809
SHAKER, I. J. (Judy)
770 Pine Street-Suite 210, Macon, GA 31201
Phone: (478) 737-5719 Fax: (478) 475-5194
**SHALLAL, John A. (Julita)
5354 Reynolds Street, Suite 206, Savannah, GA 31405
Phone: (912) 354-0392 Fax: (912) 352-1842
**SHANE, Ramon A. (Cheryl)
3564 S. Lexus, Springfield, MO 65807
Phone: (417) 887-8546
SHARMA, Mahesh S. (Aparna)
*1331 Village Green, Southlake, TX
Phone: (469) 387-4037 Fax: (412) 692-5817
**SHELBY, Stanford J. (Susan)
2751 Albert Bichnell Drive, Suite 2D, Shreveport, LA 71103
Phone: (318) 632-9438 Fax: (318) 636-2030
SHEN, Robert K. (Ann Marie)
200 First Street SW, Rochester, MN 55905
Phone: (507) 284-2511 Fax: (507) 284-0058
SHERIDAN, Brett C.
3037 Burnett Womack Building, Campus Box 7065, Chapel Hill, NC 27599
Phone: (919) 966-3381 Fax: (919) 966-3475
SHOPTAW, James Harold, Jr.
100 Medical Drive, Suite 100, Dubin, GA 31021
Phone: (478) 275-9420
**SIDELL, Peter M. (Mary Kay)
*15701 Glenisle Way, Fort Myers, FL 33912
SILVESTRY, Scott C.
660 South Euclid Ave, Campus Box 8234, St. Louis, MO 63110
Phone: (314) 362-6182
**SIMMONS Earl M., Jr. (Gerry)
*1616 S. Perry Street, Montgomery, AL 36104
Phone: (334) 264-8120
SIMPSON, William F., Jr. (Judy)
701 University Boulevard East, Suite 808, Tuscaloosa, AL 35401
Phone: (205) 349-5064 Fax: (205) 759-5639
SIMSIR, Sinan A.
4400 W. 95th Street, Suite 205, Oak Lawn, IL 60453
Phone: (847) 386-6067
**SINK, James D.
13030 Morehead, Chapel Hill, NC 27517
Phone: (919) 967-3778 Fax: (919) 967-4341
SINNING, Mark A.
2203 Nevse Blvd, New Bern, NC 28560
Phone: (252) 638-8118 Fax: (252) 638-5192
SKIPPER, Eric R.
1001 Blythe Boulevard, Suite 300, Charlotte, NC 28203
Phone: (704) 444-3918 Fax: (704) 373-0781
MEMBERSHIP ROSTER
+SKYLIZARD, Loki (Maria)
308 Buttermere Avenue, Interlaken, NJ 35211
Phone: (732) 263-5024 Fax: (732) 263-5029
SLAUGHTER, Mark (Martha)
Phone: (502) 561-2180 Fax: (502) 561-2190
**SMILEY, Robert H. (Mary Katherine)
2306 San Augustine Lane, Friendswood, TX 77546
Phone: (281) 996-0241 Fax: (281) 996-0577
SMITH, Peter K. (Cynthia)
Box 3442, Durham, NC 27710
Phone: (919) 684-2890 Fax: (919) 681-7905
SMITH, Charlie D., III (Deborah)
411 Seminole Ave, Florence, SC 29501
Phone: (803) 765-0871 Fax: (803) 765-9215
SMITH, Marvin J., III (Jill)
Heart Plaza One, 6800 IH-10 West, Suite 300, San Antonio, TX 78201
Phone: (210) 616-0008 Fax: (210) 616-0231
**SNOW, Norman J. (Renee)
PO Box 83, Post Mills, VT 5058
Phone: (802) 333-9649
**SNYDER, Harold E. (Deborah)
113 Bristol Place, Ponte Vedra Beach, FL 32082
SOBERMAN, Mark S.
Regional Cancer Treatment Center,
400 West Seventh Street, Frederick, MD 21701
Phone: (240) 566-3574
SOMMERS, Keith E.
4007 N. Taliaferro Avenue, Suite C, Tampa FL 33603
Phone: (813) 238-0810
SONETT, Joshua R.
161 Fort Washington Ave, Suite 301, New York, NY 10032
Phone: (212) 305-8086 Fax: (212) 305-4085
SONG, Howard K. (Sally)
3181 SW Sam Jackson Park Road, L353, Portland, OR 97239
Phone: (503) 494-7820 Fax: (503) 494-7829
**SPALDING, Alanson R., III (Susan)
2712 Valley Brook Place, Nashville, TN 37215
Phone: (615) 953-1075
SPEIR, Alan M.
Phone: (703) 280-5858 Fax: (703) 280-2654
SPERLING, Jason S. (Jodie)
223 North Van Dien Avenue, Ridgewood, NJ 07450
Phone: (201) 934-5129 Fax: (201) 447-8658
SPOTNITZ, William D. (Denise)
2738SW 92nd Drive, Gainesville, FL 32608
Phone: (352) 514-5009 Fax: (352) 846-0356
SPRATT, John A. (Linda)
Phone: (843) 720-8490 Fax: (843) 727-3602
SPRAY, Thomas L. (Melissa)
34th Street and Civic Center Boulevard,
Suite 12NW10, Philadelphia, PA 19104
Phone: (215) 590-2708 Fax: (215) 590-2715
**SPRINKLE, James D. (Joan)
156 Stratford Place, Danville, VA 24541
Phone: (434) 791-3455
ST. LOUIS, James D. (Jennifer)
*15700 Portico Dr, Wayzata, MN 55391
Phone: (612) 625-7132 Fax: (612) 626-8228
STAHL, Richard D. (Kathy)
9850 Genesee Avenue, Suite 560, La Jolla, CA 92037
Phone: (619) 455-6330 Fax: (619) 455-5408
STANFIELD, Mark E. (Anna)
800 Hospital Drive, Madisonville, KY 42431
Phone: (270) 326-3800 Fax: (270) 326-3855
STAPLETON, Dennis J. (Karen)
311 TaMiami Trl N., Suite 301, Naples, FL 34102
Phone: (941) 939-1767 Fax: (941) 939-5895
MEMBERSHIP ROSTER
+STASIK, Chad N. (Stephanie)
7703 Floyd Curl Drive, MC 7841, San Antonio, TX 78229
Phone: (210) 567-2878 Fax: (210) 567-2877
**STAUB, Wilson E. (Jan)
1600 Morganton Road, W-15, Pinehurst, NC 28374
Phone: (910) 692-6144
**STEIER, Michael E.
1235 Florida Avenue, Fort Myers, FL 33901
STEINBERG, John B. (Kathy)
Wheeler Heart Vascular Center, 3800 S. National Ste 400,
Springfield, MO 65807
Phone: (417) 875-3370 Fax: (417) 885-7295
STELIGA, Matthew Allen (Kelly)
4301 West Markham Ave #713, Little Rock, AR 72205
Phone: (501) 686-7884 Fax: (501) 686-8503
STELLY, Terry Chris
1855 Spring Hill Avenue, Mobile, AL 36607
Phone: (251) 633-2314 Fax: (251) 633-3135
**STEPHENSON, Sam E. (Janet)
10553 Scott Mill Road, Jacksonville, FL 32257
Phone: (904) 268-1980
STEVENS, William S., Jr. (Sarah)
SIU School of Medicine, PO Box 19684, Springfield, IL 62794
Phone: (217) 545-7600 Fax: (217) 545-2552
STEVENS, Randy M. (Sony)
3601 A Street, Philadelphia, PA 19134
Phone: (484) 270-8064
STEWART, James R. (Bobbi)
4320 Wornall Road, Suite 50-II, Kansas City, MO 64111
Phone: (913) 341-2365 Fax: (816) 531-9862
STEWART, Robert D. (Robyn)
9500 Euclid Ave, M41, Cleveland, OH 44195
Phone: (216) 444-9125 Fax: (216) 445-3692
STIEGEL, Robert M. (Marsha)
1001 Blythe Blvd.-Suite 300, Charlotte, NC 28203
Phone: (704) 373-0212 Fax: (704) 372-1249
**STONEBURNER, John M. (Frances)
*451 Southland Drive, Danville, VA 24541
Phone: (804) 793-4045
**STONEY, William S. (Marian)
St. Thomas Medical Building, 4230 Harding Road-5th Floor
Nashville, TN 37205
Phone: (615) 385-4781 Fax: (615) 385-9265
STOUFFER, Chadwick (Adeline)
Phone: (865) 288-3358 Fax: (865) 637-2114
STOWE, Cary L. (Patrice)
PO Box 643383, Vero Beach, FL 32964
Phone: (772) 563-4580 Fax: (772) 563-4690
STOWELL, Donald E. (Toni)
920 S.L. Young Blvd #WP2230, Oklahoma City, OK 73104
Phone: (405) 271-5789 Fax: (405) 271-3288
STUART, R. Scott (Gloria)
4320 Wornall Rd., Suite 50-II, Kansas City, MO 64111
Phone: (816) 931-3312 Fax: (816) 531-9862
STULAK, John M. (Jamie)
200 First St. SW, Rochester, MN 55905
Phone: (507) 255-7064 Fax: (507) 255-7378
SUAREZ-CAVELIER, Jorge E. (Diane)
Phone: (407) 425-1566 Fax: (407) 422-0166
SUNDARAM, Shankar Meenakshi (Kamilini)
*2707 Cole Avenue, Apartment 615, Dallas, TX 75204
Phone: (972) 838-0984
SUNDT, Thoralf (Kathleen)
Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114
Phone: (617) 643-9745
**SUTHERLAND, R. Duncan (Carol)
P.O. Box1385, Alto, NM 88312
Phone: (505) 336-4309
MEMBERSHIP ROSTER
**SUTTON, John P., III ()
*1010 Old Wharf, Sea Brook Island, SC 29455
Phone: (843) 768-1165
SUTTON, John Perry, III (Lauren)
Thoracic & Cardiovascular Assoc.,
Phone: (803) 254-5140 Fax: (803) 779-1279
**SWAIN, Julie A.
910 W. Muirlands Drive, La Joila, CA 92037
Phone: (760) 451-3218 Fax: (760) 728-1464
SWEENEY, Michael S. (Laura)
6560 Fannin, #1824, Houston, TX 77030
Phone: (713) 795-4334
SWISHER, Stephen G. (Kelly)
1515 Holcombe Boulevard, Box 445, Houston, TX 77030
Phone: (832)519-9750 Fax: (713) 794-4901
MEMBERSHIP ROSTER – T
**SYMBAS, Peter N. (Hytho)
69 Butler Street SE, Atlanta, GA 30303
Phone: (404) 616-4461 Fax: (404) 616-4509
**SZENTPETERY, Szabolcs (Victoria)
*3431 Lady Marian Court, Midlothian, VA 23113
Phone: (804) 545-2932
SZWERC, Michael Francis
Suite 403, 1240 S. Cedar Crest Blvd, Allentown, PA 18106
Phone: (610) 402-6890 Fax: (610) 402-6892
**TAKARO, Timothy (Marilyn)
Veterans Administration Medical Center, 1100 Tunnel Road,
Asheville, NC 28805
TAM, Vincent K.H. (Karen Ann)
9017th Avenue, Suite 330, Fort Worth, TX 76104
Phone: (682) 885-6400 Fax: (682) 885-6101
TAVARES, Sergio (Denise)
601 Texan Trail Suite 205, Corpus Christi, TX 78411
Phone: (512) 884-7081 Fax: (361) 884-5202
TAYLOR, Robert L. (Connie)
*20 Muirfield Lane, Amarillo, TX 79124
Phone: (806) 236-4279
**TEMES, Gerald D. (Maura)
Phone: (502) 589-3173
**TENEKJIAN, Vasken K. (Marilyn)
3640 High Street, Suite 2F, Portsmouth, VA 23707
Phone: (757) 397-2383 Fax: (757) 397-5201
**THIELE, J. Peter
4108 High Summit, Dallas, TX 75224
Phone: (972) 241-9846
**THIO, Richard T. (Jane)
1001 Clubland Court, Marietta, GA 30068
Phone: (770) 971-8222 Fax: (678) 560-9489
**THOMAS, James P. (Mary Lou)
535 Sanctuary Drive, Longboat Key, FL 34228
Phone: (304) 327-3524 Fax: (304) 327-8337
THOMAS, Gregory A. (Michele)
1010 First Street North, Suite 250 - The Physician Center,
Alabaster, AL 35007
Phone: (205) 620-7523 Fax: (205) 620-8673
THOMPSON, Richard (Jennifer)
6430 Winding Ridge Circle, Lincoln, NE 68512
Phone: (402)481-8430 Fax: (717) 299-6577
THOMPSON, Jess Lee, III (Sarah)
1501 North Campbell Ave, PO Box 245066, Tucson, AZ 85724
Phone: (520) 626-9752 Fax: (520) 626-9752
THOMPSON, Eric (Tanya)
1605 East Broadway, Suite 300, Columbia, MO 65203
Phone: (573) 256-7700 Fax: (573) 256-3004
THOMPSON, Karen S.
105 Thetford Drive, Houma, LA 70360
Phone: (678) 953-1820
**THOMSON, Norman B., Jr. (Gail)
3434 Gin Lane, Naples, FL 34102
Phone: (239) 403-3553 Fax: (239) 403-3875
THOURANI, Vinod H.
550 Peachtree St., 6th Floor Mot, Atlanta, GA 30308
Phone: (404) 686-2513 Fax: (404) 686-4959
**THRELKEL, James B. (Eleanor)
1315 North Lake Elbert Drive, Winter Haven, FL 33881
Phone: (863) 294-4004
MEMBERSHIP ROSTER
THURBER, John S. (Lynette)
6210 Winnebago Road, Bethesda, MD 20816
Phone: (301) 295-2552 Fax: (301) 295-2662
TONG, Betty Caroline (Suhail)
DUMC Box 3531, Durham, NC 27710
Phone: (443) 226-5069 Fax: (919) 684-8508
TOOLE, John Matthew (Katy)
25 Courtenay Drive, Suite 7018, Charleston, SC 29425
Phone: (843) 876-4843 Fax: (843) 876-4866
**TOYOHARA, Hiroshi (Akiko)
210 Crestridge Road, Knoxville, TN 37919
Phone: (865) 602-2441 Fax: (865) 584-5532
**TRAAD, Ernest A. (Nancy)
*765 Crandon Boulevard, Apt 510, Key Biscayne, FL 33149
Phone: (305) 674-2782 Fax: (305) 674-2865
MEMBERSHIP ROSTER – T
TRACHIOTIS, Gregory D. (Tanya)
50 Irving Street NW, Cardiothoracic Surgery - 1
12 VAMC, Washington, DC 20422
Phone: (202) 745-8626 Fax: (202) 745-8385
TRACHTE, Aaron L. (Leslye)
3401 W. Gore Blvd, Lawton, OK 73505
Phone: (580) 357-4339 Fax: (580) 357-4423
‡TRAN, Minh P. (Jill)
1800 Orleans Street, Zayed Suite 7107, Baltimore, MD 21287
Phone: (410) 955-2698
TRAVIS, Jeffrey A. (Sheila)
2728 Sunset Blvd, Suite 101, West Columbia, SC 29169
Phone: (803) 936-7095 Fax: (803) 936-7908
**TREASURE, Robert L.
116 LaRue Ann Court, San Antonio, TX 78213
Phone: (210) 340-1715
**TRIBBLE, David E. (Dorothy)
Phone: (803) 256-3400 Fax: (803) 256-2039
TRIBBLE, Reid W. (Mary)
Eight Richland Medical Park, Suite 400, Columbia, SC 29203
Phone: (803) 765-0871 Fax: (803) 765-9215
TRIBBLE, Curtis G. (Megan)
PO Box 800679, Charlottesville, VA 22908
Phone: (434) 924-2000 Fax: (434) 244-7588
TRIPATHY, Uttam (Shobana)
1601 Main St, Suite 500, Richmond, TX 77469
Phone: (281) 232-1908 Fax: (281) 232-1914
TROTTER, Timothy Howard
River Regions Medical Center, 2100 Highway 61, North,
Vicksburg, MS 39183
Phone: (601) 883-6911
**TROTTER, Michael C.
221 Crittenden Street, Greenville, MS 38701
**TUCKER, William Y., Jr. (Nancy)
*26074 US Highway 65, Colo, LA 50056
Fax: (910) 889-7701
TUREK, Joseph (Betsy)
200 Hawkins Drive, SE 520 GH, Iowa City, LA 52242
Phone: (319) 384-8365 Fax: (319) 356-3891
*TURK, Newton L., III (Martha)
600 Sea Island Rd, Suite 28, St. Simons Island, GA 31522
Phone: (404) 233-2351 Fax: (404) 233-2351
+TURNAGE, Bryce (Beth)
1400 20th Avenue, Suite F, Meridian, MS 39301
Phone: (601) 553-2135 Fax: (601) 553-2049
TURNER, William F. (Jody)
320 W. 7th St., Tyler, TX 75701
Phone: (903) 593-0900 Fax: (903) 593-0926
**TURNEY, Shannon W. (Peggy)
*1515 Toney Dr., Huntsville, AL 35802
Phone: (256) 881-5848 Fax: (256) 881-5848
TWEDDELL, James S. (Sue Ellen)
9000 W. Wisconsin Avenue, MS 715, Milwaukee, WI 53226
Phone: (414) 573-1146 Fax: (414) 266-2075
**TYNDAL, Edward C. (Martha Kay)
235 Tyndal Farm Rd., Columbiana, AL 35051
Phone: (205) 250-6076
MEMBERSHIP ROSTER
**TYSON, Kenneth R. T. (Sue)
601 Rocky Hollow Drive, Burnet, TX 78611
Phone: (512) 756-7591
MEMBERSHIP ROSTER – V
**UMSTOTT, Charles E. (Elizabeth)
*19 Museum Drive, Newport News, VA 23606
Phone: (757) 596-7631 Fax: (757) 596-7078
UNG, Keung (Mary)
2601 Kentucky Ave., Suite 300, Paducah, KY 42003
Phone: (270) 443-5564 Fax: (270) 443-5549
UNGERLEIDER, Ross M. (Jamie)
Brenner Children’s Hospital Ardmore Tower; 10th Floor Medical Center
Blvd, Winston-Salem, NC 27157
Phone: (336) 941-3293 Fax: (336) 716-1295
VAN GELDER, Hugh M. (Susie)
Phone: (727) 527-9779 Fax: (727) 522-0415
VAPORCIYAN, Ara A. (Phillipa)
1515 Holcombe Blvd., Box 1489, Houston, TX 77030
Phone: (713) 745-4533 Fax: (713) 794-4901
VASILAKIS, Alexander (Marion)
Heritage Valley Beaver, 1000 Dutch Ridge Road, Beaver, PA 15009
Phone: (724) 773-8289 Fax: (724) 773-4532
VASSILIADES, Thomas A., Jr.(Venetia)
8200 Coral Sea St. MVS 71, Mounds View, MN 55112
Phone: (763) 514-9800
**VAUGHAN, Dennis G., III (Edna)
1551 Ben Sawyer Villa #46, Mt. Pleasant, SC 29464
VEERAMACHANENI, Nirmal K. (Deepika)
3901 Rainbow Boulevard, Kansas City, KS 66160
Phone: (913) 588-9742
VILARO-NELMS, Juan R.
#16 Terrazas Tintillo, Guaynabo, PR 966
Phone: (787) 281-0122 Fax: (787) 753-3596
**VONTZ, Frederick K.
580 West 8th Street, Suite 6001, Jacksonville, FL 32209
**VOORHIS, Charles C., III
*418 Cherry Street, Panama City, FL 32401
VRICELLA, Luca A. (Simona)
600 N. Wolfe Street, Blalock 618, Baltimore, MD 21287
Phone: (443) 287-1262 Fax: (443) 287-3636
**WAGNER, Robert B. (Sylvia)
50 West Edmonston Drive, Rockville, MD 20852
Phone: (301) 294-9040 Fax: (301) 424-0029
WALKER, Courtnye Allyson (Elbert)
*3420 Flanders Rd, Jefferson City, MO 65109
Phone: (843) 324-8551 Fax: (573) 761-7196
**WALKER, James H. (Helen)
600 Morris Street, Suite 101, Charleston, WV 25301
Phone: (304) 388-7120 Fax: (304) 388-7124
WALKER, Jennifer (Mark)
55 Fruit Street, Cox 644, Boston, MA 02114
Phone: (617) 726-8841 Fax: (617) 726-5804
**WALKER, Olyn M. (Marva)
4415 Shady Lane, Wichita Falls, TX 76309
Phone: (940) 761-2922 Fax: (940) 761-8421
WALKER, William A.
939 Emerald Ave, Suite 905, Knoxville, TN 37917
Phone: (865) 647-3350
**WALKUP, Harry E. (Mary)
12836 Still Pond Creek Road, Worton, MD 21678
Phone: (410) 348-5618
WALL, Matthew J., Jr.
One Baylor Plaza, Houston, TX 77030
Phone: (713) 873-3421 Fax: (713) 798-6084
WALLENHAUPT, Stephen L.
Phone: (704) 384-5725 Fax: (704) 316-9144
**WALLS, Joseph T.
1031 Bourn Avenue, Columbia, MO 65203
WALSH, John A. (Mary)
61 Memorial Medical Parkway, Suite 1-800 B, Palm Coast, FL 32164
Phone: (386) 586-0760 Fax: (386) 586-0762
MEMBERSHIP ROSTER – W
MEMBERSHIP ROSTER
WALSH, Garrett L.
1515 Holcombe Boulevard, Unit 1489, Houston, TX 77030
Phone: (713) 792-6849 Fax: (713) 794-4901
WALTERS, Henry (Katherine)
Children’s Hospital of Michigan, 3901 Beaubien, Detroit, MI 48201
Phone: (313) 745-5538 Fax: (313) 993-0531
**WARE, Robert D. (Peggy)
*3548 Captians Way, Knoxville, TN 37922
Phone: (423) 632-5900 Fax: (423) 637-2114
WARREN, Edward T. (Angie)
1900 Malvern Avenue, Suite 403, Hot Springs National Park, AR 71901
Phone: (501) 262-5256 Fax: (501) 624-5029
**WATSON, Donald C., Jr. (Susan)
*47 Cedar Hill Drive, Biltmore Forest, NC 28803
Phone: (828) 277-0677 Fax: (828) 277-0677
**WATSON, Raymond R. (Barbara)
5610 Kilmory Way, Sarasota, FL 34238
Fax: (941) 492-9428
WATTS, Larry T.
1001 Blythe Blvd., Ste. 300, Charlotte, NC 28203
Phone: (704) 373-0212
WAXMAN, Jonathan
670 Glades Rd., Boca Raton, FL 33431
Phone: (561) 395-2626 Fax: (561) 395-7026
**WEAVER, James P. (Anne)
4301 Ben Franklin Blvd., Durham, NC 27704
Phone: (919) 471-0215 Fax: (919) 471-4642
**WEBB, Watts R. (Frances)
364 Windermere Blvd, Alexandria, LA 71303
Phone: (318) 445-9482
‡WEI, Benjamin (Victoria)
*3460 Oak Canyon Drive, Birmingham, AL 35243
Phone: (205) 934-5937
WEIMAN, Darryl S. (Kathleen)
910 Madison Ave, 2nd Floor Rm 208, Memphis, TN 38163
Phone: (901) 818-1892 Fax: (901) 448-7588
WELLS, Christopher D. (Eleanor)
Specialty Care, One American Center,
3100 West End Av., Nashville, TN 37203
Phone: (615) 818-0666
**WELLS, Van Henry (Ruth)
6388 Cottingham Place, Memphis, TN 38120
**WHITE, John J. (Andrea)
11803 Stendall Drive North, Seattle, WA 98133
Fax: (206) 417-3689
WHITE, Robert Keith
312 Grammont St, Ste 410, Monroe, LA 71201
Phone: (318) 966-6300 Fax: (318) 675-6141
**WILDSTEIN, Gilbert (Lynn)
4146 Glen Devon Drive, N.W., Atlanta, GA 30327
Phone: (404) 547-6755 Fax: (404) 261-2624
WILLIAMS, Mark J. (Jackie)
Brody School of Medicine at ECU, Department of Cardiovascular
Sciences, 115 Heart Drive (Mail Stop 651), Greenville, NC 27834
Phone: (252) 744-5232 Fax: (252) 744-5233
WILLIAMS, Matthew Lanier
Phone: (502) 561-2180
**WILLIAMS, Robert D.
4441 Claymont Woods Drive, Kansas City, MO 64116
Phone: (816) 453-3757 Fax: (816) 455-0405
WILLIAMS, Marcus Gerard
1 Medical Park Blvd, Suite 458 West, Bristol, TN 37620
Phone: (423) 230-6900
‡WILLIAMS, Derek
3930 Bowser Ave #2, Dallas, TX 75219
Phone: (314) 406-0260
**WILSON, Louie Cecil (Gail)
7 Yester Place, Suite 302, Mobile, AL 36608
Fax: (251) 344-4307
**WILSON, Charles H. (Judith)
1200 North Elm Street, Greensboro, NC 27401
Phone: (336) 832-8745 Fax: (336) 832-8192
MEMBERSHIP ROSTER
‡WISEMAN, James E. (Lilah)
1501 N. Campbell Ave., PO Box 245071, Tucson, AZ 85724
Phone: (281) 300-7377
**WOLF, Rodney Y. (Brenda)
6029 Walnut Grove Road, Suite 401, Memphis, TN 38120
Phone: (901) 747-3066 Fax: (902) 747-2966
MEMBERSHIP ROSTER – Y
WOLF, Bradley Aaron
6029 Walnut Grove Rd, Suite 401, Memphis, TN 38120
Phone: (901) 747-3066 Fax: (901) 747-2966
**WOLFE, Walter G. (Jackie)
P.O. Box 3507, Durham, NC 27710
Phone: (919) 684-4117 Fax: (919) 681-8912
**WOLPOWITZ, Allan (Teri Lee)
413 Wild Horse Circle, Boulder, CO 80304
Phone: (303) 413-8450 Fax: (303) 413-8451
**WOOD, Richard E. (Judith)
3600 Gaston Avenue, Suite 404, Dallas, TX 75246
Phone: (214) 827-3890 Fax: (214) 823-9310
**WOODS, Leon P. (Ann)
8409 Mile Tree Drive, Fort Smith, AR 72903
Phone: (501) 452-1379
**WOODS, Edward L. (Josephine Marcia)
The Geisinger Clinic, Cardiothoracic Surgery, Danville, PA 17822
Phone: (570) 271-6367 Fax: (570) 271-5840
**WOO-MING, Michael O. (Prudence)
Indian River Memorial Hospital 91 Cache Cay Drive, Vero Beach, FL 32963
Phone: (772) 234-2481 Fax: (772) 234-2481
WOZNIAK, Thomas C. (Kristi)
1801 N. Senate Boulevard, Suite 755, Indianapolis, IN 46202
Phone: (317) 923-1787 Fax: (317) 929-6259
**WRIGHT, Creighton B., Sr. (Carolyn)
Cardiac, Vascular & Thoracic Surgeons, Inc., 4030 Smith Road, #300,
Cincinnati, OH 45209
Phone: (513) 421-3494 Fax: (513) 345-2606
WRIGHT, Christopher C. (Sandy)
890 West Faris Road, Suite 550, Greenville, SC 29605
Phone: (864) 455-6800 Fax: (864) 455-6825
WUDEL, Leonard James, Jr. (Carlyn)
Wake Forest Baptist Medical Center,
Medical Center Boulevard, Winston-Salem, NC 27157
Phone: (336) 716-2124
**WUKASCH, Don C. (Linda)
500 W. 18th Street, Austin, TX 78701
Phone: (512) 472-4700 Fax: (512) 472-4701
WYATT, David Alan (Sharon)
2001 Crystal Spring Avenue, Suite 201, Roanoke, VA 24014
Phone: (540) 853-0100 Fax: (540) 342-9308
YANG, Stephen C.
600 North Wolfe Street, Blalock 240, Baltimore, MD 21287
Phone: (410) 561-3653 Fax: (410) 614-9428
YARBROUGH, John W. (Anne)
1480 Greenhill Rd, Columbia, SC 29206
Phone: (803) 254-5140 Fax: (803) 779-1279
YARBROUGH, William M. (Ashley)
2750 Laurel Street, Suite 305, Columbia, SC 29204
Phone: (803) 254-5140
**YEH, Thomas J. (Doris)
4700 Waters Avenue, Suite 403, Savannah, GA 31404
Phone: (912) 352-0024 Fax: (912) 353-9196
YEH, Thomas
1430 Tulane Ave (SL-22), New Orleans, LA 70112
Phone: (504) 988-7520
YENDAMURI, Sai (Sunita)
Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263
Phone: (716) 845-5873 Fax: (716) 845-7692
YOUNG, James A. (Pamela)
Harbin Clinic, LLC, 504 Redmond Road, Rome, GA 30165
Phone: (706) 236-6300 Fax: (706) 235-3104
**YOUNGBLOOD, Robert W. (Peggy)
*1517 Tanglewood Circle, Florence, SC 29501
Phone: (843) 662-9562 Fax: (843) 678-9276
**YOUSUFUDDIN, Mohammed (Nafees)
*230 Spring Valley Road, Columbia, SC 29223
Phone: (803) 788-9031
MEMBERSHIP ROSTER
YUH, David D.
Yale University Section of Cardiac Surgery, 333 Cedar Street,
Boardman Building 204, New Haven, CT 06520
Phone: (203) 785-3000 Fax: (410) 955-3809
**ZAKHARIA, Alex T. (Andree)
325 Catalina Avenue, Coral Gables, FL 33134
Phone: (305) 445-6921 Fax: (305) 661-5799
ZEHR, Kenton J.
*2301 Essex Street, Baltimore, MD 21224
Phone: (507) 254-0908
ZELLNER, James L. (Barbara)
2108 East Third Street, Suite 300, Chattanooga, TN 37404
Phone: (423) 624-5200 Fax: (423) 624-4440
**ZEOK, John V. (Suzanne)
*1601 Quaker Ridge Point, Raleigh, NC 27615
Phone: (919) 231-6333 Fax: (919) 231-6334
MEMBERSHIP ROSTER – Z
**ZIMBERG, Yale H. (Goldie)
Commonwealth Surgeon, 5855 Bremo RoadSuite 506,
Richmond, VA 23226
Phone: (804) 285-3225 Fax: (804) 285-0360
ZOCCO, James J.
Cardiac Surgical Assoc. Ltd., 7101 Jahnke Road, #500,
Richmond, VA 23225
Phone: (804) 320-2751 Fax: (804) 330-3831
ZOLLINGER, Richard W., II (Elizabeth)
3701 Oldridge Ct., Charlotte, NC 28226
Phone: (704) 543-0122
ZORN, George L. (Jennifer)
3901 Rainbow Blvd, Mailstop 4035, Kansas City, MO 66160
Phone: (816) 931-3312
**ZORN, George L., Jr. (Jane)
3116 Old Ivy Road, Birmingham, AL 35210
Phone: (205) 951-9751 Fax: (205) 975-7214
**ZUMBRO, George L., Jr. (Pennie)
501 Blackburn Dr, Augusta, GA 30904
Phone: (706) 854-8340 Fax: (706) 854-8341
ZWISCHENBERGER, Joseph B. (Sheila)
MN 264, A. B. Chandler Med Ctr, 800 Rose St, Lexington, KY 40503
Phone: (859) 323-6013 Fax: (859) 323-1045
MEMBERSHIP ROSTER – GEOGRAPHIC
GEOGRAPHIC
ALABAMA
ARKANSAS
Alabaster
Gregory A. Thomas
Fayetteville
Loyde H. Hudson
Robert C. Jaggers
Birmingham
Louis A. Brunsting, III
Robert J. Cerfolio
Orville W. Clayton
Robert J. Dabal
James Edward Davies
William L. Holman
Jorge O. Just
Donald R. Kahn
James K. Kirklin
Wade C. Lamberth
Clifton T.P. Lewis, Sr.
Stanley K. Lochridge
Douglas Minnich
Norton T. Montague III
John B. Richardson
Russell S. Ronson
Benjamin Wei
George L. Zorn, Jr.
Columbiana
Edward C. Tyndal
Huntsville
Richard L. Clay
Evan S. Cohen
Shannon W. Turney
Mobile
Larkin J. Daniels
William R. Higgs
William E. Johnson, III
Joseph LoCicero, III
Lawrence S. McGee
Peter Pluscht, III
Terry Chris Stelly
Louie Cecil Wilson
Montgomery
James N. Anderson, Sr.
Richard J. Cyrus
Earl M. Simmons, Jr.
Selma
Clyde B. Cox
Tuscaloosa
Barry D. Newsom
Ronald T. Olivet
William F. Simpson, Jr.
Fort Smith
Leon P. Woods
Jonesboro
James A. Ameika
Hot Springs National Park
Edward T. Warren
Little Rock
Gilbert S. Campbell
Frederick A. Meadors
S. Thomas Rayburn, III
Orval E. Riggs
Matthew Allen Steliga
Mountain Home
Louis W. Elkins
ARIZONA
Chandler
James S. Carter
Phoenix
Dawn E. Jaroszewski
Tuscon
Farid Gharagozloo
Gulshan K. Sethi
Jess Lee Thompson, III
James E. Wiseman
Robert S. Poston
CALIFORNIA
Clovis
Steven Paul Cummings
Davis
Elizabeth David
La Jolla
Richard D. Stahl
Julie A. Swain
Lancaster
Pavel V. Petrik
Sacramento
Broadus Zane Atkins
Joseph Huh
San Diego
Peter Pastuszko
San Ramon
Donald S. Abelson
Santa Barbara
Edward J. Jahnke
Stanford
Richard D. Mainwaring
COLORADO
Aurora
Frederick L. Grover
James Jaggers
T. Brett Reece
Boulder
Allan Wolpowitz
Colorado Springs
Jenifer L. Marks
Theolyn Price
Denver
Guillermo E. Aragon
Grand Junction
Sara Jane Pereira
Michael J. Carmichael
CONNECTICUT
Fairfield
Forrest Rubenstein
New Haven
Frank C. Detterbeck
Paul M. Kirshbom
David D. Yuh
Stamford
Timothy S. Hall
DISTRICT OF COLUMBIA
Washington
Steven W. Boyce
Marc Margolis
M. Blair Marshall
Keith D. Mortman
Michael G. Seremetis
Gregory D. Trachiotis
DELAWARE
Newark
Ray A. Blackwell
Timothy J. Gardner
FLORIDA
Alachua
Daniel R. Meldrum
Bay Pines
Richard G. Norenberg
Bellair Bluffs
Takeshi Okano
Belleair
Charles H. Lasley
Albert S. Palatchi
Boca Raton
Jonathan Waxman
Boynton Beach
Michael J. Carmichael
Joseph R. Lancaster
Bradenton
Alessandro Golino
Paul E. Prillaman, Jr.
Brandon
Ignacio G. Duarte
Clearwater
Thomas E. Deal
John C. Ofenloch
Joshua Rovin
Coral Gables
James R. Jude
Alex T. Zakharia
Doral
Alfredo Rego
Romualdo Jose Segurola
Fort Lauderdale
Cesar A. Alegre
Frank P. Catinella
Robert E. Cline
Salem M. Habal
Alexander G. Justicz
Harold G. Roberts
GEOGRAPHIC
Fort Meyers
Robert H. Buker
Brian W. Hummel
Robert D. Pascotto
Peter M. Sidell
Michael E. Steier
Gainesville
James A. Alexander
Thomas M. Beaver
Mark S. Bleiweis
Philip J. Hess
Fawad Naeem Khawaja
Charles T. Klodell
Tomas D. Martin
M. A. Nesmith, Jr.
William D. Spotnitz
Hollywood
Mark I. Block
Fred I. Ehrenstein
Richard A. Perryman
Jacksonville
J. Brooks Brown
Eric L. Ceithaml
Harry J. D’Agostino, Jr.
Fred H. Edwards
John R. Ibach Jr.
J. Kenneth Koster, Jr.
Kevin P. Landolfo
Daniel B. Nunn
Sam E. Stephenson
Frederick K. Vontz
Jupiter
Robert J. Anderson
Key Biscayne
Ernest A. Traad
Kissimmee
Kristopher M. George
Lake City
John E. Rayl
Lake Worth
Duleep J. Pradhan
Lakeland
David J. Dodd
Largo
Paul L. DeWitt
Leesburg
Wistar Moore, III
Longboat Key
James P. Thomas
Lynn Haven
John M. Kessinger
Maitland
Paul D. Schumacher
Melbourne
O. C. Mendes
Miami
Cesar A. Brea, Jr.
Roger G. Carrillo
Alex J. Furst
Gustavo Garcia
Lisardo Garcia-Covarrubias
Lynn H. Harrison
Sharon Larson
Saqib Masroor
Tomas A. Salerno
Naples
Dennis J. Stapleton
Norman B. Thomson, Jr.
New Port Richey
Theodore D. Aylward
V. Antoine Keller
Ocala
Peter Y. Kim
Orlando
Kevin D. Accola
Jeffrey N. Bott
Luis J. Herrera
Alan D. Johnston
Franklin G. Norris
Lester C. Nunnally
George J. Palmer, III
Mark E. Sand
Jorge E. Suarez-Cavelier
Ormond Beach
Jack E. Arrants
R. Samuel Cromartie, III
John B. Holt
Palm Beach Gardens
Malcolm J. Dorman
Richard S. Faro
Joseph Motta
Palm Coast
John A. Walsh
Palmetto Bay
John F. DeRosimo
Panama City
Charles C. Voorhis, III
Pensacola
David M. Conkle
James L. Lonquist
James L. Nielsen
Ponte Vedra Beach
Joseph W. Gilbert, Jr.
Harold E. Snyder
Port Charlotte
Thomas Kartis
Sarasota
W. Peter Graper
Jeffrey Edward Sell
Raymond R. Watson
South Miami
Mark R. Dylewski
St. Petersburg
F. Curtis Bryan, II
Bradley Lance Bufkin
Frank M. Byers
George R. Daicoff
Michael P. DeFrain
David S. Hubbell
Jeffrey P. Jacobs
James A. Quintessenza
Hugh M. Van Gelder
Stuart
Noble Correll
F. Michael Crouch
Sun City Center
Diane L. Jeffery
Tallahassee
Nelson H. Kraeft
David L. Saint
Tampa
Luis N. Bessone
William G. Marshall
Lary A. Robinson
Nicholas J. Sears
Keith E. Sommers
Tavares
Gary S. Allen
Vero Beach
Mark A. Malias
Cary L. Stowe
Michael O. Woo-Ming
West Palm Beach
Samuel H. Sadow
Rudolph P. Scheerer
Ivan C. Schmidt
Weston
Edward B. Savage
Winter Haven
James B. Threlkel
Winter Park
Constantine Mavroudis
Winter Springs
Patterson W. Moseley
GEORGIA
Albany
James M. Freeman
Francis Herrbold
C. Wayne Holley
Anthony V. Hoots
Athens
Theresa Duyen Luu
Cullen D. Morris
Charles Patrick Murrah
Atlanta
Aaron Abarbanell
Edward Po-Chung Chen
Joseph M. Craver
Felix G. Fernandez
Seth D. Force
Robert A. Guyton
Michael E. Halkos
Charles R. Hatcher, Jr.
Ward Vaughn Houck
Kirk R. Kanter
James R. Kauten
Michael O. Kayatta
W. Brent Keeling
Saeid Khansarinia
Brian E. Kogon
Omar M. Lattouf
Allen G. Macris
Kamal A. Mansour
Joseph I. Miller
Daniel L. Miller
Douglas A. Murphy
Allan Pickens
John D. Puskas
GEOGRAPHIC
Manu Suraj Sancheti
Peter N. Symbas
Vinod H. Thourani
Gilbert Wildstein
Augusta
Lawrence J. Freant
M. Vinayak Kamath
William Clifford Kitchens
William R. Kitchens
George L. Zumbro, Jr.
Chickamauga
David P. Hall
Decatur
Fred H. Aves
Dublin
James Harold Shoptaw, Jr.
Evans
Vijay S. Patel
Lebanon
Michael D. Horowitz
Macon
Peter James Bolan
Joe H. Johnson
Carl E. Lane
I. J. Shaker
Marietta
William A. Cooper
Ernest L. Itkin
William R. Mayfield
Richard T. Thio
Newnan
Donald C. Mullen
Riverdale
Majed S. Zakaria
Rome
Cyrus J. Parsa
James A. Young
Savannah
David V. Capallo
Dariush H. Heidary
William S. Hitch
Robert Evans Jones
Soumya R. Neravetla
John A. Shallal
Thomas J. Yeh
St. Simons Island
Joseph L. Owens, Jr.
L. Newton Turk, III
IOWA
Cedar Rapids
Mark G. Barnett
James M. Levett
Colo
William Y. Tucker, Jr.
Iowa City
Joseph Turek
IDAHO
Boise
Robert P. Barnes
Coeur d’Alene
Theodore C. Koutlas
Pocatello
Jacob DeLarosa
ILLINOIS
Chicago
Nikola Dobrilovic
Bassem N. Mora
Evanston
John A. Howington
Lincolnshire
Robert P. Dobbie
Oak Lawn
Sinan A. Simsir
Peoria
Richard C. Anderson
James P. Locher, Jr.
Rockford
David G. Cable
John C. Myers
Springfield
Stephen R. Hazelrigg
William S. Stevens, Jr.
Swansea
John D. Sadoff
Winnetka
Carl L. Backer
INDIANA
Bloomington
David Hart
Fort Wayne
Joseph Alan Greenlee, III
Granger
James P. Kelly
Indianapolis
Anthony J. Ascioti
John W. Brown
Arthur C. Coffey
Joel S. Corvera
Richard K. Freeman
Kenneth A. Kesler
Thomas C. Wozniak
Mishawaka
Truc Trung Ly
KANSAS
Kansas City
Emmanuel Daon
Nirmal K. Veeramachaneni
Overland Park
Duncan A. Killen
Shawnee MSN
Clarke L. Henry, Jr.
KENTUCKY
Lexington
Douglas C. Appleby
Michael D. Bolanos
Gary F. Earle
Victor A. Ferraris
Richard D. Floyd IV
Richard D. Floyd
Charles W. Hoopes
Graydon A. Long
Jeremiah Thomas Martin
Timothy W. Mullett
R. Herman Playforth
Hassan K. Reda
Sibu P. Saha
Joseph B. Zwischenberger
Louisville
Erle H. Austin, III
Roy G. Bowling
Lawrence G. Goldberg
Laman Gray, Jr.
Jonathan David Kraut
Robert W. Linker, III
Aaron E. Lucas
Christopher E. Mascio
David S. Nightingale
Sebastian Pagni
William E. Parks, Jr.
Samuel B. Pollock
Mark Slaughter
Gerald D. Temes
Matthew Lanier Williams
Madisonville
T. Mark Stanfield
Owensboro
Royce E. Dawson
Paducah
Carl M. Johnson
Nicholas M. Lopez
Keung Ung
Pikeville
Raed M. Alnajjar
Dennis L. Havens
LOUISIANA
Alexandria
Robert C. DeWitt
Gary P. Jones
Watts R. Webb
Baton Rouge
B. Eugene Berry
William Michael Boedefeld, II
David J. Davis
Henry D. H. Olinde
Swayze Rigby
Covington
Charles J. DiCorte
Gretna
Francis J. M. Alessi
Mark D. Kappelman
Houma
Karen S. Thompson
Marrero
Robert L. Carter
Metairie
Lawrence R. Breitkreutz
Warren L. Gottsegen
Harry A. Roach
GEOGRAPHIC
Monroe
Robert Keith White
Natchitoches
Robert D. Bloodwell
New Orleans
Umraan Saeed Ahmad
Michael John Bates
Joseph Caspi
Rodney J. Landreneau
Edward S. Lindsey
Inder Mehta
John L. Ochsner
Patrick Eugene Parrino
Timothy W. Pettitt
Frank E. Schmidt
Thomas Yeh
Herman A. Heck, Jr.
Shreveport
James M. Ciaravella, Jr.
Jane M. Eggerstedt
Sarjit S. Gill
Laurence F. Hiller
J. Stanford Shelby
Thibodaux
Tommy L. Fudge
West Monroe
Blaine M. Borders
MASSACHUSETTS
Boston
Christopher W. Baird
R. Morton Bolman, III
Phillip C. Camp
Daniel M. Cohen
John E. Mayer
Thoralf Sundt
Jennifer Walker
Cambridge
Stancel M. Riley
Falmouth
Richard B. McElvein
North Andover
William A. Cook
Worchester
Geoffrey M. Graeber
MARYLAND
Annapolis
Pendleton Alexander
Baltimore
Safuh Attar
William A. Baumgartner
Malcolm V. Brock
Duke E. Cameron
Neri M. Cohen
Fred N. Cole, Jr.
John V. Conte
James S. Gammie
Vincent L. Gott
Bartley P. Griffith
Gavin Henry
Peter J. Horneffer
Sunjay Kaushal
Joseph S. McLaughlin
Richard Norris Pierson, III
Juan A. Sanchez
Gary Schwartz
Ashish S. Shah
Minh P. Tran
Luca A. Vricella
Stephen C. Yang
Kenton J. Zehr
Bel Air
Linda W. Martin
Bethesda
Philip C. Corcoran
Keith A. Horvath
King F. Kwong
Barry J. Levin
John S. Thurber
Chevy Chase
Philip S. Mullenix
Norman A. Odyniec
Frederick
Mark S. Soberman
Glen Burnie
Christopher Sciortino
Lutherville
John C. Laschinger
Rockville
William C. DeVries
Raymond C. Read
Robert B. Wagner
Salisbury
Edward K. Carney
Silver Spring
Kenneth Cruze
Kathleen N. Fenton
Sparks Glencoe
J. Alex Haller, Jr.
Towson
Ziv Gamliel
Rochester
Shanda H. Blackmon
Stephen D. Cassivi
Joseph A. Dearanir
Hartzell V. Schaff
K. Robert Shen
John M. Stulak
Wayzata
James D. St. Louis
Worton
Harry E. Walkup
MISSOURI
MAINE
Cape Girardeau
Edward Michael Bender
Hancock
E. Converse Peirce II
Portland
Scott A. Buchanan
David L. Robaczewski
MICHIGAN
Ann Arbor
Steven F. Bolling
Himanshu Jagdish Patel
Richard L. Prager
Detroit
Robert M. Mentzer, Jr.
Henry Walters
Fenton
Joseph M. Arcidi, Jr.
Grand Rapids
Edward T. Murphy
Midland
Robert N. Jones
Muskegon
Richard S. Downey
Pontiac
William Gordon
MINNESOTA
Duluth
Stephen J. Huddleston
Antonio Laudito Laudito
Minneapolis
Mark D. Plunkett
Chesterfield
Cordie C. Coordes
Clayton
Emily A. Farkas
Columbia
Jack J. Curtis
W. Mike See
Eric Thompson
Joseph T. Walls
Holt
J. Robert Reinhardt
Jackson
Randy G. Brown
Jefferson City
Courtnye Allyson Walker
Kansas City
A. Michael Borkon
Clay M. Burnett
Richard A. Hopkins
James E. Miller
James E. O’Brien, Jr.
James R. Stewart
R. Scott Stuart
Robert D. Williams
George L. Zorn
Springfield
Kuo Fon Huang
James N. Pinckley
Ramon A. Shane
John B. Steinberg
Mounds View
Thomas A. Vassiliades, Jr.
GEOGRAPHIC
St. Louis
Hendrick B. Barner
Mark L. Blucher
Umar Sekou-Toure Boston
John E. Codd
John P. Connors
Traves D. Crabtree
Ralph J. Damiano
Melanie Edwards
Pirooz Eghtesady
Andrew C. Fiore
William A. Gay Jr.
Charles B. Huddleston
Robert G. Johnson
Donald R. Judd
Nicholas T. Kouchoukos
Russell R. Kraeger
Daniel Kreisel
Alexander Sasha Krupnick
Jennifer S. Lawton
Richard Lee
Hersh Maniar
Peter B. Manning
John P. Marbarger
Michael C. Mauney
Bryan F. Meyers
Marc R. Moon
Nabil A. Munfakh
Michael C. Murphy
Keith S. Naunheim
William Ogle
Alexander Patterson
Victor H. Ruiz
William F. Sasser
James Rowe Scharff
Stefano Schena
Scott C. Silvestry
Webster Groves
George C. Kaiser
MISSISSIPPI
Carthage
William D. Logan, Jr.
Columbus
Edward F. Crocker
Corinth
Billy D. Parsons
Greenville
Michael C. Trotter
Hattiesburg
Ralph E. Abraham
Jackson
Giorgio M. Aru
Lawrence L. Creswell
Pierre De Delva
William J. Harris III
A. Michael Koury
Russell L. McElveen
Martin H. McMullan
Gerhard H. Mundinger
Jorge D. Salazar
Meridian
Bryce Turnage
Tupelo
John W. Bowlin
Vicksburg
Timothy Howard Trotter
NORTH CAROLINA
Asheville
George M. Bilbrey
Mark Groh
John C. Lucke
Timothy Takaro
Biltmore Forest
Donald C. Watson, Jr.
Burlington
Ralph W. Bland
Cary
J. Ralph Dunn, Jr.
Chapel Hill
Thomas M. Egan
Richard H. Feins
Benjamin Haithcock
William R. Hix
Andy Christopher Kiser
Michael R. Mill
Brett C. Sheridan
James D. Sink
Charlotte
L. George Alexander
David Scott Andrews
Joseph W. Cook
Harry K. Daugherty
Felix A. Evangelist
Charles Dulaney Harr
Harold R. Howe, Jr.
Kevin W. Lobdell
Thomas S. Maxey
Benjamin Banks Peeler
Mark K. Reames
Francis Robicsek
Jay G. Selle
Eric R. Skipper
Robert M. Stiegel
Stephen L. Wallenhaupt
Larry T. Watts
Richard W. Zollinger, II
Hickory
Richard A. Carlton
Hugo L. Deaton
Mark H. Hennington
Duck
George L. B. Grinnan
Lumberton
Terry S. Lowry
Durham
Mark F. Berry
Thomas A. D’Amico
Robert D. Davis, Jr.
Jeffrey Gaca
Donald D. Glower
David H. Harpole, Jr.
Matthew Galen Hartwig
George C. Hughes, IV
Robert DB Jaquiss
Robert H. Jones
Shu S. Lin
Andrew J. Lodge
James E. Lowe
W. Benson McCutcheon, Jr.
Carmelo A. Milano
Asad A. Shah
Peter K. Smith
Betty Caroline Tong
James P. Weaver
Walter G. Wolfe
Mebane
Timothy E. Oaks
Fayetteville
William H. Newman
Fletcher
Ronald C. Hill
Gastonia
James P. Greelish
Greensboro
D. Patrick Burney
Edward B. Gerhardt
Charles H. Wilson
Greenville
W. Randolph Chitwood
Joseph R. Elbeery
T. Bruce Ferguson
Alan P. Kypson
L. Wiley Nifong
J. Mark Williams
High Point
Stephen A. Mills
New Bern
Mark A. Sinning
Newland
W. Gardner Rhea, Jr.
Pinehurst
John C. Alexander
Robin G. Cummings
T. Arthur Edgerton
Peter I. Ellman
John F. Krahnert
E. Wilson Staub
Raleigh
Albert S.Y. Chang
R. Merrill Hunter
Raleigh
Lae E. Landvater
Isaac V. Manly
Alden Parsons
Robert B. Peyton
John V. Zeok
Roxboro
Gordon M. Carver, Jr.
Southport
Gordon F. Murray
Weaverville
Calvin P. Claxton, Jr.
Winston-Salem
Bret D. Borchelt
John W. Hammon
Allen S. Hudspeth
Edward H. Kinaid
Neal D. Kon
Joel C. Morgan
Yoshio Otaki
Ross M. Ungerleider
Leonard James Wudel, Jr.
GEOGRAPHIC
NEBRASKA
Bennington
William H. Fleming
Lincoln
Richard Thompson
Omaha
Michael J. Moulton
NEW JERSEY
Camden
Michael Rosenbloom
Cherry Hill
Joseph A. Kuchler
Interlaken
Loki Skylizard
Neptune
Mark J. Krasna
Arthur J. Roberts
New Brunswick
James W. Mackenzie
Newark
James S. Donahoo
Ridgewood
Jason S. Sperling
NEW MEXICO
Albuquerque
Marco Ricci
Alto
R. Duncan Sutherland
NEVADA
Henderson
J.W. Randolph Bolton
Las Vegas
Neel V. Dhudshia
J.E. ‘Rick’ Martin
NEW YORK
Buffalo
Todd L. Demmy
Stephen W. Downing
Sai Yendamuri
New York
Paul Jubeong Chai
Abe DeAnda, Jr.
David R. Jones
Joshua R. Sonett
Plattsburgh
Craig A. Nachbauer
Syracuse
Gary R. Green
OHIO
Bentleyville
Harry Kourlis
Cincinnati
Geoffrey A. Answini
George M. Callard
William H. Cook
Donald L. Mitts
Eric J. Okum
John R. Robinson
Creighton B. Wright, Sr.
Cleveland
Peter C. Kouretas
Robert D. Stewart
Columbus
Jonathan M. Enlow
Robert S.D. Higgins
Ahmet Kilic
Jefferson M. Lyons
Dayton
Mark Peter Anstadt
Jose Rafael Rodriguez
Kettering
Karl J. Borsody
OKLAHOMA
Enid
F. Clark Sauls
Inola
Frank Ernest Schmidt, Jr.
Lawton
Aaron L. Trachte
Nichols Hills
R. Darryl Fisher
Norman
James R. McCurdy
Oklahoma City
R. Mark Bodenhamer
Ronald C. Elkins
Charles Craig Elkins
James M. Hartsuck
William D. Hawley
Paul J. Kanaly
Marco A. Paliotta
Marvin D. Peyton
Donald E. Stowell
Tulsa
Robert L. Anderson
Donald R. Bergman
Robert C. Blankenship
Frank N. Fore
Edward W. Jenkins
Billy Paul Loughridge
Clyde Redmond
OREGON
Ashland
Daniel C. Campbell, Jr.
Eugene
John M. Armitage
Portland
Paul Schipper
Howard K. Song
PENNSYLVANIA
Allentown
Michael Francis Szwerc
Beaver
Alexander Vasilakis
Bethlehem
William R. Burfeind, Jr.
Danville
Matthew A. Facktor
Anastasios C. Polimenakos
Edward L. Woods
Downingtown
Pierantonio Russo
Hershey
Joseph Brian Clark
Lancaster
Jeffrey Todd Cope
Lititz
Paul S. Brown, Jr.
Philadelphia
Joel D. Cooper
J. William Gaynor
Thomas L. Spray
Randy M. Stevens
Pittsburgh
Ahmad Reza Abrishamchian
Vinay Badhwar
Jay Kumar Bhama
Danny Chu
George J. Magovern, Jr.
Robert J. Moraca
Victor O. Morell
Arjun Pennathur
James J. Rams
Scranton
Edwin C. Neville
Seneca
James W. Klena
Sewickley
Richard E. Clark
SOUTH CAROLINA
Anderson
J. Scott Kabas
Charleston
R. Randolph Bradham
Scott M. Bradley
Mario Castillo-Sang
Fred A. Crawford, Jr.
Chadrick E. Denlinger
Michael L. Edwards
John S. Ikonomidis
Minoo Naozer Kavarana
Elizabeth M. Kline
John M. Kratz
H. Biemann Othersen, Jr.
David Scott Peterseim
Scott D. Ross
Joseph W. Rubin
Robert M. Sade
John A. Spratt
John Matthew Toole
Columbia
William B. Allen
Carl H. Almond
James Ryan Burke
Edward M. Leppard, Jr.
Dail W. Longaker
Jeffery S. Martin
Robert J. McCardle
Scott J. Petit
GEOGRAPHIC
John Perry Sutton, III
David E. Tribble
Reid W. Tribble
John W. Yarbrough
William M. Yarbrough
Mohammed Yousufuddin
Dale
Marshall C. Sanford
Florence
Scot C. Schultz
Charlie D. Smith, III
Robert W. Youngblood
Greenville
Carl E. Anderson
William Bolton
Barry R. Davis
Hugh M. Dennis
Scott H. Johnson
Christopher C. Wright
Greenwood
Claudio Guareschi
Hilton Head Island
Morris H. Drucker
Irmo
John W. Brown
Kiawah Island
Sewell H. Dixon, Jr.
Landrum
W. Robin Howe
Mauldin
James F. Ballenger
Mt. Pleasant
G. Dennis Vaughan, III
Sea Brook Island
John P. Sutton, III
Spartanburg
Henry G. Kelley, Jr.
West Columbia
Ganesh M. Pai
Jeffrey A. Travis
TENNESSEE
Bristol
William H. Messerschmidt
Marcus Gerard Williams
Chattanooga
James Robert Headrick
Clifton Reade
James L. Zellner
Cookeville
Gerald Todd Chapman
Cordova
Christian L. Gilbert
Franklin
Scott L. Faulkner
Robert B. Lee
Jackson
Arthur Grimball
John T. Matthews
Johnson City
Daniel W. McCoy
Anthony J. Palazzo
D. Glenn Pennington
Kingsport
R. Neal Carter
D. Tyler Greenfield
Cary H. Meyers
David H. Sewell
Knoxville
Sheldon E. Domm
Brent A. Grishkin
Lacy E. Harville, III
John W. Mack, Jr.
Michael L. Maggart
Thomas R. Pollard
Chadwick Stouffer
Hiroshi Toyohara
William A. Walker
Robert D. Ware
Maryville
Jason M. Budde
Memphis
Jesse T. Davis, Jr.
Christopher J. Knott-Craig
William M. Novick
Edmond W. Owen, Jr.
James W. Pate
J. Richard Prather
Glenn Phillip Schoettle
Darryl S. Weiman
Van Henry Wells
Rodney Y. Wolf
Bradley Aaron Wolf
Millington
F. Hammond Cole, Jr.
Nashville
William C. Alford
John C. Austin
Tammy M. Baxter
David P. Bichell
Karla G. Christian
Davis C. Drinkwater
William H. Edwards
Eric L. Grogan
Robert A. Hardin
Jackson Harris
Steven J. Hoff
Aaron Lee Hoffman
Eric S. Lambright
L. Lee Lancaster
Kenneth H. Laws
Simon Maltais
Walter H. Merrill
Bret Allen Mettler
Jonathan C. Nesbitt
Lawrence J. Pass
Michael R. Petracek
Joe B. Putnam, Jr.
Judson G. Randolph
J. Scott Rankin
V. Seenu Reddy
John Robert Roberts
Evelio Rodriguez
John L. Sawyers
John H. Selby, Jr.
Alanson R. Spalding, III
William S. Stoney
D. Christopher Wells
Oak Ridge
William C. Hall
Signal Mountain
Joel E. Avery
TEXAS
Abilene
David E. Carlson
Amarillo
Masoud A. Alzeerah
W. Allison Guynes
Robert L. Taylor
Arlington
Darien W. Bradford
James F. Norcross
Austin
Homer S. Arnold
Reginald C. Baptiste
Stephen J. Dewan
Mark C. Felger
Lewis G. King
R. Brent New
John D. Oswalt
Don C. Wukasch
Boerne
Ridlon J. Kiphart
Brownsville
Carlos M. Chavez
Bullard
Charles T. Meadows
Burnet
Kenneth R. T. Tyson
College Station
H. Andrew Hansen, II
Corpus Christi
Sergio Tavares
Dallas
Brian T. Bethea
Edson H. K. Cheung
Todd M. Dewey
J. Michael DiMaio
James R. Edgerton
Joseph M. Forbess
Gerald F. Geisler
Kristine J. Guleserian
Michael E. Jessen
Mitchell J. Magee
Eric N. Mendeloff
Dan M. Meyer
W. Steves Ring
Vinod A. Sebastian
Hasmukh H. Shah
Shankar Meenakshi Sundaram
J. Peter Thiele
Derek Williams
Richard E. Wood
Raghav A. Murthy
Denton
Tung H. Cai
GEOGRAPHIC
Fort Worth
Reza S. Khalafi
Eugene D. Olcott
Vincent K.H. Tam
Friendswood
Robert H. Smiley
Galveston
Vincent R. Conti
Scott D. Lick
Harlingen
Marion R. Lawler, Jr.
Houston
Faisal G. Bakaeen
William E. Cohn
Joseph Stapleton Coselli
Rajeev Dhupar
J. Michael Duncan
Anthony L. Estrera
Charles D. Fraser, Jr.
Oscar H. Frazier
Grady L. Hallman
Jeffrey S. Heinle
Michael H. Hines
Wayne Hofstetter
Adel D. Irani
Kamal G. Khalil
Min Peter Kim
Javier A. Lafuente
Scott A. LeMaire
James J. Livesay
Michael P. Macris
Hari Mallidi
Kenneth L. Mattox
Emmett Dean McKenzie
Reza J. Mehran
Carlos M. Mery
Laurens R. Pickard
Ourania Preventza
Basel Ramlawi
Michael J. Reardon
George J. Reul
Ross M. Reul
David C. Rice
Todd Rosengart
Hazim J. Safi
Michael S. Sweeney
Stephen G. Swisher
Ara A. Vaporciyan
Matthew J. Wall, Jr.
Garrett L. Walsh
Humble
Devinder S. Bhatia
Killeen
Byung H. Chung
Lufkin
David A. Ladden
McAllen
Jesus Rodriguez Aguero
Montgomery
James W. Jones
Nacogdoches
James A. Allums
Lyle L. Brown
Plano
Michael J. Mack
Robert E. Rawitscher
William H. Ryan
Port Aransas
Robert Gerald Carlson
Port Arthur
O. LaWayne Miller, Jr.
Richmond
Uttam Tripathy
Rockport
William M. Ashe
San Angelo
Jason E. Felger
Andrew Tucker Hume
San Antonio
Clinton E. Baisden
John H. Calhoon
Andrea J. Carpenter
Alfonso Chiscano
Byron N. Dooley
Amanda L. Eilers
Timothy Hamilton
Lawrence R. Hamner
Bryan Scott Helsel
S. Adil Husain
Scott B. Johnson
Lauren Kane
Robert H. LePere
Tim S. Lyda
Jeffrey D. McNeil
HelenMari Merritt
Joseph M. Monfre
Muhammad Mumtaz
Carmelo Otero
Hao Pan
Richard G. Rouse
Edward Y. Sako
J. Marvin Smith, III
Chad N. Stasik
Robert L. Treasure
Southlake
Mahesh S. Sharma
James J. Gangemi
Ravi Ghanta
William S. Hotchkiss
John A. Kern
Armin Kiankhooy
Benjamin D. Kozower
Irving L. Kron
Damien J. LaPar
Christine L. Lau
Bradley M. Rodgers
Curtis G. Tribble
Temple
Wade L. Knight
Chesapeake
Paul W. Braunstein
Texarkana
Michael Bruce Cannon
Danville
James D. Sprinkle
John M. Stoneburner
Sherman
George W. Johnson, Jr.
Tyler
Roy L. Kingry, Jr.
Ken Nelson
Peter M. Sanfelippo
William F. Turner
Victoria
Robert H. Johnston
Waco
Robert T. Angel
Philip H. Croyle
William A. Peper
Wichita Falls
Olyn M. Walker
UTAH
Lehi
James C. Jones
Ogden
Rafe C. Connors
Salt Lake City
Phillip Todd Burch
Peter J. Gruber
VIRGINIA
Arlington
John W. Rhee
Falls Church
Nelson A. Burton
Lucas R. Collazo
Sandeep Khandhar
Paul D. Kiernan
William S. Lyons
Alan M. Speir
Gainesville
Thomas M. Fulcher
Hampton
Peter M. Moy
Lynchburg
David W. Frantz
Stuart H. Harris, Jr.
Charles Ray Mulligan, Jr.
Manakin Sabot
William A. Robertson
Mc Lean
David V. Pecora
Midlothian
Szabolcs Szentpetery
Newport News
Charles E. Umstott
Bedford
Harry P. Clause, Jr.
Norfolk
Kirk Fleischer
Joseph R. Newton
Charlottesville
Gorav Ailawadi
Thomas M. Daniel
Petersburg
Frederick D. Bergen
Ernest R. Rodriguez-Ramos
GEOGRAPHIC
Portsmouth
Vasken K. Tenekjian
Richmond
Thomas D. Christopher
David H. Harpole
Vigneshwar Kasirajan
Yale H. Zimberg
J. James Zocco
Anthony D. Cassano
Roanoke
W. Scott Arnold
Joseph W. Baker
Antonio T. Donato
Paul T. Frantz
Robert L. A. Keeley
Joseph Franklin Rowe, III
David Alan Wyatt
Salem
Ben R. Barton
Spotsylvania
Michael C. Banker
Springfield
Mitchell Mills
Virginia Beach
Walter E. Beasley, III
John P. Clarke
Williamsburg
John M. Pitman, Jr.
Winchester
R. Daley Goff, Jr.
Yorktown
Walter H. Graham
VERMONT
Seattle
Jay D. Pal
John J. White
WISCONSIN
Appleton
Subhasis Chatterjee
Ellison Bay
Chester L. Holmes
Madison
Shahab A. Akhter
Nilto C. De Oliveira
Milwaukee
John David Crouch
Michael E. Mitchell
James S. Tweddell
Waukesha
John J. Kelemen, III
Wausau
William T. Mattingly
WEST VIRGINIA
Charleston
Nestor F. Dans
James H. Walker
Huntington
John D. Harrah
Morgantown
Robert A. Gustafson
Anthony Austin Holden
Donald E. McDowell
So Charleston
John Deel
Post Mills
Norman J. Snow
Wheeling
Ahmad Rahbar
WASHINGTON
WYOMING
Bellevue
Robert S. Binford
Jackson
Kenneth M. Begelman
Issaquah
Thomas O. Gentsch
Shell
Meredith L. Scott
Puyallup
Keith A Havenstrite
AUSTRALIA
Victoria
Cliff Choong
CANADA
Montreal
Basil Saad Nasir
Vancouver
Sanjiv K. Gandhi
GREECE
Glyfada
George M. Palatianos
NORWAY
Oslo
Harald L. Lindberg
PORTUGAL
Leca Da Palmeira
Mario N. Gomes
PUERTO RICO
Guaynabo
Juan R. Vilaro-Nelms
Mayaguez
Raul F. Garcia-Rinaldi
San Juan
Ivan F. Gonzalez
SOUTH KOREA
Daegu
Jae Hyun Kim
GENERAL INFORMATION
CONSTITUTION
AND BYLAWS
348 STSA 61st Annual
AnnualMeeting
Meeting
SOUTHERN THORACIC SURGICAL ASSOCIaTION
CONSTITUTION AND BYLAWS
(as amended November 1, 2013)
ARTICLE I: NAME
The name of the Corporation shall be the SOUTHERN THORACIC
SURGICAL ASSOCIaTION, INC. (hereinafter designated as “the
Association”).
ARTICLE II: OBJECTIVES
The Association is a not-for-profit corporation whose principle
objectives are to disseminate knowledge and information and to
stimulate progress in the field of thoracic and cardiovascular surgery in
the designated geographic area.
The Association will:
1. Disseminate knowledge, encourage research and report at the
annual meeting, scientific session and postgraduate course on the
advancements within the field of thoracic and cardiovascular surgery.
2. Promote fellowship among thoracic and cardiovascular surgeons
throughout the designated geographic area.
3. Assure that the activities of the Association are undertaken without
any discrimination with regard to race, color, religious creed, national
origin, ancestry, physical handicap, medical condition, marital status
or sex.
ARTICLE III: OFFICES
The Association shall have and continuously maintain a registered
office and a registered agent in the State of Illinois, and may have such
other offices in or outside the State of Illinois at the Council’s discretion.
ARTICLE IV: MEMBERS
SECTION 1. Membership. . There shall be six (6) categories of
members: Active, Senior, Resident, Student, Associate, and Honorary
Member. Members shall be individuals who support the purpose of
the Association and who agree to comply with the Association’s rules
and regulations. Active and Senior members shall be entitled to hold
office and shall have voting privileges. Active and Senior Members
must be board certified by the American Board of Thoracic Surgery or
its foreign equivalent. If an Active Member moves from the designated
membership geographical area outlined in SECTION 2, he or she may
retain membership as long as all other requirements for membership
are satisfied. Members whose practices have been limited because
of disability, or who have reached the age of 65 years, may apply for
Senior Membership. The Association shall not be required to subscribe
to The Annals of Thoracic Surgery for Senior members. Associate
Members include support staff for practicing cardiothoracic surgeons
including, but not limited to, nurses, nurse practitioners, perfusionists,
physician assistants, and research staff. Honorary membership can
be bestowed upon a worthy recipient upon recommendation of the
Council and ratification by a two-thirds majority of the votes at the
annual meeting. Honorary Members are broadly defined as physicians
who have made significant contributions to the field of cardiothoracic
surgery Nomination for Honorary Membership can be made to the
Council in writing for review prior to the spring Council Meeting.
Honorary Members are welcomed at all scientific and business
meetings of the Association, but have no obligations or responsibilities
in the organization. Honorary, Associate, Resident, and Student
Members do not have voting privileges, nor may they hold office.
Resident Members must be matched or enrolled in a thoracic surgery
educational program accredited by the Residency Review Committee
for Thoracic Surgery under the authority of the Accreditation Council for
Graduate Medical Education that is within the STSA region provided for
in SECTION 2 to be classified as a Resident Member. Resident Members
may retain membership up to three years following the completion
of their thoracic surgery training. Resident members who have been
certified in thoracic surgery by the American Board of Thoracic Surgery
(ABTS) may, upon written request to the Association and with approval
of the Membership Committee and the Council, transition directly,
with no initiation fee applied, to Active Membership. If no such official
request is forthcoming, Resident Membership will be terminated and
reinstatement will be dependent upon a formal application for Active
Membership, with its associated requirements, including initiation fee
and approval by the full membership. Student Members may apply for
membership by expressing a desire to enter the field of cardiothoracic
surgery. Student members may transfer to Resident Member status
once they have matched or enrolled in a thoracic surgery educational
program accredited by the Residency Review Committee for Thoracic
Surgery under the authority of the Accreditation Council for Graduate
Medical Education that is within the STSA region. There is no fee
for Student Members; however, Student Members must renew their
membership annually.
SECTION 2. An applicant for Active Membership must at the time
of acceptance reside, or have previously practiced cardiothoracic
surgery for at least one year, or have completed a thoracic residency
program, or have completed a thoracic or cardiovascular research or
clinical fellowship for at least twelve consecutive months in one of
the following states or regions: Alabama; Arkansas; Florida; Georgia;
Kentucky; Louisiana; Maryland; Mississippi; Missouri; North Carolina;
Oklahoma; South Carolina; Tennessee; Texas; Virginia; West Virginia;
District of Columbia; the U.S. territories and commonwealths in the
Caribbean. An applicant for active membership must be certified by the
ABTS. Applicants who meet the practice requirement above but whose
training has been in countries other than the United States of America,
and who are certified as proficient in thoracic and cardiovascular
surgery by appropriate authorities in their home country, may apply.
At least seventy-five percent of the practice of the applicant must be
devoted to the field of thoracic and cardiovascular surgery, which
may include research and peripheral vascular surgery. If an applicant
is unsuccessful in obtaining membership in two successive years,
an interval of two years must elapse before he/she may reapply. The
Membership Committee and the Council may recommend acceptance
of foreign training and certification by stating that, in their opinion,
it represents equivalent status. The Membership Committee and
Council may recommend acceptance of individuals who, despite not
meeting membership criteria regarding training, practice or research
in the STSA region, have demonstrated significant involvement with
the organization through their participation in the annual meeting,
contributions to the scientific program, and service to the organization.
Applicants so approved by the Membership Committee and the Council
may become Active Members upon election by the membership at an
annual meeting.
An applicant for Resident Membership must at the time of acceptance
be matched or enrolled in a thoracic surgery educational program
accredited by the Residency Review Committee for Thoracic Surgery
under the authority of the Accreditation Council for Graduate Medical
Education in one of the following states or regions: Alabama; Arkansas;
Florida; Georgia; Kentucky; Louisiana; Maryland; Mississippi; Missouri;
North Carolina; Oklahoma; South Carolina; Tennessee; Texas;
Virginia; West Virginia; District of Columbia; the U.S. territories and
commonwealths in the Caribbean. Individuals who have completed
their education in one of the above programs and are in the process of
acquiring certification in thoracic surgery by the ABTS are eligible to
apply for Resident Membership.
An applicant for Associate Membership must at the time of
acceptance be working in field of allied health related to the practice
of cardiothoracic surgery in one of the following states or regions:
Alabama; Arkansas; Florida; Georgia; Kentucky; Louisiana; Maryland;
Mississippi; Missouri; North Carolina; Oklahoma; South Carolina;
Tennessee; Texas; Virginia; West Virginia; District of Columbia; the U.S.
territories and commonwealths in the Caribbean.
An applicant for Student Membership must at the time of acceptance
be enrolled in medical school or general surgery residency in one of
the following states or regions: Alabama; Arkansas; Florida; Georgia;
Kentucky; Louisiana; Maryland; Mississippi; Missouri; North Carolina;
Oklahoma; South Carolina; Tennessee; Texas; Virginia; West Virginia;
District of Columbia; the U.S. territories and commonwealths in
the Caribbean. They must submit a written statement of interest in
cardiothoracic surgery.
Active Membership status will not become effective, nor a certificate
of membership presented, unless and until such elected applicant
registers at one of the next four annual meetings following his/her initial
election to membership. Resident and Associate Membership status will
not become effective, nor a certificate of membership presented, unless
and until such elected applicant registers for and attends an annual
meeting following his or her election to membership. Exception for this
requirement may be granted by a majority vote of the Council. Failure to
comply with this procedure will require reapplication for membership.
SECTION 3. Application forms for Active, Resident, Associate, and
Student Membership are available from the Secretary-Treasurer or at
www.stsa.org and are forwarded to the Chairman of the Membership
Committee for verification. Applications will be verified by the
Membership Committee in accordance with the policies and procedures
established by the Council.
SECTION 4. The Council shall issue a Certificate of the Association
evidencing the member’s admission to the Association and indicating
membership status. These certificates remain the sole property of the
Association and shall be surrendered upon written demand and/or for
non-payment of dues.
SECTION 5. Resignation. Members may resign from the Association
at any time by giving written notice to the Secretary/Treasurer of the
Association. Such resignation shall not relieve the member of any
obligation for dues, assessments or other charges previously accrued
and unpaid. Membership is not transferable or assignable.
SECTION 6. The Council, by affirmative vote of two-thirds of all Council
members present and voting at any duly constituted meeting of the
Council, may suspend or expel a member for cause after an appropriate
hearing in accordance with policies and procedures established by the
Council. The Council, by affirmative vote of a majority of all Council
members present and voting at any duly constituted meeting of the
Council may terminate the membership of any member who has
become ineligible for membership in accordance with the policies and
procedures established by the Council.
SECTION 7. Application for Reinstatement. Any former members of the
Association may apply for reinstatement through the regular application
procedure.
ARTICLE V: DUES AND ASSESSMENTS
The initiation and annual dues for each category of member of the
Association, the time for paying such dues, and other assessments,
if any, shall be determined by the Council. Annual dues are not
refundable.
ARTICLE VI: MEETING OF MEMBERS
SECTION 1. Annual Meeting. The annual meeting of the members shall
be held at a date, time and place determined by the Council and shall be
held in conjunction with the scientific session of the Association.
SECTION 2. Purpose. The purpose of the annual meeting is to: elect
officers and councilors; receive reports from the Association on the
activities of the Council; provide members an opportunity to express
their opinions on matters affecting the Association; and to dispense
with such other business, as necessary. The order of business for
a meeting shall be determined in advance by the President and
subsequently adopted at a called meeting.
SECTION 3. Special Meetings. Special meetings of the membership may
be called by the President or the Council. Such special meetings shall be
held at a date, time and place as determined by the Council.
SECTION 4. Notice of Meetings. Written notice stating the date, time and
place of any annual or special meeting shall be delivered no less than
seven (7) days, nor more than 30 days, before the date of the meeting to
each member entitled to vote at the meeting. In the case of removal of
one or more Council members, a merger, consolidation, dissolution or
sale of assets, a written notice of no less than twenty (20) days or more
than sixty (60) days before the date of the meeting will be given by, or at
the direction of, the President, the Secretary, or the Council.
SECTION 5. Quorum. The quorum for the transaction of business at
a meeting of members or special meeting shall be a majority of the
members attending that meeting.
SECTION 6. Voting. Each member with voting rights shall be entitled to
only one (1) vote. A majority of the votes present at a meeting where
a quorum is present shall be necessary for the adoption of any matter
voted upon by the members, except where otherwise provided by law,
the articles of incorporation of the Association or these bylaws.
SECTION 7. Informal Action. Required action may be taken without
a meeting if a consent in writing, setting forth the action taken, is
signed by not less than the minimum number of members necessary
to authorize such action at a meeting, except for dissolution of the
Association, which must be voted on at a special meeting of the
members entitled to vote.
ARTICLE VII: OFFICERS AND THE COUNCIL
SECTION 1. General Powers. The property, business and affairs of the
Association shall be managed by the Council. The Council may adopt
such rules and regulations for the conduct of its business as shall be
deemed advisable and may, in the execution of the power granted,
appoint such agents as necessary. In addition, the Council shall act as a
Board of Censors for the trial of all alleged offenses against the bylaws.
A report by the Chairman of the Council shall be made to the members
at the annual meeting.
SECTION 2. Number, Tenure and Qualifications. The Council shall
consist of the Past President, the Chairman of the Council (Immediate
Past President), the President, the President-Elect, the Vice President,
the Secretary/Treasurer, the Director of Continuing Medical Education,
the Historian and three Councilors-At-Large. The Secretary/Treasurer
Elect, the representative of the Board of Governors of the American
College of Surgeons, representative of the Advisory Council for
Cardiothoracic Surgery of the American College of Surgeons, the
Editor of The Annals of Thoracic Surgery, the Chairman of the Program
Committee, the Chairman of the Membership Committee, and the
Chairman of the Postgraduate Program Committee shall attend the
Council meetings without vote.
SECTION 3. Election. The eligible members will elect the Council.
Officers shall be elected annually to serve a one-year term, except the
Secretary/Treasurer whose term shall be for four years and the historian
whose term shall be for four years and who can be re-elected. The
President, Vice President and Secretary/Treasurer are not eligible for
re-election. The term of office of councilors-at-large shall be two years.
Two Councilors shall be elected one-year and one Councilor the next
year to replace the retiring members, unless a vacancy or vacancies has
occurred, in which case an additional Councilor(s) shall be appointed by
the President to fill the vacant term(s).
SECTION 4. Resignation. Any Council member may resign at any time
by giving written notice to the President. Such resignation shall take
effect when the notice is delivered, unless the notice specifies a future
date. Another exception would be, unless otherwise specified therein,
the acceptance of such resignation shall not be necessary to make it
effective.
SECTION 5. Annual Meetings. The annual meeting of the Council shall
be held at the time and place designated by the Council in connection
with the annual members meeting.
SECTION 6. Regular Meetings. The Council may hold regular meetings
at such place and at such times as designated by the Council.
SECTION 7. Special Meetings. Special meetings of the Council may be
held at any place and time on the call of the President or at the request
in writing of any three Council members.
SECTION 8. Notice of Meetings. Notice of special meetings of the
Council shall be delivered by, or at the direction of, the Secretary/
Treasurer to each Council member at least seven (7) days before the
day on which the meeting is to be held. Notice may be waived in writing
by a Council member, either before or after the meeting. Neither the
business to be transacted at, nor the purpose of any special meeting of
the Council, need be specified in the notice or waiver of notice of such
meeting.
SECTION 9. Quorum. A majority of the Council members entitled to vote
shall constitute a quorum for the transaction of business at any meeting
of the Council.
SECTION 10. Manner of Acting. The act of a majority of the Council
members at a meeting at which a quorum is present shall be the act of
the Council, unless the act of a greater number is required by law, the
articles of incorporation, or by these bylaws.
SECTION 11. Informal Action. Action may be taken by the Council
without a meeting if a consent in writing, setting forth the action so
taken, is signed by all the Council members.
SECTION 12. Participation at Meetings by Conference Telephone.
Members of the Council, or of any committee designated by the Council,
may take any action permitted or authorized by these bylaws by means
of conference telephone, or similar telecommunications equipment, in
which all persons participating in the meeting can communicate with
each other. Participation in such a meeting shall constitute presence in
person at such meeting.
SECTION 13. Compensation. Council members, as such, shall not
receive any stated compensation for their services on the Council, but
the Council may, by resolution, authorize reimbursement for reasonable
expenses incurred in the performance of their duties. The Council will
occasionally review the reimbursement policies.
ARTICLE VIII: OFFICERS AND EXECUTIVE DIRECTOR
SECTION 1. Officers. The officers of the Association shall consist of
the President, the President-Elect, the Vice President, the Secretary/
Treasurer, the Chairman (Immediate Past President), the Past President,
the Historian, and such other officers and assistant officers as may be
elected in accordance with the provisions of this Article. The Council
may elect or appoint such other officers as it shall deem necessary.
These officers shall have the authority to perform such duties as may be
prescribed from time-to-time by the Council.
SECTION 2. President. The President shall be the principal elected
officer of the Association. The President shall preside at all meetings
of the Association. The President shall appoint members to the
standing committees and to any other special committee, which may
be deemed necessary for the welfare of the association. The President
shall perform all other duties appropriate to the conduct of the office.
At the conclusion of the annual meeting, the retiring President shall
automatically become a Councilor for a two-year term of office in the
capacity of Chairman the first year and Past President the second year.
SECTION 3. President-Elect. The President-Elect shall participate in all
the meetings and deliberations of the Council during the year elected
and shall accede to the office of President the following year.
SECTION 4. Vice President. In the absence of the President, or in the
event of his or her inability or refusal to act, the Vice President shall
perform the duties of the President. When so acting, the Vice-President
shall have all the powers, and be subject to all the restrictions, of the
President. The Vice President shall perform such other duties as may be
assigned by the President or by the Council.
SECTION 5. Secretary/Treasurer. As Secretary he/she shall: keep the
minutes of the meetings of the members and of the Council in one or
more books provided for that purpose; see that all notices are duly
given in accordance with the provisions of these bylaws, or as required
by law; be custodian of the Council’s records; keep a register of the
post office address of each member, which shall be furnished to the
Secretary by such member; notify candidates of their election to
membership; and in general perform all duties incident to the office of
Secretary, and such other duties that may be assigned by the President
or by the Council. The administrative duties of the Secretary may be
assigned, in whole or in part, to the Executive Director by the Council.
As Treasurer, he/she shall keep an account of all monies received and
expended by the Association and shall make disbursements authorized
by the Council. All sums received shall be deposited or invested in such
bank, trust company, or other depositories authorized by the Council.
The Treasurer shall perform all the duties incident to the office of
Treasurer and such other duties as may be assigned by the President
or by the Council. The administrative duties of the Treasurer may be
assigned, in whole or in part by the Council, to the Executive Director.
He/she shall present an annual report to the membership for audit.
SECTION 6. Secretary/Treasurer-Elect. The Secretary/Treasurer-Elect
shall serve as understudy to the Secretary/Treasurer for a term of one
year.
SECTION 7. Chairman. The immediate Past President shall be the
Chairman of the Council and perform such duties as occasionally may
be designated by the President or by the Council. Upon termination of
the term of office as President, the President shall become Immediate
Past President for a one-year term.
SECTION 8. Past President. The Past President shall serve on the
Council and perform such duties as may be designated by the President,
Chairman of the Council, or by the Council. Upon termination of the term
of office as Immediate Past President, the Immediate Past President
shall become Previous Past President for a one year term.
SECTION 9. Director of Continuing Medical Education. The Director of
Continuing Medical Education shall be appointed by the President for
a term of four years and shall oversee and coordinate the Program and
Postgraduate Programs, and the administration aspects of continuing
education, and chair the Continuing Education Committee.
SECTION 10. Executive Director. The administrative duties and dayto-day operation of the Association shall be conducted by a salaried
staff head or firm employed or appointed by the Council. The Executive
Director shall be responsible to the Council. The Executive Director shall
have the authority to execute contracts on behalf of the Association and
as approved by the Council. The Executive Director may carry out the
duties of the Secretary of the Association and may carry out the duties
of the Treasurer as directed by the Council. The Executive Director shall
employ and may terminate the employment of staff members necessary
to carry out the work of the Association and shall perform such other
duties as may be specified by the Council.
SECTION 11. Historian. The Historian shall record the history of the
Association, keep archives of the programs and minutes of the Business
and Council meetings, and report the deaths of members at the annual
business meeting. In addition, he/she shall perform all other duties
appropriate to this office and other duties assigned by the President for
Council.
ARTICLE IX: COMMITTEES
The President shall appoint committees as may be necessary for the
proper conduct and management of the Association. The standing
Committees of the Association shall be:
SECTION 1. Executive Committee. The Executive Committee shall
consist of the officers of the Association and the Executive Director.
The Executive Director shall be ex-officio, a member of the Executive
Committee without the right to vote. The Executive Committee may
exercise the authority of the Council in the management of the affairs of
the Association during the intervals between meetings of the Council,
subject at all times to the bylaws of the Association, and the prior
resolutions, regulations and directives issued, adopted or promulgated
by the Council. A majority of the members of the Executive Committee
shall constitute a quorum for the transaction of business. Meetings
may be called by the President or by any two Executive Committee
members.
SECTION 2. Program Committee. The Program Committee shall
consist of the President, the Director of Continuing Medical Education,
the Secretary/Treasurer, and additional members appointed to the
Program Committee. Appointment to the Program Committee shall be
for a period of three years. Appointment(s) to this committee shall be
made by the President each year. The senior member of the appointed
members shall serve as Chairman. It shall be the duty of the committee
to review the abstracts of scientific papers submitted by the members
and arrange the program for the annual meeting. At least one author of
each abstract for the regular scientific program should be a member of
the association. No more than 25 percent of the papers presented at the
annual meeting may be presented by Authors who are not members,
provided that such papers are of unusual merit.
SECTION 3. Postgraduate Program Committee. The Postgraduate
Program Committee shall consist of the Director of Continuing Medical
Education and appointed members. Appointment to the Postgraduate
Program Committee shall be for a period of three years. Appointments
to this committee shall be made by the President each year. The senior
appointed member of the committee shall act as chair. It shall be the
duty of this committee to arrange a Postgraduate Continuing Medical
Education Program to cover broad and varied aspects of thoracic
surgery to be presented at the time of the annual meeting.
SECTION 4. Membership Committee. This committee shall consist of
four members. Appointment to the Membership Committee shall be for
a period of four years. One new appointee to this committee shall be
made by the President each year. The senior member of the committee
shall serve as Chairman. This committee shall receive applications for
membership in the association and after consideration of the applicants
may propose them to the Council for approval and to the membership
for election.
SECTION 5. Continuing Medical Education Committee. This committee
shall consist of the Chairman of the Postgraduate Committee, the
Chairman of the Program Committee, and the Director of Continuing
Medical Education who shall serve as Chairman. It shall be the duty of
this committee to set up the objectives of the next annual meeting with
the said objectives being presented for approval by the Council at their
interim meeting and forwarded to members prior to the annual meeting.
SECTION 6. Nominating Committee. This committee shall consist
of the four Immediate Past Presidents with the most senior Past
President serving as Chairman. This committee shall prepare a slate
of nominees for officers and Councilors for the following year. This
report is submitted to the organization at its annual meeting. The
recommendations of the Nominating Committee are not intended to
exclude direct nominations from the Floor.
SECTION 7. Other Committees. Other committees may be designated by
a resolution adopted by a majority of the Council present at a meeting
at which a quorum is present (Ad Hoc Committees may be designated
by the President with approval of the Council). Except as otherwise
provided in such resolution, members of each committee shall be
members of the Association, and the President of the Association shall
appoint the members thereof. Any member may be removed by the
person or persons authorized to appoint such member whenever in
their judgment the best interests of the Association shall be served by
such removal.
SECTION 8. Term of Office. Each member of a committee shall continue
as such until the next annual meeting of the Council or until a successor
is appointed, unless the committee is terminated, or the member is
removed from the committee, ceases to qualify as a member, or the
member resigns from the committee.
SECTION 9. Vacancies. Vacancies in the membership of any committee
may be filled by appointments made in the same manner as provided in
the case of the original appointments.
SECTION 10. Quorum. Unless otherwise provided in the resolution
of the Council designating a committee, a majority of any committee
shall constitute a quorum for committee action. The act of a majority
of committee members present and voting at a meeting, at which a
quorum is present, shall be the act of the committee.
SECTION 11. Participation at Meetings by Conference Telephone.
Committee members may participate in and act at any committee
meeting through the use of a conference telephone or other
communications equipment by means of which all persons participating
in the meeting can communicate with each other. If the Chairman of a
committee so orders, participation in such meetings shall constitute
attendance at the meeting.
SECTION 12. Meetings of Committees. Subject to action by the Council,
each committee by a majority vote of its members shall determine the
time and place of meetings and the notice required.
SECTION 13. Informal Action. Any action required or taken at a meeting
of a committee may be taken without a meeting if a consent in writing,
setting forth the action so taken, is signed by all of the committee
members.
SECTION 14. Rules. Each committee may adopt rules for its own
government not inconsistent with these bylaws or with rules adopted by
the Council.
ARTICLE X: OFFICIAL ORGAN
The Annals of Thoracic Surgery shall be the official publication of
the Southern Thoracic Surgical Association. Papers read before the
Association shall be forwarded to the Editor of The Annals of Thoracic
Surgery for consideration for publication at the time requested by the
Program Committee Chair and Editor of The Annals.
ARTICLE XI: CONTRACTS, CHECKS, DEPOSITS AND FUNDS,
BONDING
SECTION 1. Contracts. The Council may authorize any officer or
officers, agent or agents of the Association, in addition to the officers
so authorized by these bylaws, to enter into any contract or execute and
deliver any instrument in the name of, and on behalf of, the Association.
Such authority may be general or confined to specific instances.
SECTION 2. Depositories. All funds of the Association not otherwise
employed shall be deposited to the credit of the Association in such
banks, trust companies or other depositories as the Council may
designate.
SECTION 3. Checks, Drafts, Notes, Etc. All checks, drafts or other
orders for the payment of money and all notes or other evidences of
indebtedness issued in the name of the Association shall be signed by
such officer or officers, or agent or agents, of the Association and in
such manner as shall be determined by resolution of the Council.
SECTION 4. Bonding. The Council shall provide for the bonding of such
officers and employees of the Association, as needed.
SECTION 5. Delivery of Notice. Any notices required to be delivered
pursuant to these bylaws shall be deemed to be delivered when
transferred or presented in person or deposited in the United States
mail addressed to the person at his/her or its address as it appears
on the records of the Association, with sufficient first-class postage
prepaid thereon.
SECTION 6. Investments. Unless otherwise specified by the terms of a
particular gift, bequest or devise, grant or other instrument, the funds
of the Association may be invested, in such manner as the Council may
deem advantageous, without regard to restrictions applicable to trusts
or trust funds.
ARTICLE XII: BOOKS AND RECORDS
The Association shall keep correct and complete books and records
of accounts and shall also keep minutes of the proceedings of its
members, Council, and committees having any of the authority of the
Council, and shall keep at the registered or principal office a record
giving the names and addresses of the members entitled to vote. All
books and records of the Association may be inspected by any member,
or his or her agent or attorney, for any proper purpose at any reasonable
time.
ARTICLE XIII: FISCAL YEAR
The fiscal year of the Association shall be established by the Council.
Article XIV: WAIVER OF NOTICE
Whenever any notice is required to be given under the provisions of
the General Not For Profit Corporation Act of the State of Illinois or
under the provisions of the articles of incorporation or the bylaws of
the Association, a waiver in writing signed by the person or persons
entitled to such notice, whether before or after the time stated therein,
shall be deemed equivalent to the giving of such notice. Attendance at
any meeting shall constitute waiver of notice unless the person at the
meeting objects to the holding of the meeting because proper notice
was not given.
ARTICLE XV: INDEMNIFICATION OF DIRECTORS, OFFICERS,
EMPLOYEES AND AGENTS; INSURANCE
SECTION 1. Right to Indemnification. Each person who was or is a party
or is threatened to be made a party to, or is involved in, any action, suit
or proceeding—whether civil, criminal, administrative or investigative—
by reason of the fact that he/she, or a person of whom he/she is the
legal representative, is or was a director, officer, employee or agent of
the Association, or is or was serving at the request of the Association,
shall be indemnified and held harmless by the Association to the fullest
extent authorized by the laws of Illinois against all costs, charges,
expenses, liabilities and losses reasonably incurred or suffered by such
person in connection with and such indemnification shall continue
to a person who has ceased to be associated with the Association.
This includes attorneys’ fees, judgments, fines, ERISA excise taxes or
penalties and amounts paid, or to be paid, in settlement. The right to
indemnification conferred in this Article XV shall be a contract right
and shall include the right to be paid by the Association the expenses
incurred in defending any such proceeding in advance of its final
disposition. For the purpose of determining the reasonableness of
indemnifiable expenses, the fees and expenses of separate counsel
from counsel for the Association, or other joint defendants being
indemnified by the Association, shall not be indemnifiable unless there
exists a bonafide conflict of interest.
SECTION 2. Right of Claimant to Bring Suit. If a claim under Section 1
of Article XV is not paid in full by the Association within a reasonable
amount of time after a written claim has been received by the
Association, the claimant may at any time thereafter bring suit against
the Association to recover the unpaid amount of the claim and, if
successful in whole or in part, the claimant shall also be entitled to be
paid the expenses of prosecuting such a claim. It shall be a defense to
any action that the claimant has failed to meet a standard of conduct
which makes it permissible under Illinois law for the Association to
indemnify the claimant for the amount claimed. But the burden of
proving such defense shall be on the Association.
SECTION 3. Non-Exclusive of Rights. The right to indemnification and
the payment of expenses incurred in defending a proceeding in advance
of its final disposition conferred in Article XV shall not be exclusive
of any other right which any person may have or hereafter acquire
under any statute, provision of the articles of incorporation, bylaws,
agreement, vote of members or disinterested directors or otherwise.
SECTION 4. Insurance. The Association shall maintain insurance to the
extent of availability at commercial reasonable rates, at its expense,
to protect itself and any director, officer, employee or agent of the
Association or another corporation, partnership, joint venture, trust or
other enterprise against any expense, liability or loss, whether or not
the Association would have the power to indemnify such person against
such expense, liability or loss under Illinois law.
SECTION 5. Expenses as a Witness. To the extent that any director,
officer, employee or agent of the Association is by reason of such
position, or a position with another entity at the request of the
Association, a witness in any proceeding, he shall be indemnified
against all costs and expenses actually and reasonably incurred by him
or on his behalf in connection therewith.
SECTION 6. Notification. If the Association has paid indemnity or has
advanced expenses under this Article XV to a director, officer, employee
or agent, the Association shall report the indemnification or advance in
writing to the members with or before the notice of the next meeting of
the members.
SECTION 7. Effect of Amendment. Any amendment, repeal or
modification of any provision of this Article XV by the members or
the directors of the Association shall not adversely affect any right or
protection of a director or officer of the Association existing at the time
of such amendment, repeal or modification.
ARTICLE XVI: DISSOLUTION
Upon the dissolution of the Association, and after payment of all
indebtedness of the Association, any remaining funds, investments and
other assets of the Association shall be distributed to such organization
or organizations which are then qualified as exempt from taxation under
Section 501(c) 6 of the Internal Revenue Code of 1986, as amended
(or the corresponding provision of any future Internal Revenue Law of
the United States). This distribution shall only occur if the purposes
and objectives of such organization(s) are similar to the purposes and
objectives of the Association, as may be determined by vote of the then
voting members of the Association.
ARTICLE XVII: AMENDMENTS
These bylaws may be altered, amended, or repealed at the time of
the annual meeting by a two-thirds vote of the membership present,
provided that the amendment has been presented to the membership in
writing at least 30 days prior to the time of the annual meeting.
ARTICLE XVIII: PARLIAMENTARY AUTHORITY
The deliberations of the Association, Council, and committees shall be
governed by the parliamentary rules and usages contained in the then
current edition of “Roberts Rules of Order, Newly Revised”, when not in
conflict with the bylaws of the Association.
GENERAL INFORMATION
RELATIONSHIP
DISCLOSURE INDEX
COMMERCIAL DISCLOSURE STATEMENTS OF COUNCIL
MEMBERS AND PROGRAM PLANNERS
STSA would like to thank the following STSA leaders for planning the educational
content of the STSA 61st Annual Meeting. Unless otherwise noted, these STSA
leaders have no relevant commercial relationships to disclose.
Kevin Accola: Brooks Scholarship Committee
COMMERCIAL RELATIONSHIPS: Consultant: Edwards Lifesciences,
CorMatrix; Speaker: Edwards Lifesciences, CryoLife
John H. Calhoon: President Elect
Robert J. Cerfolio: Council Chair, Program Committee,
Postgraduate Committee
COMMERCIAL RELATIONSHIPS: Speakers Bureau/Honoraria: Intuitive
Surgical, Inc.; Ownership Interest/Author: Super Performing at Work
and at Home: The Athleticism of Surgery and Life
Paul J. Chai: Postgraduate Committee
Joseph A. Dearani: Brooks Scholarship Committee
Melanie A. Edwards: Program Committee Chair, CME Committee
Andrew C. Fiore: Councilor
Richard K. Freeman: CME Director, Program Committee, Postgraduate
Committee, CME Committee
David Tyler Greenfield: Brooks Scholarship Committee
John A. Howington: Postgraduate Committee
COMMERCIAL RELATIONSHIPS: Thoracic Advisory Board: Ethicon
Endo-Surgery
Charles B. Huddleston: Program Committee
Jeffrey P. Jacobs: Vice President, Program Committee
David R. Jones: Secretary/Treasurer, Program Committee, Postgraduate
Committee
Robert B. Lee: Postgraduate Committee Chair, CME Committee
Scott A. LeMaire: Postgraduate Committee
COMMERCIAL RELATIONSHIPS: Clinical Trial Investigator: Medtronic,
Inc., GlaxoSmithKline, W.L. Gore & Associates, Cook Medical, Inc.,
Edwards Lifesciences; Consultant: Medtronic, Inc.
M. Blair Marshall: Brooks Scholarship Committee
COMMERCIAL RELATIONSHIPS: Consultant: Ethicon Endo–Surgery;
Editor: Thoracic Surgery Clinics, Elsevier; Advisory Board: ClinicalKey,
Elsevier; Patent PND: Suture Training Model
Daniel L. Miller: Secretary/Treasurer-Elect, Program Committee,
Postgraduate Committee
Himanshu J. Patel: Program Committee
COMMERCIAL RELATIONSHIPS: Consultant/Patent Holder: W.L. Gore &
Associates, Inc.
Richard L. Prager: President, Postgraduate Committee, Program
Committee
RELATIONSHIP DISCLOSURE INDEX
Jorge D. Salazar: Program Committee Chair, CME Committee
Marcus G. Williams: Postgraduate Committee Chair, CME Committee
Thomas C. Wozniak: Postgraduate Committee
Stephen C. Yang: Program Committee
COMMERCIAL RELATIONSHIPS OF ABSTRACT REVIEWERS
STSA would like to thank the following leaders for reviewing the
abstracts submitted for consideration for presentation at the STSA 61st
Annual Meeting. Unless otherwise noted, the abstract reviewers have
no relevant commercial relationships.
Gorav Ailawadi
COMMERCIAL RELATIONSHIPS: Consultant/Advisory Board: Edwards
Lifesciences, Abbott Vascular, Mitralign; Speakers Bureau/Honoraria:
St. Jude Medical, Inc., Atricure
Shahab A. Akhter
Vinay Badhwar
Faisal G. Bakaeen
J. Michael DiMaio
Anthony E. Estrera
Andrew C. Fiore
Kristopher M. George
Emmett Dean McKenzie
Charles Patrick Murrah
J. Scott Rankin
COMMERCIAL RELATIONSHIPS: Ownership Interest: BioStable Science
and Engineering, Inc.
Mark S. Slaughter
COMMERCIAL RELATIONSHIPS: Principal Investigator: HeartWare, Inc.
Betty C. Tong
Nirmal Veeramachaneni
COMMERCIAL RELATIONSHIPS OF STSA STAFF
Unless otherwise noted, staff members have no relevant commercial
relationships.
Megan Drumm: Executive Director
Rachel Pebworth: Senior Coordinator
Beth Winer: Senior Manager
RELATIONSHIP DISCLOSURES FROM PRESENTERS
The following presenters have indicated, in accordance with the
Accreditation Council for Continuing Medical Education Standards
and the STSA Disclosure Policy, that they have a financial or other
relationship with a healthcare-related business or other entity whose
products or services may be discussed in, or directly affected in the
marketplace by the educational program/product under consideration.
Listed too are abstracts whose content describes the use of a device,
product, or drug, that is not FDA approved, or the off-label use of an
approved device, product, or drug.
Unless noted in this program book or verbally by the speakers, speakers
have no relevant financial relationships to disclose and will only be
presenting information on devices, products, or drugs that are FDA
approved for the purposes they are discussing.
Moderator Commercial Relationships
Melanie A. Edwards, Nothing to Disclose
Jorge D. Salazar, Nothing to Disclose
1V. Repair of Simple Bicuspid Valve Defects Using Geometric Ring
Annuloplasty
COMMERCIAL RELATIONSHIPS: Domenico Mazzitelli: Consultant/
Advisory Board: BioStable Science and Engineering Inc.; J. Scott
Rankin: Consultant/Advisory Board: BioStable Science and
Engineering Inc.
REGULATORY DISCLOSURE: This presentation describes the
HAART 200 Bicuspid Aortic Annuloplasty Ring, which has an FDA
approval status of Investigational.
COMMERCIAL RELATIONSHIPS: Daniel L. Miller: Consultant/
Advisory Board: Ethicon Endo-Surgery, Inc., Davol-Bard, Inc.
9V. P
ercutaneous Transfemoral Closure of a Pseudoaneurysm at the
Implantation
COMMERCIAL RELATIONSHIPS: Charles T. Klodell: Principal
Investigator Edwards Partner III Trial: Edwards Lifesciences;
Thomas M. Beaver: Investigator and Research Support for Edwards
PARTNER II Clinical Trial: Edwards Lifesciences
REGULATORY DISCLOSURE: This presentation illustrates an offlabel use of Amplatzer™ muscular VSD occluder (St. Jude Medical,
St. Paul, MN) for closure of a left ventricular pseudoaneurysm.
General Session
Robert B. Lee, Nothing to Disclose
Marcus G. Williams, Nothing to Disclose
Adult Cardiac Case Presentation & Expert Panel: Current Management
and Blood Utilization in Adult Cardiac Surgery
COMMERCIAL RELATIONSHIPS: Victor A. Ferraris: Speakers Bureau/Honoraria: Baxter Healthcare; Consultant/Advisory Board:
Haemonetics, NovoNordisk; Alan M. Speir: Consultant Advisory
General Thoracic Case Presentation & Expert Panel: Lung Cancer Screening at Academic and Non-academic Institutions
COMMERCIAL RELATIONSHIPS: Richard K. Freeman: Consultant/
Advisory Board: Covidien
Critical Care Case Presentation & Expert Panel: ECMO & Your Hospital
COMMERCIAL RELATIONSHIPS: Joseph B. Zwischenberger:
Ownership Interest: Avalon, Maquet
Scott A. LeMaire, Clinical Trial Investigator: Medtronic, Inc.,
GlaxoSmithKline, W.L. Gore & Associates, Cook Medical, Inc., Edwards
Lifesciences; Consultant: Medtronic, Inc.
J. Michael DiMaio, Nothing to Disclose
TAVR 2014 Update
COMMERCIAL RELATIONSHIPS: Michael J. Reardon: Consultant/
Advisory Board: Medtronic, Inc.
Current Management of Type A and B Acute Dissection
REGULATORY DISCLOSURE: This presentation addresses the offlabel use of Thoracic Endografts for treatment of Acute Type B Aortic
Dissection.
Richard K. Freeman, Consultant/Advisory Board: Covidien
Stephen C. Yang, Nothing to Disclose
SBT vs. Sublobar Resection for One-centimeter Lesions
COMMERCIAL RELATIONSHIPS: Traves D. Crabtree: Consultant/
Advisory Board: Ethicon Endo-Surgery
CONGENITAL BREAKOUT
Paul J. Chai, Nothing to Disclose
Biventricular Repair in Borderline Hearts
REGULATORY DISCLOSURE: This presentation addresses the offlabel use of Melody Valve.
GENERAL SESSION
Richard H. Feins, Research Grant/Principal Investigator: AHRQ, Teleflex;
Ownership Interest: KindHeart (Equity shareholder and medical advisor
to company producing cardiothoracic simulators)
Richard L. Prager, Nothing to Disclose
ETHICS DEBATE
Robert M. Sade, Nothing to Disclose
THURSDAY NOVEMBER 6, 2014
David R. Jones, Nothing to Disclose
Richard L. Prager, Nothing to Disclose
4. W
hen the Ross Is Not an Option: Systemic Semilunar Valve
Replacement in the Pediatric/Young Adult Population Using a Porcine
Full-root Bioprosthesis
COMMERCIAL RELATIONSHIPS: DISCUSSANT: John W. Brown:
Ownership Interest/Board of Directors: Correx, Inc.; Speakers Bureau/
Honoraria: Cryolife, Inc., Medtronic, Inc.
COMMERCIAL RELATIONSHIPS: Thomas J. Watson: Consultant/
Advisory Board: Covidien; Jiejing Qiu: Employment/Senior Research
Associate: Covidien, Inc.
DISCUSSANT: Betty C. Tong: Consultant/Advisory Board: W.L. Gore
& Associates, Inc.
AVR in Michigan
COMMERCIAL RELATIONSHIPS: DISCUSSANT: Michael J. Reardon:
Consultant/Advisory Board: Medtronic, Inc.
10.Contemporary Results of Open Surgical Repair in Patients With
Marfan Syndrome and Distal Aortic Dissection in the Endovascular
Era
COMMERCIAL RELATIONSHIPS: Joseph S. Coselli: Royalties/
Consultant/Advisory Board: Vascutek Ltd., a Terumo Company
DISCUSSANT: G. Chad Hughes: Consultant/Advisory Board: W.L.
Gore & Associates, Inc., Medtronic, Inc., Vascutek Terumo; Speakers
Bureau/Honoraria: W.L. Gore & Associates, Inc., Medtronic Vascular,
Vascutek Terumo
BASIC SCIENCE FORUM
John S. Ikonomidis, Nothing to Disclose
Christine L. Lau, Nothing to Disclose
1B. P
ulsatile Flow Does Not Improve Function During Prolonged Ex Vivo
Lung Perfusion
COMMERCIAL RELATIONSHIPS: DISCUSSANT: Michael J. Weyant:
Principal Investigator: XVIVO, Inc.
2B. Circulating Tumor Cells From 4D Model Has Increased Activator
Protein-1 Expression Compared to Primary Tumor
COMMERCIAL RELATIONSHIPS: Min P. Kim: Speaker Bureau/
Honoraria: Ethicon Endo-Surgery, Inc.
4B. P
ediatric End-stage Failing Hearts Demonstrate Increased Cardiac
Stem Cells
COMMERCIAL RELATIONSHIPS: DISCUSSANT: John E. Mayer:
Consultant/Advisory Board: Medtronic, Inc. (Serve on Data Safety
and Monitoring Board for Native Transcatheter Pulmonary Valve)
5B. Timing of Adding Blood to Prime Affects Inflammatory Response to
Neonatal Cardiopulmonary Bypass
COMMERCIAL RELATIONSHIPS: Benjamin S. Schmidt: Research
Support: Medtronic, Inc.; Magan R. Lane: Research Support:
Medtronic, Inc.; Vanessa M. DiPasquale: Research Support:
Medtronic, Inc.; Lori P. Graf: Research Support: Medtronic, Inc.;
Yoshio Ootaki: Research Support: Medtronic, Inc.; James E. Jordan:
Research Support: Medtronic, Inc.; Ross M. Ungerleider: Research
Support: Medtronic, Inc.
Melanie A. Edwards, Nothing to Disclose
13. A Community-based Multi-disciplinary CT Screening Program
COMMERCIAL RELATIONSHIPS: Daniel L. Miller: Consultant/
Advisory Board: Ethicon Endo-Surgery, Inc., Bard-Davol, Inc.
16. Longitudinal Trends in Morbidity and Mortality With Introduction of
Robotic Assisted Thoracic Surgical Procedures at a Major Academic
Cancer Center
COMMERCIAL RELATIONSHIPS: DISCUSSANT: Mark W. Onaitis:
Speakers Bureau/Honoraria: Intuitive Surgical, Inc.
17. Variation in Outcomes for Risk-adjusted Pediatric and Congenital
Cardiac Operations: An Analysis of the Society of Thoracic Surgeons
COMMERCIAL RELATIONSHIPS: DISCUSSANT: Frederick L. Grover: Consultant/Advisory Board: Somalution
GENERAL SESSION
Kent Trinkle Education Lectureship: The University of Louisville and the Mason Dixon Line: Re-establishing Ties With the STSA
COMMERICAL RELATIONSHIPS: Mark S. Slaughter: Research
Support/Principal Investigator: HeartWare, Inc.; Consultant/
Advisory Board: Carmat, SCR
Gorav Ailawadi, Consultant/Advisory Board: Edwards Lifesciences,
Abbott Vascular, Mitralign; Speakers Bureau/Honoraria: St. Jude
Medical, Inc., Atricure
Himanshu J. Patel, Principal Investigator/Co-Investigator: Medtronic,
Inc., Edwards Lifesciences; Principal Investigator: W. L. Gore &
Associates, Inc., Cook Medical; Ownership Interest: W. L. Gore &
Associates, Inc.
19. Retrograde Ascending Aortic Dissection After TEVAR for Distal Aortic
Dissection and Zone 0 Landing: Association, Risk Factors, and True
Incidence
COMMERICAL RELATIONSHIPS: Ourania Preventza: Consultant:
Medtronic, Inc.; Speaker Bureau/Honoraria: Cook Medical, Inc., W.L.
Gore & Associates, Inc.; Joseph S. Coselli: Consultant/Advisory
Board: Medtronic, Inc., St. Jude Medical, Inc. Terumo, Vascutek,
W.L. Gore & Associates, Inc.; Speakers Bureau/Honoraria: Terumo,
Vascutek
REGULATORY DISCLOSURES: This presentation describes the
off-label use of Gore Thoracic Stent graft for various thoracic aortic
pathologies of the arch and of the descending thoracic aorta. This
stent graft is approved by the FDA for some of the pathologies
described in the abstract. This presentation describes the off-label
use of Cook TX-2 Thoracic Stent graft for various thoracic aortic
pathologies of the arch and of the descending thoracic aorta. This
stent graft is approved by the FDA for some of the pathologies
described in the abstract. This presentation describes the off-label
use of the Medtronic Thoracic Endograft, which is FDA approved.
COMMERICAL RELATIONSHIPS: Vinod Thourani: Consultant/
Advisory Board: Edwards Lifesciences, Sorin, St. Jude Medical, Inc.,
DirectFlow; Co-founder/Ownership Interest: Apica
22. Long-term Survival Following Bovine Pericardial Versus Porcine
Matter?
COMMERICAL RELATIONSHIPS: DISCUSSANT: William H. Ryan:
Consultant/Advisory Board: Edwards Lifesciences, Medtronic, Inc.
23. Red Blood Cells and Mortality After Coronary Artery Bypass Surgery:
Are We Really Transfusing Patients to Death?
COMMERICAL RELATIONSHIPS: DISCUSSANT: Alan M. Speir:
Consultant Advisory Board: Medtronic, Inc.
24. Transcatheter Aortic Valve Replacement (TAVR) vs. Off Pump Aortic
Valve Bypass (AVB) With an Apico-Aortic Conduit: A Comparison of
Outcomes and Hospital Economics
COMMERICAL RELATIONSHIPS: DISCUSSANT: Faisal G. Bakaeen:
Principal Investigator: VA Cooperative Studies Program, NHLBI;
Speakers Bureau/Honoraria: AstraZenca
Traves D. Crabtree, Consultant/Advisory Board: Ethicon Endo-Surgery,
Inc.
Mitchell J. Magee, Nothing to Disclose
25. An Assessment of the Optimal Time for Removal of Esophageal
Stents Used in the Treatment of an Esophageal Anastomotic Leak or
Perforation
REGULATORY DISCLOSURE: This presentation describes the offlabel use of an esophageal stent for the treatment of an esophageal
perforation or intrathoracic esophageal anastomotic leak.
CONGENITAL BREAKOUT
Moderator Commercial Relationship
Lauren Kane, Nothing to Disclose
Faisal G. Bakaeen, Principal Investigator: VA Cooperative Studies
Program, NHLBI; Speakers Bureau/Honoraria: AstraZenca
Jennifer S. Lawton, Nothing to Disclose
Gender Matter?
COMMERICAL RELATIONSHIPS: DISCUSSANT: Gorav Ailawadi:
Consultant/Advisory Board: Edwards Lifesciences, Abbott Vascular,
Mitralign; Speakers Bureau/Honoraria: St. Jude Medical, Inc.,
Atricure
COMMERICAL RELATIONSHIPS: DISCUSSANT: Himanshu J. Patel:
Principal Investigator/Co-Investigator: Medtronic, Inc., Edwards
Lifesciences; Principal Investigator: W. L. Gore & Associates, Inc.,
Cook Medical; Ownership Interest: W. L. Gore & Associates, Inc.
40. A New Surgical Approach to Exclude the Left Atrial Appendage
COMMERICAL RELATIONSHIPS: Niv Ad: Consultant/Advisory
Board: Atricure, Estech, Medtronic, Inc.; Speaker Bureau/Honoraria:
Atricure, Estech, Medtronic, Inc.
Mark J. Krasna, Nothing to Disclose
Theresa D. Luu, Nothing to Disclose
CONGENITAL BREAKOUT
Jennifer C. Hirsch-Romano, Nothing to Disclose
Jeffrey P. Jacobs, Nothing to Disclose
47. Early Outcomes of Pulmonary Valve Replacement With the Mitroflow
Bovine Pericardial Bioprosthesis
REGULATORY DISCLOSURE: This presentation describes the offlabel use of the Sorin Mitroflow Aortic Pericardial Heart Valve for
pulmonary valve replacement.
CODING UPDATE
Peter K. Smith, Nothing to Disclose
Anthony L. Estrera, Nothing to Disclose
Charles Patrick Murrah, Nothing to Disclose
COMMERCIAL RELATIONSHIPS: Joseph T. McGinn: Speaker
Bureau/Honoraria: Medtronic, Inc. DISCUSSANT: Kevin D. Accola:
Consultant: Edwards Lifesciences, CorMatrix; Speakers Bureau/
Honoraria: Edwards Lifesciences, Cryolife
COMMERCIAL RELATIONSHIPS: DISCUSSANT: Neal D. Kon:
Advisory Board/Consultant: Medtronic, Inc.
Min P. Kim, Speakers Bureau/Honoraria: Ethicon Endo-Surgery, Inc.
Daniel L. Miller, Thoracic Surgery Advisory Board: Ethicon EndoSurgery, Inc., Davol, A Bard Company
TRANSPLANT BREAKOUT
Shahab A. Akhter, Nothing to Disclose
Allan Pickens, Nothing to Disclose
CONGENITAL BREAKOUT
Paul J. Chai, Nothing to Disclose
Charles B. Huddleston, Nothing to Disclose
John W. Hammon, Nothing to Disclose
65. Osler Almon Abbott: The Man, The Award and His Legacy
COMMERICAL RELATIONSHIPS: Thoracic Surgery Advisory Board:
Ethicon Endo-Surgery, Inc., Davol, A Bard Company
John H. Calhoon, Nothing to Disclose
Robert J. Cerfolio, Speakers Bureau/Honoraria: Intuitive Surgical, Inc.;
Ownership Interest/Author: Super Performing at Work and at Home:
The Athleticism of Surgery and Life
66. One Hundred Safe Transports on Extracorporeal Life Support to a
COMMERICAL RELATIONSHIPS: Daniel Brodie: Research Support:
Maquet Cardiovascular; Consultant/Advisory Board: ALung
Technologies
DISCUSSANT: Joseph B. Zwischenberger: Ownership Interest:
Avalon, Maquet
GENERAL INFORMATION
PROGRAM
PARTICIPANTS
Abrams, Darryl . . . . . . . . . . . . 39, 202
Block, Peter . . . . . . . . . . . . . . . . . 27, 110
Accola, Kevin . . . . . . . . . . . . 5, 35, 170
Boles, Lindsay . . . . . . . . . . . . . 39, 206
Acker, Micheal . . . . . . . . . . . . . 36, 186
Boodhwani, Munir . . . . . . . . . . 20, 60
Ad, Niv . . . . . . . . . . . . . . . . . . . . 32, 150
Book, Wendy . . . . . . . 32, 33, 160, 166
Adusumilli, Prasad . . 25, 29, 102, 126
Boorse, Richard . . . . . . . . . . . . 40, 214
Aftab, Muhammad . . . 15, 25, 56, 106
Bott, Matthew . . . . . . . . 20, 36, 62, 180
Agerstrand, Cara . . . . . . . . . . . 39, 202
Bove, Edward . . . . . . . . 20, 40, 64, 216
Ahmad, Usman . . . . . . . . . . . . 29, 126
Boyd, Jack . . . . . . . . . . . . . . . . . . 28, 118
Ailawadi, Gorav . . . 21, 27, 31, 35, 76,
144, 168
Bremner, Ross . . . . . . . . . . . . . 37, 190
Ajani, Jaffer . . . . . . . . . . . . . . . . 24, 92
Akhter, Shahab . . . . . . . . . 32, 36, 154
Alarcon, Diana . . . . . . . . . . . . . 37, 190
Alsoufi, Bahaaldin . . . 29, 32, 33, 39,
132, 160, 166, 208
Anderson, David . . . . . . . . . . . . 15, 58
Aranki, Sary . . . . . . . . . . . . . . . . 35, 52
Argenziano, Michael . . . . . . . . . . . . . 19
Ascioti, Anthony . . . . . . . . . . . 28, 120
Astarci, Parla . . . . . . . . . . . . . . . 20, 60
Atluri, Pavan . . . . . . . . . . . . . . . 36, 186
Awais, Omar . . . . . . . . . . . . . . . 28, 122
Azizzadeh, Ali . . . . . . . . . . . . . . . 27, 112
Babaliaros, Vasilis . . . . . . . . . . . 27, 110
Babu, Ashok . . . . . . . . . . . . . . . 36, 184
Bacchetta, Matthew . . . . . . . . 39, 202
Bacha, Emile . . . . . . . . . . . . . . . 37, 194
Backer, Carl . . 30, 37, 39, 142, 194, 206
Bains, Manjit . . . . . . . 25, 29, 102, 126
Bakaeen, Faisal . . . . . . . . . . 28, 31, 118
Baker, Craig . . . . . . . . . . . . . . . . 40, 216
Baker, Joshua . . . . . . . . . . . . . . . 23, 84
Bansal, Neeraj . . . . . . . . . . . . . 40, 216
Barnes, Michael . . . . . . . . . . . . 37, 198
Baumgartner, William . 6, 19, 25, 106
Bavry, Anthony . . . . . . . . . . . . . 15, 58
Beaver, Thomas . . . . . 15, 27, 58, 110
Beckler, Vickie . . . . . . . . . . . . . . 24, 96
Bell, Gail . . . . . . 21, 24, 28, 70, 94, 116
Bell, Marshall . . . . . . . . . . . . . . . 23, 90
Beman, Scott . . . . . . . . . . . . . . 40, 214
Bennett, Daine . . . . . . . 23, 36, 90, 184
Berfield, Kathleen . . . . 21, 25, 74, 106
Bianco, Valentino . . . . . . . . . . 28, 122
Biscotti, Mauer . . . . . . . . . . . . 39, 202
Biswas Roy, Sreeja . . . . . . . . . 37, 190
Blackmon, Shanda . . . . . 5, 15, 44, 50
Blasberg, Justin . . . . . . . . . . . 32, 154
Bozzay, Tom . . . . . . . . . . . . . . . 33, 162
Broderick, Stephen . . . 20, 36, 62, 180
Brodie, Daniel . . . . . . . . . . . . . 39, 202
Brooks, Maria . . . . . . . . . . . . . . 35, 172
Brown, John . . . . . . . . . 20, 28, 66, 118
Bryant, Ayesha . . . . . . . . . . . . 32, 152
Bryant, Roosevelt . . . . . . . . . . 30, 140
Burke, Floyd . . . . . . . . . . . . . . . . 15, 58
Burkhart, Harold . . . . . . . . . . . .32, 160
Byers, Karen . . . . . . . . . . . . . . . 29, 124
Byrne, John . . . . . . . . . . . . . . . 35, 174
Caan, Aaron . . . . . . . . . . . . . . . . 24, 96
Calhoon, John . . . . . . . . . 4, 20, 39, 66
Cameron, Duke . . . . . . . . . . . . . . 20, 60
Carlucci, Robert . . . . . . . . . . . . 35, 170
Carpenter, Andrea . . . . . . . . . . 35, 168
Carr, Michael . . . . . . . . . . . . . . 30, 142
Carrillo, Sergio . . . . . . . . . . . . . . 37, 192
Cerfolio, Robert . . . . . 4, 5, 32, 39, 152
Chai, Paul . . . 5, 16, 18, 33, 37, 162, 194
Chapple, Kristina . . . . . . . . . . . 37, 190
Charlton-Ouw, Kristofer . . . . . 27, 112
Cheema, Faisal . . . . . . . . . . . . 40, 212
Chelliah, Anjali . . . . . . . . . . . . . 37, 194
Chen, Edward . . 5, 17, 24, 27, 98, 108
Chen, Fengju . . . . . . . . . . . . . . . 23, 82
Chen, Li . . . . . . . . . . . . . . . . . . . 36, 182
Cheng, Allen . . . . . . . . . . . . . . . 29, 204
Chipman, Carl . . . . . . . . . . . . . 33, 162
Chores, Jeffrey . . . . . . . . . . . . 31, 144
Clabby, Martha . . . . . . . . . . . . 29, 132
Clark, Joseph . . . . . . . . . . . . . . 33, 164
Cleveland, Joseph . . . . . . . . . 36, 184
Cohen, Gordon . . . . . . . . . . . . . 30, 136
Cohn, Lawrence . . . . . . . . . . . 35, 174
Collins, Brian . . . . . . . . . . . . . . 36, 180
Colvin-Adams, Monica . . . . . 37, 188
Cooley, Denton . . . . . . . . . . . . . 27, 108
PROGRAM PARTICIPANTS
Corvera, Joel . . . . . . . . . . . . . . . 28, 118
Emani, Sitaram . . . . . . . . . . 15, 18, 48
Coselli, Joseph . . . . 5, 22, 27, 78, 108
Emery, Robert . . . . . . . . . . . . . 36, 186
Costello, John . . . . . . . . . . . . . 30, 142
Englum, Brian . . . . . . . . . . . . . . 28, 114
Crabtree, Traves . . . . . 18, 20, 28, 36,
Escobar, Antonio . . . . . . . . . . 30, 136
62, 180
Estrera, Anthony . . 24, 27, 35, 98, 112
Creighton, Chad . . . . . . . . . . . . 23, 82
Evans, Charlie . . . . . . . . . . . . . 40, 212
Crosby, Ivan . . . . . . . . . 21, 35, 76, 168
Feins, Richard . . . . . . . . . . . . . . . . . . . 19
Curran, Thomas . . . . . . . . . . . 32, 156
Fenton, Kathleen . . . . . . . . . . . . . . . . 19
Dake, Megan . . . . . . . . . . . . . . 28, 120
Ferguson, Mark . . . . . . . . . . . . 29, 128
Daly, Richard . . . . . . . . . . . . . . 31, 148
Fernandez, Felix . . . . . 21, 29, 72, 130
Dawood, Murtaza . . . . . . . . . . 40, 212
Ferraris, Victor . . . . . . . . . . 16, 36, 182
De Kerchove, Laurent . . . . . . . 20, 60
Filardo, Giovanni . . . . . . . . . . . 25, 104
de la Cruz, Kim . . . . . . . . . . . . . . 22, 78
Finley, David . . . . . . . . . . . . . . . 25, 102
De Marchi, Lorenzo . . . . . . . . . 15, 46
Fischlein, Theodor . . . . . . . . . . . 15, 42
Dearani, Joseph . . . . . . . . . 5, 31, 148
Foley, Lisa . . . . . . . . . . . . . . . . . . 23, 90
DeLaRosa, Jacob . . . . . . . . . . 31, 146
Force, Seth . . . . . . . . . . . . . . . . . . 21, 72
Demmy, Todd . . . . . . . . . . . . . 36, 178
Fortuna, Randall . . . . . . . . . . . . 37, 196
DeNino, Walter . . . . . . 21, 25, 74, 106
Foster, Nathaniel . . . . . . . . . . . 40, 212
Denlinger, Chadrick . . . . . . . . . . 23, 82
Fraser, Jr, Charles . . . . . . . . . . . 20, 66
Deshmukh, Savitha . . . . . . . . . 23, 86
Freeman, Kirsten . . . . . . . . . . . 23, 90
Deshpande, Shriprasad . . . . 39, 208
Freeman, Richard . . . 4, 5, 17, 28, 120
Devaney, Eric . . . . . . . . . . . . . . 30, 138
Frye, Robert . . . . . . . . . . . . . . . 35, 172
Devireddy, Chandan . . . . . . . . 27, 110
Fudge, James . . . . . . . . . . . . . . 15, 58
Dexter, Elisabeth . . . . . . . . . . . 36, 178
Fuller, John . . . . . . . . . . . . . . . . 31, 144
Diao, Xiayang . . . . . . . . . . . . . . 40, 212
Fullerton, David . . . . . . 23, 36, 90, 184
Dibardino, Daniel . . . . . . . . . . 30, 138
Gaffey, Ann . . . . . . . . . . . . . . . . 36, 186
Dickinson, Timothy . . . . . . . . 31, 144
Gal, Tamas . . . . . . . . . . . . . . . . 36, 182
DiMaio, J. Michael . . . . . . . . . . . . . . . 17
Gammie, James . . . . 32, 40, 150, 212
DiNatale, Joseph . . . . . . . . . . 35, 170
Ganapathi, Asvin . . . . . . . . . . . 28, 114
DiPasquale, Vanessa . . . . . . . . 23, 88
Gangadharan, Sidhu . . . . . . . 32, 156
Dodge-Khatami, Ali . . . . . . . . . 20, 66
Garcia, Andrea . . . . . . . . . . . . . . 27, 108
Donohue, Janet . . . . . . . . . . . . . 20, 64
Gaynor, J. William . . . . . . . . . 25, 104
Downey, Robert . . . . . . . . . . . 25, 102
Gencol, Tuba . . . . . . . . . . . . . . 37, 194
Durbin, Eric . . . . . . . . . . . . . . . . 36, 182
Ghanie, Amanda . . . . . . . . . . . 25, 102
Dycoco, Joe . . . . . . . . . . . . . . . 25, 102
Ghoreishi, Mehrdad . . . . . . . . 40, 212
Earing, Michael . . . . . . . . . . . . . 37, 198
Gillespie, Theresa . . . . . . . . . . 29, 130
Ebeid, Makram . . . . . . . . . . . . . 20, 66
Glower, Donald . . . . . . . . . . 17, 28, 114
Eckman, Peter . . . . . . . . . . . . . 37, 188
Goldberg, Lee . . . . . . . . . . . . . 36, 186
Edwards, Melanie . . . . . . 5, 20, 24, 62
Goldhaber, Samuel . . . . . . . . 35, 174
Eghtesady, Pirooz . . . . . . . . . . 29, 132
Gomez-Arostegui, Juliana . . 30, 138
Ehrlich, Alexandra . . . . . . . . . 32, 160
Gonzales, Lorena . . . . . . . . . . . 27, 108
El Khoury, Gebrine . . . . . . . . . . 20, 60
Gooding, William . . . . . . . . . . 28, 122
Ellis, Jennifer . . . . . . . . . . . . . . . . . . . . 19
Gosev, Igor . . . . . . . . . . . . . . . . 35, 174
Ellis, Michelle . . . . . . . . . . . . . . 31, 144
Gossett, Jeffery . . . . . . . . . . . 33, 162
El-Said, Howaida . . . . . . . . . . . 30, 138
Graf, Lori B . . . . . . . . . . . . . . . . . . 33, 88
El-Sayed Ahmed, Magdy . . . . . 15, 56
Green, Susan . . . . . . . . . . . . . . . 22, 78
Eltayeb, Osama . . . . . 30, 39, 142, 206
Griffith, Bartley . . . . . . . . . . . . 40, 212
Grosser, Rachel . . . . . . . . . . . . 25, 102
Jacobsen, Roni . . . . . . . . . . . . . 37, 198
Grover, Frederick . . . 25, 36, 104, 184
Jaggers, James . . . . . . . . . 16, 30, 142
Guleserian, Kristine . . . . . . . . . 39, 208
James, Bryce . . . . . . . . . . . . . . 36, 180
Gupta, Bhawna . . . . . . . . . . . . . 20, 66
Jaquiss, Robert . . . . . . . . . . . . 30, 140
Guyton, Robert . . . . . . 24, 27, 98, 110
Javed, Quratulain . . . . . . . . . . 35, 174
Buitrago, Daniel . . . . . . . . . . . . 29, 126
John, Ranjit . . . . . . . . . . . . . . . . 37, 188
Haddad, Nadime . . . . . . . . . . . . 15, 46
Jones, David . . . . .4, 5, 18, 20, 25, 29,
102, 126
Halkos, Michael . . . . . . . . . . . . . 24, 98
Hammon, John . . . . . . . . 4, 23, 38, 90
Hammoud, Zane . . . . . . . . . . . 29, 124
Han, Jane . . . . . . . . . . . . . . . . . 25, 104
Hance, John . . . . . . . . . . . . . . . 32, 158
Hanley, Frank . . . . . . . . . . . . . . . 37, 192
Harpole, David . . . . . . . . . . . . . . . . . . 18
Harrion, T. Daniel . . . . . . . . . . 40, 214
Harvey, Laura . . . . . . . . . . . . . . 37, 188
Hegde, Sanjeet . . . . . . . . . . . . 30, 138
Heinle, Jeffrey . . . . . . . . . . . . . . . . . . . . .
Helms, Gerald . . . . . . . . . . . . . . 24, 96
Heng, Elbert . . . . . . . . . . . . . . . . 23, 84
Hennon, Mark . . . . . . . 21, 28, 70, 116
Herbert, Morley . . . . . . . . . . . . 29, 130
Higgins, Kristin . . . . . . . . . . . . . 37, 198
Hill, Garrick . . . . . . . . . . . . . . . . 24, 100
Hill, Kevin . . . . . . . . . . . . . . . . . 36, 176
Hines, Michael . . . . 20, 32, 37, 64, 192
Hirsch-Romano, Jennifer . . . 35, 172
Hlatky, Mark . . . . . . . . . . . . . . . 29, 124
Hodari, Arielle . . . . . . . . . . . . . . 24, 92
Hofstetter, Wayne . . . . . . . . . . 37, 188
Holley, Christopher . . . . . . . . . 37, 150
Holmes, Sari . . . . . . . . . . . . . . . . 15, 46
Hong, Young . . . . . . . . . . . . . . 36, 186
Howard, Jessica . . . . . . . . . . 5, 24, 96
Howington, John . . . . . . . . . . 5, 24, 96
Huang, James . . . . . . 25, 29, 102, 126
Huang, Miriam . . . . . . . . . . . . . 36, 178
Jordan, James . . . . . . . . . . . . . . 23, 88
Joyce, Lyle . . . . . . . . . . . . . . . . 31, 148
Kane, John . . . . . . . . . . . . . . . . 36, 178
Kanter, Kirk . . . . . . 16, 29, 33, 39, 132,
166, 208
Karamlou, Tara . . . . . 24, 25, 100, 104
Karimi, Ashkan . . . . . . . . . . . . . 15, 58
Kaushal, Sunjay . . . . . . . . . . . . . 23, 86
Kay, Joseph . . . . . . . . . . . . . . . 24, 100
Kayatta, Michael . . . . 27, 31, 110, 146
Keeling, William . . . . . . . . . . . . 24, 98
Keenan, Jeffrey . . . . . . . . . . . . . 28, 114
Kemp, Aaron . . . . . . . . . . . . . . 30, 138
Kent, Michael . . . . . . . . . . . . . . 32, 156
Kern, John . . . . 21, 27, 35, 76, 112, 168
Khan, Muhammad . . . . . . . . . 30, 140
Khanna, Amber . . . . . . . . . . . . 24, 100
Kheir, John . . . . . . . . . . . . . . . . . 15, 48
Khullar, Onkar . . . . . . . 21, 29, 72, 130
Kilgo, Patrick . . . . . . . . . . . . . . . . 27, 110
Killu, Keith . . . . . . . . . . . . . . . . . 29, 124
Kim, Dennis . . . . . . . . . . . . . . . 29, 132
Kim, Min . . . . . . . . . . . . . . . . 23, 36, 82
Kim, Sunghee . . . . . . 25, 30, 104, 140
Kirklin, James . . . . . . . . . . . . . . 39, 204
Klodell, Charles . . . . . . . . . . . . . 15, 58
Knott-Craig, Christopher . . . . . . . . . 18
Koenig, Steven . . . . . . . . . . . . . 23, 80
Kogon, Brian . . . . . 25, 29, 32, 33, 39,
100, 132, 160, 166, 208
Huddleston, Charles . . . 5, 33, 37, 166
Kon, Neal . . . . . . . . . . . . . . . . . . 35, 174
Hughes, G. Chad . . . . . 22, 28, 78, 114
Korbin, Dale . . . . . . . . . . . . . . . 36, 186
Husain, S. Adil . . . . . . . . . . . . . . . . . . . . .
Krasna, Mark . . . . . . . . . . . . . 24, 32, 92
Ibrahimiye, Ali . . . . . . . . . . . . . 37, 194
Kreisel, Daniel . . . . . . . 20, 36, 62, 180
Ikonomidis, John . . . . . . . . . . . . . . 4, 23
Kron, Irving . . . . . . . . . . 21, 35, 76, 168
Imamura, Michiaki . . . . . . . . . 33, 162
Krupnick, Alexander . 20, 36, 62, 180
Ising, Mickey . . . . . . . . . . . . . . 39, 204
Kumar, S. Ram . . . . . . 29, 30, 40, 134,
136, 216
Jacobs, Jeffrey . . 4, 5, 15, 18, 24, 25,
30, 32, 100, 104, 140
Jacobs, Marshall . . . . 24, 25, 30, 100,
104, 140
Kurie, Jonathan . . . . . . . . . . . . . 23, 82
Lada, Michal . . . . . . . . . . . . . . . . 24, 92
Ladowski, Joe . . . . . . . . . . . . . . 28, 118
Lai, Wyman . . . . . . . . . . . . . . . 37, 194
Masoudi, Frederick . . . . . . . . .24, 100
Lamberti, John . . . . . . . . . . . . 30, 138
Massimiano, Paul . . . . . . . . . . 32, 150
Lane, Magan . . . . . . . . . . . . . . . 23, 88
Mastrobuoni, Stefano . . . . . . . 20, 60
Lange, Rüdiger . . . . . . . . . . . . . . 15, 42
Mavromatis, Kreton . . . . . . . . . 27, 110
Langston, Kyle . . . . . . . . . . . . . 40, 214
Mayer, John . . . . . . . . . . . . . . . . . 23, 86
LaPar, Damien . . . . . 21, 25, 35,74,76,
106, 168
Mazzitelli, Domenico . . . . . . . . . 15, 42
Laschinger, Mary . . . . . . . . . . 40, 212
Lau, Christine . . . . . . . . . . . . . . . . . 4, 23
Lawton, Jennifer . . . . . . . . 31, 35, 172
Lazar, John . . . . . . . . . . 21, 25, 74, 106
Leacche, Marzia . . . . . . . . . . . 35, 174
Lee, Hang B . . . . . . . . . . . . . . . . . 23, 84
Lee, Robert . . . . . . . . . . . . . . . 5, 16, 17
Lee, Sang Mee . . . . . . . . . . . . . 29, 128
LeMaire, Scott . . . . . . . . . 5, 17, 22, 78
Lemus, Ruth . . . . . . . . . . . . . . . 40, 216
Lerakis, Stam . . . . . . . . . . . . . . . 27, 110
Mayfield, William . . . . . . . . . . . 24, 96
McDonald, Donna . . . . . . . . . . 24, 94
McGinn, Joseph . . . . . . . . . . . 35, 170
McKenzie, E. Dean . . . . 23, 29, 88, 134
Meguid, Robert . . . . . . . . . . . . 36, 184
Mehran, Reza . . . . . . . . . . . . . . . 24, 92
Mehta, Inder . . . . . . . . . . . . . . . . . 15, 52
Meng, Xiangzhong . . . . . . . . . . 23, 90
Meyers, Bryan . . . . . . . 20, 36, 62, 180
Miller, Charles . . . . . . . . . . . . . . 27, 112
Miller, Daniel . . 4, 5, 7, 15, 24, 36, 38,
54, 96, 200
Leshnower, Bradley . . 24, 27, 98, 110
Minnich, Douglas . . . . . . . . . . 32, 152
Levasseur, Stephanie . . . . . . 37, 194
Mishra, Dhruva . . . . . . . . . . . . . 23, 82
Li, Chun . . . . . . . . . . . . . . . . . . . . 27, 110
Mishra, Rachana . . . . . . . . . . . . 23, 86
Li, Zhuo . . . . . . . . . . . . . . . . . . . 31, 148
Mitchell, John . . . . . . . . . . . . . 36, 184
Liao, Kenneth . . . . . . . . . . . . . . 37, 188
Mohammad, Farah . . . . . . . . 29, 124
Likosky, Donald . . . . . 28, 31, 116, 144
Molloy, William . . . . . . . . . . . . 35, 170
Linden, Allison . . . . . . . . . . . . . . 15, 46
Monge, Michael . . . . 30, 39, 142, 206
Linsky, Paul . . . . . . . . . . . . . . . . . 23, 80
Mongero, Linda . . . . . . . . . . . . 39, 202
Lippel, Matthew . . . . . . . . . . . 37, 194
Monreal, Gretel . . . . . . . . . . . . . 23, 80
Lipscomb, Joseph . . . . . . . . . 29, 130
Morales, David . . . . . . . . . . . . 30, 140
Litt, Marc . . . . . . . . . . . . 21, 25, 74, 106
Mori, Makoto . . . . . . . . . . . . . . 33, 166
Liu, Yuan . . . . . . . . . . . . . . . . . . . 24, 92
Mullett, Timothy . . . . . . . . . . . 32, 158
Loor, Gabriel . . . . . . . . . 21, 25, 71, 106
Murrah, C. Patrick . . . . . . . . . . . . . . . 35
Low, Donald . . . . . . . . . . . . . . . . 24, 92
Muster, Allan . . . . . . . . . . . . . . . 34, 96
Lucas, Victor . . . . . . . . . . . . . . . . . 15, 52
Myers, John . . . . . . . . . . . . . . . 33, 164
Luketich, James . . . . . . . . . . . 28, 122
Nabagiez, John . . . . . . . . . . . . 35, 170
Luu, Theresa . . . . . . . . . . . . 24, 32, 96
Neely, Robert . . . . . . . . . . . . . . 35, 174
Maas, Amanda . . . . . . . . . . . . . 27, 110
Nelson, Jennifer . . . . . 20, 21, 25, 64,
74, 106
MacGillivray, Thomas . . . . . . . 23, 84
Macke, Ryan . . 21, 25, 32, 74, 106, 154
Magee, Mitchell . . . . . . . . . . . . . . . . . 28
Mahan, Angela . . . . . . . . . . . . 36, 182
Mahidhara, Raja . . . . . . . . . . . 28, 120
Mahle, William . . . . . . 29, 39, 132, 208
Mainwaring, Richard . . . . . . . . 37, 192
Maloney, James . . . . . . . . . . . 32, 154
Mares, Joshua . . . . . . . . . . . . . . 23, 90
Marshall, M. Blair . . . . . . . . . 5, 15, 46
Martin, Jeremiah . . . 32, 36, 158, 182
Marx, Gerald . . . . . . . . . . . . . . . 15, 48
Nguyen, Tom . . . . . . . . . 21, 25, 27, 74,
106, 112
Nickleach, Dana . . . . . . . . . . . 29, 130
Nöbauer, Christian . . . . . . . . . . . 15, 42
Noirhomme, Philippe . . . . . . . 20, 60
Nwogu, Chukwumere . . . . . . 36, 178
O’Brien, Sean . . . . . . . . . . . . . . 25, 104
Odell, David . . . . . . . . . 21, 25, 74, 106
Ohye, Richard . . . . . . . . . . . . . . 20, 64
Onaitis, Mark . . . . . . . . . . . . . . . 25, 102
Ootaki, Yoshio . . . . . . . . . . . . . . 23, 88
Oster, Matthew . . . . . . 32, 33, 160, 166
Roth, Jack . . . . . . . . . . . . . . . . . . 24, 92
Paone, Gaetano . . . . . . 24, 28, 31, 94,
116, 144
Roy, Samit . . . . . . . . . . . . . . . . . 37, 188
Park, Julie . . . . . . . . . . . . . . . . . . . 15, 52
Rubinfeld, Ilan . . . . . . . . . . . . . 29, 124
Park, Soon . . . . . . . . . . . . . . . . . 31, 148
Pasquali, Sara . . . . 20, 24, 25, 30, 64,
100, 104, 140
Patel, Aalok . . . . . . . . . . . . . . . . . 20, 62
Patel, Himanshu . . . . 5, 21, 27, 31, 70,
144, 146
Rubay, Jean . . . . . . . . . . . . . . . . 20, 60
Rusch, Valerie . . . . . . . . . . . . . 25, 102
Ruzmetov, Mark . . . . . . . . . . . . 37, 196
Ryan, William . . . . . . . . . . . . . . . 28, 114
Sachdeva, Ritu . . . . . . . . . . . . . 29, 132
Sade, Robert . . . . . . . . . . . . . . . . . . . . 19
Patel, Parth . . . . . . . . . . . . . . . . . 28, 118
Safi, Hazim . . . . . . . . . . . . . . . . . 27, 112
Patterson, George . . . 20, 36, 62, 180
Sako, Edward . . . . . . . . . . . . . . 35, 172
Paugh, Theron . . . . . . . . . . . . . 31, 144
Salazar, Jorge . . 5, 18, 20, 23, 24, 29,
39, 66, 84, 206
Pennathur, Arjun . . . . . . . . . . . 28, 122
Petersen, John . . . . . . . . . . . . . . 15, 58
Petracek, Michael . . . . . . . . . . . . 21, 76
Pfeiffer, Steffen . . . . . . . . . . . . . . 15, 42
Phillips, Emily . . . . . . . . . . . . . . 36, 186
Piazza, Gregory . . . . . . . . . . . . 35, 174
Pickens, Allan . . . . . . . . . . . . 21, 36, 72
Picone, Anthony . . . . . . . . . . . 36, 178
Pizarro, Christian . . . . . . . . . . . 30, 138
Prager, Richard . . . . 4, 5, 7, 19, 20, 21,
24, 26, 28, 31, 70, 94, 116, 144
Pratt, Clayton . . . . . . . . . . . . . . . 20, 64
Samson, Pamela . . . . . . . . . . . . 20, 62
Sandhu, Harleen . . . . . . . . . . . . 27, 112
Sarin, Eric . . . . . . . . . . . . 24, 27, 98, 110
Sarkaria, Inderpal . . . . . . . . . . 25, 102
Sarwark, Anne . . . . . . 30, 39, 142, 206
Schaff, Hartzell . . . . . 31, 35, 148, 172
Schechter, Matthew . . . . . . . . . 28, 114
Schlosser, Brian . . . . . . . . . . . 29, 132
Schmidt, Benjamin . . . . . . . . . . 23, 88
Schmidt, Henner . . . . . . . . . . . . 24, 92
Schmocker, Ryan . . . . . . . . . . 32, 154
Preventza, Ourania . . . 22, 24, 78, 108
Schreiber, Christian . . . . . . . . . . 15, 42
Price, Matt . . . . . . . . . . . . . . . . . . 22, 78
Schubert, Sarah . . . . . . . . . . . 33, 164
Price, Theolyn . . . . . . . . . . . . . . . . 21, 72
Schumer, Erin . . . . . . . . 23, 39, 80, 204
Pritchard, Graciela . . . . . . . . . 32, 150
Sepesi, Boris . . . . . . . . . . . . . . . 24, 92
Puri, Varun . . . . . . . . . . 20, 36, 62, 180
Shah, Amee . . . . . . . . . . . . . . . 37, 194
Qiu, Jiejing . . . . . . . . . . . . . . . . . . 21, 68
Shah, Ishan . . . . . . . . . . . . . . . . 31, 148
Quader, Mohammed . 21, 35, 168, 76
Shah, Jitendra . . . . . . . . . . . . . . 37, 196
Quaegebeur, Jaan . . . . . . . . . 37, 194
Shahian, David . . . . . . . 6, 24, 25, 26,
94, 104
Raju, Vijayakumar . . . . . . . . . . . 15, 48
Ramalingam, Suresh . . . . . . . 29, 130
Rankin, J. Scott . . . . . . . . . . . . . . 15, 42
Raviendran, Raveen . . . . . . . . 30, 138
Rawn, James . . . . . . . . . . . . . . 35, 174
Reardon, Michael . . 15, 17, 21, 50, 70
Reddy, V. Mohan . . . . . . . . . . . . 37, 192
Reece, Thomas . . . . . . 23, 36, 90, 184
Reidy, Michael . . . . . . . . . . . . . 28, 122
Reis, Victor . . . . . . . . . . . . . . . . 40, 214
Reul, Ross . . . . . . . . . . . . . . . . . . . 15, 56
Rice, David . . . . . . . . . . . . . . . . . 24, 92
Rich, Jeffrey . . . . . . . . . 24, 35, 76, 168
Rizk, Nabil . . . . . . . . . . . 25, 29, 102, 126
Robinson, Joshua . . . . . . . . . . 36, 206
Shariff, Masood . . . . . . . . . . . . 35, 170
Sharma, Sudhish . . . . . . . . . . . 23, 86
Shih, Terry . . . . . . . . . . . . . . . . . . 24, 94
Shinkawa, Takeshi . . . . . . . . . 33, 162
Simpson, David . . . . . . . . . . . . . 23, 86
Singh, Ashima . . . . . . . . . . . . . 35, 172
Slaughter, Mark . . . . . . . 6, 23, 26, 39,
80, 204
Smith, Michael . . . . . . . . . . . . 37, 190
Smith, Peter . . . . . . . . . . . . . . . . . . . . . 34
Sobieski, Michael . . . . . . . . . . . 23, 80
Soltys, Anna . . . . . . . . . . . . . . . 40, 214
Sonett, Joshua . . . . . . . . . . . . 39, 202
Speir, Alan . . . . . . . . 16, 21, 28, 35, 76,
116, 168
Rocco, Gaetano . . . . . . . . . . . . 29, 126
Starnes, Vaughn . . . . 29, 30, 40, 135,
136, 216
Welke, Karl . . . . . . . . . 25, 37, 104, 196
Stein, William . . . . . . . . 21, 74, 25, 106
Wells, Winfield . . . . . .29, 30, 40, 134,
136, 216
Stephens, Elizabeth . 25, 37, 106, 194
Weyant, Michael . . . . . 23, 36, 80, 184
Stewart, James . . . . . . . . . . . . . 27, 110
Whyte, Richard . . . . . . . . . . . . 35, 156
Stone, James . . . . . . . . . . . . . . . 23, 84
Wigfield, Chris . . . . . . . . . . . . . 29, 128
Strickman, Neil . . . . . . . . . . . . . . 15, 56
Wiggins, Luke . . . . . . . . . . . . . 29, 134
Stulak, John . . . . . . . . . . . . . . . . 40, 212
Sundt, Thoralf . . . . . . . . . . . . . . 23, 84
Suri, Rakesh . . . . . . . . . . . . . . . 31, 148
Swisher, Stephen . . . . . . . . . . . 24, 92
Syed, Amjad . . . . . . . . . . . . . . . . 28, 118
Szwerc, Michael . . . . . . . . . . . 40, 214
Takayama, Hiroo . . . . . . . . . . . 39, 202
Tang, Xinyu . . . . . . . . . . . . . . . .33, 162
Williams, Jaelene . . . . . 31, 24, 28, 70,
94, 116
Williams, Marcus . . . . . . . . . . 5, 16, 17
Woo, Y. Joseph . . . . . . . . . . . . 36, 186
Wozniak, Thomas . . . . . . . . . . . . . 5, 17
Wurlitzer, Katherine . . . . . . . . 39, 206
Yang, Haoxian . . . . . . . . . . . . . 29, 126
Taylor, Bradley . . . . . . . . . . . . . 40, 212
Yang, Stephen . . . . . . 5, 15, 17, 21, 39,
40, 74, 210, 214
Taylor, Mary . . . . . . . . . . . . . . . . 20, 66
Yendamuri, Sai . . . . . . . . . . . . 36, 178
Tchantchaleishvili, Vakhtang . . . . 21,
25, 74, 106
Theurer, Patricia . . . . . . . . 70, 94, 116
Thourani, Vinod . . . . . 24, 27, 98, 110
Thrall, Michael . . . . . . . . . . . . . . 23, 82
Tong, Betty . . . . . . . . . . . . . . . . . . 21, 68
Trehan, Kanika . . . . . . . . . . . . . 39, 210
Tribble, Curtis . . . . . 5, 31, 39, 148, 210
Tridandapani, Srini . . . . . . . . . . . 21, 72
Trivedi, Jaimin . . . . . . . . . . . . . 39, 204
Tweddell, James . . . . . . . . . . . . 37, 198
Ungerleider, Ross . . . . . 15, 20, 23, 37,
52, 64, 88, 198
van Berkel, Victor . . . . . . . . . . . 23, 80
Vaporciyan, Ara . . . . . . . . . . 19, 24, 92
Vasquez, Julio . . . . . . . . . . . . . 31, 146
Verhelst, Robert . . . . . . . . . . . . 20, 60
Vigneswaran, Wickii . . . . . . . 29, 128
Vincent, Robert . . . . . . . . . . . . 39, 208
Vlahakes, Gus . . . . . . . . . . . . . . 23, 84
Vricella, Luca . . . . . . . . . . . . . . . . 37, 196
Walia, Rajat . . . . . . . . . . . . . . . . 37, 190
Walker, Jennifer . . . . . . . . . . . . 23, 84
Wallace, Amelia . . . . . . . . . . . 24, 100
Walsh, Garrett . . . . . . . . . . . . . . 24, 92
Wang, Hanghang . . . . . . . . . . . 28, 114
Wang, Thomas . . . . . . . . . . . . 32, 156
Watanabe, Naruhito . . . . . . . . 37, 192
Watson, Thomas . . . . . 21, 24, 68, 92
Wehman, Brody . . . . . . . . . . . . 23, 86
Wei, Benjamin . . . . . . 25, 32, 106, 152
Yerebakan, Halit . . . . . . . . . . . 37, 194
Yilmaz, Betul . . . . . . . . . . . . . . 37, 194
Youssef, Samuel . . . . . 21, 25, 74, 106
Yu, Sunkyung . . . . . . . . . . . . . . 20, 64
Zamora, Martin . . . . . . . . . . . . 36, 184
Zhang, Ruoyu . . . . . . . . . . . . . 29, 128
Zhou, Xun . . . . . . . . . . . . . . . . . 39, 210
Zoeller, Keith . . . . . . . . . . . . . . . 23, 80
Zwischenberger, Joseph . . 5, 17, 36,
39, 182, 202
STSA STAFF
Headquarters Office
633 North Saint Clair St.
Floor 23
Chicago, IL 60611-3658
Phone: 800.685.7872
Fax: 773.289.0871
Web: www.stsa.org
Megan Drumm
Executive Director
Phone: 312.202.5864
Rachel Pebworth
Senior Coordinator
Phone: 312.202.5835
Beth Winer
Senior Manager
Phone: 312.202.5855
SOUTHERN THORACIC SURGICAL ASSOCIATION
633 North Saint Clair St.
Floor 23
Chicago, IL 60611
Phone: 800.685.STSA (7872)
Fax: 773.289.0871
[email protected]
www.stsa.org

TUCSON, ARIZONA

Transcription

Similar documents

Hajoca Corporation

Scanned Document

SPECIALTY GLASS - OBSCURE glaztech.com - Glaz

Cellofoam`s PERMACOOL® Shippers

Skibox - PistenBully

Brotoloc South Brochure

Kelly Order Form

Halloween flyer

The Royal LePage Shelter Foundation

carribbean1 (2)